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Summary 
 
All organisms rely on immune defences in order to protect themselves from a variety 
of pathogens. However, the tools and mechanisms available to accomplish an immune 
response vary among animal life. Depending on the species level of organization, several 
mechanisms can be simultaneously employed. Vertebrates arose approximately 500 Mya, 
being presently divided in jawless (lampreys and hagfish) and jawed vertebrates 
(cartilaginous and bony fish, amphibians, reptiles, birds and mammals). The hallmark of 
this group of organisms is the emergence of a new kind of immune cell - the lymphocyte - 
bearing somatically diversified and clonally expressed antigen receptors, in which each 
lymphocyte is armed with a single receptor. As a consequence, a vast repertoire of Ag 
receptors/immune cells can be generated. Two distinct lineages of lymphocytes are 
present, B and T cells, with functions in humoral (antibodies) and cellular immunity, 
respectively. In the case of jawed vertebrates, the Ag receptors are based on 
immunoglobulin (Ig) domains. B cell receptors (BCRs) exist at the surface of B cells, while 
T cell receptors (TCRs) are present on the plasma membrane of T cells. T cells only 
recognize antigens in the context of major histocompatibility molecules (MHC). These are 
divided in MHC class I (MHC-I) and class II (MHC-II) molecules generally serving to 
present endogenous peptides to CD8+ T cells and exogenous peptides to CD4+ T 
lymphocytes, respectively. Nearly all nucleated cells have class I complexes, while only 
professional antigen presenting cells (APCs) contain the class II ones. Dendritic cells, the 
most important type of APC, are indeed a jawed vertebrate innovation. Besides this 
important function of sampling peptides, reporting the state of a cell, MHC is also crucial 
for the education of T lymphocytes, a process that takes place in the thymus, a novel 
vertebrate-specific immune-related organ.  
MHC class I molecules are formed by the heavy chain (HC), β2-microglobulin and a 
loaded short peptide. Assembly is a tightly regulated process that occurs within the 
endoplasmic reticulum (ER) with assistance of common chaperones and dedicated 
factors. Early oxidative folding of the HC involves calnexin and ERp57. The subsequently 
formed HC/β2m heterodimer is highly unstable in the absence of peptides. Calreticulin 
(CRT), ERp57, protein disulfide isomerase (PDI) and tapasin (TPN) provide further 
stabilization. Peptides originated in the cytosol are translocated into the ER through the 
transporter-associated with antigen processing (TAP). The complex of TAP, TPN, MHC 
class I, ERp57 and CRT is called the peptide loading complex and ensures efficient 
peptide loading onto class I complexes. Once binding a peptide with sufficient affinity, the 
PLC disassembles and trimeric complexes are transported through the golgi to the cell 
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membrane. The contact MHC/peptide-TCR is the first step to build up a T cell immune 
response, which in the case of MHC-I culminates in death of the presenting cell by a 
specific cytotoxic CD8+ T cell. 
Genes of the MHC, which are unique to the genome of jawed vertebrates, are key 
elements of cell-mediated immune responses, greatly impacting the way a host reacts to 
pathogens. In recent years, reports on bony fish MHC genes have been accumulating in 
the literature. Commercial relevance of some fish species used in aquaculture has been 
fuelling research in the field of fish immunology. European sea bass (Dicentrarchus 
labrax, L.) is a widely cultured species in Mediterranean fish farms. For this reason, a 
thorough characterization of its immune system is currently of extreme importance for 
understanding host-pathogen interactions and for vaccine development. These have been 
two major lines of research of the Fish Immunology and Vaccinology Group, where this 
thesis was developed. In this context, the working plan included cloning, sequencing and 
molecularly/structurally characterizing the presentation and processing genes of the class 
I pathway, for which there was no previous knowledge in this species. 
The gene and cDNA of sea bass β2m (Dila-β2m) and several cDNAs of MHC-I HC 
(Dila-UA) were characterized. While Dila-β2m is single-copy, numerous Dila-UA 
transcripts were identified per individual with variability at the peptide-binding domain 
(PBD), and unexpected diversity at the cytoplasmic regions (CYT). Phylogenetic analysis 
places all Dila-UA sequences in the U lineage of teleost fish. The α1 domains resemble 
those of the recently proposed L1 trans-species lineage. Although no Dila-specific α1, α2 
or α3 sub-lineages could be observed, two highly distinct sub-lineages were identified at 
the CP/TM/CYT regions. The three-dimensional homology model of sea bass MHC-I 
complex is consistent with other characterized vertebrate MHC-I structures. Furthermore, 
basal tissue-specific expression profiles were determined for both molecules, and 
expression of β2m was evaluated after poly I:C stimulus. Results suggest these molecules 
are orthologues of other β2m and teleost classical MHC-I. 
TAP1 and TAP2 genes and transcripts were isolated and characterized. Only the 
TAP2 gene is structurally similar to its human ortholog. As other TAP molecules, sea bass 
TAP1 and TAP2 are formed by one N-terminal accessory domain, one core membrane-
spanning domain and one canonical C-terminal nucleotide-binding domain. Homology 
modelling of the sea bass TAP dimer predicts that its quaternary structure is in 
accordance with that of other ABC transporters. Phylogenetic analysis segregates sea 
bass TAP1 and TAP2 into each subfamily cluster, placing them in the fish class.  
The gene and cDNA of the glycoprotein TPN have been isolated and characterized. 
The mature form retains a conserved N-glycosylation site three conserved mammalian 
 xv 
tapasin motifs, two Ig superfamily domains, a transmembrane domain and an ER-
retention di-lysine motif at the C-terminus, suggestive of a function similar to mammalian 
tapasins. A three-dimensional homology model of sea bass tapasin was calculated and is 
consistent with the structural features described for the human molecule.  
CRT (Dila-CRT) gene and cDNA have been isolated and characterized. The mature 
protein retains two conserved motifs, three structural/functional domains (N, P and C), 
three type 1 and 2 motifs repeated in tandem, a conserved pair of cysteines and ER-
retention motif. It is a single-copy gene composed of 9 exons. Dila-CRT three-dimensional 
homology models are consistent with the structural features described for mammalian 
molecules.  
The last chapter reports the isolation and characterization of full cDNA and genomic 
clones from sea bass PDI (Dila-PDI) and ERp57 (Dila-ERp57). As described in other 
species, both molecules are composed of four thioredoxin-like domains (abb’a) followed 
by a C-terminal tail, retaining two CGHC active sites and an ER-signalling sequence, 
suggestive of a conserved function. Additionally, three-dimensional homology models 
further support Dila-PDI and Dila-ERp57 as orthologs of mammalian PDI and ERp57, 
respectively. Finally, high similarity is observed to their vertebrate counterparts (> 69% 
identity), especially among the few ones from closely related teleosts (> 79% identity).  
In conclusion, transcripts and genes of MHC-I HC, β2m, TPN, TAP1, TAP2, CRT, 
ERp57 and PDI were identified following a homology cloning strategy. Collectively this 
work shows evolutionary conservation of the basic structures of these molecules, 
suggestive of similar functions. Furthermore, this work reports important primary data that 
can be used to develop new tools and further study the roles of these elements in sea 
bass immunity, particularly the class I presentation pathway and the establishment of 
CD8+ cytotoxic immunity. 
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Resumo 
 
Todos os organismos necessitam de um sistema imune que os proteja de uma 
variedade de agentes invasores. Contudo, as ferramentas e os mecanismos disponíveis 
para levar a cabo uma resposta imune variam entre os diversos animais. Dependendo do 
nível de organização da espécie, vários mecanismos de defesa poderão ser activados em 
simultâneo. Os vertebrados, que surgiram há aproximadamente 500 Ma, incluem 
actualmente dois grupos: amandibulados (lampreias e peixes-bruxa) e mandibulados 
(peixes cartilagíneos e ósseos, anfíbios, répteis, aves e mamíferos). A particularidade 
destes grupos de organismos é o aparecimento de um novo tipo de célula imune - 
linfócito - que contém receptores de antigénio diversificados de forma somática e 
expressos de forma clonal, de tal maneira que cada linfócito expressa um receptor único. 
Como consequência, pode gerar-se um vasto repertório de receptores de 
antigénio/células imunes. Existem duas linhagens diferentes de linfócitos, B e T, com 
funções na resposta imune humoral (anticorpos) e celular, respectivamente. No caso dos 
vertebrados mandibulados, os receptores de antigénio têm por base domínios de 
imunoglobulina. Os receptores de células B (BCR) existem à superfície dos linfóctos B, 
enquanto os receptores de células T (TCR) estão presentes na superfície da membrana 
plasmática dos linfócitos T. As células T apenas reconhecem antigénios quando estes 
lhes são apresentados no contexto de moléculas do complexo maior de 
histocompatibilidade (MHC). Estas por sua vez estão divididas em MHC classe I (MHC-I) 
e MHC classe II (MHC-II), que respectivamente apresentam, de uma forma geral, 
péptidos endógenos a linfócitos T CD8+ e péptidos exógenos a linfócitos T CD4+. As 
moléculas de MHC-I existem em quase todas as células nucleadas, enquanto as de 
MHC-II estão presentes apenas nas chamadas células apresentadoras de antigénio 
(APC) profissionais. As células dendríticas que constituem o mais importante tipo de 
APCs, são na verdade uma inovação dos vertebrados mandibulados. Além da importante 
função na apresentação de péptidos, informando em que estado se encontra uma célula, 
as moléculas de MHC são também cruciais na educação dos linfócitos T, um processo 
que tem lugar no timo, um órgão linfóide também específico dos vertebrados. 
As moléculas de MHC classe I são formadas por uma cadeia pesada (HC) e uma 
molécula de β2-microglobulina carregando um pequeno péptido. A ‘montagem’ é um 
processo estritamente regulado que ocorre no interior do retículo endoplasmático (ER) 
com intervenção de moléculas comuns e outras específicas. A flexibilização oxidativa 
inicial da HC por forma a atingir a conformação correcta envolve a calnexina e o ERp57. 
O dímero HC/β2m que subsequentemente se forma é altamente instável na ausência de 
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péptidos. As moléculas calreticulina (CRT), ERp57, PDI e tapasina (TPN) proporcionam-
lhe estabilidade. Péptidos formados no citoplasma são transportados para o ER através 
do transportador associado ao processamento de antigénio (TAP). O complexo formado 
pelo TAP, TPN, MHC-I HC, β2m, ERp57 e CRT designa-se complexo de carregamento 
de péptido (PLC), e assegura o eficiente carregamento de péptidos aos complexos MHC-
I. Uma vez ligado a um péptido com afinidade suficiente, o PLC é desagregado, e os 
complexos MHC-I triméricos são transportados através do aparelho de Golgi até à 
membrana celular. O reconhecimento MHC/péptido-TCR constitui o primeiro passo para 
que se desenvolva uma resposta imune com células T, a qual no caso do MHC-I culmina 
na morte da célula apresentadora pela célula T CD8+ citotóxica. 
Os genes do MHC, que existem apenas no genoma dos vertebrados mandibulados, 
são elementos chave da imunidade celular, afectando largamente o resultado de uma 
doença. Recentemente, têm-se acumulado na literatura artigos referentes aos genes do 
MHC dos peixes ósseos. A relevância comercial de algumas espécies de peixes usadas 
em aquacultura tem incentivado a investigação na área da imunologia de peixes. O 
robalo (Dicentrarchus labrax, L.) é uma espécie altamente cultivada em aquaculturas do 
Mediterrâneo. Por esta razão, uma caracterização minuciosa do seu sistema imune é de 
extrema importância para que se compreendam interacções parasita-hospedeiro e para o 
desenvolvimento de vacinas. Estas são na verdade as principais linhas de investigação 
do grupo de Imunologia e Vacinação de Peixes do IBMC, onde o trabalho desta tese foi 
desenvolvido. Neste contexto, o plano de trabalhos incluiu a clonagem, sequenciação e 
caracterização molecular e estrutural dos genes de MHC-I envolvidos na apresentação e 
no processamento de antigénio, acerca dos quais nada se sabia nesta espécie.  
O gene e o cDNA da β2m (Dila-β2m) e vários cDNAs da HC MHC-I (Dila-UA) do 
robalo foram caracterizados. Existe um único gene da Dila-β2m, mas vários transcritos de 
Dila-UA foram identificados por individuo, apresentando variabilidade no domínio de 
ligação ao péptido (PBD), e diversidade inesperada ao nível das regiões citoplasmáticas 
(CYT). A análise filogenética coloca as sequências Dila-UA na linhagem U dos peixes 
teleósteos. Os domínios α1 assemelham-se aos da linhagem trans-específica L1 
recentemente proposta. Apesar de não terem sido identificadas sub-linhagens para os 
domínios α1, α2 e α3, foram encontradas duas sub-linhagens claramente divergentes 
nas regiões CYT. Os modelos tridimensionais de homologia do complexo MHC-I do 
robalo são consistentes com as estruturas de outros vertebrados. Os perfis de expressão 
basal foram determinados para ambas as moléculas em diferentes tecidos e a expressão 
da β2m foi também avaliada após um estímulo com poly I:C. Os resultados sugerem que 
estas moléculas são ortólogas de outras β2m e de MHC-I clássicos de teleósteos. 
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Os genes TAP1 e TAP2 foram isolados e caracterizados. Apenas o TAP2 tem uma 
organização idêntica ao equivalente humano. Tal como outras moléculas TAP, as 
moléculas TAP1 e TAP2 do robalo são formadas por um domínio N-terminal acessório, 
um domínio central que atravessa a membrana e um domínio C-terminal típico de ligação 
a nucleótidos. A modelação por homologia do TAP do robalo prevê que a sua estrutura 
quaternária é concordante com outros transportadores ABC. A análise filogenética separa 
o TAP1 e TAP2 do robalo em cada uma das subfamílias, colocando-os na classe dos 
peixes. 
O gene e o cDNA da TPN foram isolados e caracterizados. Na sua forma matura, 
esta proteína retém um local conservado de N-glicosilação, três motivos típicos de TPNs 
de mamíferos, um domínio transmembranar e um motivo formado por duas lisinas 
responsável pela retenção no ER, sugerindo uma função semelhante às tapasinas de 
mamíferos. O modelo tridimensional da TPN do robalo calculado por homologia é 
consistente com as características estruturais descritas para a molécula humana. 
O gene e o cDNA da CRT (Dila-CRT) foram isolados e caracterizados. A proteína 
contém dois motivos conservados, os três domínios estruturais/funcionais (N, P, C), três 
motivos tipo 1 e 2 repetidos em sequência, um par conservado de cisteínas e um motivo 
de retenção no ER. Os modelos tridimensionais obtidos por homologia são consistentes 
com as características estruturais descritas para as moléculas de mamíferos. 
 O último capítulo descreve a identificação e a caracterização de clones completos 
de cDNA e gene do PDI (Dila-PDI) e ERp57 (Dila-ERp57) do robalo. Tal como descrito 
noutras espécies, ambas as moléculas do robalo são compostas por quatro domínios de 
tioredoxina (abb’a’) seguidos por uma cauda C-terminal, dois locais activos CGHC e uma 
sequência de sinalização do retículo, sugerindo uma função conservada. Os modelos 
tridimensionais determinados por homologia também suportam a ortologia das moléculas 
de robalo com as de mamífero. Finalmente, foi observada uma elevada semelhança com 
os equivalentes noutros vertebrados (> 69% identidade), especialmente os de outros 
peixes ósseos (> 79% identidade). 
Concluindo, os transcritos e os genes das moléculas MHC-I HC, β2m, TPN, TAP1, 
TAP2, CRT, ERp57 e PDI foram obtidos seguindo um estratégia de clonagem por 
homologia. No conjunto, este trabalho mostra a conservação evolutiva das estruturas 
básicas destas moléculas, sugerindo funções similares. Além disso, os resultados 
descritos serão importantes para o desenvolvimento de novas ferramentas e futuros 
estudos que visem determinar o papel destes elementos na imunidade do robalo, em 
particular na via de apresentação de antigénio do MHC-I e no estabelecimento de 
respostas imunes mediadas por células T citotóxicas CD8+. 
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1. Comparative immunology 
 
All organisms must be able to protect themselves from a variety of invading 
pathogens (including viruses, bacteria, fungi and parasites) in order to survive.  
Independently of their nature, pathogens will cause their hosts some level of fitness-
diminishing harm, induce responsiveness, and undertake evasive strategies [1, 2]. The 
need for self-defence in the struggle for survival favoured the evolutionary development of 
simple-to-complex immune systems across the diversity of animal life (Fig 1). Depending 
on the organism, immune systems may comprise molecules, cells, tissues and organs, 
whose coordinated action (immune response) protects hosts from the infectious microbes 
(or even non-infectious foreign macromolecules) [1]. Individual species typically employ 
several mechanisms simultaneously to achieve functional redundancy of such an 
important system [3].  
 
 
 
Figure 1. Simplified phylogeny of animals. Approximate time in millions of years for the emergence of the 
main group of organisms is in parenthesis, and approximate number of species of main taxa are indicated is in 
brackets. Examples of organism(s) of each class are given. Morphological and functional considerations and 
comparative genome analyses have led to the notion that whole genome duplications accompanied the 
evolution of vertebrates [4]. The first genome duplication (1R) is believed to have given rise to the ancestor of 
all vertebrates; the increased genome complexity provided the opportunity for morphological and functional 
diversifications. A second genome duplication (2R) is thought to have led to the emergence of jawed 
vertebrates. A third genome duplication (3R) has occurred in the stem lineage of ray-finned fishes, giving rise 
to a teleost-specific genome organization. Adapted from [5, 6].  
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1.1 Historical view 
Historically, immune functions have been divided into two separate domains, with 
independent functions: innate and adaptive immunity. Innate defences, providing the first 
line of response, relied on programs of enzymatic (e.g. complement system) and cellular 
activation (e.g. macrophages) [3], underlying immune responses such as the recognition 
of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors 
(PRRs) [7] that rapidly induce antimicrobial responses. Adaptive responses, characterized 
by the capacity of memory formation, were attributed to the function of different types of 
lymphocytes [3]. This dichotomy was supported by their sequential appearance in 
evolutionary history, innate responses being already present in invertebrates, and 
adaptive responses being the hallmark of vertebrate immunity [3]. However, recent 
research led to the realization that innate immune systems also incorporate certain 
aspects of immune memory and that innate and adaptive immune functions are intimately 
linked [3]. Many of these insights emerged from comparative analyses in a limited number 
of species [3]. 
 
Figure 2. Overview of novel features of immune responses in distinct animal lineages. Recent findings 
are influencing the understanding of immune function and mechanisms of immune recognition. Four lineages 
are represented Porifera, Cnidaria, Protostomes and Deuterostomes. Relationships are not to time of 
divergence scale. TLR, Toll-like receptor; FREP, fibrinogen-related proteins; AMP, antimicrobial peptide; 
Dscam, Down syndrome cell adhesion protein; VCBPs, variable region-containing chitin-binding proteins; 
NLRs, intracellular NOD-like receptors; LRR, leucine-rich repeat; IgSF, immunoglobulin superfamily; Ab, 
antibodies; TCR, T cell receptor; MHC, major histocompatibility complex. RAG-1 and RAG-2 have been 
identified in sea urchin, but only a gene-like RAG1 has been characterized in amphioxus. Adapted from [1]. 
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FIGURE 1 | An overview of some of the novel features associated
with immune responses of representatives of major animal lineages
(see text for details).TLR, Toll-like receptor; AMP, antimicrobial pep ide;
Dscam, Down syndrome cell adhesion protein; VCBPs, variable
region-containing chitin-binding proteins; NLRs, intracellular NOD-like
receptors; LRR, leucine-rich repeat; IgSF, immunoglobulin superfamily;
Ab, antib dies; TCR, T cell receptor; MHC, major histocompatibility
complex.
and Hoffmann, 2007). Insects are by no means immunologically
bereft though. They have a number of other effective defense com-
ponents not seen in many other organisms. They have elaborate
cascades of CLIP-serine proteases that mediate and coordinate
phagocytosis, nodule formation, encapsulation, and AMP forma-
tion, and they can deposit layers of melanin around foreign objects
(Kanost et al., 2004). They engage multimeric fibrinogen-related
proteins (FREPs) in parasite recognition (Dong and Dimopou-
los, 2009) and employ Down syndrome cell adhesion molecule
(Dscam), a member of the IgSF, in antigen recognition. Tens of
thousands of Dscam isoforms can potentially be generated by
alternative splicing (Schmucker and Chen, 2009) and parasite
challenge-specific Dscam splice form repertoires can be produced
(Dong et al., 2006).
Insect studies provide additional examples of immunological
novelty, at the ordinal, family, or even genus level. One exam-
ple is provided by Drosophila and Anopheles, both in the same
order (Diptera), but representing very different life styles and hav-
ing been separate lineages for 250 million years. Gene families
involved in immunity have evolved rapidly and divergently in the
two dipterans. For example, with respect to thioester containing
proteins (TEPs),Anopheles has 10 genes andDrosophila only four,
with only one orthologous pair between the two. Anopheles has
58 fibrinogen-like immunogenes whereas Drosophila has only 14,
with only two shared orthologous pairs (Dong and Dimopoulos,
2009).
At the family level, a comparison of three different mosquito
genera (Aedes, Anopheles, and Culex, all in the Culicidae) has
revealed prominent genus specific expansion of some immune
gene families (Bartholomay et al., 2010). Comparative studies of
Drosophila species are particularly revealing, showing that novel
immune genes and immune gene families have originated rela-
tively recently, suggestive of a role of parasites in driving adaptive
evolution in flies (Sackton et al., 2007). Furthermore, for par-
ticular immune proteins, the amino acids under positive selec-
tion vary between Drosophila species groups, suggesting different
fly species experience different parasite pressures (Morales-Hojas
et al., 2009). Insects with very different life styles, such as the
social honey bees (Evans et al., 2006) and ants (Smith et al.,
2011), and symbiont-dependent aphids (Pennisi, 2009) likewise
have immune systems that are surprisingly divergent from the
Drosophila immune system.
The other major lineage of protostomes, the Lophotrochozoa,
includes prominent groups such as the flatworms, annelids, and
mollusks. In the polychete annelid Capitella capitata, TLRs have
undergone an expansion to over 100 genes,most of which are sim-
ilar, suggestive of recent duplication. Another annelid, the leech
Helobdella robusta, has only 16 TLR homologs which are not only
highly divergent from one another but also are not orthologous
to any of the polychete sequences (Davidson et al., 2008). In the
freshwater snail Biomphalaria glabrata, FREPs are encoded by an
expanded gene family, and are implicated in defense against gas-
tropod parasites such as digenetic trematodes (Hanington et al.,
2010a,b). In B. glabrata, FREPs are particularly noteworthy for
being comprised of juxtaposed IgSF and fibrinogen domains, and
for the fact they are somatically diversified during the production
of hemocytes by the snails (Zhang et al., 2004). Expanded families
of C-type lectins are present in other mollusks and the bivalve
www.frontiersin.org March 2012 | Volume 3 | Article 25 | 3
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Undoubtedly, humans and mice are intensively studied by immunologists and most 
knowledge about immune defences is coming from research in these models, but 
important discoveries made in non-model organisms greatly influenced the field of 
immunology [8]. E.g. observations of phagocytosis by amebocytes in echinoderms were in 
the origin of the concept of self/non-self recognition [9]; cellular and humoral immune 
functions in T and B lineages of lymphocytes [10] as well as gene conversion as a 
strategy in diversification of immune receptors [11] were firstly found in birds; studies in 
insects identified Toll receptors as mediators of innate immunity [12]; more recently, the 
ability of B cells to act as professional phagocytes came from studies in teleosts [13] and 
led to the discovery of phagocytic B cells in mammals. Clearly the study of other groups of 
organisms from invertebrates to vertebrate ancestors is relevant to our understanding of 
mammalian immunology. 
 
1.2 The current picture 
The emergence of new forms of immunity across animal life is currently a topic of 
great interest [1, 3, 14-16]. Invertebrates, comprising the majority of animal species on 
Earth (Fig. 1), can display simple-to-complex immune systems [1, 17] that are comparable 
to those of vertebrates [18, 19] in terms of the multitude of (i) mechanisms employed, (ii) 
immune-related molecules and (iii) effector cells (Fig. 2) [3]. Recent findings are detailed 
in Table 1. Discoveries go from observation of elements used in vertebrate immune 
recognition and microbial defence in sponges, to the realization that cnidarians have a 
complete set of immune genes in common with humans [1], but also from genome 
reductions in some organisms to expanded innate immune systems in others (Table 1) [1], 
giving the impression that a simplification of innate immunity occurred in mammals [2]. 
Additionally, as mentioned above, invertebrates also seem to exhibit hallmarks previously 
associated to vertebrate adaptive immunity [3]. Namely, several distinct mechanisms for 
generating diverse antigen receptors occur in molluscs (FREPs), arthropods (Dscam), 
echinoderms (Sp185/333) and cephalochordates (VCBPs) [1] (Fig. 2, Table 1). 
Furthermore, humoral and cellular responses seem also relevant in invertebrates [3]. 
Surprising is the observation that invertebrates can have increased and cross-protecting 
resistance to pathogens [20-22] with effects on immune effector cells [23]. This memory in 
invertebrates represents a state of alert [3] and has been referred to as ‘trained immunity’ 
[23], distinguishing it from vertebrate immunological memory based on clonal selection of 
immune cells [24]. In contrast to vertebrates, no antigen-triggered proliferative responses 
have yet been demonstrated [3]. Additionally, innate cell (NK cell) memory has been 
reported in mice [25]. 
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Table 1. Overview of animal immune systems emphasizing distinctive features and diversified defence 
molecules (Adapted from [1]). 
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Table 1 | An overview of animal immune systems emphasizing distinctive immune features and diversified defense molecules.
Phylum Body plan Specialized
defense cells
Genome
reduction
Distinctive
immune features
Diversified
defense molecules
Reference
Porifera (sponges) Diploblastic No No TIR domains, lack external LRR, MyD88
homolog, NF-κB rudiments, lack death
domains, LPS-interacting proteins,
perforin-like molecules, antiviral 2′-5′
oligoadenylate system
Scavenger receptor cysteine-rich
molecules
Wiens et al. (2007), Schroder
et al. (2008)
Cnidaria (anemones,
corals, jellyfish,
Hydra
Diploblastic
with mesoglea
No No BonafideTLR and NF-κB pathway,
complement-3 component, multiple
NACHT domains and NLRs likely,
recognizable RAG1 homolog. Hydra lacks
canonical TLR with both LRR andTIR,
allorecognition molecules present
including with IgSF domains
Diverse C-type lectins Wood-Charlson and Weis
(2009), Miller et al. (2007),
Augustin et al. (2010), Hemm-
rich et al. (2007), Nicotra et al.
(2009)
BILATERIA PROTOSTOMES ECDYSOZOA
Nematoda
(Caenorhabditis and
many others)
Triploblastic No Yes OneTLR that plays a role in defense
against some bacteria, lacks canonical Toll
pathway and NLRs, but can mount
inducible defense responses and have
several novel defense-related signaling
pathways
Produces many caenopores and other
antimicrobial peptides including 42 NLPs
caenacins, diverse C-type lectins
Irazoqui et al. (2010), Roeder
et al. (2010)
Arthropoda (insects,
crustaceans, and
many others
Triploblastic Yes Yes NLR and complement-3 components
lacking, have one or twoTLRs functioning
with NF-κB pathways, TLRs do not engage
ligands directly, produce antimicrobial
peptides, CLIP-protease cascades,
melanization reactions
Multimeric fibrinogen-related molecules,
the IgSF member Dscam with multiple
isoforms
Lemaitre and Hoffmann
(2007), Kanost et al. (2004),
Dong and Dimopoulos (2009),
Schmucker and Chen (2009),
Dong et al. (2006), Brites et al.
(2008), Smith et al. (2011)
LOPHOTROCHOZOA
Annelida
(earthworms,
leeches,
polychaetes)
Triploblastic Yes No Over 100TLR genes, extensive
involvement of coelomocytes from
coelom in defense, cytotoxicity against
allogeneic cells, hemolytic and clotting
factors in body fluid, antimicrobial
peptides, and protective body mucus
Expanded set of TLRs in polychaetes Davidson et al. (2008), Salzet
et al. (2006)
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Mollusca
(cephalopods, snails,
bivalves chitons,
others)
Triploblastic Yes No Involvement of body mucus in protection,TLRs
andToll pathway present, little melanization,
hemocytes working with lectins like galectins
or fibrinogen-containing proteins (FREPs),
mitogen-activated protein kinase pathways,
complement-like factors antimicrobial peptides
Somatic diversification of FREPS by point
mutation and gene conversion, large C-type
lectin families, diversified myticin C in bivalves
Hanington et al. (2010a,b), Bayne
(2009), Zhang et al. (2004),
Yoshino et al. (2008), Costa et al.
(2009), Loker (2010)
DEUTEROSTOMES
Echinodermata
(sea urchins, starfish,
brittle stars, crinoids,
sea cucumbers)
Triploblastic Yes No “Expanded” innate immune system with
>220TLRs, >200 NLRs, >200 SRCR genes,
Toll pathway, lectin and alternative pathways,
RAG1 and RAG2 homologs present
In addition to expanded sets of TLRs, NLRs,
and SRCRs, they also have novel Sp 185/333
gene family producing diverse immune
proteins
Messier-Solek et al. (2010), Hibino
et al. (2006), Ghosh et al. (2010)
CHORDATA
Cephalochordata
(amphioxus)
Triploblastic Yes No “Expanded innate immune system with ∼72
TLRs, >92 NLRs, −270 SRCRs, >1200 C-type
lectins, possesses distinctive variable
region-containing chitin-binding proteins
(VCBPs), have functioning complement, RAG1
and possibly RAG2 present
In addition to expanded sets of TLRs, NLRs,
SRCRs, and lectins, they have polymorphic
VCBPs arising from a variety of mechanisms
Huang et al. (2008), Messier-
Solek et al. (2010), Dishaw et al.
(2008, 2010), Cannon and Litman
(2009)
Urochordata
(tunicates)
Triploblastic Yes Yes V-like and CI-like domains present, VCBPs
present, have threeTLRs, lack complement, or
expansion of any gene family relevant to
vertebrate immunity
Have expanded families of C-type lectins and
fibrinogen-related proteins
Azumi et al. (2003), Cannon et al.
(2004)
Agnathans
(lampreys, hagfish)
Triploblastic Yes No Lack RAG1 and RAG2 and do not produce
TCRs or immunoglobulins, but do have two
basic types of lymphocytes and produce
variable lymphocyte receptors (VLRs) with
LRRs
Produce diverse VLRs through somatic
rearrangement of modules with leucine-rich
repeats
Pancer et al. (2004), Rogozin et al.
(2007)
Gnathostomes (fish,
amphibians reptiles,
birds, mammals)
Triploblastic Yes No Modest numbers of TLRs (10–25) and NLRs
(20–35), three complement pathways, somatic
diversification of both Ig andTCR, involvement
of MHC, memory, heightened secondary
response, affinity maturation in some
Both Ig andTCRs diversified somatically Messier-Solek et al. (2010), Lit-
man et al. (2010)
w
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w
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1.3 Important observations 
According to Litman and Copper [8], some of the most notable discoveries 
recognized on the evolution of immunity include the following: (i) innate immunity 
preceded adaptive immunity in the evolution of immune recognition, providing the 
common basis of immune recognition between invertebrates and vertebrates [26, 27]; (ii) 
invertebrate immune-type receptors may undergo diversification [28, 29], and even 
immunological memory and cross-resistance can be achieved [22]; (iii) polymorphic 
cellular receptors in marine invertebrates may ensure self/non-self recognition of cells 
[30]; (iv) clonally diverse lymphocytes are a vertebrate innovation [8]. 
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2. Vertebrate immune system 
 
Vertebrates are divided in two groups: jawless (Agnatha) and jawed 
(Gnathostomata) vertebrates, comprising roughly 100 species of lampreys and hagfish 
and approximately 62,000 species from cartilaginous fish to mammals [6], respectively. It 
has been suggested that the emergence of vertebrates involved a change in the 
structure/function of the ancestral immune system [14, 15, 18, 19, 31, 32]. Normally, it is 
highlighted that vertebrates added adaptive immunity to innate defences, gaining antigen-
specific memory and more rapid and efficient secondary immune responses [32]. 
However, as a consequence of the recent findings mentioned above, the functional 
distinctions between innate and adaptive immunity are becoming less clear [3]. Despite 
these developments, the vertebrate immune system exhibits unique innovations [3], 
further discussed below.  
 
2.1 Two different systems 
Lymphocyte-based adaptive immunity emerged twice in the early phases of 
vertebrate evolution (convergent evolution) demonstrating clear selective advantages of 
being equipped with such an immune system [32]. Uniquely, both jawless and jawed 
vertebrates have an adaptive immune system based on somatically diversified and 
clonally expressed antigen receptors (Fig. 3) [18]. With somatic diversification (Box 1), a 
wide range of antigen specificities is created, requiring elimination of unwanted self-
reactivity [33]. The fact that each lymphocyte is armed with a single receptor [18] confers 
an advantage regarding the elimination of the repertoire of self-reactive cells and 
generation of immune memory [3]. Despite having common design principles in 
generating a vast repertoire of antigen receptors/cells, the molecular nature of the antigen 
receptors and their mechanisms of assembly are different in the two clades [32]. 
Furthermore, besides the emergence of novel cell types (lymphocytes and also dendritic 
cells) and distinct genetic innovations (VLRs vs Ig/TCR/MHC), novel immune-related 
tissues (thymus and spleen) are also vertebrate-specific [32]. Functional cooperation of 
innate and adaptive arms is fundamental [32], and many of the effectors operating this 
crosstalk already exist in ancient vertebrates [32]. 
Remarkably, all vertebrates possess two major types of lymphocytes, B-like and T-
like cells, mediating humoral and cellular immunity, respectively (Fig. 3) [34]. B cells 
express antigen receptors on their surface and upon antigen encounter can secrete them 
as antibodies. In contrast, the antigen receptors of vertebrate T cells are always cell 
surface-bound, even after antigenic stimulation [32].  
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Figure 3. Specificities of lymphocytes. Both groups of vertebrates possess T- and B-like cells. In jawed 
vertebrates, B and T cells have two sub-lineages each. This seems also true for the T-like cell lineage of 
jawless vertebrates, but is currently unknown if a second B-like cell lineage exists in jawless fish. In jawed 
vertebrates, B cells express immunoglobulins (Igs) and T cells express T cell receptors (TCRs). Distinct sub-
lineages of lymphocytes express structurally different antigen receptors. However, for B cells this is not always 
the case; for instance, all mammalian B cells express the same type of Ig (not shown). In lampreys, there are 
three different types of variable lymphocyte receptors (VLRs): VLRB is expressed by B-like cells, while VLRA 
and VLRC are expressed by separate lineages of T-like cells. All these antigen receptors are subject to 
somatic diversification. For VLRs, this occurs by gene conversion, which is presumably initiated by cytidine 
deaminases (CDAs), and the two known CDA genes (CDA1 and CDA2) are expressed in a lineage-specific 
manner. In jawed vertebrates, somatic diversification of Igs and TCRs occurs by V(D)J recombination, which 
is carried out by the recombination activating gene (RAG) proteins and associated molecules. All vertebrate 
antigen receptors are clonally expressed. Adapted from [3]. 
 
2.1.1 Jawless vertebrates 
Jawless vertebrates rely on leucine-rich repeat (LRR)-containing antigen receptors 
termed variable lymphocyte receptors (VLRs) [19, 35]. Three VLR genes have been 
identified: VLRA, VLRB and VLRC [18]. VLRB antigen receptors are expressed by the B-
like cells of lampreys and can be secreted, similar to antibodies [36]. By contrast, VLRA 
and VLRC antigen receptors [35, 37] are exclusively expressed by two distinct T-like cell 
lineages [37, 38] and are located on the cell membrane, similar to a T-cell receptor (TCR) 
[39]. VLRs are assembled from incomplete genomic elements by a gene conversion 
process [40] (Box 1), with the involvement of cytidine deaminases (CDA) [41]. The two 
known CDAs are expressed in a lineage-specific fashion: CDA1 is involved in VLRA (and 
possibly VLRC) assembly, while CDA2 participates in VLRB assembly [35]. The diversity 
of VLRs is generated by combinatorial use of variable numbers of leucine-rich repeat 
(LRR) elements [19, 42]. 
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Box 1. Somatic diversification 
 
Adapted from [14, 18].  
Changes in the sequence of DNA that occur in individual cells and their progeny. Includes V(D)J 
recombination, gene conversion, somatic hypermutation and class switch recombination. 
 
V(D)J recombination 
Generates highly diverse repertoires of T and B cell receptors (TCR and BCR). Variability is achieved by 
combination of pre-existing multi-copy gene segments called variable (V), diversity (D) and joining (J) 
segments found in the BCR-heavy and TCR-β and -δ chains. D segments are absent in the BCR-light (κ 
and λ) and TCR-α and -λ chains, so only V and J recombination occurs. It involves breakage and repair of 
DNA [14]. The reaction is initiated by the recombination activation gene 1 (RAG1) and RAG2 proteins, that 
bind to conserved recombination signal sequences (RSS) flanking all recombining gene segments in Ig 
and TCR loci [33]. The recombinase introduces double-stranded DNA breaks [14]. Subsequently, terminal 
deoxynucleotidyltransferase (TdT) adds random nucleotides to gene elements (junctional diversity), 
dramatically increasing repertoire diversity [14]. Finally, fusion of segments, i.e. non-homologous end-
joining, takes place with the help of DNA repair proteins. The RSSs are joined without further end 
processing and form excision circles [14]. This recombination process involves a loss of germline-encoded 
nucleotides and addition of non-templated nucleotides [33]. It occurs in all jawed vertebrates [33]  either in 
translocon or cluster configuration. Combinatorial diversity and junctional variability synergize to generate 
receptor specificities [33]. Once functional DNA rearrangements occur, TCR sequences are unaltered; 
however, after encounter with antigen, B cells further recombine the receptor by somatic hypermutation 
and class-switch recombination [14]. 
 
Gene conversion 
This is a process during which heteroduplexes between non-identical stretches of DNA are formed and 
resolved through recombination [33]. It is initiated by DNA double-strand breaks and results in 
nonreciprocal transfer of genetic information [19], i.e. the donor gene(s) remains unmodified and an 
acceptor gene acquires the recombined segment. In chickens, variable (V)-region pseudogenes are 
donors that modify the functional, rearranged V gene [43], and this process generates a diverse repertoire. 
The generation of functional variable lymphocyte receptor (VLR) genes in lampreys also uses a similar 
process. In VLR genes, multiple short stretches of sequences encoding leucine-rich repeats (LRRs) are 
situated next to the single incomplete constant part of the VLR locus [19]. Gene conversion generates one 
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complete gene per allele, similarly to the translocon configuration [18]. This mechanism does not generate 
junctional diversity [33]. 
 
Somatic hypermutation 
Process that starts upon receptor-antigen interaction and targets rearranged V(D)J regions of 
immunoglobulin genes [33]. Its purpose is to provide a clonal population of B cells expressing receptors 
with higher affinity for an antigen. It is initiated by activation-induced cytidine deaminase (AID), which 
deaminates individual cytidines within the V(D)J exon of the Ig gene, leading to uracyl (U):guanidine (G) 
mismatches [14]. Subsequent error-prone repair results in individual point mutations and B cells with 
higher affinity for the original antigen are selected [14].  
 
Class-switch recombination 
This process exchanges the constant region domains of a rearranged Ig gene by a deletional DNA 
rearrangement [33]. Since each constant region mediates a specialized function, switching permits 
adaptive guidance of antibodies, providing alternative effector functions [33]. Creating a new heavy chain 
requires loop-out and deletion of DNA between switch regions, employing transcription of the switch 
regions. Requisite switching factors include AID and components of general DNA repair [33]. AID creates 
U:G mismatches in the highly repetitive switch (S) regions that are upstream of the exons encoding the 
constant regions of different isotypes [14]. Error-prone repair leads to the generation of double-strand DNA 
breaks, excision of the intervening DNA and fusion of the remains of the switch regions [14]. 
 
 
2.1.2 Jawed vertebrates 
The antigen receptors of jawed vertebrates belong to the immunoglobulin (Ig) 
superfamily. Igs serve as the receptors for B cells (BCR), whereas T cells use T-cell 
receptors (TCRs) [6]. Two functionally distinct lineages of T cells exist in jawed 
vertebrates, one expressing an αβ T cell receptor (TCR) and the other expressing a γδ 
TCR [44]. BCRs are composed of two membrane-spanning heavy chains and two 
associated light chains in the case of Igs, and TCRs of two membrane-spanning 
molecules, either α and β or γ and δ [32]. T-cell antigen receptors are further associated 
with cell-type specific CD8 or CD4 co-receptors. Functional antigen receptor genes are 
formed through V(D)J recombination (Box 1) initiated by recombination-activating gene 
(RAG) products; variable (V)-, diversity (D)-, and joining (J)-type segments from germline 
Ig and TCR genes are assembled to form functional antigen receptor genes [32]. In 
addition, non-germline-encoded sequence variability at the junctions (typically encoding 
the antigen-binding surface of the antigen receptors) makes a significant contribution to 
the diversity of functional BCRs and TCRs [32]. Junction diversity is considered an 
important difference between jawless and jawed vertebrates [3]. Cytidine deaminases are 
also used during generation of the primary repertoire of Igs in jawed vertebrates [43] and 
in their diversification during immune responses [45].  
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2.2 Myeloid cells as antigen presenting cells 
Hematopoietic cells originate both the myeloid and lymphoid cells. Immune systems 
initially relied on multi-function innate cells from the myeloid lineage, with phagocytosis of 
pathogens and infected/damaged cells as a major function [32]. Lymphocytes represent 
an innovation of vertebrates [3] and include ‘innate’ (natural killer cells) and ‘adaptive’ 
lymphocytes (T and B cells), with sequential evolutionary appearance. T and B 
lymphocytes, but not NK cells, express somatically assembled antigen receptors, in a ‘one 
receptor/one cell’ fashion [3]. In vertebrates, the myelomonocytic cells (macrophages and 
dendritic cells) also function as antigen-presenting cells [32]. Importantly, they provide 
information to B and T lymphocytes either indirectly, through the production of 
chemokines and other cytokines [46], or directly presenting antigens through cell-to-cell 
contacts (Fig. 4) [47]. DCs are present in early jawed vertebrates [32]: they have been 
identified in teleosts [48-51] and their presence suggested in cartilaginous fish [52, 53]). 
Although not yet described, it is expected that jawless vertebrates also possess antigen-
presenting cells and molecules [18]. The antigen presentation system of jawed 
vertebrates is discussed in section 3. 
 
Figure 4. Developmental origin 
and functional cooperation of 
major immunological cell types. 
The precursors of lymphoid and 
myeloid lineages are believed to 
differentiate from hematopoietic 
stem cells (HSCs) in general 
hematopoietic tissues. The 
common lymphoid progenitor 
(CLP) gives rise to T and B 
lineages. Whereas T cell 
precursors migrate to and 
differentiate in the thymus (thymoid 
in lamprey), B cells mature in 
hematopoietic tissues. The 
common myeloid precursor (CMP) originates different cell types, including antigen-presenting dendritic cells 
(here indicated by M). The reciprocal interactions of lymphocytes and antigen-presenting cells through direct 
cell-cell contacts and/or via interleukins, chemokines and other cytokines regulate immune responses in 
secondary lymphoid tissues. Adapted from [32]. 
 
2.3 Lymphoid organs 
Lymphoid organs are integral parts of vertebrate adaptive immune systems for ~500 
million years (Fig. 5) [6]. Functionally they are divided into two main categories: (i) primary 
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or central and  (ii) secondary or peripheral lymphoid organs [54]. The first are required for 
the development of lymphocytes and of their primary repertoire [54]. The second are 
involved in the coordination of immune responses, enabling interactions between immune 
cells [54]. Lymphoid tissues functionally equivalent to secondary lymphoid organs often 
emerge under inflammatory conditions and are in this case named tertiary lymphoid 
tissues [54]. 
 
 
Figure 5. Evolution of lymphoid tissues in vertebrates. The emergence of vertebrate classes is indicated 
on a time scale of millions of years (Ma). General hematopoietic tissues (ght) in lower vertebrates are 
considered homologous to the bone marrow (bm) in tetrapods. The spleen probably originated in the common 
vertebrate ancestor. The evolutionary emergence of lymph node-like structures began with reptiles (dotted 
line). The phenotype of the extinct common ancestor of all vertebrates is hypothetical. Adapted from [6]. 
 
The sites of B lymphopoiesis vary among species according to the anatomical 
locations of general hematopoietic tissues, and successive stages of B-cell development 
take place in various locations (either within a specific tissue or in different tissues) [6]. For 
instance, in birds, B-cell development starts in the spleen [55], ending in the bursa of 
Fabricius [10], whereas in mammals the spleen appears to be the site where B cells 
complete the maturation process [56] that begins in the bone marrow.  
 T cell progenitors [57, 58] also originate in general hematopoietic tissues, but migrate 
to the thymus [59] for differentiation. Hence, in stark contrast to B cells, T-cell 
development is initiated and terminated in the thymus, which is the most ancient primary 
lymphoid organ and is present in all vertebrates (including lampreys, in the form of 
thymoids [60]) [6]. The thymus is always associated with the pharynx, although its precise 
location and organization varies considerably among vertebrate species [6].  
such structures have been detected in ducks [78]. When
these findings are interpreted in the light of detailed
genotype/phenotype correlations derived fromwell-studied
model organisms, naturally occurring variation among
closely related species can be exploited to test the relation-
ship of form nd function without the need for experim n-
tal modifications. As a second case in point, we note that
the analysis of the cod genome has unexpectedly revealed a
loss of the MHCII pathway. Instead, expansion of the
MHCI gene family has occurred, which was accompanied
by the emergen e of a unique coll ction of Toll-like receptor
genes [83]. In the context of the present discussion, it will
be interesting to determine whether this functional idio-
syncrasy translates into modified structures dedicated to
organizing efficient T–B help (such as the white pulp of the
spleen). Finally, comparative analyses have proven useful
for the identification of the thymus equivalent in lamprey
larvae. Based on a phylogenetic analysis ofFoxn1 orthologs
and paralogs, the pharyngeal endoderm was defined as a
common expression domain of these genes in all chordates
[32]. This information, coupled with the identification of a
distinct T-like lymphocyte lineage and its characteristic
gene expression pattern [4], ultimately guided the identi-
fication of presumptive thymopoietic tissue in lamprey
larvae; a morphologically inconspicuous tissue at the tips
of their gill filaments [21].
Collectively, comparative immunology (amalgamating
anatomical, functional and genomic information) might
become a prime strategy to derive the core components
of the adaptive immune systems of vertebrates.
From evolutionary origins to artificial replacements
It appears that the dual nature of the immune system with
respect to two types of lymphocytes underpinning the
humoral and cellular immune responses was already
established in the last common ancestor of all vertebrates,
indicating that the immune system of primordial verte-
brates was already highly complex. With regard to lym-
phoid tissues, the major components (such as the thymus)
have exhibited remarkable stability over half a billion
years, despit ome morphological variations. Compara-
tive immunological approaches have thus led to a better
appreciation of the underlying design principles of adap-
tive immunity. This information will greatly facilitate the
interpretation of data resulting from the genome sequenc-
ing and RNA expression analyses of those low r vertebrate
species that are not easily amenable to experimental ma-
nipulation. Moreover, this knowledge may also inspire the
development of new strategies for medical interventions
modulating immune responses and restoring essential
immu e facilities. This is exemplified by a rec nt attempt
at the reconstruction of thymopoiesis in a dysfunctional
Foxn1-deficient thymic rudiment; instead of restoring the
expression of the Foxn1 transcription factor to regain
thymopoietic functions, this work focused on the replace-
ment of several downstream effectors of Foxn1 [41], alone
or in combination. Examination of the hematopoietic prop-
erties of Foxn1-deficient epithelium supplied with Ccl25,
Cxcl12, stem cell factor (Scf/kitL), and Dll4 indicated that
only two factors, Cxcl12 and Dll4 (both evolutionarily
conserved in all vertebrates [32]), suffice to promote the
development of CD4/CD8 double-positive immature thy-
mocytes. This finding will encourage the search for addi-
tional factors (such as those regulating sufficient levels of
MHC expression in the Foxn1-deficient epithelium) to
achieve further maturation of thymocytes until the stage
of thymic emigrants. Ultimately, the identification of
a minimum set of factors required for a functional thy-
mopoietic environment might be exploited to generate
ectopic thymopoietic tissue, replacing or supplementing
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Figure 1. Evolutionary trajectory of lymphoid tissues in vertebrates. The emergence of major vertebrate classes is indicated on a time scale of million years (Ma) before
present; c.f. Box 1. General hematopoietic tissues (ght) in lower vertebrates are considered to be homologous to the bone marrow (bm) in tetrapods. The spleen probably
originated in the common vertebrate ancestor; the evolutionary emergence of lymph node-like structures began with reptiles (dotted line). The phenotype of the extinct
common ancestor of all vertebrates is hypothetical.
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 Box 2. Fundamental features of bony fish immune systems.  
 
The immune system of bony or teleost fish includes most of the elements of the innate immune system 
present in mammals: cytokines, lectins, complement system, PRRs (such as Toll-like receptors, TLRs; 
NOD-like receptors, NLRs; RIG-like receptors, RLRs; C-type-lectin receptor, CLRs; antinmicrobial peptides 
(AMPs), macrophages, neutrophils, NK cells [61, 62]. Several of these innate immune components, such 
as lectins, complement and natural killer cell receptors have a more diverse repertoire in teleosts than in 
mammals [63-65]. Importantly, they are among the earliest organisms with a lymphocyte-based adaptive 
immune system relying on rearranging immunoglobulin (Ig) segments through RAG gene products. Hence, 
they have Igs (B cell receptors/antibodies), T cell antigen receptors (TCR), MHC class I and II molecules, T 
and B cells, spleen and thymus [31]. Besides the similarities between teleost and mammalian immune 
systems, but specificities have also been reported. For instance, they have dendritic cells, the most 
specialized antigen-presenting cells, but lack lymph nodes and bone marrow, which are very important 
lymphoid tissues [66]. Nevertheless, they do have a functional ortholog of mammalian bone marrow, the 
head kidney, which represents the main teleost hematopoietic lymphoid tissue [66]. Teleosts also lack 
germinal centers and antibody class-switch recombination, despite expressing the activation-induced 
cytidine deaminase (AID). The mucosa-associated lymphoid tissue, that plays a crucial role in the 
maintenance of mucosal homeostasis, is found within the skin, gill and gut [67].  Only three 
immunoglobulin classes have been identified in teleosts: immunoglobulin M (IgM), IgD and IgT (or IgZ in 
some species) [68-70]. Representatives of the four mammalian TCR chains (α, β, γ and δ) have been 
described in teleosts [71].  
Adapted from [72].  
 
Notably, vertebrate evolution is characterized by an increasing complexity of 
secondary lymphoid tissues, suggested from the growing complexity of the spleen and 
from the emergence of novel structures, such as lymph nodes in more recent groups of 
organisms [32]. 
In bony fish, immune-related tissues include the mucous skin, gills, gut-associated 
lymphoid tissue, the mentioned thymus and spleen, and also the head-kidney [73]. Other 
important features of the teleost immune system are summarized in Box 2. 
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 plasmacytoid dendritic cells) have also been shown to ingest microbes, 
albeit with a greatly restricted capacity15–17. It was initially believed 
that primary B cells from vertebrates were incapable of phagocytosis. 
However, that paradigm was broken by the finding that the primary 
IgM+ B cells of teleosts have potent phagocy ic ability and are able 
to engulf and kill microbes18. All tele st species analyzed thus far 
have phagocytic B cells, which suggests that this is a general feature 
of teleost B cells18,19. Those findings have also been extended to the 
amphibian Xenopus laevis, in which a large proportion of blood IgM+ 
B cells are able to engulf large particles18. Moreover, small numbers 
of blood phagocytic IgM+ B cells have been found in a reptile: the 
red-ear  slider tu tle20.
T e di covery of phagocytic B c lls in fish nd their ev luti nary 
preservation in amphibians and reptiles led to the investigation of 
whether such phagocytic ability is conserved in subsets of mammalian 
B cells. That does indeed seem to be the case because the peritoneal 
cavity of mice has a large proportion of phagocytic B cells (~10–17%), 
although they can also be found in other lymphoid sites but at a lower 
frequency (~1.6%)21. Most of the phagocytic B cells in the perito-
neal cavity are B 1 cells, with relatively very few phagocytic B-2 cells. 
Phagocytosis occurs in a manner independent of the B cell antigen 
receptor (BCR), which leaves the nature of the phagocytic receptors 
unknown21. Both phagocytic B-1 cell subsets (B-1a and B-1b) are able 
to mature their phagosomes into phagolysosomes and are able to kill 
internalized bacteria. In addition to taking up large particles, B-1a 
and B-1b cells in the peritoneal cavity are able to efficiently present 
antigen from internalized particles to CD4+ T cells. Similar to what 
has been found for dendritic cells and macrophages, the ability of 
both B-1 subsets in the peritoneal cavity to present particulate anti-
gen is vastly superior to their ability to present the same amount of 
soluble antigen21. Although macrophages in the peritoneal cavity are 
the leukocytes with the greatest phagocytic ability in mice, they are 
considerably less potent antigen-presenting cells than are B-1 cells in 
the peritoneal cavity, whereas dendritic cells in the bone marrow are 
the most efficient. Whether phagocytic B cells can also cross-present 
to CD8+ T cells remains to be investigated.
Most of the aforementioned findings about phagocytic B-1 cells in 
the peritoneal cavity21 have been confirmed by an additional study22, 
although that second study did not compare the phagocytic, bacte-
ricidal and antigen-presenting abilities of B-1 cells in the peritoneal 
cavity with those of macrophages and bone marrow dendritic cells. 
A further study has reported the existence of phagocytic B cells in 
the liver and spleen of mice23, although this work did not address the 
presence of such cells in the peritoneal cavity. In agreement with the 
findings about the mouse peritoneal cavity21, most phagocytic B cells 
in liver and spleen belong to the B-1 subset. However, the observed 
centage of phagocytic B-2 cells in liver and spleen23 is greater than 
that reported for B-2 cells in the peritoneal cavity and spleen21,22. The 
reasons for the differences noted for phagocytic B-2 cells in those 
three studies21–23 remain unknown. Whether phagocytic B cells in 
mouse liver and spleen can act as antigen-presenting cells remains to 
be investigated, although phagocytic B cells in the liver, but not those 
in the spleen, have been shown to secrete interleukin 12 (IL-12)23.
From an evolutionary perspective, the innate traits of B-1 cells 
that have b en identifi d (such as their phagocytic and microbicidal 
ability) might suggest that the most ancient B cell lineage had many B-1 
cell–like features shared by fish B cells and B-1 cells. Accordingly, B-1 cells 
would have subsequently evolved from that primordial fish B-1 cell–
like lineage. That hypothesis would fit well with the concept of an 
evolutionarily layered immune system24 in which B-1 cells would 
constitute the evolutio arily oldest layer and would thus have more 
innate features than B-2 cells have. Because of the more specialized 
role of B-2 cells in adaptive immunity, B-2 cells would have emerged 
later and would thus represent the most evolved layer of all B cell 
subsets. Alternatively, it is possible that other B cell lineages exist in 
Table 1 Fundamental features of adaptive immune systems of 
teleost fish and mammals
Teleosts Mammals
Immunoglobulin IgM, IgD and IgT  
(or IgZ)
IgM, IgG, IgA, IgD 
and IgE
AID Yes Yes
Class-switch recombination No Yes
Somatic hypermutation +++ +++
Affinity maturation + +++
Memory responses + +++
TCR, CD4, CD8 Yes Yes
MHC class I and II Yes Yes
CD28, CD40, CD80, CD86, ICOS Yes Yes
TH1, TH2 and TH17 cytokines Yes Yes
Spleen, thymus and bone marrow Spleen and thymus but 
no true bone marrow
Yes
Mucosa-associated lymphoid tissue Yes Yes
Germinal centers and lymph nodes No Yes
Comparison of key elements of immunoglobulin-based adaptive immune systems of 
teleost fish and mammals. MHC, major histocompatibility complex; ICOS, inducible 
costimulator; TH1, TH2 and TH17, subsets of helper T cells.
Box 1 Teleost immunoglobulins 
IgM: Teleost IgM is a tetrameric molecule and is by far the most prevalent immunoglobulin in plasma59,60. Gut and skin mucus are reported to have very low  
concentrations of IgM61–63. IgM tetramers in teleosts are formed in the apparent absence of intermolecular interactions mediated by immunoglobulin joining 
chains. Moreover, these tetramers are in various oxidation states that seem to influence their effector functions64. All teleost B cells that express surface IgM 
also express surface IgD. Teleost IgM is secreted mainly by plasmablasts and plasma-like cells that are located mostly in the head kidney and are key to eliciting 
memory IgM responses65. After booster immunization, teleost fish undergo a substantial increase in IgM titers59,60, a process that is temperature dependent. 
However, teleosts show a moderate increase in IgM affinity60,66 relative to the maturation responses of very high affinity noted for IgG.
IgD: The organization of the gene encoding IgD in teleosts is very variable, a fact reflected in the variety of secreted IgD isoforms with different molecular masses 
that seem to be present as monomers in serum67. Although the role of teleost IgD remains obscure, it has been postulated that catfish IgD functions as a PRR, 
as secretory IgD lacks a variable region67. However, secretory IgD in trout does contain a variable region and thus could potentially be involved in the adaptive 
recognition of antigens68.
IgT: Teleost IgT is specialized in gut mucosal immunity49. IgT is present in serum as monomers, whereas in the gut mucus it forms mainly multimers similar in 
mass to those of IgM. However, IgT multimers are associated in a noncovalent manner. An additional lineage of teleost B cells that uniquely express surface IgT 
has been identified in rainbow trout and has been found to represent the main B cell subset in the gut49. Mucosal IgT and IgM in trout associate with a polymeric 
immunoglobulin receptor for their transport into the gut lumen49. Consistent with the prevalent roles of IgT in gut immunity, most bacteria in the gut lumen 
of rainbow trout are coated with IgT, and IgT responses to gut parasites are measurable only in the gut, whereas IgM responses are detected only in serum49. 
Although it is suspected that IgT has a key role in other mucosal areas (such as the skin and gills), this remains to be investigated.
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3. The jawed vertebrate antigen presentation system 
 
3.1 Functions 
In jawed vertebrates (cartilaginous and bony fish, amphibians, reptiles, birds and 
mammals), antigen presentation occurs through two pathways, ending with the formation 
of MHC-peptide complexes at the cell surface [74]. Peptides derived from intracellular 
degradation processes are loaded and the complexes delivered to the cell surface [75].  
Providing processed antigen structures to T lymphocytes is the first step to initiate 
antigen-specific immune responses, since TCRs only recognize antigens in complex with 
MHC molecules [33]. On the other hand, the wide range of TCR antigen specificities 
created with somatic diversification requires a dedicated quality control system to 
eliminate self-reactivity [33]. Hence, as pivotal elements of this quality control system, 
MHC complexes are necessary for T-cell development in the thymus and for immune 
surveillance in the periphery [57]. Developing T cells are first subjected to positive 
selection to ensure that the TCR can interact with self-MHC molecules and in a 
subsequent negative-selection step, TCRs with high affinity for self are eliminated [33]. It 
has been hypothesized that such a quality control system was not created de novo but 
instead co-opted an ancestral recognition system discriminating between self and non-
self, with expected function in sexual selection [33, 76]. Indeed, MHC-associated behavior 
in animals indicating that MHC peptide ligands act as olfactory cues, has been described 
in different species attesting involvement of MHC in sexual selection functions [76-80].  
Of note, the chromosomal MHC region is unique to the genomes of jawed 
vertebrates. Hence, if a functionally equivalent antigen presentation system exists in 
lamprey and hagfish, as it is anticipated to, its molecular components must be different 
from the MHC system [32].  
 
3.2 History and genetics 
MHC research started in the beginning of the 20th century, when Little and Tyzzer 
[81] analysed the fate of tumours transplanted between mice. However, it was only in the 
late 1930’s that Gorer identified the genetic factors influencing transplant outcome in mice 
[82]. George Snell further characterized these genetic factors in transplantation studies 
using congenic mouse strains (in two congenic strains, the mice are identical at all loci 
except the one at which they are selected to be different). In 1948 he proposed to call the 
genes responsible for causing a grafted tissue to be perceived as similar or different from 
one's own tissues, ‘histocompatibility (H) genes’, as they determine tissue compatibility 
between individuals [83]. The genetic region controlling graft rejection and containing 
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several linked genes was called major histocompatibility complex, or MHC. 
Due to whole genome duplication events, the MHC occurs in four paralogous 
regions in the typical vertebrate genome, yet antigen presentation genes occur in only one 
paralogous segment [84]. Characteristically, the genes responsible for antigen 
presentation are: (i) polygenic - exist as multiple loci; (ii) polymorphic - multiple variable 
alleles are present within a population; and (iii) co-dominantly expressed - for each locus, 
alleles inherited from both progenitors are expressed. 
 
3.3 Genomic organization 
In humans, MHC or HLA (human leukocyte antigen) genes are closely linked in a 
region of approximately 4 megabases (without extended regions), located on 
chromosome 6 [85]. This is a gene-rich region including over 260 genes, 40% of which 
are associated with immune functions [86]. The MHC region is further divided into regions 
with similar functions, and includes (in order of physical location from centromere to 
telomere): extended class II, class II, class III, class I, and extended class I regions (Fig. 
6) [87]. The number of genes and the presence of each region varies between species 
[87].  
 
 
Figure 6. Human MHC region. Genes in human MHC are arranged from the centromere (cen) to telomere 
(map not drawn to scale). Human antigen processing genes such as immunoproteasome (LMP) and 
transporter (TAP) and LMP genes are located in class II region and TPN in extended class II region. The size 
of the extended MHC depicted here is approximately 8 megabases. From [84]. 
 
The class I region is composed of classical (Ia) and non-classical (Ib) genes. 
Classical class I molecules are expressed on nearly all nucleated cells and form 
heterotrimers consisting of one α or heavy chain (HC) and β2-microglobulin (β2m) 
coupled with a peptide. Of note, the β2m gene is located outside the MHC region in all 
jawed vertebrates except sharks [88], probably indicative of primitive sinteny. Typically, 
class Ia molecules present peptide antigens to CD8+ T lymphocytes, while the functions 
and expression profiles of the non-classical genes are diverse [87]. Members of both 
categories may also be monitored by natural killer cells, acting as ligands for their innate 
receptors [89, 90]. Class II molecules have their expression restricted to fewer cell types 
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that belong to the myeloid/lymphoid lineages, namely macrophages/monocytes, dendritic 
cells and B cells, and also form heterotrimers of one α chain, one β chain and the loaded 
peptide. These complexes present peptide antigens to CD4+ T lymphocytes. The class III 
region contains a highly dense selection of diverse immune (TNF family members, 
complement, etc.) and non-immune genes [87].  
In teleosts, the genomic organization of MHC genes is different and variable 
patterns are found at the species level [84]. Uniquely, their class Ia and II genes are found 
in different linkage groups on different chromosomes [84]. For this reason, Stet proposed 
to call them simply MH genes instead [91]. In addition, as opposed to human, the antigen 
processing genes LMP (proteasome), TAP (transporter) and TPN (tapasin) are closely 
linked to class Ia genes, comprising a true class I region [84]. This holds also true for all 
non-mammalian vertebrates studied to date [84], such as chicken [92], amphibians [93] 
and cartilaginous fish [94]. The fact that Chondrichthyes possess linkage of some MHC 
class I, II and III genes [94], suggests that the common ancestor of all jawed vertebrates 
should possess an organized MHC. Finally, some non-immune genes found in the human 
class III region and in the extended class II region are also linked to class I in teleosts; but 
none of the class III immune genes is linked to the class I or class II [84].  
 
3.4 Diversity of MHC genes 
The number of class Ia loci varies between organisms. Most mammals possess and 
express two or more class Ia loci. In humans, the class I heavy chains are encoded by 
three genes (HLA-A, HLA-B and HLA-C in humans) [74]. HLA-A and HLA-B display higher 
expression levels than HLA-C [95]. The chicken MHC (or B locus), having only 19 genes 
dispersed over a 92 kb region after loss of non-essential elements, is characterized as the 
minimal essential MHC [92], still object of recombination [96]. Chicken have only two class 
Ia genes but only one is highly expressed at the cell surface [84]. There is also a single 
polymorphic class II β chain expressed while class II α is monomorphic [84]. Similar to 
chicken, Xenopus has one highly expressed class Ia molecule and two or three class II α 
and β [84]. Within teleosts, given the high number of species and the divergence time 
separating them, the scenario is quite variable. For instance, salmonids such as rainbow 
trout and Atlantic salmon, display also a single expressed class I α chain [97-99], but 
Atlantic cod has many (up to 43 loci) class I molecules [100]. Surprisingly, it has been 
found that Atlantic cod has lost the complete set of MHC class II genes [101]. Intermediate 
situations have also been described including e.g. two class Ia genes in medaka [102] or 
twelve in stickleback [103]. 
In contrast to human, chicken TAP and TPN genes have high allelic polymorphism 
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[104], while in Xenopus at least two allelic lineages of TAP have been described [105]. 
All teleost MHC class I (Ia and Ib) loci described to date have been classified into 
four different lineages: U, Z, L, and S [106-108]. The U lineage is present in all teleosts 
and includes both class Ia (highly polymorphic) and Ib (non-polymorphic) loci. The single 
expressed highly polymorphic locus of salmonids, as well as most of the teleost class I 
published sequences belong to the U lineage.  The Z lineage is present in fewer but still 
numerous teleosts and includes genes with features typical of Ia genes, (such as 
ubiquitous expression and almost complete conservation of anchor residues) [107]. The L 
lineage, found only in cyprinids and salmonids, includes non-classical but extensively 
diversified and divergent genes [107]. Finally, the S lineage was described only in 
salmonids and catfish [107]. 
Notably, differences in genomic patterns observed between teleost species, include: 
conservative number of class I genes (limited diversity) in some teleosts, but higher 
number in others; conservative number of class II loci, with reported absence in one 
species; presence of different lineages of class I genes; different relative evolution rates 
between class I and class II regions (fragmented MHC allows class I and class II genes to 
evolve independently, under different selection pressures). 
The different numbers of genes and varying organizations of MHC gene clusters 
can be explained by rapid evolution [87]. After divergence from the common ancestor, the 
MHC changes rapidly through repeated gene duplication (birth and death model [109, 
110]) and polymorphism (point mutations - substitutions, insertions, deletions; and 
translocations - exon shuffling, gene conversion, unequal cross-over [111]), showing 
variation even among closely related species of the same lineage [87, 112]. On the other 
hand, standing genetic variation allows faster evolutionary changes (e.g. allele frequency 
shifts), as was recently demonstrated in two stickleback groups under the effect of distinct 
parasites [113]. Different pathogen pressures (pathogen-driven selection) [114], specific to 
each species, could drive rapid diversification through selection of resistant alleles [113] 
either by overdominance  (heterozygous advantage) or negative frequency (rare allele 
advantage)  [114]. MHC-based mate choice (sexual selection) also helps explain standing 
variation, although it is still unclear whether individuals aim at reducing inbreeding, select 
for specific MHC alleles, ensure offspring are heterozygous at locus or maximize diversity 
across several loci [114]. Another model explains variation not directly under selection, 
proposing that recessive disease-causing mutations can accumulate in the MHC and 
natural selection fails to purge them because they are only rarely expressed in a 
homozygous state (given the high number of alleles and gene diversity) [115]. 
Controversies and difficulties in evaluating their interacting roles apart, these mechanisms 
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are not mutually exclusive and can all contribute to the maintenance of high levels of MHC 
polymorphism [116]. 
 
3.5. Molecular structure of MHC 
As previously mentioned, classical MHC-I molecules are involved in the formation of 
trimeric complexes consisting of a HC non-covalently associated to soluble β2m and a 
loaded peptide [117]. The HC consists of three extracellular domains (α1, α2, and α3), a 
membrane-anchored region and a cytoplasmic tail. The polymorphic residues of class I 
molecules are confined to α1 and α2 domains, which form a peptide-binding groove called 
the peptide-binding region (PBR). This consists of two anti-parallel α-helices forming the 
walls and a platform of eight anti-parallel β-strands (Fig. 7). The ends of the class I 
peptide-binding groove are closed, limiting the maximum length of class I-binding peptides 
to 8-11 amino acids. The membrane-proximal α3 domain and β2m are both homologues 
with the Ig C1 domains. CD8 co-receptor (on αβ T cells) interacts with a conserved region 
of the α3 domain of HC.  
 
 
Figure 7. MHC-I structure. (A) MHC-I αβ heterodimer chains (Dila-UA/Dila-β2m predicted model), with α1, 
α2 and α3 regions and β2m-subunit indicated. (B) Top view of MHC-I heterodimer showing the peptide-
binding region. Disulfide bonds as spheres. Side-chains of anchor residues close the ends of the groove, 
limiting the size of peptides that can bind. Transmembrane and cytoplasmic regions are not shown.  
 
Also as referred above, MHC-II molecules form trimeric complexes that consist of 
non-covalently associated α and β chains and a loaded peptide. Each chain contains two 
extracellular domains (α1 and α2 or β1 and β2, respectively) (Fig. 8), a transmembrane 
and a cytoplasmic region [117]. Most of the polymorphism is found within the β1 domain of 
the β chain. The membrane-proximal α2 and β2 domains, both homologous with the Ig C1 
domain, show very low polymorphism. The CD4 co-receptor (on αβ T cells) interacts with 
conserved region of β2 domain of class II. The membrane distal α1 and β1 domains 
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together constitute the platform of β-strands that supports two anti-parallel α-helices and 
form a peptide binding groove similar to that of MHC class I molecules  (Fig. 8). However, 
the ends of the peptide-binding groove are open, allowing longer peptides of 12-25 or 
more amino acids to bind. 
 
 
Figure 8. MHC-II structure. (A) MHC-II α chains (Dila-DAA/HLA-DRA1, green/white), with α1 and α2 regions 
indicated. (B) MHC-II β chains (Dila-DAB/HLADRB1, yellow/orange), with β1 and β2 domains denoted. (C) 
MHCII αβ-heterodimer viewed from top (peptide-binding region). Disulfide bonds are shown as space-filling 
model. Transmembrane and cytoplasmic regions are not shown. Adapted from [118]. 
 
3.6 MHC intracellular pathways 
Peptide presentation is based on a complex system, involving protein degradation 
machinery, peptide transporters, chaperones for peptide loading and the MHC molecules 
themselves [75]. As mentioned above, there are two different antigen-processing 
pathways that serve to present peptides to TCRs on T lymphocytes. These pathways, and 
the machinery required for them, have distinct roles in the immune system, and function to 
sample different environments for antigenic peptides [119].  
MHC-I molecules are loaded in the endoplasmic reticulum (ER) with peptides 
derived from degradation of cytosolic proteins by nuclear and cytosolic proteasomes, and 
these MHC-I/peptide complexes are then surface expressed displaying their antigenic 
cargo to cytotoxic to CD8+ T cells (Fig. 9), which can thereby efficiently recognize and 
eliminate infected or malignantly transformed cells. ER chaperone proteins such as 
calreticulin, ERp57, protein disulfide isomerase (PDI) and tapasin stabilize empty 
heterodimers. Tapasin interacts with TAP, coupling peptide translocation with delivery to 
class I molecules. Upon peptide binding, the chaperones are released and assembled 
MHC/peptide complexes leave the ER for presentation at the cell surface [74]. Peptides 
and class I molecules that fail to associate in the ER are returned to the cytosol for 
degradation [120].  
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Figure 9. MHC-I antigen presentation pathway. The 
presentation of intracellular antigenic peptides by MHC-I 
molecules is a multi-step process. First, antigens are 
degraded by the proteasome. Then, the resulting 
peptides are translocated via transporter associated with 
antigen presentation (TAP) into the ER and loaded onto 
MHC-I molecules. MHC-I/peptide complexes are 
released from the ER and transported via the Golgi to 
the plasma membrane for antigen presentation to CD8+ 
T cells. ERAD, ER-associated protein degradation. 
Adapted from [74]. 
 
 
 
 
 
MHC-II molecules exit the ER in association with the invariant chain occupying their 
peptide-binding groove. In the endocytic pathway proteolysis results in degradation of the 
invariant chain leaving a residual fragment (CLIP) in the binding groove [74]. With the help 
of HLA-DM CLIP is replaced by peptides resulting from the proteolysis of proteins resident 
or internalized into the endocytic pathway [74]. At the surface they are monitored by CD4+ 
T cells (Fig. 10).  
Hence, MHC-I generally serves as a reporter of intracellular infection, while MHC-II 
senses the antigens present in the extracellular environment. Nevertheless, different 
mechanisms of cross-presentation of exogenous peptides by class I molecules [119] have 
been described, involving various cell types: endothelial [121] and other non-professional 
antigen presenting cells [122], and APCs, the most important being dendritic cells [123], 
potent activators of T cells. The different proposed routes of MHC I cross-presentation can 
be proteasome/TAP-dependent (cytosolic cross-presentation pathway) [124] or -
independent (vacuolar cross-presentation pathway), requiring vacuolar cathepsins [125]. 
On the other hand, endogenous proteins can also be cross-presented by MHC class II 
molecules when these proteins are degraded through autophagy or other pathways [126].  
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Figure 10. MHC-II antigen presentation 
pathway. MHC-II α- and β-chains assemble in 
the endoplasmic reticulum (ER) and form a 
complex with the invariant chain (Ii). The MHC-
II/Ii heterotrimer is transported through the Golgi 
to the MHC class II compartment (MIIC), either 
directly and/or via the plasma membrane. 
Endocytosed proteins and Ii are degraded in the 
MIIC by resident proteases. The class 
II-associated Ii peptide (CLIP) fragment of Ii 
remains in the peptide-binding groove of the 
MHC-II dimer and is exchanged for an antigenic 
peptide with the help of the dedicated chaperone 
HLA-DM (known as H2-M in mice). MHC-II 
molecules are then transported to the plasma 
membrane to present antigenic peptides to 
CD4+ T cells. Adapted from [74]. 
 
3.7 Assembly of MHC-I molecules 
Proper assembly of MHC-I/peptide complexes is required for their stable surface 
expression [127]. This process occurs in the ER and uses both conventional chaperones 
and dedicated factors. It is initiated in the cytosol by proteasomal degradation of proteins,  
originating small peptides [128]. The MHC-I peptidome includes DRiPs (defective 
ribosomal products), which are derived from non-functional proteins, and peptide 
fragments generated by ligation (non-encoded in the genome) [74]. The 26S proteasome 
generates peptides with defined C-termini, but extended at their N-termini. Two other 
proteasomes have been described: the immunoproteasome, expressed by immune cells; 
and the thymus-specific proteasome, expressed in thymic epithelial cells (TECs) [74], both 
altering the degradation pattern of the 26S proteasome [129, 130]. Immunoproteasomes 
are more active than 26S proteasomes under conditions of immune stress or IFNγ 
exposure [74]. Once generated, peptides of 8-16 residues are translocated by TAP into 
the ER, with ATP consumption [131]. ER aminopeptidases associated with antigen 
presentation (ERAAP/ERAP1 and ERAP2), can further trim the peptides within the ER. 
TAP also acts as a platform for folding MHC-I molecules by binding to one or more 
molecules of tapasin (the dedicated class I chaperone) [132]. In the ER, class I molecules 
are partially folded and stabilized by additional common chaperones: calnexin, calreticulin, 
ERp57, and peptide-binding chaperone PDI [133]. Together, calnexin and ERp57 catalyze 
MHC-I HC oxidative folding during early assembly events [134]. Subsequently, HC/β2m 
association occurs needing further stabilization. Calreticulin binds N-glycosylated MHC-I 
molecules, stabilizing the MHC-I HC/TPN interaction [135]. The complex of TAP, TPN, 
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MHC-I, ERp57 and CRT is called the peptide loading complex (PLC) (Fig. 11). The PLC 
ensures efficient peptide loading onto MHC-I molecules. PLC-associated PDI has been 
inconsistently found [134], Nevertheless, a role as a peptide carrier, protecting peptides 
from degradation and delivering them to the MHC in the PLC [136] and another 
maintaining HC oxidized state (re-oxidation of α2) [137] have been described. After 
binding to a peptide with sufficient affinity, the class I complex is released from the PLC 
and goes to the cell surface. Tapasin may also act as a peptide editor, resulting in loading 
of a more diverse array of peptides [138].  PDI has been further involved in PLC 
disassembly [139]. 
 
Figure 11. The PLC components and defined 
intermolecular interactions. (i) Tapasin (red) acts as a 
bridge between TAP (yellow) and the remaining PLC 
components. This interaction is important for stabilizing TAP 
[140] and the entire PLC assembly [141], and involves the 
TPN transmembrane (TM) domain and the N-terminal TM 
domains of TAP1 and TAP2 [141-143]. (ii) ERp57 (green) is 
covalently associated to TPN. This involves a disulfide bond 
between C95 of tapasin and C57 of ERp57, which is an active 
site cysteine [144]. Despite ERp57 typically forming transient 
mixed disulfides with its substrates, the conjugate is not a 
folding intermediate [145]. All TPN in the PLC is stably 
disulfide-linked to ERp57 [145, 146]. (iii) The tip of the CRT 
(blue) P-domain binds to residues in the b’ domain of ERp57 
[147]. (iv) CRT binds to a monoglucosyslated N-linked glycan at N86 of the class I HC (brown) [148]. The 
glycan is sufficient to mediate HC binding [148] but the existence of additional polypeptide-based CRT 
interactions has been suggested [149]. (v) The interaction between the MHC-I HC and TPN includes: ER 
luminal domains of TPN interaction with two solvent-exposed regions in the ER luminal domains of HCs. One 
region comprises the α3 domain (residues 222–227/229), which is also the binding site for the CD8 co-
receptor [150-152]. The second binding site is a loop in the α2 domain (residues 128–136), which lies 
adjacent to the carboxyl-terminal end of the peptide-binding groove and connects the short α2-1 helix to the β 
sheets underlying the peptide-binding groove [153-155]. Adapted from [132]. 
 
The MHC-I antigen-processing machinery can be affected in different ways by 
viruses, which can interfere either by transcriptional downregulation of antigen-processing 
machinery components [156], or by targeting the functionality of the PLC at the protein 
level [157]. Interestingly, host cells evolved strategies to potentially overcome the plethora 
of inhibitory mediators. Peptide translocation through gap junctions and cross-
presentation by neighbouring cells would help limit the spread of infection, enabling 
pathogen-derived peptides from an infected cell that may have had its MHC machinery 
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disarmed to be presented [158]. It remains to be seen whether bacteria and other 
pathogens can also target the biosynthesis of MHC-I molecules [158].  Another way of 
circumventing viral immune evasion strategies that target the conventional pathway is by 
TAP-independent presentation mediated by autophagy, utilizing the vacuolar pathway 
[159]. Viral effects can also indirectly contribute to the inhibition of the IFN-mediated 
induction of MHC [160]. Likewise, many tumors also escape immune surveillance by 
irreversibly or reversibly downregulating MHC-I molecules [161]. Immune escape by 
contagious cancers through epigenetic downregulation of MHC molecules has been 
recently described [162].  
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4. Aim of this project 
 
The European sea bass (Dicentrarchus labrax) was the first marine non-salmonid 
species to be commercially cultured in Europe and at present is the most important 
commercial fish cultured in Mediterranean areas (Food and Agriculture Organization, 
FAO). The annual world production of sea bass was estimated at 120,000 tons in 2010 
(FAO), with Portugal among the world producers. Nevertheless, aquaculture remains an 
activity with a marginal contribution to the Portuguese national economy (FAO).  
As species in rearing conditions are affected by a variety of infectious diseases 
caused by numerous pathogens, including viruses, bacteria, fungi and parasites, their 
economic importance to the aquaculture industry has been fuelling research on fish 
immunology. To prevent losses, it is mandatory to gain insights on the function and 
organisation of the immune system of such species, in order to improve health control.  
The FIV laboratory at IBMC uses this species for studying host-pathogen 
interactions [163, 164]. Characterising the immune system of sea bass is an important 
goal, since a better understanding of the way in which it responds to infection will lead to 
improved vaccination strategies. On the other hand, being a bony fish offers a multitude of 
opportunities to explore the immune defences of this species.  
As previously described, genes of the MHC have a crucial role in disease outcome, 
since they are one of the main players in adaptive immunity. This work aimed at gaining 
insights on sea bass MHC-I, namely through the identification and characterization at the 
genetic and structural levels of the class I complex subunits as well as the key elements of 
the processing pathway, for which there was no previous knowledge. The specific goals 
were: 
• Clone, sequence and characterize the α and β subunits of sea bass MHC class I 
complexes 
• Clone, sequence and characterize of the molecules involved in antigen processing 
pathway 
• Use the obtained information to produce new tools, namely polyclonal and/or 
monoclonal antibodies, that could assist on further studies of the MHC class I 
presentation mechanism in this species, contributing to its understanding. 
 
 
General introduction 
 
	   26	  
References  
 
1. Loker ES. Macroevolutionary Immunology: A Role for Immunity in the Diversification 
of Animal life. Front Immunol. 2012 3:25. 
2. Zhu LY, Nie L, Zhu G, Xiang LX, Shao JZ. Advances in research of fish immune-
relevant genes: a comparative overview of innate and adaptive immunity in teleosts. 
Dev Comp Immunol. 2013 39:39-62. 
3. Boehm T. Evolution of vertebrate immunity. Curr Biol. 2012 22:R722-32. 
4. Van de Peer Y, Maere S, Meyer A. The evolutionary significance of ancient genome 
duplications. Nat Rev Genet. 2009 10:725-32. 
5. Robert J. Comparative study of tumorigenesis and tumor immunity in invertebrates 
and nonmammalian vertebrates. Dev Comp Immunol. 2010 34:915-25. 
6. Boehm T, Hess I, Swann JB. Evolution of lymphoid tissues. Trends Immunol. 2012 
33:315-21. 
7. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010 
140:805-20. 
8. Litman GW, Cooper MD. Why study the evolution of immunity? Nat Immunol. 2007 
8:547-8. 
9. Metchnikoff I. Lectures on the Comparative Pathology of Inflammation Delivered at 
the Pasteur Institute. Lectures on the Comparative Pathology of Inflammation 
Delivered at the Pasteur Institute; 1891. 
10. Cooper MD, Peterson RD, Good RA. Delineation of the Thymic and Bursal 
Lymphoid Systems in the Chicken. Nature. 1965 205:143-6. 
11. Reynaud CA, Anquez V, Grimal H, Weill JC. A hyperconversion mechanism 
generates the chicken light chain preimmune repertoire. Cell. 1987 48:379-88. 
12. Hoffmann JA. The immune response of Drosophila. Nature. 2003 426:33-8. 
13. Li J, Barreda DR, Zhang YA, Boshra H, Gelman AE, Lapatra S, et al. B lymphocytes 
from early vertebrates have potent phagocytic and microbicidal abilities. Nat 
Immunol. 2006 7:1116-24. 
14. Litman GW, Rast JP, Fugmann SD. The origins of vertebrate adaptive immunity. 
Nat Rev Immunol. 2010 10:543-53. 
15. Hirano M, Das S, Guo P, Cooper MD. The evolution of adaptive immunity in 
vertebrates. Adv Immunol. 2011 109:125-57. 
16. Kasamatsu J. Evolution of innate and adaptive immune systems in jawless 
vertebrates. Microbiol Immunol. 2013 57:1-12. 
CHAPTER 1 
	   27	  
17. Ghosh J, Lun CM, Majeske AJ, Sacchi S, Schrankel CS, Smith LC. Invertebrate 
immune diversity. Dev Comp Immunol. 2011 35:959-74. 
18. Boehm T. Design principles of adaptive immune systems. Nat Rev Immunol. 2011 
11:307-17. 
19. Boehm T, McCurley N, Sutoh Y, Schorpp M, Kasahara M, Cooper MD. VLR-based 
adaptive immunity. Annu Rev Immunol. 2012 30:203-20. 
20. Kurtz J, Franz K. Innate defence: evidence for memory in invertebrate immunity. 
Nature. 2003 425:37-8. 
21. Kurtz J. Specific memory within innate immune systems. Trends Immunol. 2005 
26:186-92. 
22. Sadd BM, Schmid-Hempel P. Insect immunity shows specificity in protection upon 
secondary pathogen exposure. Curr Biol. 2006 16:1206-10. 
23. Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host 
defense. Cell Host Microbe. 2011 9:355-61. 
24. Silverstein AM. The Clonal Selection Theory: what it really is and why modern 
challenges are misplaced. Nat Immunol. 2002 3:793-6. 
25. Paust S, von Andrian UH. Natural killer cell memory. Nat Immunol. 2011 12:500-8. 
26. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives 
in innate immunity. Science. 1999 284:1313-8. 
27. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune 
responses. Nat Immunol. 2004 5:987-95. 
28. Zhang SM, Adema CM, Kepler TB, Loker ES. Diversification of Ig superfamily genes 
in an invertebrate. Science. 2004 305:251-4. 
29. Watson FL, Puttmann-Holgado R, Thomas F, Lamar DL, Hughes M, Kondo M, et al. 
Extensive diversity of Ig-superfamily proteins in the immune system of insects. 
Science. 2005 309:1874-8. 
30. Laird DJ, De Tomaso AW, Weissman IL. Stem cells are units of natural selection in 
a colonial ascidian. Cell. 2005 123:1351-60. 
31. Flajnik MF, Kasahara M. Origin and evolution of the adaptive immune system: 
genetic events and selective pressures. Nat Rev Genet. 2010 11:47-59. 
32. Boehm T, Iwanami N, Hess I. Evolution of the immune system in the lower 
vertebrates. Annu Rev Genomics Hum Genet. 2012 13:127-49. 
33. Boehm T. Co-evolution of a primordial peptide-presentation system and cellular 
immunity. Nat Rev Immunol. 2006 6:79-84. 
34. McCurley N, Hirano M, Das S, Cooper MD. Immune related genes underpin the 
evolution of adaptive immunity in jawless vertebrates. Curr Genomics. 2012 13:86-
General introduction 
 
	   28	  
94. 
35. Guo P, Hirano M, Herrin BR, Li J, Yu C, Sadlonova A, et al. Dual nature of the 
adaptive immune system in lampreys. Nature. 2009 459:796-801. 
36. Alder MN, Herrin BR, Sadlonova A, Stockard CR, Grizzle WE, Gartland LA, et al. 
Antibody responses of variable lymphocyte receptors in the lamprey. Nat Immunol. 
2008 9:319-27. 
37. Kasamatsu J, Sutoh Y, Fugo K, Otsuka N, Iwabuchi K, Kasahara M. Identification of 
a third variable lymphocyte receptor in the lamprey. Proc Natl Acad Sci U S A. 2010 
107:14304-8. 
38. Kishishita N, Matsuno T, Takahashi Y, Takaba H, Nishizumi H, Nagawa F. 
Regulation of antigen-receptor gene assembly in hagfish. EMBO Rep. 2010 11:126-
32. 
39. Pancer Z, Amemiya CT, Ehrhardt GR, Ceitlin J, Gartland GL, Cooper MD. Somatic 
diversification of variable lymphocyte receptors in the agnathan sea lamprey. 
Nature. 2004 430:174-80. 
40. Nagawa F, Kishishita N, Shimizu K, Hirose S, Miyoshi M, Nezu J, et al. Antigen-
receptor genes of the agnathan lamprey are assembled by a process involving copy 
choice. Nat Immunol. 2007 8:206-13. 
41. Rogozin IB, Iyer LM, Liang L, Glazko GV, Liston VG, Pavlov YI, et al. Evolution and 
diversification of lamprey antigen receptors: evidence for involvement of an AID-
APOBEC family cytosine deaminase. Nat Immunol. 2007 8:647-56. 
42. Pancer Z, Cooper MD. The evolution of adaptive immunity. Annu Rev Immunol. 
2006 24:497-518. 
43. Reynaud CA, Bertocci B, Dahan A, Weill JC. Formation of the chicken B-cell 
repertoire: ontogenesis, regulation of Ig gene rearrangement, and diversification by 
gene conversion. Adv Immunol. 1994 57:353-78. 
44. Kreslavsky T, Gleimer M, von Boehmer H. Alphabeta versus gammadelta lineage 
choice at the first TCR-controlled checkpoint. Curr Opin Immunol. 2010 22:185-92. 
45. Chaudhuri J, Basu U, Zarrin A, Yan C, Franco S, Perlot T, et al. Evolution of the 
immunoglobulin heavy chain class switch recombination mechanism. Adv Immunol. 
2007 94:157-214. 
46. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune 
system. Science. 2010 327:291-5. 
47. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of 
monocytes, macrophages, and dendritic cells. Science. 2010 327:656-61. 
CHAPTER 1 
	   29	  
48. Aghaallaei N, Bajoghli B, Schwarz H, Schorpp M, Boehm T. Characterization of 
mononuclear phagocytic cells in medaka fish transgenic for a cxcr3a:gfp reporter. 
Proc Natl Acad Sci U S A. 2010 107:18079-84. 
49. Lugo-Villarino G, Balla KM, Stachura DL, Banuelos K, Werneck MB, Traver D. 
Identification of dendritic antigen-presenting cells in the zebrafish. Proc Natl Acad 
Sci U S A. 2010 107:15850-5. 
50. Haugland GT, Jordal AE, Wergeland HI. Characterization of small, mononuclear 
blood cells from salmon having high phagocytic capacity and ability to differentiate 
into dendritic like cells. PLoS One. 2012 7:e49260. 
51. Bassity E, Clark TG. Functional identification of dendritic cells in the teleost model, 
rainbow trout (Oncorhynchus mykiss). PLoS One. 2012 7:e33196. 
52. Rumfelt LL, McKinney EC, Taylor E, Flajnik MF. The development of primary and 
secondary lymphoid tissues in the nurse shark Ginglymostoma cirratum: B-cell 
zones precede dendritic cell immigration and T-cell zone formation during ontogeny 
of the spleen. Scand J Immunol. 2002 56:130-48. 
53. Ohta Y, Landis E, Boulay T, Phillips RB, Collet B, Secombes CJ, et al. Homologs of 
CD83 from elasmobranch and teleost fish. J Immunol. 2004 173:4553-60. 
54. Boehm T, Bleul CC. The evolutionary history of lymphoid organs. Nat Immunol. 
2007 8:131-5. 
55. Pickel JM, McCormack WT, Chen CH, Cooper MD, Thompson CB. Differential 
regulation of V(D)J recombination during development of avian B and T cells. Int 
Immunol. 1993 5:919-27. 
56. Brendolan A, Rosado MM, Carsetti R, Selleri L, Dear TN. Development and function 
of the mammalian spleen. Bioessays. 2007 29:166-77. 
57. Boehm T, Bleul CC. Thymus-homing precursors and the thymic microenvironment. 
Trends Immunol. 2006 27:477-84. 
58. Bhandoola A, von Boehmer H, Petrie HT, Zuniga-Pflucker JC. Commitment and 
developmental potential of extrathymic and intrathymic T cell precursors: plenty to 
choose from. Immunity. 2007 26:678-89. 
59. Anderson G, Lane PJ, Jenkinson EJ. Generating intrathymic microenvironments to 
establish T-cell tolerance. Nat Rev Immunol. 2007 7:954-63. 
60. Bajoghli B, Guo P, Aghaallaei N, Hirano M, Strohmeier C, McCurley N, et al. A 
thymus candidate in lampreys. Nature. 2011 470:90-4. 
61. Magnadottir B. Innate immunity of fish (overview). Fish Shellfish Immunol. 2006 
20:137-51. 
62. Magor BG, Magor KE. Evolution of effectors and receptors of innate immunity. Dev 
General introduction 
 
	   30	  
Comp Immunol. 2001 25:651-82. 
63. Vasta GR, Nita-Lazar M, Giomarelli B, Ahmed H, Du S, Cammarata M, et al. 
Structural and functional diversity of the lectin repertoire in teleost fish: relevance to 
innate and adaptive immunity. Dev Comp Immunol. 2011 35:1388-99. 
64. Yoder JA, Litman GW. The phylogenetic origins of natural killer receptors and 
recognition: relationships, possibilities, and realities. Immunogenetics. 2011 63:123-
41. 
65. Sunyer JO, Zarkadis IK, Lambris JD. Complement diversity: a mechanism for 
generating immune diversity? Immunol Today. 1998 19:519-23. 
66. Zapata A, Amemiya CT. Phylogeny of lower vertebrates and their immunological 
structures. Curr Top Microbiol Immunol. 2000 248:67-107. 
67. Salinas I, Zhang YA, Sunyer JO. Mucosal immunoglobulins and B cells of teleost 
fish. Dev Comp Immunol. 2011 35:1346-65. 
68. Danilova N, Bussmann J, Jekosch K, Steiner LA. The immunoglobulin heavy-chain 
locus in zebrafish: identification and expression of a previously unknown isotype, 
immunoglobulin Z. Nat Immunol. 2005 6:295-302. 
69. Hansen JD, Landis ED, Phillips RB. Discovery of a unique Ig heavy-chain isotype 
(IgT) in rainbow trout: Implications for a distinctive B cell developmental pathway in 
teleost fish. Proc Natl Acad Sci U S A. 2005 102:6919-24. 
70. Zhang YA, Salinas I, Li J, Parra D, Bjork S, Xu Z, et al. IgT, a primitive 
immunoglobulin class specialized in mucosal immunity. Nat Immunol. 2010 11:827-
35. 
71. Laing KJ, Hansen JD. Fish T cells: recent advances through genomics. Dev Comp 
Immunol. 2011 35:1282-95. 
72. Sunyer JO. Fishing for mammalian paradigms in the teleost immune system. Nat 
Immunol. 2013 14:320-6. 
73. Rauta PR, Nayak B, Das S. Immune system and immune responses in fish and their 
role in comparative immunity study: a model for higher organisms. Immunol Lett. 
2012 148:23-33. 
74. Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding of 
MHC class I and MHC class II antigen presentation. Nat Rev Immunol. 2011 
11:823-36. 
75. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. 
Annu Rev Immunol. 2005 23:975-1028. 
76. Milinski M, Griffiths S, Wegner KM, Reusch TB, Haas-Assenbaum A, Boehm T. 
Mate choice decisions of stickleback females predictably modified by MHC peptide 
ligands. Proc Natl Acad Sci U S A. 2005 102:4414-8. 
CHAPTER 1 
	   31	  
77. Spehr M, Kelliher KR, Li XH, Boehm T, Leinders-Zufall T, Zufall F. Essential role of 
the main olfactory system in social recognition of major histocompatibility complex 
peptide ligands. J Neurosci. 2006 26:1961-70. 
78. Leinders-Zufall T, Ishii T, Mombaerts P, Zufall F, Boehm T. Structural requirements 
for the activation of vomeronasal sensory neurons by MHC peptides. Nat Neurosci. 
2009 12:1551-8. 
79. Leinders-Zufall T, Brennan P, Widmayer P, S PC, Maul-Pavicic A, Jager M, et al. 
MHC class I peptides as chemosensory signals in the vomeronasal organ. Science. 
2004 306:1033-7. 
80. Milinski M, Croy I, Hummel T, Boehm T. Major histocompatibility complex peptide 
ligands as olfactory cues in human body odour assessment. Proc Biol Sci. 2013 
280:20122889. 
81. Little CC, Tyzzer EE. Further experimental studies on the inheritance of 
susceptibility to a Transplantable tumor, Carcinoma (J. W. A.) of the Japanese 
waltzing Mouse. J Med Res. 1916 33:393-453. 
82. Gorer PA. The genetic and antigenic basis of tumour transplantation. J Pathol 
Bacteriol. 1937 44:691-7. 
83. Snell GD. Methods for the study of histocompatibility genes. J Genet. 1948 49:87-
108. 
84. Flajnik MF, Kasahara M. Comparative genomics of the MHC: glimpses into the 
evolution of the adaptive immune system. Immunity. 2001 15:351-62. 
85. Shiina T, Hosomichi K, Inoko H, Kulski JK. The HLA genomic loci map: expression, 
interaction, diversity and disease. J Hum Genet. 2009 54:15-39. 
86. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene 
map of the extended human MHC. Nat Rev Genet. 2004 5:889-99. 
87. Kelley J, Walter L, Trowsdale J. Comparative genomics of major histocompatibility 
complexes. Immunogenetics. 2005 56:683-95. 
88. Ohta Y, Shiina T, Lohr RL, Hosomichi K, Pollin TI, Heist EJ, et al. Primordial linkage 
of beta2-microglobulin to the MHC. J Immunol. 2011 186:3563-71. 
89. Deng L, Mariuzza RA. Structural basis for recognition of MHC and MHC-like ligands 
by natural killer cell receptors. Semin Immunol. 2006 18:159-66. 
90. Parham P, Moffett A. Variable NK cell receptors and their MHC class I ligands in 
immunity, reproduction and human evolution. Nat Rev Immunol. 2013 13:133-44. 
91. Stet RJ, Kruiswijk CP, Dixon B. Major histocompatibility lineages and immune gene 
function in teleost fishes: the road not taken. Crit Rev Immunol. 2003 23:441-71. 
92. Kaufman J, Milne S, Gobel TW, Walker BA, Jacob JP, Auffray C, et al. The chicken 
General introduction 
 
	   32	  
B locus is a minimal essential major histocompatibility complex. Nature. 1999 
401:923-5. 
93. Ohta Y, Goetz W, Hossain MZ, Nonaka M, Flajnik MF. Ancestral organization of the 
MHC revealed in the amphibian Xenopus. J Immunol. 2006 176:3674-85. 
94. Ohta Y, Okamura K, McKinney EC, Bartl S, Hashimoto K, Flajnik MF. Primitive 
synteny of vertebrate major histocompatibility complex class I and class II genes. 
Proc Natl Acad Sci U S A. 2000 97:4712-7. 
95. Neefjes JJ, Ploegh HL. Allele and locus-specific differences in cell surface 
expression and the association of HLA class I heavy chain with beta 2-
microglobulin: differential effects of inhibition of glycosylation on class I subunit 
association. Eur J Immunol. 1988 18:801-10. 
96. Hosomichi K, Miller MM, Goto RM, Wang Y, Suzuki S, Kulski JK, et al. Contribution 
of mutation, recombination, and gene conversion to chicken MHC-B haplotype 
diversity. J Immunol. 2008 181:3393-9. 
97. Grimholt U, Drablos F, Jorgensen SM, Hoyheim B, Stet RJ. The major 
histocompatibility class I locus in Atlantic salmon (Salmo salar L.): polymorphism, 
linkage analysis and protein modelling. Immunogenetics. 2002 54:570-81. 
98. Shum BP, Guethlein L, Flodin LR, Adkison MA, Hedrick RP, Nehring RB, et al. 
Modes of salmonid MHC class I and II evolution differ from the primate paradigm. J 
Immunol. 2001 166:3297-308. 
99. Aoyagi K, Dijkstra JM, Xia C, Denda I, Ototake M, Hashimoto K, et al. Classical 
MHC class I genes composed of highly divergent sequence lineages share a single 
locus in rainbow trout (Oncorhynchus mykiss). J Immunol. 2002 168:260-73. 
100. Miller KM, Kaukinen KH, Schulze AD. Expansion and contraction of major 
histocompatibility complex genes: a teleostean example. Immunogenetics. 2002 
53:941-63. 
101. Star B, Nederbragt AJ, Jentoft S, Grimholt U, Malmstrom M, Gregers TF, et al. The 
genome sequence of Atlantic cod reveals a unique immune system. Nature. 2011 
477:207-10. 
102. Tsukamoto K, Hayashi S, Matsuo MY, Nonaka MI, Kondo M, Shima A, et al. 
Unprecedented intraspecific diversity of the MHC class I region of a teleost medaka, 
Oryzias latipes. Immunogenetics. 2005 57:420-31. 
103. Sato A, Figueroa F, O'HUigin C, Steck N, Klein J. Cloning of major histocompatibility 
complex (Mhc) genes from threespine stickleback, Gasterosteus aculeatus. Mol Mar 
Biol Biotechnol. 1998 7:221-31. 
104. Kaufman J. Antigen processing and presentation: Evolution from a bird's eye view. 
Mol Immunol. 2013 55:159-61. 
CHAPTER 1 
	   33	  
105. Ohta Y, Powis SJ, Lohr RL, Nonaka M, Pasquier LD, Flajnik MF. Two highly 
divergent ancient allelic lineages of the transporter associated with antigen 
processing (TAP) gene in Xenopus: further evidence for co-evolution among MHC 
class I region genes. Eur J Immunol. 2003 33:3017-27. 
106. Dijkstra JM, Katagiri T, Hosomichi K, Yanagiya K, Inoko H, Ototake M, et al. A third 
broad lineage of major histocompatibility complex (MHC) class I in teleost fish; MHC 
class II linkage and processed genes. Immunogenetics. 2007 59:305-21. 
107. Lukacs MF, Harstad H, Bakke HG, Beetz-Sargent M, McKinnel L, Lubieniecki KP, et 
al. Comprehensive analysis of MHC class I genes from the U-, S-, and Z-lineages in 
Atlantic salmon. BMC Genomics. 2010 11:154. 
108. Stet RJ, Kruiswijk CP, Saeij JP, Wiegertjes GF. Major histocompatibility genes in 
cyprinid fishes: theory and practice. Immunol Rev. 1998 166:301-16. 
109. Nei M, Rooney AP. Concerted and birth-and-death evolution of multigene families. 
Annu Rev Genet. 2005 39:121-52. 
110. Nei M, Gu X, Sitnikova T. Evolution by the birth-and-death process in multigene 
families of the vertebrate immune system. Proc Natl Acad Sci U S A. 1997 94:7799-
806. 
111. Wegner KM. Historical and contemporary selection of teleost MHC genes: did we 
leave the past behind? Journal of Fish Biology. 2008 73:2110-32. 
112. Mehta RB, Nonaka MI, Nonaka M. Comparative genomic analysis of the major 
histocompatibility complex class I region in the teleost genus Oryzias. 
Immunogenetics. 2009 61:385-99. 
113. Eizaguirre C, Lenz TL, Kalbe M, Milinski M. Rapid and adaptive evolution of MHC 
genes under parasite selection in experimental vertebrate populations. Nat 
Commun. 2012 3:621. 
114. Piertney SB, Oliver MK. The evolutionary ecology of the major histocompatibility 
complex. Heredity (Edinb). 2006 96:7-21. 
115. van Oosterhout C. A new theory of MHC evolution: beyond selection on the immune 
genes. Proc Biol Sci. 2009 276:657-65. 
116. Edwards SV, Hedrick PW. Evolution and ecology of MHC molecules: from genomics 
to sexual selection. Trends Ecol Evol. 1998 13:305-11. 
117. Madden DR. The three-dimensional structure of peptide-MHC complexes. Annu Rev 
Immunol. 1995 13:587-622. 
118. Silva DS, Reis MI, Nascimento DS, do Vale A, Pereira PJ, dos Santos NM. Sea 
bass (Dicentrarchus labrax) invariant chain and class II major histocompatibility 
complex: sequencing and structural analysis using 3D homology modelling. Mol 
General introduction 
 
	   34	  
Immunol. 2007 44:3758-76. 
119. Wagner CS, Grotzke JE, Cresswell P. Intracellular events regulating cross-
presentation. Front Immunol. 2012 3:138. 
120. Hughes EA, Hammond C, Cresswell P. Misfolded major histocompatibility complex 
class I heavy chains are translocated into the cytoplasm and degraded by the 
proteasome. Proc Natl Acad Sci U S A. 1997 94:1896-901. 
121. Bagai R, Valujskikh A, Canaday DH, Bailey E, Lalli PN, Harding CV, et al. Mouse 
endothelial cells cross-present lymphocyte-derived antigen on class I MHC via a 
TAP1- and proteasome-dependent pathway. J Immunol. 2005 174:7711-5. 
122. Giodini A, Rahner C, Cresswell P. Receptor-mediated phagocytosis elicits cross-
presentation in nonprofessional antigen-presenting cells. Proc Natl Acad Sci U S A. 
2009 106:3324-9. 
123. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, et al. In vivo 
depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by 
exogenous cell-associated antigens. Immunity. 2002 17:211-20. 
124. Amigorena S, Savina A. Intracellular mechanisms of antigen cross presentation in 
dendritic cells. Curr Opin Immunol. 2010 22:109-17. 
125. Tiwari N, Garbi N, Reinheckel T, Moldenhauer G, Hammerling GJ, Momburg F. A 
transporter associated with antigen-processing independent vacuolar pathway for 
the MHC class I-mediated presentation of endogenous transmembrane proteins. J 
Immunol. 2007 178:7932-42. 
126. Crotzer VL, Blum JS. Autophagy and adaptive immunity. Immunology. 2010 131:9-
17. 
127. Pamer E, Cresswell P. Mechanisms of MHC class I--restricted antigen processing. 
Annu Rev Immunol. 1998 16:323-58. 
128. Sijts EJ, Kloetzel PM. The role of the proteasome in the generation of MHC class I 
ligands and immune responses. Cell Mol Life Sci. 2011 68:1491-502. 
129. Toes RE, Nussbaum AK, Degermann S, Schirle M, Emmerich NP, Kraft M, et al. 
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by 
quantitative analysis of cleavage products. J Exp Med. 2001 194:1-12. 
130. Nitta T, Murata S, Sasaki K, Fujii H, Ripen AM, Ishimaru N, et al. Thymoproteasome 
shapes immunocompetent repertoire of CD8+ T cells. Immunity. 2010 32:29-40. 
131. Abele R, Tampé R. Peptide trafficking and translocation across membranes in 
cellular signaling and self-defense strategies. Current Opinion in Cell Biology. 2009 
21:508-15. 
132. Wearsch PA, Cresswell P. The quality control of MHC class I peptide loading. Curr 
Opin Cell Biol. 2008 20:624-31. 
CHAPTER 1 
	   35	  
133. Kim Y, Kang K, Kim I, Lee YJ, Oh C, Ryoo J, et al. Molecular mechanisms of MHC 
class I-antigen processing: redox considerations. Antioxid Redox Signal. 2009 
11:907-36. 
134. Van Hateren A, James E, Bailey A, Phillips A, Dalchau N, Elliott T. The cell biology 
of major histocompatibility complex class I assembly: towards a molecular 
understanding. Tissue Antigens. 2010 76:259-75. 
135. Wearsch PA, Peaper DR, Cresswell P. Essential glycan-dependent interactions 
optimize MHC class I peptide loading. Proc Natl Acad Sci U S A. 2011 108:4950-5. 
136. Cho K, Cho S, Lee SO, Oh C, Kang K, Ryoo J, et al. Redox-regulated peptide 
transfer from the transporter associated with antigen processing to major 
histocompatibility complex class I molecules by protein disulfide isomerase. Antioxid 
Redox Signal. 2011 15:621-33. 
137. Park B, Lee S, Kim E, Cho K, Riddell SR, Cho S, et al. Redox regulation facilitates 
optimal peptide selection by MHC class I during antigen processing. Cell. 2006 
127:369-82. 
138. Zarling AL, Luckey CJ, Marto JA, White FM, Brame CJ, Evans AM, et al. Tapasin is 
a facilitator, not an editor, of class I MHC peptide binding. J Immunol. 2003 
171:5287-95. 
139. Lee S, Park B, Kang K, Ahn K. Redox-regulated export of the major 
histocompatibility complex class I-peptide complexes from the endoplasmic 
reticulum. Mol Biol Cell. 2009 20:3285-94. 
140. Garbi N, Tiwari N, Momburg F, Hammerling GJ. A major role for tapasin as a 
stabilizer of the TAP peptide transporter and consequences for MHC class I 
expression. Eur J Immunol. 2003 33:264-73. 
141. Leonhardt RM, Keusekotten K, Bekpen C, Knittler MR. Critical role for the tapasin-
docking site of TAP2 in the functional integrity of the MHC class I-peptide-loading 
complex. J Immunol. 2005 175:5104-14. 
142. Procko E, Raghuraman G, Wiley DC, Raghavan M, Gaudet R. Identification of 
domain boundaries within the N-termini of TAP1 and TAP2 and their importance in 
tapasin binding and tapasin-mediated increase in peptide loading of MHC class I. 
Immunol Cell Biol. 2005 83:475-82. 
143. Koch J, Guntrum R, Tampe R. The first N-terminal transmembrane helix of each 
subunit of the antigenic peptide transporter TAP is essential for independent tapasin 
binding. FEBS Lett. 2006 580:4091-6. 
144. Dick TP, Bangia N, Peaper DR, Cresswell P. Disulfide bond isomerization and the 
assembly of MHC class I-peptide complexes. Immunity. 2002 16:87-98. 
General introduction 
 
	   36	  
145. Peaper DR, Wearsch PA, Cresswell P. Tapasin and ERp57 form a stable disulfide-
linked dimer within the MHC class I peptide-loading complex. EMBO J. 2005 
24:3613-23. 
146. Peaper DR, Cresswell P. The redox activity of ERp57 is not essential for its 
functions in MHC class I peptide loading. Proc Natl Acad Sci U S A. 2008 
105:10477-82. 
147. Frickel EM, Riek R, Jelesarov I, Helenius A, Wuthrich K, Ellgaard L. TROSY-NMR 
reveals interaction between ERp57 and the tip of the calreticulin P-domain. Proc 
Natl Acad Sci U S A. 2002 99:1954-9. 
148. Wearsch PA, Jakob CA, Vallin A, Dwek RA, Rudd PM, Cresswell P. Major 
histocompatibility complex class I molecules expressed with monoglucosylated N-
linked glycans bind calreticulin independently of their assembly status. J Biol Chem. 
2004 279:25112-21. 
149. Ireland BS, Brockmeier U, Howe CM, Elliott T, Williams DB. Lectin-deficient 
calreticulin retains full functionality as a chaperone for class I histocompatibility 
molecules. Mol Biol Cell. 2008 19:2413-23. 
150. Kulig K, Nandi D, Bacik I, Monaco JJ, Vukmanovic S. Physical and functional 
association of the major histocompatibility complex class I heavy chain alpha3 
domain with the transporter associated with antigen processing. J Exp Med. 1998 
187:865-74. 
151. Suh WK, Derby MA, Cohen-Doyle MF, Schoenhals GJ, Fruh K, Berzofsky JA, et al. 
Interaction of murine MHC class I molecules with tapasin and TAP enhances 
peptide loading and involves the heavy chain alpha3 domain. J Immunol. 1999 
162:1530-40. 
152. Harris MR, Lybarger L, Myers NB, Hilbert C, Solheim JC, Hansen TH, et al. 
Interactions of HLA-B27 with the peptide loading complex as revealed by heavy 
chain mutations. Int Immunol. 2001 13:1275-82. 
153. Lewis JW, Neisig A, Neefjes J, Elliott T. Point mutations in the alpha 2 domain of 
HLA-A2.1 define a functionally relevant interaction with TAP. Curr Biol. 1996 6:873-
83. 
154. Peace-Brewer AL, Tussey LG, Matsui M, Li G, Quinn DG, Frelinger JA. A point 
mutation in HLA-A*0201 results in failure to bind the TAP complex and to present 
virus-derived peptides to CTL. Immunity. 1996 4:505-14. 
155. Yu YY, Turnquist HR, Myers NB, Balendiran GK, Hansen TH, Solheim JC. An 
extensive region of an MHC class I alpha 2 domain loop influences interaction with 
the assembly complex. J Immunol. 1999 163:4427-33. 
CHAPTER 1 
	   37	  
156. Loch S, Tampe R. Viral evasion of the MHC class I antigen-processing machinery. 
Pflugers Arch. 2005 451:409-17. 
157. Roder G, Geironson L, Bressendorff I, Paulsson K. Viral proteins interfering with 
antigen presentation target the major histocompatibility complex class I peptide-
loading complex. J Virol. 2008 82:8246-52. 
158. Antoniou AN, Powis SJ. Pathogen evasion strategies for the major histocompatibility 
complex class I assembly pathway. Immunology. 2008 124:1-12. 
159. Tey SK, Khanna R. Autophagy mediates transporter associated with antigen 
processing-independent presentation of viral epitopes through MHC class I 
pathway. Blood. 2012 120:994-1004. 
160. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev. 2001 14:778-809, 
table of contents. 
161. Bubenik J. MHC class I down-regulation: tumour escape from immune surveillance? 
(review). Int J Oncol. 2004 25:487-91. 
162. Siddle HV, Kreiss A, Tovar C, Yuen CK, Cheng Y, Belov K, et al. Reversible 
epigenetic down-regulation of MHC molecules by devil facial tumour disease 
illustrates immune escape by a contagious cancer. Proc Natl Acad Sci U S A. 2013 
110:5103-8. 
163. do Vale A, Costa-Ramos C, Silva A, Silva DS, Gartner F, dos Santos NM, et al. 
Systemic macrophage and neutrophil destruction by secondary necrosis induced by 
a bacterial exotoxin in a Gram-negative septicaemia. Cell Microbiol. 2007 9:988-
1003. 
164. do Vale A, Silva MT, dos Santos NM, Nascimento DS, Reis-Rodrigues P, Costa-
Ramos C, et al. AIP56, a novel plasmid-encoded virulence factor of Photobacterium 
damselae subsp. piscicida with apoptogenic activity against sea bass macrophages 
and neutrophils. Mol Microbiol. 2005 58:1025-38. 
 
 
 
 
 
 
CHAPTER 2 
 
Molecular cloning and characterization of sea bass 
(Dicentrarchus labrax, L.) MHC class I heavy chain and β2-
microglobulin 
 
 
 
 
 
 
 
Rute D. Pinto, Elisa Randelli, Francesco Buonocoro, Pedro J. B. Pereira and Nuno 
M. S. dos Santos 
Dev Comp Immunol. 2013, 39 (3): 234-254, doi:10.1016/j.dci.2012.10.002 
 
CHAPTER 2 
 
	   41	  
 
 
Molecular cloning and characterization of sea bass (Dicentrarchus labrax, L.) MHC
class I heavy chain and b2-microglobulin
Rute D. Pinto a,c, Elisa Randelli d, Francesco Buonocore d, Pedro J.B. Pereira b, Nuno M.S. dos Santos a,⇑
a Fish Immunology and Vaccinology Group, Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal
bBiomolecular Structure Group, Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal
c Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal
dDepartment for Innovation in Biological, Agro-food and Forest systems (DIBAF), University of Tuscia, Largo dell’Università snc, 01100 Viterbo, Italy
a r t i c l e i n f o
Article history:
Received 26 April 2011
Revised 10 October 2012
Accepted 11 October 2012
Available online xxxx
Keywords:
Dicentrarchus labrax
b2m
MHC class I
Gene cloning
Tissue-specific expression
Homology modeling
a b s t r a c t
In this work, the gene and cDNA of sea bass (Dicentrarchus labrax) b2-microglobulin (Dila-b2m) and sev-
eral cDNAs of MHC class I heavy chain (Dila-UA) were characterized. While Dila-b2m is single-copy,
numerous Dila-UA transcripts were identified per individual with variability at the peptide-binding
domain (PBD), but also with unexpected diversity from the connective peptide (CP) through the 30
untranslated region (UTR). Phylogenetic analysis segregates Dila-b2m and Dila-UA into each subfamily
cluster, placing them in the fish class and branching Dila-MHC-I with lineage U. The a1 domains resemble
those of the recently proposed L1 trans-species lineage. Although no Dila-specific a1, a2 or a3 sub-lin-
eages could be observed, two highly distinct sub-lineages were identified at the CP/TM/CYT regions.
The three-dimensional homology model of sea bass MHC-I complex is consistent with other character-
ized vertebrate structures. Furthermore, basal tissue-specific expression profiles were determined for
both molecules, and expression of b2m was evaluated after poly I:C stimulus. Results suggest these mol-
ecules are orthologues of other b2m and teleost classical MHC-I and their basic structure is evolutionarily
conserved, providing relevant information for further studies on antigen presentation in this fish species.
! 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Class I major histocompatibility complexes (MHC) are heterotri-
mers formed by a membrane-anchored a-chain, a soluble b2-
microglobulin (b2m) moiety and an antigen (Bjorkman et al.,
1987b). MHC genes have a crucial role in the adaptive immunity
of jawed vertebrates (Flajnik and Kasahara, 2010). Classical class
I genes are polymorphic, exist on nearly all cell types, and present
either self or foreign peptides from proteasomal degradation of
cytosolic proteins to T cell receptors (TCRs) on cytotoxic CD8+ T
cells. Once activated by presentation of an altered/non-selfpeptide,
the CD8+ T cell kills the peptide-presenting cell (Rudolph et al.,
2006). b2-Microglobulin is not covalently attached to the class I
heavy chain (HC), and is freely exchangeable with blood b2m
in vivo (Kimura et al., 1983). Besides classical MHC or class Ia anti-
gens (Grey et al., 1973), b2m also associates with most non-classi-
cal or class Ib molecules (including HLA-E, -F, -G, and -H) and other
MHC-related proteins (such as CD1 (Sugita et al., 1997) and FcRn
(Simister and Ahouse, 1996)). Assembly of the trimeric complexes
is a tightly regulated process (Peaper and Cresswell, 2008) occur-
ring in the endoplasmic reticulum (ER) with assistance of several
chaperones that form the peptide loading complex (PLC), where
b2m is essential for proper folding, peptide binding and surface
expression of the assembled molecules (Hansen et al., 1988; Viti-
ello et al., 1990). The PLC, which stabilizes the empty HC-b2m di-
mer and helps loading high affinity peptides (Diedrich et al.,
2001; Wearsch and Cresswell, 2008), includes calreticulin (CRT),
ER protein of 57 kDa (ERp57), tapasin (TPN) and the transporter-
associated with antigen processing (TAP). The TAP1/TAP2 heterodi-
mer transports peptides from the cytosol into the ER, while TPN
makes the bridge between the class I itself and the transporter
(Sadasivan et al., 1996), being important for peptide-editing (Chen
and Bouvier, 2007; Praveen et al., 2010). Tapasin also covalently
binds to ERp57 (Peaper et al., 2005) forming the conjugate consid-
ered to be the functional unit of the PLC (Wearsch and Cresswell,
2007), thereby protecting the empty peptide-binding groove
against a2 disulfide reduction, until that protection is provided
by a peptide ligand (Kienast et al., 2007). Other interactions be-
tween the PLC components include the contact between CRT and
ERp57 (Frickel et al., 2002), and the lectin-like association of CRT
with the monoglycosylated N-linked glycan on the HC (Sadasivan
et al., 1996; Wearsch et al., 2004).
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The three-dimensional structures of bovine, human and grass
carp b2m have been elucidated (Becker and Reeke, 1985; Bjorkman
et al., 1987b; Chen et al., 2010b), unveiling an immunoglobulin-
like domain, with a seven-stranded anti-parallel b-sandwich stabi-
lized by a single disulfide bond (Trinh et al., 2002). Also the crystal
structures of human (Bjorkmann et al., 1987; Saper et al., 1991),
mouse (Achour et al., 1998), chicken (Koch et al., 2007) and bovine
(Macdonald et al., 2010) MHC class I trimeric complexes (extracel-
lular HC domains, b2m and epitope) have been determined. The
MHC class I heavy chain typically consists of a peptide-binding do-
main (PBD) formed by two adjacent helical regions (a1 and a2) ar-
ranged on top of an eight-stranded b-sheet. The antigen-binding
cleft, containing six pockets for peptide side-chain binding, is char-
acteristically tapered and blocked at both ends by bulky side-
chains. The side-chains of the most highly variable residues of
the PBD point into the groove and up from the top of both helices,
while highly conserved residues are found at both ends of the
groove (Madden, 1995). The peptide is held in an extended cen-
ter-arched or zigzag conformation (Batalia and Collins, 1997), run-
ning along the length of the cleft. Below the PBD there is also a
typical Ig-C folding domain (a3 region), making the connection
to the transmembrane anchor and cytoplasmic domain (Madden,
1995). While the position of the a3 domain relative to the PBD
seems to be variable, that of the b2m is well conserved due to
extensive binding to both a1 and a2 (Koch et al., 2007; Macdonald
et al., 2010).
Since the characterization of human b2m and HC in the 80s
(Bjorkman et al., 1987b; Gussow et al., 1987), both molecules have
been identified in many jawed vertebrates, from mammals to bony
and cartilaginous fish. A distinct genomic organization of the MHC
region has been described for bony fish: unlike all other jawed ver-
tebrates, classical class I and II genes are not linked (Bingulac-
Popovic et al., 1997; Hansen et al., 1999; Sato et al., 2000); but
as in other non-mammalian vertebrates there is a true class I re-
gion, displaying tight linkage of presenting and processing genes
(reviewed by (Kulski et al., 2002)). Furthermore, MHC class I has
been shown to evolve differently in various teleost species with
large expansions (i.e. high number of expressed class Ia loci) re-
ported e.g. in cod (Miller et al., 2002) and to a lesser extent in stick-
leback (Sato et al., 1998), while other species present a more
conservative number of genes: two classical loci in medaka (Tsu-
kamoto et al., 2005) and only one in salmonids (Grimholt et al.,
2002; Shum et al., 2001). This major highly polymorphic locus, as
well as both medaka loci, belongs to the U lineage, but several U
lineage loci with little or no polymorphism (non-classical) are also
present (Lukacs et al., 2010; Tsukamoto et al., 2005). Besides the
broad U lineage, encompassing most published class I sequences
from fishes, other three MHC class I loci-lineages have been iden-
tified in teleosts, namely: Z, L and S lineages (Dijkstra et al.,
2007; Lukacs et al., 2010; Stet et al., 1998). The Z lineage has rep-
resentatives from fewer teleosts, the L lineage only from cyprinids
and salmonids, and S lineage only from salmonids and catfish (Luk-
acs et al., 2010). Remarkably, the different domains of the MHC
class I also evolve differently (locus-specific, variable and con-
certed/species-specific manners for a1, a2 and a3 domains,
respectively), and across-species lineages for the individual do-
mains have been reported (Nonaka et al., 2011). Recently, several
immune-related genes have been identified in European sea bass
by generating ESTs (Sarropoulou et al., 2009), but neither b2m
nor MHC class I genes or transcripts have been characterized in de-
tail. In this study, the b2-microglobulin and several classical MHC
class I HC molecules from sea bass, an important species for the
Mediterranean fish-farming industry, were isolated and character-
ized for the first time. The sequence of the Dila-b2m gene, as well
as its organization and copy-number were determined. Several
transcripts of the MHC class I and two partial genes were also iden-
tified and their copy-number evaluated. Comparative sequence
and phylogenetic analyses were performed for both proteins and
the structure of the complex was predicted by 3D homology mod-
eling. Furthermore the expression profile of both molecules was
determined by real-time PCR and the expression of b2m was also
analyzed in the head kidney of stimulated fish.
2. Materials and methods
2.1. Fish
Sea bass, Dicentrarchus labrax, were kept in a recirculating,
ozone-treated salt-water (25–30‰) system at 22 ± 1 !C and fed
with commercial pellets twice a day. Organs used for cDNA cloning
and genomic DNA extraction were removed from fish previously
sacrificed with a lethal dose of 2-phenoxyethanol (Pancreac;
>5 mL/10 L). For the expression experiments sea bass juveniles (ap-
prox. 150 g) were obtained from an aquaculture farm (‘‘Nuova Az-
zurro’’, Civitavecchia, Italy), kept at 15 ± 1 !C, and the organs
removed as described above.
2.2. cDNA cloning
2.2.1. b2m
cDNA previously obtained from head kidney mRNA of one stim-
ulated fish was used. Degenerate primers were designed based on
conserved regions of several fish b2m amino-acid sequences avail-
able in the GenBank database. The cDNA was amplified by PCR
with primers b2mFW1/b2mRV3 (Table S1). Reaction conditions
were: 94 !C for 2 min; 30 cycles of 94 !C for 45 s, 51 !C for 1 min,
72 !C for 30 s; and 72 !C for 5 min. The amplification product
(!160 bp) was purified (QIAquick Gel Extraction Kit, Qiagen),
cloned (pGEM"-T Easy Vector Systems, Promega) and sequenced
(Eurofins).
The resulting partial nucleotide sequence was used to design
three specific reverse primers (DLb2mRV1, DLb2mRV2,
DLb2mRV3; Table S1) in order to obtain the 50 untranslated region
(UTR) of the molecule. Total RNA previously isolated from the head
kidney of one stimulated fish was used to synthesize first-strand
cDNA with Superscript III™ (Invitrogen) and primer DLb2mRV1.
After cDNA purification (Sephadex G-50 span column), the 50 RACE
System for Rapid Amplification of cDNA Ends (Invitrogen) was
used to prepare dCTP-tailed cDNA. Tailed cDNA (2 L) was first
amplified with primers AAP/DLb2mRV2 (Table S1). The reaction
was performed in the above-described conditions, except for
annealing at 54 !C. A single PCR product of !300 bp was obtained
and later purified, cloned and sequenced as described above.
To obtain the full-length sea bass b2m cDNA, specific primers
were designed at the beginning of the 50 UTR. DLb2mFW1 and
APv2 (Table S1) were used in a first amplification PCR (cDNA syn-
thesized with APv2 using the total RNA previously used in 50 RACE)
with the following conditions: 94 !C for 2 min; 30 cycles of 94 !C
for 45 s, 52 !C for 1 min, 72 !C for 1 min; and 72 !C for 5 min. The
!1200 bp PCR product was purified, cloned and sequenced (3 inde-
pendent clones).
2.2.2. Heavy chain
Degenerate primers were designed based on conserved regions
of several fish HC amino-acid sequences available in the GenBank
database. The cDNA previously used for obtaining b2m was ampli-
fied with primers MHCIFW1/MHCIRV1 (Table S1). Cycling condi-
tions were: 94 !C for 2 min; 30 cycles of 94 !C for 45 s, 51 !C for
1 min, 72 !C for 30 s; and 72 !C for 5 min. The resulting product
(!560 bp) was purified, cloned, and plasmid DNA extracted and se-
quenced as described above.
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Using the partial nucleotide sequence obtained, specific reverse
primers (DLMHCIRV1, DLMHCIRV2; Table S1) were designed in or-
der to obtain the 50 UTR. Total RNA previously isolated from the
head kidney of one stimulated fish was now used to synthesize
first-strand cDNA with Superscript III™ (Invitrogen) and primer
DLMHCIRV1. After purification and dCTP tailing (as described
above), the cDNA (2 L) was first amplified with primers AAP/
DLMHCIRV1 (Table S1). The reaction was performed as previously
described except for annealing at 52 !C, and extension for 90 s. A
second PCR amplification was performed using DLMHCIRV2/AUAP
primers adjusting annealing to 55 !C. Two PCR products (!400 bp)
were obtained and later purified, cloned and sequenced as de-
scribed above.
To amplify full-length sea bass MHCI cDNA, specific primers
were designed at the beginning of the 50 UTR. DLMHCIFW3
(Table S1) and APv2 were used in a 50 L first amplification PCR
(cDNA synthesized with APv2 using the total RNA previously ob-
tained in the laboratory from the head kidney of one stimulated
fish) in the following conditions: 94 !C for 2 min; 30 cycles of
94 !C for 45 s, 59 !C for 1 min, 72 !C for 2 min; and 72 !C for
5 min. A semi-nested PCR was performed with primers DLMH-
CIFW4/APv2 (Table S1), in the same conditions except for anneal-
ing at 58 !C. The !2500 bp PCR product was purified, cloned and
sequenced (2 independent clones). Additional full-length cDNA
clones of MHCI were obtained from the thymus of a different fish,
using DLMHCIFW3/APv primers with annealing at 61 !C. The
!2500 bp PCR product was purified, cloned and 12 independent
clones sequenced. Finally, full transcripts from a third fish (HK
cDNA) were also amplified using primers DLMHCIFW3/DLMH-
CIRV17 (Cyt-L1) or DLMHCIRV15 (Cyt-L2) (Table S1). The
!2500 bp PCR products were purified, cloned and six independent
clones from each were sequenced.
2.3. Genomic DNA cloning
Genomic DNA (gDNA) was isolated from erythrocytes from two
different fish, as described by Stet et al. (1993). To obtain the full
b2m gene, gDNA was amplified by PCR using primers
DLb2mFW1/DLb2mRV4 (Table S1) in the following conditions:
94 !C for 2 min; 30 cycles of 94 !C for 45 s, 46 !C for 1 min, 72 !C
for 2 min; and 72 !C for 5 min. The PCR product was purified,
cloned and 3 independent clones were sequenced.
To obtain Dila-UA partial genes, gDNA (Fish 3) was amplified
with primers DLMHCIFW18/DLMHCIRV22 (Cyt-L1) or DLMH-
CIFW8/DLMHCIRV14 (Cyt-L2) (Table S1). The PCR products of
!2.3 and !3.9 kb, respectively were purified and directly
sequenced.
2.4. Sequence analysis
Full nucleotide and protein sequences from sea bass b2m and
HC were compared to several b2m and HC sequences currently
available in the GenBank database [http://www.ncbi.nlm.nih.gov/
genbank/]. The multiple sequence alignments were made using
CLUSTAL W (Higgins, 1994) and formatted with Bioedit (Hall,
1998). Putative leader sequences were identified with SignalP 3.0
(Bendtsen et al., 2004). Boundaries of the Ig-like domain as well
as of the Ig/MHC protein were predicted with InterPro Scan (Zdob-
nov and Apweiler, 2001). The transmembrane region was pre-
dicted with the Swiss Model domain annotation tool (Arnold
et al., 2006). Molecular weights of the derived polypeptides were
calculated with Expasy compute pI/MW tool [http://www.exp-
asy.org/tools/pi_tool.html]. Putative N-glycosylation sites were
predicted with the Expasy post-translational modification tool
[http://www.cbs.dtu.dk/services/NetNGlyc/]. Neighbor-joining phy-
logenetic trees were constructed either with MEGA v5.05 (Tamura
et al., 2011), using p-distance parameter and pairwise deletion of
gaps or with ClustalX (Larkin et al., 2007), using all sites for sepa-
rate domain analyses. All trees were tested for reliability using
1000 bootstrap replications. Percentages of similarity and identity
were calculated with MatGAT (Campanella et al., 2003) using de-
fault parameters. Finally, ligand-type specificity of all sea bass
MHC class I heavy chain molecules was predicted with MHCLIG
[http://imed.med.ucm.es/MHCLIG/].
2.5. Southern blotting
Genomic DNA (!10 g) was digested (ON at 37 !C) with different
restriction enzymes (BamHI, EcoRI and HindIII for b2m, and EcoRI,
NcoI and NdeI for MHCI HC all zero cutters within the probe), sep-
arated by electrophoresis in a 0.8% agarose gel and subjected to
Southern blotting (Ausubel et al., 1999). Segments of the sea bass
b2m (exon II) and of MHCI HC (exon IV) cDNAs, were amplified
with primers DLb2mFW4/DLb2mRV7 and DLMHCIFW6/DLMH-
CIRV8 (Table S1), respectively, with conditions: 94 !C for 2 min;
30 cycles of 94 !C for 45 s, 54 !C/58 !C for 1 min (b2m/HC), 72 !C
for 20 s; and 72 !C for 5 min. Both PCR products (273 bp for b2m
and 246 bp for HC) were purified as described before, labeled
and used as probes.
Preparation of the labeled probes, hybridization and post-
hybridization stringency washes were performed accordingly to
Gene Images™ AlhPhos Direct™ Labelling and Detection System
(Amersham Biosciences). For signal generation and detection the
Chemiluminescent Signal Generation and Detection with CDP-
Star™ protocol from the same kit was followed.
2.6. 3D homology modeling
Suitable structural templates for Dila-b2m (grass carp b2m
[PDB: 3gbl]) and Dila-UA (chicken MHC class I HC [PDB: 3bev]),
were identified by a BLAST search as implemented in the SWISS-
MODEL Protein Modelling Server (Arnold et al., 2006) and the auto-
matic sequence alignments thus obtained were used for homology
modeling with the same server. The calculated global energies
were of "4362.397 kJ/mol (Dila-b2m) and of "9596.217 and
"11186.899 kJ/mol (Dila-UA⁄06 and ⁄12, respectively). The tem-
plates used in model generation display identities of approxi-
mately 62% (Dila-b2m) and 36–38% (Dila-UA⁄06 and ⁄12,
respectively). The secondary structure elements were identified
with PROMOTIF (Hutchinson and Thornton, 1996). A dimeric mod-
el was generated by superposing the b2m and HC (Dila-UA⁄06)
homology models with the corresponding chains of the experi-
mental chicken tertiary complex (Koch et al., 2007), and submitted
to geometry regularization with PHENIX (Adams et al., 2010), with
a resulting QMEAN score of 0.536 (Benkert et al., 2011). Model
quality was assessed with WHATCHECK (Hooft et al., 1996) and
PROCHECK (Laskowski et al., 1993). Pictures of the homology mod-
els were prepared with PyMOL [http://pymol.org/].
2.7. Quantitative PCR analyses of b2m and MHC class I
2.7.1. Basal expression analyses
To study the MHC class I andb2m basal expression, six sea bass
juveniles were sampled and leucocytes from different tissues
(muscle, thymus, head kidney (HK), liver, spleen, gills, brain,
peripheral blood leucocytes (PBL), gut) obtained as described pre-
viously (Scapigliati et al., 2001). Total RNA was isolated from each
tissue separately with Tripure (Roche), resuspended in DEPC-trea-
ted water and used for real-time quantitative PCR. For reverse tran-
scription, the BioScript RNase H minus (Bioline) enzyme was used
as previously described (Buonocore et al., 2007). The expression
levels of the selected transcripts were determined with a
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Mx3000P™ real time PCR system (Stratagene) equipped with ver-
sion 2.02 software and using Brilliant SYBR Green Q-PCR Master
Mix (Stratagene) following the manufacturer’s instructions, with
ROX as internal passive reference dye. Specific PCR primers were
designed for the amplification of about 200 bp products from
MHC class I (in the conserved region of all known sea bass MHC
class I sequences), b2m, and from 18 S ribosomal RNA (Table S1),
the later used as a house-keeping gene. Ten ng of cDNA template
were used in each PCR reaction, with conditions: 95 !C for
10 min, followed by 35 cycles of 95 !C for 45 s, 52 !C for 45 s and
72 !C for 45 s. Triplicate reactions were performed for each tem-
plate cDNA (replaced with water in all blank control reactions).
The analysis was carried out using the endpoints method option,
with collection of the fluorescence data at the end of each exten-
sion stage of amplification. A relative quantitation has been per-
formed, comparing the levels of the target transcripts (MHC class
I and b2m) to a reference transcript (calibrator, the tissue with
the lowest expression, in this case muscle). A normaliser target
(18S ribosomal RNA) is included to correct for differences in total
cDNA input between samples. The results are expressed as the
mean ± SD of the results obtained from the six individuals. The
real-time PCR products from the different tissues were succes-
sively examined by agarose gel electrophoresis to investigate their
specificity and size and sequenced to verify the correct
amplification.
2.7.2. b2m expression analysis after in vitro stimulation
In vitro expression studies were performed using head kidney
leukocytes (Scapigliati et al., 2001) isolated from six juvenile sea
bass (150 g weight) cultured in L-15 medium (Gibco) containing
10% FCS, adjusted to 1 ! 105 cells/ml and incubated at 18 !C for
6 h and 24 h with 50 g/ml of poly I:C (Sigma). The control cell sam-
ple was stimulated with L-15 alone. Total RNA was isolated with
Tripure (Roche), resuspended in DEPC-treated water and used for
real-time quantitative PCR. The primers and real time PCR condi-
tions were the same as described in the previous section, except
that the calibrator for this experiment was the time 0 control.
The results were expressed as the mean ± SD of the results
Fig. 1. Nucleotide and deduced amino acid sequences of sea bass b2m gene. The ORF and the predicted protein are shown in uppercase letters. The translation start and stop
codons and the initial methionine are boxed. The predicted signal peptide is highlighted in bold, and cysteines are in inverted type. Within the 30 UTR, the putative instability
motifs are shaded in grey. The poly-adenylation signal sequences are in bold and shaded in grey. The intron splicing consensus sequences (gt/ag) are underlined.
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Fig. 2. (A) Schematic representation of sea bass and human b2m gene structures. Boxes represent exons and horizontal lines introns. White and black boxes differentiate
coding and untranslated regions, respectively. Values above boxes and below the lines represent the number of nucleotides (size) of exons and introns, respectively. Exon
numbers are indicated below boxes by Roman numerals. (B) Schematic representation of the structures of sea bass MHC class I heavy chain full transcripts. Black bars
represent 50 and 30 UTRs, while the different exons/domains within the MHC class I heavy chain coding region are represented by patterned/labeled bars: grey – signal
peptide; a1–a1 domain; a2–a2 domain; a3–a3 domain; black circles – connective peptide; horizontal lines – transmembrane domain; white – cytoplasmic tail. The name of
each transcript is indicated on the left. (C) Schematic representation of two Dila-UA partial gene structures. Boxes represent exons and horizontal lines introns. White and
black boxes differentiate coding and untranslated regions, respectively. Values below boxes and lines represent the number of nucleotides of exons and introns, respectively.
Putative exon numbers are indicated inside boxes by Roman numerals. Boxes are labeled according to the distinct domains they codify: a3–a3 domain; CP, connective
peptide; TM, transmembrane domain; Cyt, cytoplasmic tail; 30 UTR–30 UTR. Please note that for both genes the a3 and the 30 UTR regions are incomplete.
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obtained from six fish and the differences were considered signif-
icant if p < 0.05 using the two-way ANOVA analysis followed by
Bonferroni’s post test.
3. Results and discussion
3.1. Transcripts and gene sequences analysis
3.1.1. b2-Microglobulin
The full-length sea bass b2m (Dila-b2m) cDNA was obtained by
RT-PCR using mRNA extracted from the head kidney of one fish.
BLAST analysis confirmed highest similarity with fish b2m. The
here described Dila-b2m sequence [GenBank: HQ290128] has a to-
tal size of 1208 bp, with a 58 bp 50 UTR, and a 799 bp 30 UTR
(excluding the poly(A)-tail). Within the 30 UTR there are five poten-
tial polyadenylation signals, the last of which 17 nucleotides up-
stream from the actual poly(A)-tail, as well as two ATTTA
instability motifs, believed to be responsible for rapid mRNA deg-
radation (Shaw and Kamen, 1986). These features are also ob-
served in the here-reported Dila-b2m gene [GenBank: HQ290127]
(Fig. 1), which displays a three-exon structure.
In the Dila-b2m gene all intron donor/acceptor sites match the
consensus motifs (gt/ag), and the codons in the exon boundaries
are split by introns between the first and second nucleotides
(Fig. 1). Exon I encodes the 50 UTR, the putative leader peptide,
the first six amino acids of the mature protein and the first nucle-
otide of codon 7; exon II covers the remaining two nucleotides of
codon 7 and the IgSf C domain to the first base of codon 113; final-
ly, exon III encodes the remaining two bases of codon 113, the
three-last amino acids of the protein and the 30 UTR (Fig. 1). Both
features of the exon/intron pattern from the sea bass b2m gene,
i.e. phase-one introns and correspondence of exons to functional
domains of the protein, are typical in members of the Ig superfam-
ily (Williams and Barclay, 1988). Morevoer, the Dila-b2m 3-exon
gene organization (Fig. 2A) is shared by several other fish species,
namely sturgeon (Lundqvist et al., 1999), walleye (Christie et al.,
2007), grass carp (Hao et al., 2006), catfish (Criscitiello et al.,
1998), tongue sole (Xu et al., 2010), and sandbar shark (Chen
et al., 2010a). These, present a genomic structure different from
that of human b2m, which has four exons (Gussow et al., 1987).
In human b2m, besides the last four amino acids of the protein
and the stop codon, exon III includes only the first 14 nucleotides
of the 30 UTR, being the remaining portion specified by exon IV.
The 4-exon structure of human b2m gene is also found in mouse
(Parnes and Seidman, 1982), chicken (Riegert et al., 1996) and zeb-
rafish (Ono et al., 1993). Japanese flounder b2m gene has been re-
ported to contain a single exon (Choi et al., 2006).As in other fish
b2m, introns are smaller than in those of the human gene (Fig. 2A).
3.1.2. MHC class I heavy chain
Two complete cDNA sequences from one individual, 11 from a
second fish and 11 others from a third one were identified and des-
ignated MhcDila-UA⁄01-MhcDila-UA⁄24 [GenBank: HQ290103–
HQ290115; and JX171686–JX171696], after sequence analysis had
confirmed highest similarity to fishMHC class I molecules, skipping
only the middle letter locus designation according to Klein and co-
workers nomenclature (Klein et al., 1990).MhcDila-UA⁄13 contains
a 50 UTR and an ORF comprising only the signal peptide and the pep-
tide-binding region (PBR) –a1 and a2 – domain (Fig. 2B) due to the
transcription of an intron that prematurely introduces a stop codon.
Therefore it most likely represents a splice variant, as in absence of
the intronic sequence, the coding region would continue through
the a3 to the transmembrane domain prematurely ending before
the full cytoplasmic tail (possibly due to the presence of several ade-
nosines to which the oligod (T) paired, originating a truncated tran-
script), or an expressed pseudogene. All the remaining sequences
(Fig. 2B) are composed of 50 and 30 UTRs, as well as of signal peptide,
a1,a2, anda3 domains, and of connective peptide/transmembrane/
cytoplasmic tail (CP/TM/CYT) regions, and were used for further
analysis.
The here reported sea bass class I full transcripts have total sizes
of 2404–2683 bp, with 50 UTRs of 66–83 bp (differences resulting
from different primer usage), ORFs of 1068–1215 bp and 30 UTRs
of 1141–1500 bp excluding polyadenylation tails (Table 1). Ex-
pected variability is denoted at the nucleotide level on the PBR do-
mains (Figs. S1 and S2). However, striking differences at nucleotide
composition and length of the CP/TM/CYT and 30 UTR regions
(Figs. S1 and S2 and 2B) segregate them into two main groups.
One is more homogeneous being characterized by generally short
CPs (20 residues; three exceptions), constant TM regions (23 resi-
dues), short CYT tails (25 residues), and longer 30 UTRs with 11–
15 potential poly(A) signals, 6–7 ATTTA instability motifs and
two stretches of CA dinucleotide repeats [(CA)n] of variable lengths
(polymorphism; Table 1 and Fig. S1). The significance of these
putative microsatellites remains to be investigated, although the
presence of such a feature has been previously reported in Atlantic
salmon (Grimholt et al., 1993).
The other group of transcripts is represented by long CPs (29
residues), heterogeneous TM regions (20–25 residues) and CYT
tails (27–62 residues), and 30 UTRs with 4–9 poly(A) signals, gener-
ally 9 ATTTA motifs and no microsatellites (Table 1and Fig. S2).
Variations at the TM domains are due to predicted boundaries
and not to indels – insertions/deletions – along the domain, while
those at the CYT tails starkly differ in size.
Nevertheless, both groups of European sea bass Dila-UA tran-
scripts have a predicted leader peptide of 19 amino acids and, with
few exceptions, a1, a2, and a3 domains of 89, 92, and 90 amino
acids, respectively (Table 1). Hence, it can be inferred that differ-
ences in length/size among European sea bass MHC class I UA se-
quences result essentially from distinct CP/TM/CYT regions
(Fig. 2B and Table 1).
Partial genes from each of these groups were isolated in order to
elucidate if some of the observed transcripts could be splice vari-
ants. These sequences, corresponding to regions from the a3 to
the 30 UTR, were named MhcDila-UA⁄25 and ⁄26 [GenBank:
JX171697 and JX171698]. Likely, transcript Dila-UA⁄16 originates
on gene Dila-UA⁄25, while Dila-UA⁄21 on gene Dila-UA⁄26, since
they were obtained from the same fish and there is 100% identity
on coding regions. The remaining transcripts may be allelic forms
or originate on different genes. In both Dila-UA partial genes all in-
tron donor/acceptor sites flanking the exons match the consensus
motifs (gt/ag), and the codons in the exon boundaries are split by
introns between the first and second nucleotides; however they
differ not only in size (2453 and 3835 bp for short and long CYT
tails, respectively), but also in gene organization (number and
length of exons/introns) (Fig. 2C). Dila-UA⁄25 has five exons while
Dila-UA⁄26 has six, with the CPs and the CYT tails encoded by
more than one exon (Fig. 2C). Although the cytoplasmic tails are
differently organized in three or five exons, no alternative splicing
sites could be identified in the current transcripts, even within the
more heterogeneous long CYT tails group.
3.2. Southern blot
Southern blot results suggest that a single gene encodes Dila-
b2m in sea bass (Fig. 3A). Similar results have been reported in
other organisms including mammals (Parnes and Seidman, 1982),
birds (Riegert et al., 1996), amphibians (Stewart et al., 2005), carti-
laginous (Chen et al., 2010a) and bony fish (Choi et al., 2006; Chris-
tie et al., 2007; Criscitiello et al., 1998; Dixon et al., 1993; Ono et al.,
1993). In some species, a higher copy-number of the b2m gene is
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explained by the polyploidy of genomes: sturgeon (Lundqvist et al.,
1999), common carp (Dixon et al., 1993) and African clawed frog
(Stewart et al., 2005) are tetraploid species, displaying two copies
of the b2m gene, while barbs being hexaploid have three copies of
the gene (no diploidization) (Kruiswijk et al., 2004). In cod, how-
ever, which is a diploid species, two fragments were also identified
but were suggested to be alleles of a single gene (Persson et al.,
1999). Limited polymorphism of this molecule was long reported
in mice (Goding and Walker, 1980). Nevertheless, in rainbow trout,
sequence diversity in b2m cDNA clones from a single fish has been
reported (Shum et al., 1996) and is now known that b2m is en-
coded by three genes segregating as tetraploid loci (Magor et al.,
2004).
For Dila-UA, using an a3 domain-specific probe, multiple bands
(5–8) were observed upon southern blot analysis of two sea bass
genomes (Fig. 3B). This result determines MHC class I molecules
are polygenic, although the actual number of class I loci in Euro-
pean sea bass is still not clearly defined; it is also suggestive of hap-
lotypic variation, since the pattern is not identical in the analysed
individuals. Polygenic class I molecules have been reported in
mammals, birds, amphibians, cartilaginous and bony fish (re-
viewed in (Kelley et al., 2005)) and haplotype variation is also com-
mon among teleost fish (Figueroa et al., 2001; Michalova et al.,
2000; Murray et al., 2000). Co-dominance is another important fea-
ture of MHC class I alleles, but there are species where a single
gene is dominantly expressed (e.g. in salmonids (Aoyagi et al.,
2002; Miller et al., 2006), African clawed frog (Flajnik et al.,
1999) and chicken (Kaufman et al., 1999)). Although it is difficult
to determine from our data whether the different cDNA clones
are alleles or the products of different genes, one can say that at
Fig. 3. (A) Sea bass b2m is a single copy gene. Southern blot analysis of genomic DNA from one animal digested with three restriction enzymes (isolated and combined). The
blot was later probed with a region of b2m that included part of exon II. All enzymes are zero cutters within the probe: one band can be seen for each of these individual
digestions and for each set. Sizes of the MWmarker are indicated on the left. (B) Sea bass MHC class I heavy chain is a multi-copy gene. Caption as for b2m, except that results
from two different animals are shown and the probe includes exon IV. Multiple bands can be seen for each of the individual digestions and for each set.
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least six different MHC class I genes must occur in sea bass since
eleven different transcripts were obtained in each of two individu-
als (Table 1). This is in accordance to the 5–8 bands observed on
southern blot, which suggests a total of 10–16 sequences may exist
per fish. Therefore at least two genes may still be undiscovered.
3.3. Protein sequence comparison
3.3.1. b2-Microglobulin
Amino acid sequences of b2m from several vertebrate species
(Table S2) were aligned with that of Dila-b2m using CLUSTALW
(Fig. 4). In sea bass, a predicted 101-residue (11.6 kDa) mature pro-
tein would be generated by cleavage of the putative 15-amino acid
signal peptide. Although the majority of the analyzed bony fish
species have a 97-residue b2m (two amino acids shorter than in
human, mouse and amphibians), in other members of the supra-
order Percomorpha it is 100-residue long. The cartilaginous fish
display smaller mature proteins of 94 or 95 amino acids. Sea bass
b2m, as all other fish species, except for sturgeon, has a deletion of
two residues in the region corresponding to the F–G loop. The IgC1
motif and the Ig/MHC protein signature (sb residues 82–88;
[FY]XCX[VA]XH) (Fig. 4), and the canonical pair of cysteines
(hC25–C80, sbC29–C84) covalently linking the IgSf domain through
strands B and F in human b2m (Bjorkman et al., 1987b), are con-
served across species. As in other b2m proteins, no putative glyco-
sylation sites are present on the sea bass sequence, although they
were predicted for a few fish species (Criscitiello et al., 1998; Hao
et al., 2006; Yu et al., 2009). Overall, conservation can be observed
between sea bass and human b2m sequences (Fig. 4), especially in
secondary structure elements (Saper et al., 1991) (least conserved
regions include b-strands E and G and loop F–G), and among resi-
dues involved in interactions with MHC class I a1, a2 and a3 re-
Fig. 4. Alignment of b2m amino acid sequences. Amino acid sequences were retrieved from GenBank (Table S2) and aligned with CLUSTALW. Dashes indicate gaps that
maximize the alignment; Identical residues, conserved and semi-conserved substitutions are denoted under the alignment with, (⁄), (:) and (.), respectively. Identity and
similarity are displayed by black and grey shading, respectively. Predicted IgSf C domain is indicated above the alignment. Canonical cysteines involved in an intra-chain
disulfide bond (B–F) are marked with (e). Four pairs of salt bridges are indicated with (s, h and d). Residues of human b2m that contact CD8 (Gao et al., 1997) are indicated
with (N). Topohydrophobic residues are indicated with (t). Residues involved in two new hydrogen bonds in grass carp are indicated with (). Letters (a–g) above the alignment
denote b-strands (Saper et al., 1991). The numbers 1, 2, and 3 above the alignment indicate the contacts of human b2m with heavy chain a1, a2, and a3, respectively (Saper
et al., 1991).
R.D. Pinto et al. / Developmental and Comparative Immunology xxx (2012) xxx–xxx 9
Please cite this article in press as: Pinto, R.D., et al. Molecular cloning and characterization of sea bass (Dicentrarchus labrax, L.) MHC class I heavy chain and
b2-microglobulin. Dev. Comp. Immunol. (2012), http://dx.doi.org/10.1016/j.dci.2012.10.002
MHC/β2m 
 
	   50	  
	  	  
gions (Tysoe-Calnon et al., 1991): globally 11/18 conserved and 4/
18 conservatively substituted residues (a1: 2/4 conserved and 2/4
conservatively substituted; a2: 3/5 conserved; a3: 6/9 conserved
and 2/9 conservatively substituted). Of note hD53/sbD57, involved
in important hydrogen bonds to the HC a1 domain, is conserved
across species, except for tongue sole where it is conservatively re-
placed by glutamate. Also residues hH31, hW60, and hF62 (sbH35,
sbW64 and sbF66), known to form hydrogen bonds to the a2 do-
main, are totally preserved in sea bass and highly conserved across
species. Finally, human Q8, Y10, R12 and N24 (sea bass Q12, Y14, R16
and I28) form hydrogen bonds while Y26 (sea bass H30) establishes
hydrophobic interactions to the HC a3 domain. The non-conserva-
tive replacement of N24 by I28 in sea bass (note that isoleucine is
present in bony fish and Xenopus; Fig. 4) leads to the loss of this
interaction since the asparagine side-chain is involved. Conserva-
tion of the remaining residues as well as of their HC partners
means those interactions are plausible in the sea bass MHC class
I complex, as happens in most characterized species. The contacts
with CD8a1, when cytotoxic T lymphocytes recognize target cells,
are made through residues hK58 and hW60 (Gao et al., 1997), which
in sea bass are conservatively substituted (Q62) and conserved
(W64), respectively. Four salt bridges have been described in
HLA-bound human b2m (Saper et al., 1991): E16/K19, D38/R45, D38/
R81, and E77/K94. Only the first one is preserved in sea bass (E20/
K23) and highly conserved across species. Two new hydrogen
bonds involving K66 have been described in grass carp b2m con-
necting strands C–E (Chen et al., 2010b). This lysine is characteris-
tic of fish b2m (replaced by arginine in tongue sole), being absent
in Xenopus tropicalis (M), chicken (V), mouse (A), bovine (S) and hu-
man (Y) (Fig. 4). The environment of K66 in grass carp (K70 in sea
bass) is maintained, allowing the establishment of the hydrogen
bonds described for fish b2m, namely I37/K66 (sb I41/K70) and E38/
K66 (sb Q42/K70). The typical hydrophobic core described for the
Ig fold, with 10 topohydrophobic positions indicated as key mark-
ers of the C1 set (Halaby et al., 1999) is mostly conserved in sea
bass. Finally, over the complete b2m sequence, eight residues are
totally conserved and ten other show >90% conservation across
species (Fig. 4).
3.3.2. MHC class I heavy chain
MHC class I amino acid sequences from several vertebrate spe-
cies (Table S2) were aligned with some Dila-UA sequences using
CLUSTALW (Fig. 5). Cleavage of the putative 19-amino acid signal
peptides, and in accordance to what was previously discussed,
would yield 336–385-residue mature proteins. Among all analyzed
species the sea bass clone Dila-UA⁄11 originates the longest pro-
tein and the African barb the shortest. The sea bass transcripts dif-
fered by 48/89 residues in the a1 domain, 55/92 in the a2 domain
and 22/90 in the a3 domain (Fig. S3). The a1 and a2 domains of
Dila-UA display high diversity. As mentioned above, unexpected
and striking variability is also observed within the CP/TM/CYT
(Fig. 5 and Fig. S3) yielding two groups of MHC class I molecules
(short and long CYT tails) with distinct molecular weights
(Table 1).
The insertion of a unique fragment – WGKTGIR[ST][EN] – in the
CP of all sea bass transcripts with long CYTs and of three with short
CYTs (Dila-UA⁄01-⁄03) makes them longer (Fig. 5 and Fig. S3). A
similar insertion is also observed in Sparus aurata and Takifugu
rubripes sequences (Fig. 5). No TM is predicted in the Gasterosteus
aculeatus sequence, which possibly corresponds to a secreted form
of the protein. In all other species here analyzed there is a TM re-
gion, including all sea bass sequences (Fig. 5 and Fig. S3). Six Dila-
UAmolecules (⁄07, ⁄11, ⁄12, ⁄22, ⁄23 and ⁄24) display at their long
cytoplasmic tail a tyrosine equivalent to that (Y320) reported to be
involved in endolysosomal traffic of mammalian MHC class I com-
plexes during cross-presentation of exogenous peptides in den-
dritic cells (Lizee et al., 2003). However, although conserved in
several distantly related species, this residue is absent in most
here-analyzed Actinopterygii HCmolecules. Furthermore, the pres-
ence of leucine–isoleucine motifs within the long cytoplasmic tail
molecules (Dila-UA⁄08 to ⁄12 and Dila-UA⁄20 to ⁄24) might also
target them to endosomes, which would resemble MHC class II
transport (Pieters et al., 1993). All Dila-UA characteristic long CYTs
contain one or two cysteines (Fig. 5 and Fig. S3). Existence of cys-
teines on the cytoplasmic tails of MHC class I molecules (also ob-
served in 10 of the analyzed species) has been reported to affect
the expression level and conformation of the proteins at the cell
surface in humans, and also to influence the binding/recognition
of killer cell inhibitory receptors (Barel et al., 2003). For all this,
it is conceivable that these two groups of European sea bass
MHC class I molecules with distinct specificities at the CYT region
may have different functions.
In spite of these segregating differences, both groups of sea bass
protein sequences showed the typical features of classical MHC
class I a chains when aligned with those of other species (Fig. 5
and Fig. S3). One pair of cysteines in the a2 domain (C100/C164)
and another in the a3 domain (C200/C260), responsible for two
intrachain disulfide bonds in the human molecule, could be identi-
fied. Exceptionally, some of the sea bass transcripts show one (C67)
or two cysteine residues (C35/C67) in the a1 domain (Dila-UA⁄07,
⁄10, ⁄11 and ⁄12; Fig. 5 and Fig. S3) as previously reported in me-
daka (Nonaka and Nonaka, 2010). An additional cysteine residue
(in a position equivalent to C67) has been reported in human
HLA-B27, an allele associated with an autoimmune disorder (Anto-
niou et al., 2004).
A potential N-glycosylation site (N86QT) was identified in a con-
served position (Fig. 5 and Fig. S3). Site-directed mutagenesis of
the MHC class I HC (mouse) determined that the glycosylated res-
idue on the a1 domain is the binding site for calreticulin (CRT)
(Turnquist et al., 2002), raising the possibility that a similar inter-
action occurs in sea bass HC.
Within the PBD, eight sites (YYRTKWYY) have been identified as
important anchor residues for peptide binding (based on the mam-
malian motif YYYTKWYY), almost all of which are conserved in sea
bass MHC class I molecules (Fig. 5 and Fig. S3): Y7 (I7 in Dila-
UA⁄04; Fin Gadus morhua; A in Danio rerio and Channa argus),
Y59, R84 (Y in mammals and iguana,), T142 (I in G. aculeatus,), K145
(R in G. morhua), W146 (L in Dila-UA⁄05, ⁄08, ⁄17, ⁄20-⁄23, Aulon-
ocara hansbeanschi, C. argus, Homo sapiens HLA-C), Y159 (D in Epi-
nephelus coioides), and Y171 (F in Protopterus aethiopicus).
Additional important residues for peptide binding (located at the
bottom of the groove) (Bjorkman et al., 1987a) that are reasonably
conserved include L5, Y9, F21 (Y in Dila-UA⁄10-⁄12) and G25 (S in
Dila-UA⁄04) (Hansen et al., 1996). Also F122 (I122 in Dila-UA⁄08,
⁄20 and ⁄21; Y in mammals and iguana and also ancient Actin-
opterygii and Heterodontus francisci), L160 (Y in Dila-UA⁄01-⁄03)
and W167, part of the peptide-binding site (Saper et al., 1991), are
well conserved in sea bass and across species.
Several structurally important residues of the a3 domain (Wil-
liams and Barclay, 1988), apart from the conserved cysteines, are
totally conserved in the sea bass sequences: F205, Y206, P207, W214,
G236, Y258 and F262 (phenyalanine in all Percomorpha, although va-
line in most other species) are absolutely or highly conserved
across species.
Important residues establishing contacts with b2m (Koch et al.,
2007) are highly conserved across species including sea bass (F8,
T10, V22, Q31 (except ⁄24), K45, Q95, Q114, G116, D118, G119, D121,
K192, E229, D235 and Q239), while others are conservatively substi-
tuted in the later (V24, E120).
Additionally, a series of acidic residues thought to be critical for
CD8 binding on cytotoxic T cells during antigen recognition by T
cell receptors in mammals (Gao et al., 1997; Kern et al., 1998;
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Wang et al., 2009) are also found in the a3 domains of the sea bass
clones – E223 [DN]V[DE]HGE229 – although the identities are low
between the various species (Fig. 5), suggestive of species-specific
CD8 binding, as previously proposed (Kaufman et al., 1994). Other
CD8-contacting residues include S209, T211 and Q263 also in the a3
domain (Gao et al., 1997; Kern et al., 1998; Wang et al., 2009), con-
served in the sea bass sequences but not across species; and Q114
and D121(Gao et al., 1997; Koch et al., 2007) highly conserved in
the a2 domains across species.
Residues believed to be involved in electrostatic interactions in
the human molecule (Saper et al., 1991) are present in identical
locations in the sea bass clones (Fig. 5 and Fig. S3). All these resi-
dues are invariant across species, except for D28 replaced by a gly-
cine in Poecilia reticulata and an asparagine in S. aurata and
Salvelinus alpinus. Another pair of residues in the a3 region in-
volved in a salt bridge in human MHC seems to be present in most
species (sb D217/R257) (Saper et al., 1991).
It has been demonstrated by co-precipitation experiments that
polymorphisms at position 116 of HC a2 domain in both HLA-A
and -B molecules affect binding to CRT, TAP and TPN (Turnquist
et al., 2002). Although speculative, variability at the corresponding
position is also observed in sea bass (sb115: W/Y/D/F), raising the
possibility of different affinities between distinct sea bass MHC
class I alleles and the PLC members.
The regions of MHC class I HC that seem to interact with TPN
reside in the a2 and a3 domains (Turnquist et al., 2002). These in-
clude a highly conserved solvent-exposed region (loop 128–136, sb
L127KTETFIAP) and the a3 region that also participates in CD8
Fig. 5. Alignment of MHC class I heavy chain amino acid sequences. Amino acid sequences were retrieved from GenBank (Table S2) and aligned with CLUSTALW. Dashes
indicate gaps that maximize the alignment, and dots denote residues identical to the first sequence of the alignment. Identical residues, conserved and semi-conserved
substitutions are denoted below the alignment with, (⁄), (:) and (.), respectively. Numbers right to the sequences denote their lengths; those within parenthesis indicate the
size of individual domains. Canonical cysteines involved in an intra-chain disulfide bonds within a2 and a3 domains as well as other cysteines mentioned in the text are
displayed in inverted type. Conserved residues located at the edges of the binding cleft are highlighted with red shading. Other important residues within the PBD are marked
with (.). Residues involved in salt bridges are denoted with green shading. Residues that contact b2m are highlighted with ($). Residues that contact CD8 (Gao et al., 1997;
Kern et al., 1998; Wang et al., 2009) are indicated with yellow shading. A grey bar above the alignment denotes residues involved in tapasin contacts. For each sequence an
open box delimits the TM domain. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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binding (sb 219–226) (Van Hateren et al., 2010). Namely S132 (a2
domain) and D227 and E229 (a3 domain) were found to affect asso-
ciation with TPN. Human S132 corresponds to the totally conserved
T131 in sea bass. Regarding the a3 domain residues, human D227 is
equivalent to D224 or N224 with similar frequencies. Human E229
corresponds to sea bass E226 or frequently D226. The conservative
nature of the replacements in sea bass, when at all, suggests the
two interactions are maintained, a hypothesis that needs further
experimentation.
Overall, conservation of important functional and structural
residues points to the classical nature of the reported sea bass
sequences. Nevertheless, insights on the polymorphism level and
on the tissue distribution of individual genes, both hallmarks of
classical MHC class I, are needed to confirm this. Finally all sea bass
Dila-UA molecules were predicted to bind peptide ligands, accord-
ing to the MHCLIG server (data not shown).
3.4. 3D homology modeling
The Dila-b2m and Dila-UA extracellular structures were pre-
dicted by comparative modeling using the grass carp b2m [PDB:
3gbl; (Chen et al., 2010b)] and chicken MHC [PDB: 3bev; (Koch
et al., 2007)] crystal structures as templates, respectively
(Fig. S4). The homology model of Dila-b2m is compatible with
the seven-stranded b-sandwich fold typical of the IgSf constant
(C) domain described for other b2m molecules. The seven
b-strands are organized in two b-sheets with an ABDE-CFG
arrangement stabilized by a disulfide between strands B and F
(Fig. S4A). A conserved two-residue b-bulge (hD53L54/sbD57L58),
which has been proposed to prevent protein aggregation (Richard-
son and Richardson, 2002) and to facilitate binding to the heavy
chain (Trinh et al., 2002) is also present between the short D1
and D2 strands. Although the aspartate of this motif is widely con-
served (glutamate in tongue sole), the leucine residue is replaced
by methionine in mouse, chicken and tongue sole, and by proline
in amphibians.
The homology model of Dila-UA is also structurally compatible
with the PBD (a1 and a2) and the Ig fold (a3) described for other
MHC class I HC molecules (Fig. S4B). As described for the crystal
structures of human, mouse, chicken and bovine MHC class I, the
modeled sea bass Dila-UA PBD is composed of two adjacent helical
regions on top of an anti-parallel eight-stranded b-sheet (Figs. S4B
and C), while the a3 domain consists of a typical Ig-fold (Fig. S4B).
The eight anchor residues (red) important for peptide binding and
Fig. 5. (continued)
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other highly conserved residues (pink) contacting the peptide oc-
cupy reasonable spatial positions (Fig. S4C). Three of the identified
sea bass HC molecules (Dila-UA⁄10-⁄12) bear two additional
cysteines within the a1 domain, which could form an extra
disulfide bridge similar to that present in the a2 domain, linking
the a1-helix to the floor of the groove (Fig. S4D). Despite one can-
not discuss polymorphism given the undefined allele/locus nature
of the transcripts, variable positions in the extracellular region
were mapped to the homology model and as previously discussed
highest diversity is located at the PBD (Fig. S4E). At last, the relative
positions of sea bass b2m and HC in the context of the putative het-
erodimer, based on the chicken MHC class I structure are shown in
Fig. S4I.
3.5. Phylogenetic analysis
In order to analyze the evolutionary relationships of the b2m and
MHC class I HC proteins from different organisms and distinct lin-
eages, a joint neighbor-joining treewasconstructed (Fig. 6)withboth
groups of proteins clearly separated. As expected, Dila- b2m (mature
protein) clusterswithother bonyfish sequences being closely related
tomolecules of species from the same order (e.g. Asian sea bass, yel-
low croaker and walleye). Sturgeon b2m clusters with the teleosts,
although it represents a primitive form of Actinopterygii. Addition-
ally, a series of pair-wise alignments were performed with MatGAT
in order to calculate similarity and identity of b2m amino acid se-
quences between species. The results confirm those previously ob-
tained with the neighbor-joining method (Table S3).
Regarding the MHC class I phylogeny (Fig. 6), all sea bass se-
quences (full-length) starkly diverge from MHC molecules of the
L, S and Z teleost lineages (Dijkstra et al., 2007; Lukacs et al.,
2010; Stet et al., 1998), clustering together and with other mole-
cules of the U lineage (Stet et al., 1998), broadly represented
among teleosts. Except for the Sarcopterygii molecule that falls
within the Z lineage, all proteins are separated according to the
class of the organisms: Mammalia, Reptilia, Aves, Amphibia,
Chondrichthyes, and Actinopterygii. Within the Actinopterygii, it
is obvious the separation between Teleostei and the ancient Chon-
drostei. As expected, the Dila-UA sequences are closely related to
molecules of species from the Perciformes (e.g. S. aurata, E. coioides,
Epinephelus akaara or Stizostedion vitreus) or Percomorpha (e.g. G.
aculeatus). MatGAT analysis confirms these results (Table S4).
These data suggest that all the sea bass clones belong to the teleost
U lineage of MHC class I molecules.
Fig. 5. (continued)
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Finally, neighbor joining trees were constructed in order to
evaluate the evolutionary relationships between sea bass class I
molecules and those of other fish, separately analyzing the do-
mains (Fig. 7). Here, the topologies of the a1, a2 and a3 domains
differed, reflecting distinct evolutionary pathways of these func-
tionally distinct regions (Fig. 7A–C). All teleost U lineage genes
clustered together in all domains, except for a1, where some se-
quences group with Z lineage sequences. However, for this region
the bootstrap values are not supportive of the observed topology
(when pairwise deletion of gaps is used instead of all sites, Z line-
age loci form a separate cluster with high bootstrapping also in a1
– not shown). Sea bass sequences of each extracellular region
grouped altogether with high bootstrap values, but with low boot-
strapping within the Dila-UA cluster (Fig. 7A–C), suggesting a
recent expansion of sea bass class I molecules, similarly to the
stickleback example (Sato et al., 1998). Here, repeated gene dupli-
cation and strong positive selection are hypothesized as the driving
forces in the origin and maintenance of diversity in class Ia
(Schaschl and Wegner, 2007). Recently, Nonaka et al. (2011)
reported the existence of four across-species a1 lineages (L1–L4)
established with high bootstrapping while studying medaka MHC
class I. A previous study on rainbow trout UBA genes already
attributed relevance to trans-species sharing of a1 lineages (Kiryu
et al., 2005). The a1 domain tree generated with our data also
displays these four lineages, suggesting all sea bass a1 domain
sequences resemble those of the described L1 lineage (Fig. 7A).
Similarly to the pufferfishes, they fit in the L1+ designation for hav-
ing (i) two additional residues and (ii) in some sequences one or
two cysteine residues (Table 1 and Fig. S3), features shared with
L2 and L3 lineages (Nonaka et al., 2011). As a consequence of its
long-term conservation, a1 yielded some insights on the ortholo-
gous relationships among teleost U lineage genes (Nonaka et al.,
2011). Accordingly, L1 includes sequences from Acanthopterygii
and salmonids (Protacanthopterygii), being considered the major
a1 lineage of euteleostclass I HC genes (Nonaka et al., 2011). In
the present data, no sea bass representatives are observed among
the other domain lineages, in spite of L3 being also present in other
Percomopha and Perciformes species and even in a sea bass partial
sequence (Nonaka et al., 2011). Nevertheless, in accordance to the
southern results, putatively undetected Dila-UA loci could belong
to the mentioned L3 a1 lineage. The a2 tree (Fig. 7B) segregates
the U lineage genes in two groups, in accordance to Nonaka et al.
(2011) results, with all Dila-UA sequences included in the major
one, although no further subdivisions could be inferred. Accumula-
tion of point mutations and recombination events between
sequences that increase their own diversity may be in the origin
of such a topology (Nonaka et al., 2011). Regarding the a3 tree
(Fig. 7C), species-specific (or related species) clusters were formed
Fig. 5. (continued)
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suggesting homogenization of a3 regions between loci after speci-
ation, according to previous findings (Nonaka et al., 2011). Finally,
two sub-lineages were recognized in sea bass for the CYT regions,
designated Cyt-L1 and Cyt-L2 (Fig. 7D). Sub-lineage Cyt-L1 corre-
sponds to the characteristically short tails, whilst the Cyt-L2 repre-
sents the longer ones. Similar results were obtained when the 30
UTRs were used in the phylogenetic analysis (data not shown).
Hence, based on the CYT and 30 UTR regions, Dila-UA transcripts
can be divided into two families, in contrast to medaka where
inter-locus homogenization was observed for these domains (Non-
aka and Nonaka, 2010). Locus specificities of TM-CYT and 30 UTR
regions were reported in human (Parham et al., 1989), mouse
(Pullen et al., 1992) and Atlantic cod (Miller et al., 2002).
3.6. Basal expression analyses
The basal expression analysis of b2m in organs and tissues of
non-stimulated sea bass is shown in Fig. 8A. Real-time PCR analysis
detected the presence of b2m mRNA in all examined tissues dem-
onstrating almost constitutive expression in juvenile sea bass, as
observed in other teleosts (Choi et al., 2006; Shum et al., 1996;
Yu et al., 2009). The highest level of b2m mRNA was detected in
the thymus, the main site of T cell lymphopoiesis in vertebrate spe-
cies (Hansen and Zapata, 1998) and the organ with the highest
number of T-cells in sea bass (Abelli et al., 1996), followed by
HK, PBL, spleen and gills with comparable levels; the lowest level
of expression was detected in the muscle followed by brain. Com-
paring to other fish species, low b2m expression was found in the
muscle and brain of walleye (Stizostedium vtreum) (Christie et al.,
2007), large yellow croaker (Pseudosciaena crocea) (Yu et al., 2009)
and rainbow trout (Oncorhynchus mykiss) (Shum et al., 1996), in
agreement with the sea bass data, whereas the tissue with the high-
est expression is not conserved among the mentioned teleosts.
The MHC-I levels show a similar distribution when compared to
those of b2m in the same tissues of sea bass, as shown in Fig. 8B,
which is in agreement with the findings in rainbow trout (Shum
et al., 1996). Hence, the highest expression was found in the thy-
mus followed by gills, spleen, HK and gut, whilst the lowest
expression was detected in the liver and brain (also in trout (Han-
sen et al., 1996)). These results of ubiquitous expression further
support the classical nature of at least one or some of the Dila-
UA sequences (Kaufman et al., 1994), since it was not determined
which ones were amplified here.
3.7. b2m expression analyses after in vitro stimulation
To investigate whether b2m expression levels could be modu-
lated with poly I:C, which simulates a viral infection, in vitro stim-
ulation of HK leucocytes was studied both for short (6 h) and long
(24 h) periods of time (Fig. 9). Head kidney was chosen, since in
some teleosts it has been shown to have both the presence of di-
verse effector cell types in large numbers and of hematopoietic
stem cells (HSCs) that in turn have the ability to reconstitute reci-
pient lympho-hematopoietic organs, as in ginbuna carp (Kobayashi
et al., 2006). A significant increase (p < 0.05) of b2m expression was
detected after 24 h, whereas a small increase was evidenced after
6 h of stimulation. These results are in agreement with the up-reg-
ulation after poly I:C stimulation evidenced in large yellow croaker,
P. crocea (Yu et al., 2009).
Fig. 5. (continued)
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It has been demonstrated in bony fish that IFN- expression can
be induced by poly I:C (Zou et al., 2005) and moreover, in mam-
mals, INF- up-regulates the expression of MHC-class I heavy chain
and b2m (Sugita et al., 1987), a pattern similar to the one detected
in sea bass.
4. Conclusions
In the present study, the b2m cDNA and gene as well as several
MHC class I HC transcripts and two partial genes from sea bass
were cloned for the first time. All characteristic domains that are
present in MHC class I complex light and heavy chains from other
species are observed in both identified molecules. For b2m, charac-
teristics such as exon/intron boundaries, gene number, tissue
expression, and poly I:C inducibility (possible IFN-c regulation)
are also conserved, although the 3-exon structure is different from
that of the human gene. For the HC, besides the PBD, striking var-
iability was unexpectedly observed from the connective peptides
through the 30 UTR regions. Further genomic analysis of a1 through
30 UTR regions in one individual fish revealed that two types of
genes were being transcribed, containing distinct exon/intron
structures and different exons and introns lengths. The observed
specificities could potentially be responsible for distinct functions,
Fig. 6. Phylogenetic tree of b2m and MHC class I heavy chain amino acid sequences from different vertebrate species. neighbor-joining tree calculated with MEGA v5.05
(Tamura et al., 2011), using p-distance parameter and pairwise deletion of gaps. The branches were validated by bootstrap analysis from 1000 replications, represented by
percentages in branch nodes. Mature and precursor forms were used for b2m and heavy chain sequences, respectively. These sequences are the same used in Figs. 4 and 5.
Fish MHC class I molecules from distinct lineages (U, S, L and Z) were used and are labeled (accession numbers detailed in Table S2).
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Fig. 7. Phylogenetic trees of MHC class I heavy chain separate domains from different vertebrate species. Nucleotide sequences were used to construct each neighbor-joining
tree, calculatedwith ClustalX (Larkin et al., 2007) and editedwithMEGA v5.05 (Tamura et al., 2011), using all sites. The brancheswere validated by bootstrap analysis from1000
replications, represented by values in branch nodes. Sea bass sequences are in bold. Putative pseudogenes are indicatedwith suffix ‘p’. Genes from the twoMHC class I regions of
the tetraploidsalmonid species are denoted with _IA or _IB. Accession numbers from sequences retrieved from NCBI GenBank are detailed on Table S2. (A) a1 domains. (B) a2
domains. (C) a3 domains. (D) Connective peptide, transmembrane and cytoplasmic regions. Medakaa1 domain L1–L4 lineages (Nonaka et al., 2011) as well as the two Dila-UA
sub-lineages Cyt-L1 and Cyt-L2 are indicated. The three nile tilapia (Orni) sequences were not used in the cytoplasmic tails tree due to their extremely short length.
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an issue that requires further elucidation. Nonetheless, sequence
conservation of important residues, variability, polygeny and ubiq-
uitous tissue-specific expression suggest that at least one or some
of the sea bass clones here identified represent classical MHC class
I genes. Phylogenetic analysis places all of them among the U
lineage of teleost MHC class I a chains. Separate domain analysis
Fig. 7. (continued)
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classified all sea bass a1 regions as part of the trans-species L1
lineage, which includes Acanthopterygii and salmonid HC genes,
being closely related to the pufferfish ones. Although no distin-
guishable Dila-specific sub-lineages among a1, a2 and a3 domains
could be observed, two well-separated sub-lineages of CP/TM/CYT
regions were identified (Cyt-L1 and Cyt-L2) possibly originated in
different ancestral genes. Dila-b2m and Dila-UA 3D homology
models have been compared to those of other vertebrate mole-
cules. Altogether these results indicate that the reported Dila-
b2m is orthologue of other b2m molecules while the Dila-UA tran-
scripts are orthologues of other Acanthopterygii and salmonid U
lineage MHC class I a genes, both providing important primary
data for future studies on identification of virus-derived T-cell epi-
topes and other aspects of the antigen presentation pathway in this
species.
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Table S1 
Primers used in this study. 
 
 
Letter nucleotide code: H= A, C, T; R= A, G; Y= C, T; S= G, C; W= A, T; V= A, G, C; N= A, T, C, G; I= 
deoxyinosine. 
Table S1 
Primers used in this study. 
Designation Nucleotide sequence 5’-3’  Usage 
AAP GGCCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG 5'RACE 
APv GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTTTTTV cDNA synthesis; PCR (full cDNA) 
AUAP GGCCACGCGTCGACTAGTAC 5'RACE 
APv2 GACTCAGGACTTCAGGACTTAGTTTTTTTTTTTTTTTTTV cDNA synthesis; PCR (full cDNA) 
AUAP2 GACTCAGGACTTCAGGACTTAG PCR (full cDNA) 
T7 TAATACGACTCACTATAGGGCGA sequencing 
SP6 CTATTTAGGTGACACTATAGAATAC sequencing 
b2mFW1 CCHCCHAARRTSSAIGTITA PCR (partial cDNA)  
b2mRV3 TCRAARGCSARRTCIGTYTG PCR (partial cDNA)  
DLb2mFW1 TAGTCGCTCCTGTTTTTCAT PCR (full cDNA and gene) 
DLb2mFW3 GCCGGAGGGATGAACATTAT sequencing (full gene) 
DLb2mFW4 CTAAACCCAAGGTTCAGGTGTA southern blot 
B2M FW GGTTCAGGTGTACAGCC  qPCR 
DLb2mRV1 AAGGCGAGGTCGGTCTGCTT 5'RACE; cDNA synthesis 
DLb2mRV2 ATCCTTCAGCAACTGGATGT 5'RACE 
DLb2mRV4 AAATTTAAAGAGGCATTTAT PCR (full gene) 
DLb2mRV6 GCACCCCCACATTCTCTTAC sequencing (full gene) 
DLb2mRV7 CCCAGGCATAGGTTTTCGTTTC southern blot 
B2M RV CCTTGTGGGTGTGAAGG qPCR 
MHCIFW1 GWSMYCRAYTTYCCIGARTT PCR (partial cDNA)  
MHCIRV1 TCRAAICCIGTIGCRTGRCA PCR (partial cDNA)  
DLMHCIFW2 GGAGCTCTCTGCTGAGAACA sequencing (full cDNA) 
DLMHCIFW3 CAACTGGAAACAGTGTGTGTGAG PCR (full cDNA) 
DLMHCIFW4 GTGTGTGAGTTTCTCTGGATAAAG PCR (full cDNA) 
DLMHCIFW5 AGGCATCACAGCACTTTCTA sequencing (full cDNA) 
DLMHCIFW8 GCTGCCACGCTACAGGTTTC PCR (partial gene) 
DLMHCIFW18 CGATGGATCCTTCCAGATGAG PCR (partial gene) 
MHC-I FW AARMAMTACCTCACCCAGR qPCR 
DLMHCIRV1 GCCGTACATGTTCTGGACAA 5'RACE; cDNA synthesis 
DLMHCIRV2 CGGCTGTGACTCTGCTCATC 5'RACE 
DLMHCIRV4a GTTGAACAGTTTCTGTAAAT sequencing (full cDNA) 
DLMHCIRV4b CTGCATGTAAATCACATAAC sequencing (full cDNA) 
DLMHCIRV4c TCAACATTCTCGTCACTCTT sequencing (full cDNA) 
DLMHCIRV5 ACCTCTTCAATCTGTCACTC sequencing (full cDNA) 
DLMHCIRV8 CACCATAGAGCTGAAACACACAGTC southern blot 
DLMCHIRV14 CTCAGAAGTTCAATGTTGCAGATTT PCR (partial gene, Cyt-L2) 
DLMHCIRV15 AGTCCAAGTGAACTACACATCTCATT PCR (full cDNA, Cyt-L2) 
DLMHCIRV17 ACAGGACTTTATTGAAATCAAAAGTACA PCR (full cDNA, Cyt-L1) 
DLMHCIRV22 CGCTCCTCGTTCGAGTGCAAAA PCR (partial gene, Cyt-L1) 
MHC-I RV CTCCATCTTTCCTCCAGAT  qPCR 
RIB FW CCAACGAGCTGCTGACC  qPCR 
RIB RV CCGTTACCCGTGGTCC  qPCR 
      
Letter nucleotide code: H= A, C, T; R= A, G; Y= C, T; S= G, C; W= A, T; V= A, G, C; N= A, T, C, G; I= 
de inosine. 
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Table S3 
Percentages of amino acid similarity and identity among mature β2m molecules from different species. 
 
 
Table S3 
Percentages of amino acid similarity and identity among mature !2m molecules from different species. 
 
  Similarity (%) Identity (%) 
1. Dicentrarchus labrax - - 
2. Pseudosciaena crocea 82.2 73.3 
3. Stizostedion vitreum 83.2 71.3 
4. Lates calcarifer 80.2 74.3 
5. Oryzias latipes 79.2 63.4 
6. Salmo salar 81.2 67.3 
7. Oncorhynchus mykiss 80.2 65.3 
8. Ictulurus punctatus 81.2 64.4 
9. Ctenopharyngodon idella 79.2 59.4 
10. Danio rerio 81.2 59.4 
11. Barbus intermedius 79.2 63.4 
12. Cyprinus carpio 75.2 62.4 
13. Acipenser baerii 75.2 61.2 
14. Gadus morhua 68.3 53.5 
15. Paralichthys olivaceus 75.2 52.5 
16. Cynoglossus semilaevis 66.3 45.5 
17. Raja eglanteria 58.4 39.6 
18. Carcharhinus plumbeus 59.4 44.6 
19. Xenopus laevis 62.4 37.3 
20. Xenopus tropicalis 54.5 35.3 
21. Gallus gallus 58.4 41.7 
22. Mus musculus 66.3 43.3 
23. Bos taurus 65.3 44.7 
24. Homo sapiens 63.4 43.7 
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Table S4 
Percentages of similarity and identity among MHC class heavy chain molecules from different species. 
 
Table S4 
Percentages of similarity and identity among MHC class heavy chain molecules from different species. 
  Dila-UA Cyt-L1   Dlia-UA Cyt-L2   
  Similarity (%) Identity (%) Similarity (%) Identity (%) 
Dila-UA Cyt-L1 84.5-100 78.7-99.7 74.3-84.2 66.6-77.5 
Dlia-UA Cyt-L2 74.3-84.2 66.6-77.5 79.4-99.5 71.0-99.7 
Stizostedion vitreus 81.5-86.3 69.6-73.5 72.7-79.3 62.3-67.0 
Sparus aurata 76.2-79.9 66.3-69.0 75.1-78.3 64.2-66.7 
Psetta maxima 77.9-80.8 66.0-68.5 68.2-74.1 57.5-62.7 
Epinephelus coioides 77.7-81.3 65.5-67.8 71.7-74.7 59.4-63.3 
Epinephelus akaara 78.5-81.9 64.9-67.5 73.3-77.1 59.7-64.3 
Paralichthys olivaceus 77.3-80.3 63.0-66.7 71.5-74.8 58.3-62.9 
Takifugu rubripes 71.9-76.0 60.3-64.1 68.7-74.7 56.9-62.5 
Oryzias luzonensis 76.5-80.4 61.0-65.2 68.1-73.0 53.2-58.5 
Oryzias latipes 76.6-80.3 60.3-66.3 68.1-73.5 54.0-58.1 
Oryzias dancena 72.8-77.0 59.0-62.9 64.6-71.4 50.6-55.7 
Gasterosteus aculeatus 70.1-75.2 58.3-63.3 65.9-71.4 54.1-58.3 
Poecilia reticulata 70.8-74.1 58.4-62.5 62.6-68.4 48.5-55.2 
Cynoglossus semilaevis 74.9-79.2 58.2-61.9 67.6-73.0 52.7-56.8 
Verasper variegatus 73.4-76.4 57.3-61.9 67.9-72.2 53.2-57.6 
Aulonocara hansbaenschi 72.1-76.3 57.1-59.0 64.1-72.5 50.0-56.2 
Channa argus 68.9-73.6 54.5-59.5 65.1-69.3 51.3-55.1 
Oncorhynchus mykiss 72.2-76.5 55.8-59.7 64.7-72.5 50.5-56.6 
Salmo trutta 68.9-72.5 54.3-56.7 63.1-68.1 49.0-54.8 
Salmo salar 70.9-73.2 53.1-55.3 63.4-70.6 47.7-53.3 
Salvelinus alpinus 72.5-75.1 53.0-55.2 66.3-73.0 49.3-54.3 
Oncorhynchus gorbuscha 65.4-68.7 50.3-53.9 59.5-65.9 45.9-51.6 
Gadus morhua 68.7-70.9 51.7-55.4 62.9-68.7 49.4-55.3 
Ctenopharyngodon idella 62.1-65.4 44.9-47.1 56.6-62.1 41.9-44.3 
Barbus intermedius 60.1-62.8 42.2-45.9 54.2-59.9 38.2-42.5 
Cyprinus carpio 59.7-64.0 43.8-46.8 54.0-61.9 40.1-44.8 
Ictalurus punctatus 59.8-61.7 42.9-45.9 54.7-61.9 39.2-46.0 
Danio rerio 59.4-61.7 39.1-42.1 54.5-59.9 36.9-41.4 
Acipenser sinensis 58.3-62.4 39.9-42.5 53.4-61.3 36.4-41.7 
Polyodon spathula 57.4-60.4 39.5-41.9 53.2-61.6 36.5-42.7 
Protopterus aethiopicus 46.4-48.7 27.0-30.2 48.2-52.3 27.4-29.2 
Heterodontus francisci 54.8-56.7 36.7-39.5 50.6-55.6 33.2-36.4 
Triakis scyllium 53.9-57.0 36.2-39.4 49.8-54.2 33.3-36.7 
Ginglymostoma cirratum 51.2-55.2 35.5-38.6 48.4-52.3 32.8-36.0 
Xenopus laevis 52.2-56.3 33.3-36.4 49.6-54.6 31.8-35.8 
Xenopus tropicalis 53.1-56.7 34.6-36.7 50.7-56.4 31.5-35.2 
Gallus gallus 52.9-55.0 31.9-33.9 48.0-54.0 29.5-35.0 
Iguana iguana 51.0-55.1 32.3-35.4 47.8-51.7 29.6-33.2 
Mus musculus H-2K 52.6-54.7 31.9-33.7 48.1-52.3 29.6-32.8 
Homo sapiens HLA-C 49.7-51.6 28.6-30.6 47.6-50.7 26.7-30.6 
Homo sapiens B*35 51.8-54.4 28.6-30.2 49.1-52.4 28.3-30.3 
Homo sapiens HLA-A-0205 50.7-53.2 28.8-29.8 47.9-51.3 27.5-29.8 
     
Barbus intermedius ZE 43.9-48.2 27.0-29.9 47.0-50.4 27.8-30.6 
Cyprinus carpio ZE 45.9-48.0 28.3-31.7 47.5-50.3 28.4-30.3 
Danio rerio ZE 46.7-49.7 28.1-32.2 48.2-50.7 28.2-32.1 
Salmo salar ZE 47.7-50.3 28.4-31.0 43.1-49.3 25.9-30.8 
Paralichthys olivaceus ZE 43.3-46.3 26.2-27.3 39.8-44.4 23.3-27.1 
Danio rerio L 43.0-45.9 24.7-26.1 40.1-44.4 23.2-26.7 
Oncorhynchus mykiss LBA 46.2-49.6 24.9-26.8 44.1-47.5 23.4-26.4 
Salmo salar SAA 45.2-48.6 23.1-25.2 40.3-45.2 19.8-23.0 
Oncorhynchus mykiss SAA 45.8-49.4 23.3-25.2 41.8-45.5 20.0-22.9 
Salmo trutta SAA 43.3-46.4 22.3-24.7 39.6-43.1 19.8-21.7 
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Figure S1. Alignment of MHC class I heavy chain nucleotide sequences with short cytoplasmic tails. 
Nucleotide sequences were aligned with CLUSTALW. Dashes indicate gaps that maximize the alignment, and 
dots denote residues identical to the first sequence of the alignment. Identical residues, conserved and semi-
conserved substitutions are denoted below the alignment with, (*), (:) and (.), respectively. Numbers right to 
the sequences denote their lengths. 5’UTRs, distinct domains and 3’UTRs are indicated above the alignment. 
Start and stop codons are bold and underlined. Grey shading highlights a different start of domain. Cyan 
shading denotes location of intron according to MhcDila-UA*25. 
                    !5’UTR                                                                           !Signal Peptide  
MhcDila-UA*05       CAACTGGAAACAGTGTGTGTGAGTTTCTCTGGATAAAGAAATATTTCTTCTTCAGTTCATTAAATCCTCAGATTGAACACA ATGAAGACCCTGATGTTTGTGTTCCTGCTGGGAATAGGTCTACATGGCG 130   
MhcDila-UA*06       ............................................C.................................... ....................A............................ 130   
MhcDila-UA*17       .........................................C..C.................................... .....................G........................... 130   
MhcDila-UA*18       .........................................C..C...........................C........ ................................................. 130   
MhcDila-UA*19       .........................................C..C...........................C........ ................................................. 130   
MhcDila-UA*04       ............................................C.................................... .....................G........................... 130   
MhcDila-UA*15       .........................................C..C.................................... .....................G........................... 130   
MhcDila-UA*16       .........................................C..C.................................... .....................G........................... 130   
MhcDila-UA*14       ........G................................C..C.................................... .....................G........................... 130   
MhcDila-UA*01       --------------......................G-...C..C.................................... .....................G........................... 115   
MhcDila-UA*02       --------------......................G-...C..C.................................... .....................G........................... 115   
MhcDila-UA*03       .........................................C..C.................................... .....................G........................... 130   
Clustal Consensus                 **********************. *** ** *************************** ******** ********************. *************************** 109   
                             !alpha 1 domain 
MhcDila-UA*05       CTGCGGCA GTGACTCACTCTCTGAAGTATTTCTACACTGCGTCTTCTGGAGTCCCAAACTTCCCAGAGTTTGTGGCTGTTGGGTTGGTCGATGAAGGTCAGATGTATTACTATGACAGTAACACCAGGAG 260   
MhcDila-UA*06       ........ .................................................................TA.......T.....T.......CA.....AAG.C...................... 260   
MhcDila-UA*17       ........ ..................................................................A.............T..............AG......................... 260   
MhcDila-UA*18       ........ ..................................................................T.............T..............AG........................A 260   
MhcDila-UA*19       ........ ..................................................................T.............T..............AG........................A 260   
MhcDila-UA*04       ........ ..................AT................................................CC..TC......T.....T.T.......A......................... 260   
MhcDila-UA*15       ........ .................................................................TA.............T.......C.......AT.C.....................A 260   
MhcDila-UA*16       ........ .................................................................TA.............T.......C.......AT.C.....................A 260   
MhcDila-UA*14       ........ .................................................................TA.............T.......C.......AT.C.....................A 260   
MhcDila-UA*01       ........ ..................................................................AT............T..C....T..........C...................... 245   
MhcDila-UA*02       ........ ..................................................................AT............T.......T..........C...................... 245   
MhcDila-UA*03       ........ ..................................................................AT............T.......T..........C...................... 260   
Clustal Consensus   ******** ******************::*********************************************     **   ***** ** **:* :*****.  * *********************. 223   
 
MhcDila-UA*05       AGCAGAACCCAAACAGGACTGGATGAGCAGAGTCACAGCAGAGGATCCTCAGTACTTGGAGAGGGAGACTCAGAAGTCTCTGGGTGCCCAGCAGACCTTCAAAGCCAACATTGAAATCTTGAAGCCACGC 390   
MhcDila-UA*06       ..............................................T.........G....G...T........TC.T.......T....................GG...................... 390   
MhcDila-UA*17       ........................................................G.......C.........TC.A.T..A................A................CTG.......G... 390   
MhcDila-UA*18       ..AT.T...............................A....T.............G....G..............CG.T.....AA.......TGG.......T...........CTGC.....AG... 390   
MhcDila-UA*19       ..AT.T...............................A....T.............G....G..............CG.T.....AA.......TGG.......T...........CTGC.....AG... 390   
MhcDila-UA*04       ..........................A...........A.................G......A..........TCCG.T.....CA........A.....................TGC.....AG... 390   
MhcDila-UA*15       ...C......................................CAGAG..G.C....G...CT..C.....G.C.TT.T.GC.............GT........G........G..CTGC.....AG... 390   
MhcDila-UA*16       ...C......................................CAGAG..G.C....G...CT..C.....G.C.TT.T.GC.............GT........G...........CTGC.....AG... 390   
MhcDila-UA*14       ...C......................................CAGAG..G.C....G...CT..C.....G.C.TT.T.GC.............GT........G...........CTGC.....AG... 390   
MhcDila-UA*01       ......................................A..GCA.AG..G.C....G....TAT......GG...CGG.T.....A.........T........G...........CTGC.....AG... 375   
MhcDila-UA*02       ......................................A..GCA.AG..G.C....G....TAT......GG...CGG.T.....A.........T........G...........CTGC.....AG... 375   
MhcDila-UA*03       ......................................A..GCA.AG..G.C....G....TAT......GG...CGG.T.....A.........T........G...........CTGC.....AG... 390   
Clustal Consensus   **. *:********************.**********..**. ..: ** * **** ***  .  :**** . *:   *  *.** .*******   **.**** *..*****.**    *****..*** 310   
                                    !alpha 2 domain 
MhcDila-UA*05       TTCAACCAAACTGGA GGTGTCCACATTGTCCAGAACATGTACGGCTGTGAGTGGGATGATGAGACTGGAGAGGTTGATGGTAATTATCAGTTTGGTTATGATGGAGAAGACTTCATAGCATTAGACCTGA 520   
MhcDila-UA*06       ............... ............T.....TGG..............AC....C.........AAT....C.A.....TT.ATG....A...............C..............T....... 520   
MhcDila-UA*17       ............... .........G..T.....GTG.......................................A.....TT.C............................TG.......T....... 520   
MhcDila-UA*18       ............... ............T.....CTG.........................T.............................................G..............T....... 520   
MhcDila-UA*19       ............... ............T.....CTG.........................T.............................................G..............T....... 520   
MhcDila-UA*04       ............... ............AA.....GG....................C..................A.....T..G....AGA..............................T....... 520   
MhcDila-UA*15       ............... ............AA......G..............................AAT......A.....TT.ATG....GG.....................G.......T....... 520   
MhcDila-UA*16       ............... ............AA......G..............................AAT......A.....TT.ATG....GG.....................G.......T....... 520   
MhcDila-UA*14       ............... ............AA......G..............................AAT......A.....TT.ATG....GG.....................G.......T....... 520   
MhcDila-UA*01       ............... .........G..TA.....GG.......................................A.....T..G......GG.........................T...T....... 505   
MhcDila-UA*02       ............... .........G..TA.....GG.......................................A.....T..G......GG.........................T...T....... 505   
MhcDila-UA*03       ............... .........G..TA.....GG.......................................A.....T..G......GG.........................T...T....... 520   
Clustal Consensus   *************** *********.** :****   **************. **** ****:****..:**** *.*****::* : **.   ************** ***** .*** ***:******* 418   
 
 
MhcDila-UA*05       AGACAGAGACATGGACCGCTCCAGTTCCACAGGCTTTCATCACCAAAAACAAGTTGGATAATGACAGAGCTCAGATATCATATTTAAACAACTACCTCACCCAGGAGTGCATTGACTGGTTGAAGAAGTA 650   
MhcDila-UA*06       ..........T....T.........G.........G...........C......G.......ATT.A........C.G..CG...T..A......................................... 650   
MhcDila-UA*17       ............AC.T.......AAA.........G....................A.....A...A....G.....G..C..AG...AC........................................ 650   
MhcDila-UA*18       .......................AAA.A.......G..................G.A..............TTC.AC...C.GAAG..G...............ATT....................... 650   
MhcDila-UA*19       ..........G............AAA.A.......G..................G.A..............TTC.AC...C.GAAG..G...............ATT................G...... 650   
MhcDila-UA*04       ............AC.T.......AAA.........G...........C.G....G...........A....GT....G..C.GAG...A...............ATT..TCC.................. 650   
MhcDila-UA*15       .......................A.G.........G..................G................T.T...G..C.GAC...AC.A............ATT....................... 650   
MhcDila-UA*16       .......................A.G.........G..................G................T.T...G..C.GAC...AC.A............ATT....................... 650   
MhcDila-UA*14       .......................A.G.........G..................G................T.T...G..C.GAC...AC.A............ATT....................... 650   
MhcDila-UA*01       ............TC.T.......AGA.........G...........C......G................TTCT.GG.TGGGCGG..GC.A...TA.......ATT..TCC...G.............. 635   
MhcDila-UA*02       ............TC.T.......AGA.........G...........C......G................TTCT.GG.TGGGCAG..GC.A...TA.......ATT..TCC...G.............. 635   
MhcDila-UA*03       ............TC.T.......AGA.........G...........C......G................TTCT.GG.TGGGCAG..GC.A...TA.......ATT..TCC...G.............. 650   
Clustal Consensus   ********** *  * *******.  *.******* ***********.* **** *.*****.: *.**** : :   *: .    ** .*.*** :*******.: ** . *** *******.****** 510   
                                                       !alpha 3 domain 
MhcDila-UA*05       TGTGGACTATGGGAGGAGCTCTCTGCTGAGAACA GACCGTCCCTCAGTGTCTCTCCTCCAGAAGACTTCCTCCTCTCCAGTCAGCTGCCACGCTACAGGTTTCTACCCTGACAGTGCCACACTCATCTGG 780   
MhcDila-UA*06       .................................. ........G.........T............................................................................. 780   
MhcDila-UA*17       .................................. ........G.........T..............C.............................................................. 780   
MhcDila-UA*18       .................................. ..................T........................................................A.................... 780   
MhcDila-UA*19       .................................. ..................T........................................................A.................... 780   
MhcDila-UA*04       .................................. ..G.T............................C.........................................A.................... 780   
MhcDila-UA*15       .T................................ ........G..................................................................A.................... 780   
MhcDila-UA*16       .T................................ ........G..................................................................A.................... 780   
MhcDila-UA*14       .T................................ ........G..................................................................A.................... 780   
MhcDila-UA*01       ....A............................. ..G.T........................A..................C............................................... 765   
MhcDila-UA*02       ....A............................. ..G.T...........................................C............................................... 765   
MhcDila-UA*03       ....A............................. ..G.T...........................................C............................................... 780   
Clustal Consensus   * **.***************************** ** * *** ********* **********.*** **************.**************************.******************** 630   
 
MhcDila-UA*05       AGGAAAGATGGAGTGGAGCTTCATGAGAACGTGGAACACGGAGAGATCCTCCTCAACCATGATGGATCCTTCCAGATGAGTGTTGACCTGAAGCTTCCTTCATCAGTCACACCTGAAGACTGGAGGAGGT 910   
MhcDila-UA*06       ...........................................................C...................................................................... 910   
MhcDila-UA*17       ..................A......................................A.C..............................G.C..---............---................. 904   
MhcDila-UA*18       .............A....A........................................C...................................................................A.. 910   
MhcDila-UA*19       .............A....A........................................C...................................................................A.. 910   
MhcDila-UA*04       ............C.....A........G........................C....A.C.....................A........G.C..---............---................. 904   
MhcDila-UA*15       .............A.....................C.......................C...................................................................A.. 910   
MhcDila-UA*16       .............A.....................C.......................C...................................................................A.. 910   
MhcDila-UA*14       .............A.....................C.......................C...................................................................A.. 910   
MhcDila-UA*01       .............A....A........G.......C.......................C................................A....A................................ 895   
MhcDila-UA*02       .............A....A........G.......C.......................C................................A....A................................ 895   
MhcDila-UA*03       .............A....A........G.......C.......................C................................A....A................................ 910   
Clustal Consensus   ************ :****.********.*******.**************** ****.* *********************.********.* **   ************   **************.** 743   
                                                                          !CP                                                                      !TM domain 
MhcDila-UA*05       ACGACTGTGTGTTTCAGCTCTATGGTGGGAAGAACGACATCGTCACTAAACTG GACAAAGCAGTGATCAGGACCAAT---------------------------GAAGAGAAACCTGATAACACG ACTGT 1013  
MhcDila-UA*06      .T............................................C...... ........................---------------------------..................... ..... 1013  
MhcDila-UA*17       .....................C.....T.......A.........TC...... ........................---------------------------..................... ..... 1007  
MhcDila-UA*18       ..............................................C...... ........................---------------------------..................... ..... 1013  
MhcDila-UA*19       ..............................................C...... .......................---------------------------..................... ..... 1013  
MhcDila-UA*04       .....................C.....T.................TC...... ..............T.........---------------------------....G---TTT...C.CG..T .TCA. 1004  
MhcDila-UA*15       ..............................................C...... ........................---------------------------..................... ..... 1013  
MhcDila-UA*16       ..............................................C...... ...................... .---------------------------..................... ..... 1013  
MhcDila-UA*14       ..............................................C...... ........................---------------------------..................... ..... 1013  
MhcDila-UA*01       ..A..................C.....T.................TC...... ......T...A.....AA..T..CTGGGGCAAGACTGGGATCAGGAGTGAG..................... ..... 1025  
MhcDila-UA*02       ..A..................C.....T.................TC...... ......T...A.....AA..T..CTGGGGCAAGACTGGGATCAGGAGTGAG..................... ..... 1025  
MhcDila-UA*03       ..A..................C.....T.................TC...... ......T...A.....AA..T..CTGGGGCAAGACTGGGATCAGGAGTGAG..................... ..... 1040  
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Figure S1 (continued) 
 
MhcDila-UA*05       AGACAGAGACATGGACCGCTCCAGTTCCACAGGCTTTCATCACCAAAAACAAGTTGGATAATGACAGAGCTCAGATATCATATTTAAACAACTACCTCACCCAGGAGTGCATTGACTGGTTGAAGAAGTA 650   
MhcDila-UA*06       ..........T....T.........G.........G...........C......G.......ATT.A........C.G..CG...T..A......................................... 650   
MhcDila-UA*17       ............AC.T.......AAA.........G....................A.....A...A....G.....G..C..AG...AC........................................ 650   
MhcDila-UA*18       .......................AAA.A.......G..................G.A..............TTC.AC...C.GAAG..G...............ATT....................... 650   
MhcDila-UA*19       ..........G............AAA.A.......G..................G.A..............TTC.AC...C.GAAG..G...............ATT................G...... 650   
MhcDila-UA*04       ............AC.T.......AAA.........G...........C.G....G...........A....GT....G..C.GAG...A...............ATT..TCC.................. 650   
MhcDila-UA*15       .......................A.G.........G..................G................T.T...G..C.GAC...AC.A............ATT....................... 650   
MhcDila-UA*16       .......................A.G.........G..................G................T.T...G..C.GAC...AC.A............ATT....................... 650   
MhcDila-UA*14       .......................A.G.........G..................G................T.T...G..C.GAC...AC.A............ATT....................... 650   
MhcDila-UA*01       ............TC.T.......AGA.........G...........C......G................TTCT.GG.TGGGCGG..GC.A...TA.......ATT..TCC...G.............. 635   
MhcDila-UA*02       ............TC.T.......AGA.........G...........C......G................TTCT.GG.TGGGCAG..GC.A...TA.......ATT..TCC...G.............. 635   
MhcDila-UA*03       ............TC.T.......AGA.........G...........C......G................TTCT.GG.TGGGCAG..GC.A...TA.......ATT..TCC...G.............. 650   
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                                                       !alpha 3 domain 
MhcDila-UA*05       TGTGGACTATGGGAGGAGCTCTCTGCTGAGAACA GACCGTCCCTCAGTGTCTCTCCTCCAGAAGACTTCCTCCTCTCCAGTCAGCTGCCACGCTACAGGTTTCTACCCTGACAGTGCCACACTCATCTGG 780   
MhcDila-UA*06       .................................. ........G.........T............................................................................. 780   
MhcDila-UA*17       .................................. ........G.........T..............C.............................................................. 780   
MhcDila-UA*18       .................................. ..................T........................................................A.................... 780   
MhcDila-UA*19       .................................. ..................T........................................................A.................... 780   
MhcDila-UA*04       .................................. ..G.T............................C.........................................A.................... 780   
MhcDila-UA*15       .T................................ ........G..................................................................A.................... 780   
MhcDila-UA*16       .T................................ ........G..................................................................A.................... 780   
MhcDila-UA*14       .T................................ ........G..................................................................A.................... 780   
MhcDila-UA*01       ....A............................. ..G.T........................A..................C............................................... 765   
MhcDila-UA*02       ....A............................. ..G.T...........................................C............................................... 765   
MhcDila-UA*03       ....A............................. ..G.T...........................................C............................................... 780   
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MhcDila-UA*05       AGGAAAGATGGAGTGGAGCTTCATGAGAACGTGGAACACGGAGAGATCCTCCTCAACCATGATGGATCCTTCCAGATGAGTGTTGACCTGAAGCTTCCTTCATCAGTCACACCTGAAGACTGGAGGAGGT 910   
MhcDila-UA*06       ...........................................................C...................................................................... 910   
MhcDila-UA*17       ..................A......................................A.C..............................G.C..---............---................. 904   
MhcDila-UA*18       .............A....A........................................C...................................................................A.. 910   
MhcDila-UA*19       .............A....A........................................C...................................................................A.. 910   
MhcDila-UA*04       ............C.....A........G........................C....A.C.....................A........G.C..---............---................. 904   
MhcDila-UA*15       .............A.....................C.......................C...................................................................A.. 910   
MhcDila-UA*16       .............A.....................C.......................C...................................................................A.. 910   
MhcDila-UA*14       .............A.....................C.......................C...................................................................A.. 910   
MhcDila-UA*01       .............A....A........G.......C.......................C................................A....A................................ 895   
MhcDila-UA*02       .............A....A........G.......C.......................C................................A....A................................ 895   
MhcDila-UA*03       .............A....A........G.......C.......................C................................A....A................................ 910   
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                                                                          !CP                                                                      !TM domain 
MhcDila-UA*05       ACGACTGTGTGTTTCAGCTCTATGGTGGGAAGAACGACATCGTCACTAAACTG GACAAAGCAGTGATCAGGACCAAT---------------------------GAAGAGAAACCTGATAACACG ACTGT 1013  
MhcDila-UA*06       .T............................................C...... ........................---------------------------..................... ..... 1013  
MhcDila-UA*17       .....................C.....T.......A.........TC...... ........................---------------------------..................... ..... 1007  
MhcDila-UA*18       ..............................................C...... ........................---------------------------..................... ..... 1013  
MhcDila-UA*19       ..............................................C...... ........................---------------------------..................... ..... 1013  
MhcDila-UA*04       .....................C.....T.................TC...... ..............T.........---------------------------....G---TTT...C.CG..T .TCA. 1004  
MhcDila-UA*15       ..............................................C...... ........................---------------------------..................... ..... 1013  
MhcDila-UA*16       ..............................................C...... ........................---------------------------..................... ..... 1013  
MhcDila-UA*14       ..............................................C...... ........................---------------------------..................... ..... 1013  
MhcDila-UA*01       ..A..................C.....T.................TC...... ......T...A.....AA..T..CTGGGGCAAGACTGGGATCAGGAGTGAG..................... ..... 1025  
MhcDila-UA*02       ..A..................C.....T.................TC...... ......T...A.....AA..T..CTGGGGCAAGACTGGGATCAGGAGTGAG..................... ..... 1025  
MhcDila-UA*03       ..A..................C.....T.................TC...... ......T...A.....AA..T..CTGGGGCAAGACTGGGATCAGGAGTGAG..................... ..... 1040  
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                                                                                        !CYT tail 
MhcDila-UA*05       CATCATCATTGCTGCAGTGGTTGTTCTCGCTCTCGTCCTCATCGCTGTGATTGGAGCCGTCATCTAT AAAAAGAAGAATGAGAAACGCCCTCCATCTCCTATAAGCAACCCTGAGGTCATGGAGCAACTG 1143  
MhcDila-UA*06       ................................................................... ........A.....C................................................ 1143  
MhcDila-UA*17       .........................................................T......... ............................................................... 1137  
MhcDila-UA*18       .........................................................T......... ............................................................... 1143  
MhcDila-UA*19       .........................................................T......... ............................................................... 1143  
MhcDila-UA*04       .................................................G.....TT.T........ ........A....CC................................................ 1134  
MhcDila-UA*15       .................................T.C.G....T.T...................... ........A.....C..........................................G..... 1143  
MhcDila-UA*16       .................................T.C.G....T.T...................... ........A.....C..........................................G..... 1143  
MhcDila-UA*14       .................................T.C.G....T.T...................... ........A.....C.........................G................G..... 1143  
MhcDila-UA*01       ............C......................C.G....T.T...........T.......... .......................................................C....... 1155  
MhcDila-UA*02       ............C......................C.G....T.T...........T..C....... ...............................................A............... 1155  
MhcDila-UA*03       ............C......................C.G....T.T...........T.......... ...............................................A............... 1170  
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                                    !3’UTR       
MhcDila-UA*05       AACCCAAATGCCTAA ACAACAAAAACACCAT-CTGAACACAGTTTATGGACACATTTTGCACTCGAACGAGGAGCGGTCCCTCCACATTCTCCTCTGTAAACTGGGAATTCATTGGTTGTTCATCATCAT 1272  
MhcDila-UA*06       ............... ................-.................................................................................................. 1272  
MhcDila-UA*17       ............... ................-...............................................................C.................................. 1266  
MhcDila-UA*18       ............... ................-...............................................................C.................................. 1272  
MhcDila-UA*19       ............... ................-...............................................................C.................................. 1272  
MhcDila-UA*04       ...........T... ...............CC..................T............................................C.................................. 1264  
MhcDila-UA*15       ........A...... .....T.........CC..................TT........................A..................C...................A.AA......CA... 1273  
MhcDila-UA*16       ........A...... .....T.........CC..................TT........................A..................C...................A.AA......CA... 1273  
MhcDila-UA*14       ........A...... .....T.........CC..................TT........................A..................C...................A.AA......CA... 1273  
MhcDila-UA*01       ...........T... .....------....CC..............................................T...........AA...C.................................. 1279  
MhcDila-UA*02       ...........T... .....------....CC..............................................T...........AA...C.................................. 1279  
MhcDila-UA*03       ...........T... .....------....CC..............................................T...........AA...C....................C............. 1294  
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MhcDila-UA*05       ACAATAAACTGATCAGGGTTGGAAATCTAGTAGTAGATGCTTATTAATTGGAATACAAAGAACACAAATTTGATAAATTAGTTTACAAACATTTTACA---TAACAAATATAAACATAAATGGCGACATT 1399  
MhcDila-UA*06       .........................................................................................-........---............................. 1398  
MhcDila-UA*17       .........................................................................................-........---............................. 1392  
MhcDila-UA*18       .........................................................................................-........---............................. 1398  
MhcDila-UA*19       .........................................................................................-........---............................. 1398  
MhcDila-UA*04       ...........................................................A......G...........G...................---.T........................... 1391  
MhcDila-UA*15       ...G..........................................................................G...................---.T........................... 1400  
MhcDila-UA*16       ...G..........................................................................G...................---.T........................... 1400  
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MhcDila-UA*05       TATATTAAGAAAATAAATAGTTATTTTATTCTCTGGTTGTATTAGATCACTGGAAGCAAAACTGAAAATCAATCAGCAACATCCAAAAGTATACTTCCTATATTGGACACTCTGTATTGCCTTTAGGTGT 1889  
MhcDila-UA*06       ...........................-....................................C................................................................. 1877  
MhcDila-UA*17       ...........................-................................-...C................................................................. 1872  
MhcDila-UA*18       ...........................-................................-...C................................................................. 1876  
MhcDila-UA*19       ................G..........-................................-...C................................................................. 1879  
MhcDila-UA*04       ..............C.T----......G........................------------------G.................A...G...............C.............G...T... 1882  
MhcDila-UA*15       ...................A..C....G........C....AC......T......T.......C.......................T...G.......................C..T..G....... 1871  
MhcDila-UA*16       ...................A..C....G........C....AC......T......T.......C.......................T...G.......................C..T..G....... 1871  
MhcDila-UA*14       ...................A..C....G........C....AC......T......T.......C.......................T...G.......................C..T..G....... 1870  
MhcDila-UA*01       ..............CG----..C....G....................................C...........................G..........................T..G...T... 1850  
MhcDila-UA*02       ..............CG----..C.C..G....................................C...........................G..........................T..G...T... 1851  
MhcDila-UA*03       ..............CG----..C....G....................................C...........................G..........................T..G...T... 1866  
Clustal Consensus   **************..    **.* ** ******** ****: ****** **                  .***************** ***.***************.******* ** ** *** *** 1495  
 
MhcDila-UA*05       TAATGTAATAATAAAAT--------------------------------------------------------------------------------------------------------TTTGTTTCA 1915  
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Figure S1 (continued) 
 
 
 
MhcDila-UA*05       CTCGGGTGAATTATCTGGATTTGTAAATAATTCATTGGACACACATTTCCACCTGTTTCCTGCTACATGGTTTAATTTACAGAAACTGTTCAACATCTTGAAATACATGCAAATACTGAAT-AAACAGTG 2044  
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MhcDila-UA*17       .........................................................................................................................-........ 2027  
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MhcDila-UA*16       ..G.TT.....................................T.......T...G..A...........................................................C..-.....C.. 2130  
MhcDila-UA*14       ..G.TT.....................................T.......T...G..A...........................................................C..-.....C.. 2129  
MhcDila-UA*01       ..G........................................T.......T...G..A...................................................G..........-........ 2109  
MhcDila-UA*02       ..G........................................T.......T...G..A...................................................G..........-........ 2110  
MhcDila-UA*03       ..G........................................T.......T...G..A...................................................G..........-........ 2125  
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MhcDila-UA*05       ATAGT-TTGTATCAATGTTGCCCATCCCCATACACACAG----------------------ACACACA-CACACACACACACACACACACACACACACAAACAATATAAGAATCAGGACAGAATTAAGGT 2150  
MhcDila-UA*06       ....G-..............................T..ACACACACACACACACACACAC.......-........................................................T..T. 2160  
MhcDila-UA*17       ....G-.........................------------------------------.......-..............A..............G---.....CT.C................... 2122  
MhcDila-UA*18       ....GG....................T..CATT.TT-------------------------......C-..............A..G...........G---.....CT.C................... 2133  
MhcDila-UA*19       ....G-.......................CAT-----------------------------......CA..............A..............G---.....CT.C................... 2131  
MhcDila-UA*04       ....G-..................C......------------------------------------------------------...............TAT....CT.C..............T..T. 2216  
MhcDila-UA*15       ....G-..........................------------CACACACACACACACAC.......-......................A...A.............................T..T. 2246  
MhcDila-UA*16       ....G-.........................----------------ACACACACACACAC.......-......................A...A.............................T..T. 2242  
MhcDila-UA*14       ....G-..........................------------TACACACACACACACAC.......-......................A...A.............................T..T. 2245  
MhcDila-UA*01       .....-......T....................----------ACACACACACACACACAC.......-........................................................T..T. 2227  
MhcDila-UA*02       .....-......T..................--------------------ACACACACAC.......-........................................................T..T. 2218  
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MhcDila-UA*05       TCCAGTTGTGTAAATAGTTTGCTTGTTTATTTCTTTAAAAGTGATCAAATTTAAAAATGTTGTTTTGATTCCAATCAGGCCAAAGTATATAATTTATGTTTTTGAGATTTTTCTGAATTAAGCAAGAGTG 2280  
MhcDila-UA*06       .................................................................................................................................. 2290  
MhcDila-UA*17       .................................................................................................................................. 2252  
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MhcDila-UA*19       .................................................................................................................................. 2261  
MhcDila-UA*04       ..........................A............................GG.T....................................................-.................. 2345  
MhcDila-UA*15       ..........................A............................G..C....................................................................... 2376  
MhcDila-UA*16       ..........................A............................G..C....................................................................... 2372  
MhcDila-UA*14       ..........................A............................G..C....................................................................... 2375  
MhcDila-UA*01       ..........................A............................G..T..............................................................A........ 2357  
MhcDila-UA*02       ..........................A............................G..T..............................................................A........ 2348  
MhcDila-UA*03       ..........................A............................G..T..............................................................A........ 2371  
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MhcDila-UA*05       TGTTATTGTTATTGTTTTTGTTTTCATAATATCTCTGTTTTAATTAGTTTGGAAACTATTATATTTAAATTTTAGCTGAAAGGGTTGTGGGATGTTTTAAGCTTCTCAGCACACTGATAGAAATCTTTTT 2410  
MhcDila-UA*06       .................................................A.......................................A...................--................... 2418  
MhcDila-UA*17       .............................................................................................................--................... 2380  
MhcDila-UA*18       ..................................--......................C..................................................--................... 2389  
MhcDila-UA*19       ....................C........................................................................................--................... 2389  
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MhcDila-UA*15       .............................................................................A..T............................--.......G..........G 2504  
MhcDila-UA*16       .............................................................................A..T............................--.......G..........G 2500  
MhcDila-UA*14       .............................................................................A..T............................--.......G..........G 2503  
MhcDila-UA*01       .....................................................G............C..........A..T............................--.......G..........G 2485  
MhcDila-UA*02       ..................................................................C..........A..T............................--.......G..........G 2476  
MhcDila-UA*03       ..................................................................C..........A..T............................--.......G..........G 2499  
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MhcDila-UA*05       GAAAATACT---TGCTAATATTTAGGGACAAGGGACATTTTCTCTCTTAGTTTTCTAGAAAATACTCAAAATTACTTTTTGTG--TTAGATTGAGTGGATTAATCTCAGATTAAATTGTTCAACTGTTTT 2535  
MhcDila-UA*06       .........---.......................................................................--..G............G............................. 2543  
MhcDila-UA*17       .........---.......................................................................--..G..................T....................... 2505  
MhcDila-UA*18       .........---...............................--------A..A............................--..GA......................................... 2506  
MhcDila-UA*19       .........---.......................................................................--..G..................T....................... 2514  
MhcDila-UA*04       .........TCT........................................A.A.................C.A.CAA.CA.GG..GA...........G....................T........ 2597  
MhcDila-UA*15       .........TCT..................T.......................A...---------................--..GA...........G....................T........ 2623  
MhcDila-UA*16       .........TCT..................T.......................A...---------................--..GA...........G....................T........ 2619  
MhcDila-UA*14       .........TCT..................T.......................A...---------................--..GA...........G....................T........ 2622  
MhcDila-UA*01       .........TCT..................T.......................A...---------................--..GA...........G....................T........ 2604  
MhcDila-UA*02       .........TCT..................T.......................A...---------................--..GA...........G....................TG....... 2595  
MhcDila-UA*03       .........TCT..................T.......................A...---------................--..GA...........G....................T........ 2618  
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MhcDila-UA*05       GTTCCCTTTGTACTTTTGATTTCAATAAAGTCCTGTCAAGTCTAAAAAAAAAAAAAAAA-------- 2594  
MhcDila-UA*06       ..........................................C................AA------ 2604  
MhcDila-UA*17       ....................................------------------------------- 2541  
MhcDila-UA*18       ...A................................------------------------------- 2542  
MhcDila-UA*19       ....................................------------------------------- 2550  
MhcDila-UA*04       ..................................A.A.....C................AA------ 2658  
MhcDila-UA*15       -...................................------------------------------- 2658  
MhcDila-UA*16       -...................................------------------------------- 2654  
MhcDila-UA*14       -...................................------------------------------- 2657  
MhcDila-UA*01       -...................................A.....C..GTCC..........AAAAAAA- 2669  
MhcDila-UA*02       -...................................A.....C..GTCC..........AAAAAAA- 2660  
MhcDila-UA*03       -...................................A.....C..GTCC..........AAAAAAAA 2684  
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Figure S2. Alignment of MHC class I heavy chain nucleotide sequences with long cytoplasmic tails. 
Nucleotide sequences were aligned with CLUSTALW. Dashes indicate gaps that maximize the alignment, and 
dots denote residues identical to the first sequence of the alignment. Identical residues, conserved and semi-
conserved substitutions are denoted below the alignment with, (*), (:) and (.), respectively. Numbers right to 
the sequences denote their lengths. 5’ UTRs, distinct domains and 3’ UTRs are indicated above the 
alignment. Start and stop codons are bold and underlined. Grey shading highlights a different start of domain. 
Cyan shading denotes location of intron according to MhcDila-UA*26. 
 
 
                    !5’UTR                                                                             !Signal Peptide 
MhcDila-UA*20       CAACTGGAAACAGTGTGTGTGAGTTCCTCTGGATAAAGAAACATCTCT--TCTTCAGTTCATTAAATCCTCAGATTGAACACA ATGAAGACCCTGATGTTTGTGGTCCTGCTGGGAATAGGTCTACATGG 128   
MhcDila-UA*21       .........................T......................--................................. ............................................... 128   
MhcDila-UA*08       .........................T......................--...............................T. .....................T......................... 128   
MhcDila-UA*09       .........................T.................CT..AGTGA............................... ............................................... 130   
MhcDila-UA*22       .........................TT.....................T--................................ ...................................T........... 128   
MhcDila-UA*23       .........................TT.....................T--................................ ............................................... 128   
MhcDila-UA*24       .........................T......................T--................................ ............................................... 128   
MhcDila-UA*12       .........................TT..............T......T--................................ ............................................... 128   
MhcDila-UA*07       .........................T...............T......-----.............................. .....................T......................... 125   
MhcDila-UA*11       .........................TT..............T......T--................................ ............................................... 128   
MhcDila-UA*10       .........................T......................T--.......................C........ ............................................... 128   
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                               !alpha 1 domain 
MhcDila-UA*20       CGCTGCGGCA GTGACTCACTCTCTGAAGTATTTCTACACTGCGTCTTCTGGAGTCCCAAACTTCCCAGGGTTTGTGATTGTTGGGTTGGTTGATGAAGTTCAGATGTATCACTATGACAGTAACACCAGG 258   
MhcDila-UA*21       .......... ..........................................................A............................................................. 258   
MhcDila-UA*08       .......... ..........................................................A...........................T.G......AG..T.................... 258   
MhcDila-UA*09       .......... ..........................................................A......T.C......T.............CA.....AAG...................... 260   
MhcDila-UA*22       .....T.... ...................................................C......A.............................C......AG.ATC................... 258   
MhcDila-UA*23       .....T.... ...................................................C......A.............................C......AG.ATC................... 258   
MhcDila-UA*24       .......... ..........................................................A.......GC...................A...C....A..T..................C. 258   
MhcDila-UA*12       .....T.... ..........................................................A..A....TC..................T........AAG.....G..............T. 258   
MhcDila-UA*07       .......... ...............................G..........................A.......TC....................G......AG..T.................... 255   
MhcDila-UA*11       .....T.... ..........................................................A..A....TC..................T........AAG.....G..............T. 258   
MhcDila-UA*10       .......... ...............................G..........................A..A....TC..................T........AAG.....G..............T. 258   
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MhcDila-UA*20       AGAGCAGAACCCAAACAGGACTGGATGAGCAGAGTCACAGAAGGCAAAGCTGACTACTGGGAGTATGAGACTGGGAACGGTTTGGGTACCCAGCAGATCTTCAAAGGCAACATTGAAACTGCGAAGCAGC 388   
MhcDila-UA*21       .................................................................................................................................. 388   
MhcDila-UA*08       ........................................C..A..G...............C.GG......CA...GC........G........G.........C....................... 388   
MhcDila-UA*09       ........................................C..AGG.TT..C.G.........GGG.T....CA..T.TT.C.....T.........C........A...........TCTT.....CA. 390   
MhcDila-UA*22       ...TTC.T................G...A..AG------.C..TAG.TC..C.G.........AGG......CA...GTC.CC....G.........A........C...........TA.......... 382   
MhcDila-UA*23       ...TTC.T................G...A..AG------.C..TAG.TC..C.G.........AGG......CA...GTC.C.....G.........A........C...........TA.......... 382   
MhcDila-UA*24       ...TTCAT.T..............................C..AGG.TC..C.G....T....AGGT.C...CA.GT.TT.C............C..C........C...........TA.......... 388   
MhcDila-UA*12       ...AAC......................A...........C..AGG.TC..C.G.........G.GC.....CA.CT.T..C.....T.........C........C...........TCTT........ 388   
MhcDila-UA*07       ....AT.T................................C..A..G................G.GC.....CA.CT.T..C.....T.........C........C...........TCTT........ 385   
MhcDila-UA*11       ...AAC......................A..............AGG.TC..C.G.........G.GC.....CA.CT.T..C.....CA........C........C...........TA.......... 388   
MhcDila-UA*10       ...AAC..................................C..A..G................ACGC.....CA.CT.T..C.....CA.......TC......G.C...........TCTT........ 388   
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                                      !alpha 2 domain 
MhcDila-UA*20       GCTTCAACCAAACTGGA GGTGTCCACATTTACCAGTTTATGTACGGCTGTGAGTGGGACGATGAGACTGGAGAGGTTAATGCTTATGATCAAGATGGTTATGATGGAGAAGACATCCTAACATTTGACTG 518   
MhcDila-UA*21       ................. ................................................................................................................. 518   
MhcDila-UA*08       ................. ................................................................................................................. 518   
MhcDila-UA*09       ................. .........C........AAG....................T......T..AAT..........G..T.ATG..GTGG..................T..G..G........CT 520   
MhcDila-UA*22       ................. ............GT....AAC....................T......................G.........GTGG..................T..A...........CT 512   
MhcDila-UA*23       ................. ............GT....AAC....................T......................G.........GTGG..................T..A...........CT 512   
MhcDila-UA*24       ................. .........G.............CG.A...........................A.CACC....G..TCAC...G.T...................T..A..GT.......CT 518   
MhcDila-UA*12       ................. ............GT....AGG...GTT..............T......T..AAT..........G....T..........................T..A..G........CT 518   
MhcDila-UA*07       ................. ..G.........GT.........CG.A..............T............A.CACC..C.G..TCAC...GTGG..................T..A..GT.......CT 515   
MhcDila-UA*11       ................. ............GT....AAG....................T......................G.........GT....................T..A..GT.......CT 518   
MhcDila-UA*10       ................. ............GC....C.G....................T..................G...G.A..T....GTT...................T..A..G........CT 518   
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MhcDila-UA*20       GAGGACAGAGACATTCATCGCTCCAGTGCCACAGGCTCTCATCACCAAACACAAGTTGGATAATAATAAAGCTCATATAGCTGGGAGAAAAAACTACCTCACCCAGATTTGTCCTGAGTGGTTGAAGAAG 648   
MhcDila-UA*21       .................................................................................................................................. 648   
MhcDila-UA*08       .................................................................................................................................. 648   
MhcDila-UA*09       ..A...........A.........GACA.........G..................G.A.....G.C.G....T.......ACA.GAC..G....................CAT...C............ 650   
MhcDila-UA*22       ..A........................T.........G.......................TGGG.C.GT....TCTC...CA.TGAG............................GC............ 642   
MhcDila-UA*23       ..A........................T.........G.......................TGGG.C.GT....TCTC...CA.TGAG.............................C............ 642   
MhcDila-UA*24       ..A..T........GG.....................G..................G......AGT.TGG---ATC.C..AGA.---............G.G...............C............ 642   
MhcDila-UA*12       ..A...........GG.C.......AAA.A.......T...AA......A......G....C....C.......TG......CA..C............T......GAG..CAT...C............ 648   
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MhcDila-UA*21       .................................................................................................................................. 2487  
MhcDila-UA*08       .................................................................................................................................. 2296  
MhcDila-UA*09       .................................................................................................................................. 2495  
MhcDila-UA*22       .......A.......................................................................................................................... 2450  
MhcDila-UA*23       .......A.......................................................................................................................... 2450  
MhcDila-UA*24       .......A...............................................................................G.......................................... 2447  
MhcDila-UA*12       .......A.......................................................................................................................... 2453  
MhcDila-UA*07       ...................................T......GA......G..G...CTG..G..G.A........A....C..CA..............-..................C.......... 2473  
MhcDila-UA*11       ...........................................A.............C....G......................................C............................ 2575  
MhcDila-UA*10       G.CCACA.G.G.CGCT....C-.C...T.ACATC.--C.A.AGG...AC.CAGTGA.AA...CAGGTA..AT.G..CA.GA.AA.A.ATG.GAC.CAT........G..TGTG.A..A.AC.......-- 2438  
Clustal Consensus   .*  :... * *.   ****  *.***:*: :: *   *.*:  ***: * :.  :*  .** : . .**::* ** :* : :...*   *.. * ::**  ****.**  :.*:**:* .*******   1686  
 
 
 
 
MhcDila-UA*20       AACGTACATATAGACTCAGTTATGTGATTTACATGCAGCAACATCCACTCTTGTCCCCCTAAATGCTGTCGAACATTCAGCCCTTTGATTTATAACTGGAGACG--TCTGCAGCACTCTGCACTGTATTT 2138  
MhcDila-UA*21       ........................................................................................................--........................ 2138  
MhcDila-UA*08       ........................................................................................................--........................ 1947  
MhcDila-UA*09       .........................................T..............................................................--........................ 2146  
MhcDila-UA*22       ..T...................................................................A..............A..................--........................ 2101  
MhcDila-UA*23       ..T...................................................................A..............A..................--........................ 2101  
MhcDila-UA*24       ..T...................................................................A..............A..................--........................ 2098  
MhcDila-UA*12       ..T.......................................................T...........A..............A..................--........................ 2104  
MhcDila-UA*07       ..T...................................................................C..............A..................--........................ 2097  
MhcDila-UA*11       ..T.........................................T.............T.............................................--........................ 2188  
MhcDila-UA*10       TTG.C.A..C..C.AA.T---C.C...CAC....TAGA......GAGAGGAGT.....T.T..CA.A..G---TTA.TG.GATGC..C.G.G.CT...TGTT.TGTA.A.A..TTA.AAA.T.....A.G 2131  
Clustal Consensus   :: * *.**.** *.:*:   .* *** : **** ...*** ** ...  :  ***** *:** .*:**     ::* .* .   :*.* *.*.:*** . :*   :*:*.** :.*.:.*:*****:*  1507  
 
MhcDila-UA*20       ATCAAGAAGTGGGTTGGTCTCTCCATCAGAAGATAACAGCG-TTAGAGAACATTTATTCTTATTTCTTTATAAAGGGCCGCTTCAAAAA---------------------CTTATTGGT----------- 2235  
MhcDila-UA*21       .........................................-....................................T..........---------------------.........----------- 2235  
MhcDila-UA*08       .........................................-....................................T..........---------------------.........----------- 2044  
MhcDila-UA*09       .........................C...............-....................................T..........---------------------.........----------- 2243  
MhcDila-UA*22       .........................................-....................................T..........---------------------.........----------- 2198  
MhcDila-UA*23       .........................................-....................................T..........---------------------.........----------- 2198  
MhcDila-UA*24       .........................................-....................................T..........---------------------.........----------- 2195  
MhcDila-UA*12       .........................................-....................................T..........---------------------.........----------- 2201  
MhcDila-UA*07       .........................................-....................................T...C....C.TTGCCCCTATATTTGACATCA.........GAACTGAACTG 2226  
MhcDila-UA*11       .........................................-..................................-.T...C....C.TTGCCCCTATATTTGACATCA....A....GAACTGAACTG 2316  
MhcDila-UA*10       G.G....GA..AT..------C.A...T.TG-----....TG..T...TGAT.AG.CGGAGT..GT..CCAC..AA..T....G--------------------------T...AA.T.----------- 2213  
Clustal Consensus   .* ****..**. **       *.* *:*:.     ****  **:***:..:*: *   : :**  ** .:.**.. * ***                             ***::* *            1557  
 
MhcDila-UA*20       --------GGATTTTAGATTCCTTGTATCATACATTGGGGTGAATAGCAGTGTACCTTCACACTTACTTACTATATGCAATGCAATATATCCTTTGGGTCTGTTCAGAAATCAAATCAAATCCCTGATTG 2357  
MhcDila-UA*21       --------.......................................................................................................................... 2357  
MhcDila-UA*08       --------.......................................................................................................................... 2166  
MhcDila-UA*09       --------.......................................................................................................................... 2365  
MhcDila-UA*22       --------.......................................................................................................................... 2320  
MhcDila-UA*23       --------.......................................................................................................................... 2320  
MhcDila-UA*24       --------.......................................................................................................................... 2317  
MhcDila-UA*12       --------.......................................................................................................................... 2323  
MhcDila-UA*07       GGAAAGAT...................G.G.........A...C.G....................................A...------------..AA..................A......... 2344  
MhcDila-UA*11       GGAAAGAT....................................................................................AA......AA....-.............A......... 2445  
MhcDila-UA*10       --------TA..G...AT..GTG...G.G.GT.....-----.T..T...G--.TG..TTT..AA...G..ACC.ACAG.A.---------------..GACA..CAGTT.A..GG..G..A.A.AG..T 2313  
Clustal Consensus            .** ***.:**   ***.  . :*****     * *. ***   *  ** : **::*** **:. *: ..*:*                * : :**. .::*.**. **.*:.*.*..**  1616  
 
MhcDila-UA*20       ATTTTAGGTGTGACTGGTCATGAATGCAATTTATTGGGTGATTCTGATTTTTACCTTTGACTTTTACGTTTATTATTTATTTTGAGGTGTTACTATTATTTGCTTTATTGTAATTATTATAATCAATATT 2487  
MhcDila-UA*21       .................................................................................................................................. 2487  
MhcDila-UA*08       .................................................................................................................................. 2296  
MhcDila-UA*09       .................................................................................................................................. 2495  
MhcDila-UA*22       .......A.......................................................................................................................... 2450  
MhcDila-UA*23       .......A.......................................................................................................................... 2450  
MhcDila-UA*24       .......A...............................................................................G.......................................... 2447  
MhcDila-UA*12       .......A.......................................................................................................................... 2453  
MhcDila-UA*07       ...................................T......GA......G..G...CTG..G..G.A........A....C..CA..............-..................C.......... 2473  
MhcDila-UA*11       ...........................................A.............C....G......................................C............................ 2575  
MhcDila-UA*10       G.CCACA.G.G.CGCT....C-.C...T.ACATC.--C.A.AGG...AC.CAGTGA.AA...CAGGTA..AT.G..CA.GA.AA.A.ATG.GAC.CAT........G..TGTG.A..A.AC.......-- 2438  
Clustal Consensus   .*  :... * *.   ****  *.***:*: :: *   *.*:  ***: * :.  :*  .** : . .**::* ** :* : :...*   *.. * ::**  ****.**  :.*:**:* .*******   1686  
 
 
 
MhcDila-UA*20       GTACATTTTAAAATTGTTTG----TTTTTATATACTAGTGTGCTCAGGAATCTCTTGAAAATGAGATGTGTAGTTCACTTGGACT--------------------------------------------- 2568  
MhcDila-UA*21       ....................----............T................................................--------------------------------------------- 2568  
MhcDila-UA*08       ....................----............T................................................AATTGAATAAATAAAGGATACAAACACAAAAAAAAAAAAAAAAAA 2422  
MhcDila-UA*09       ....................----............T................................................AATTGAATAAATAAAGGATACAAACACAAAAAAAAAAAAAAAAAA 2621  
MhcDila-UA*22       ....................----............T........G.......................................--------------------------------------------- 2531  
MhcDila-UA*23       ....................----............T........G.......................................--------------------------------------------- 2531  
MhcDila-UA*24       ....................----............T........G.......................................--------------------------------------------- 2528  
MhcDila-UA*12       ....................----............T........G..................................C....AATTGAATAAATAAAGGATACAAACACAAAAAAAAAAAAAAAAAA 2579  
MhcDila-UA*07       ....................TCTG............TA...............A........T..............T.......AATTGAAGAAATAAAGGATACAAACACAAAAAAAAAAAAAAAAAA 2603  
MhcDila-UA*11       ....................----............T........G...............................T...C...AATTGAATAAATAAAGGATACAAACACAAAAAAAAAAAAAAAAAA 2701  
MhcDila-UA*10       --.A..GA.CTC.G..GAA.------------A...GAGAACAAA.A.TT...ACAA....AA.A.AAAAA.A--------------------------------------------------------- 2497  
Clustal Consensus     *.** :*.:.* ** ::*            :*** . .: .:...*::***. :.****: *.*:.:.:*.                                                          1722  
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Figure S3. Alignment of sea bass MHC class I heavy chain amino acid sequences. Amino acid 
sequences were aligned with CLUSTALW. Dashes indicate gaps that maximize the alignment, and dots 
denote residues identical to the first sequence of the alignment. Identical residues, conserved and semi-
conserved substitutions are denoted below the alignment with, (*), (:) and (.), respectively. Numbers right to 
the sequences denote their lengths; those within parenthesis indicate the size of individual domains. 
Canonical cysteines involved in an intra-chain disulfide bonds within α2 and α3 domains as well as other 
cysteines mentioned in the text are displayed in inverted type. Conserved residues located at the edges of the 
binding cleft are highlighted with red shading. Other important residues within the PBD are marked with (▼). 
Residues involved in salt bridges are denoted with green shading. Residues that contact β2m are highlighted 
with ($). Residues that contact CD8 (Gao et al., 1997; Kern et al., 1998; Wang et al., 2009) are indicated with 
yellow shading. A grey bar above the alignment denotes residues involved in tapasin contacts. For each 
sequence an open box delimits the TM domain. 
 
Signal Peptide 
 
 
MhcDila-UA*05          MKTLMFVFLLGIGLHGAAA 19  
MhcDila-UA*06          ................... 19  
MhcDila-UA*18          ................... 19  
MhcDila-UA*19          ................... 19  
MhcDila-UA*17          .......V........... 19  
MhcDila-UA*04          .......V........... 19  
MhcDila-UA*14          .......V........... 19  
MhcDila-UA*15          .......V........... 19  
MhcDila-UA*16          .......V........... 19  
MhcDila-UA*01          .......V........... 19  
MhcDila-UA*02          .......V........... 19  
MhcDila-UA*03          .......V........... 19  
MhcDila-UA*10          .......V........... 19  
MhcDila-UA*09          .......V........... 19  
MhcDila-UA*20          .......V........... 19  
MhcDila-UA*21          .......V........... 19  
MhcDila-UA*08          ................... 19  
MhcDila-UA*07          ................... 19  
MhcDila-UA*22          .......V.........V. 19  
MhcDila-UA*23          .......V.........V. 19  
MhcDila-UA*24          .......V........... 19  
MhcDila-UA*12          .......V.........V. 19  
MhcDila-UA*11          .......V.........V. 19  
Clustal Consensus      *******.*********.* 17  
 
 
 
!1 domain 
                           !  $!$          !$ $!     $             $ 
MhcDila-UA*05          VTHSLKYFYTASSGVPNFPEFVAVGLVDEGQMYYYDSNTRRAEPKQDWMSRVTAEDPQYLERETQKSLGAQQTFKANIEILKPRFNQTG 89  
MhcDila-UA*06          ......................T......A.ISH......................S..W.GV..IF..S......G............ 89  
MhcDila-UA*18          ......................S........ID.......KDV..........TD....W.G....R..N..W..V...TA.Q...... 89  
MhcDila-UA*19          ......................S........ID.......KDV..........TD....W.G....R..N..W..V...TA.Q...... 89  
MhcDila-UA*17          ......................T........ID..........................W..Q..IY.S....L.....TV........ 89  
MhcDila-UA*04          ......I................LS...DV..N................N...E.....W.....IR..H..N.......A.Q...... 89  
MhcDila-UA*14          ......................T......A..IH......K.............DRAD.WDWQ.DIFA....V..G...TA.Q...... 89  
MhcDila-UA*15          ......................T......A..IH......K.............DRAD.WDWQ.DIFA....V..G..GTA.Q...... 89  
MhcDila-UA*16          ......................T......A..IH......K.............DRAD.WDWQ.DIFA....V..G...TA.Q...... 89  
MhcDila-UA*01          ......................I......V...H...................EGKAD.W.Y..GNG..T..I..G...TA.Q...... 89  
MhcDila-UA*02          ......................I......V...H...................EGKAD.W.Y..GNG..T..I..G...TA.Q...... 89  
MhcDila-UA*03          ......................I......V...H...................EGKAD.W.Y..GNG..T..I..G...TA.Q...... 89  
MhcDila-UA*10          ..........G.........Y.S.....DV.ISHC....M.N............DRAD.W.TQ..LC..H..S.........Q...... 89  
MhcDila-UA*09          ......................T......A.ISH......................S..W.GV..IF..S.....D............. 89  
MhcDila-UA*20          ...................G..I......V...H...................EGKAD.W.Y..GNG..T..I..G...TA.Q...... 89  
MhcDila-UA*21          ......................I......V...H...................EGKAD.W.Y..GNG..T..I..G...TA.Q...... 89  
MhcDila-UA*08          ......................I.....D..ID.....................DRAD.WDW....R.....V......TA.Q...... 89  
MhcDila-UA*07          ..........G...........S........ID........DV...........DRAD.W.EQ..LC..S............Q...... 89  
MhcDila-UA*22          .................L....I......A.IES.......FV.....VN--K.V....W.......P....N.......A.Q...... 87  
MhcDila-UA*23          .................L....I......A.IES.......FV.....VN--K.V....W............N.......A.Q...... 87  
MhcDila-UA*24          .............................IP.N......T.FIS..................Y..VF..T.P........A.Q...... 89  
MhcDila-UA*12          ....................Y.S.....DV.ISHC....M.N.......N.........W.EQ..LC..S............Q...... 89  
MhcDila-UA*11          ....................Y.S.....DV.ISHC....M.N.......N...E.....W.EQ..LC..H..........A.Q...... 89  
Clustal Consensus      ****** ***.******:* :* :.***:  :   **** :  .****:.  .   .:* :  *    . *  :* .*   * ****** 50  
 
Signal Peptide 
 
 
MhcDila-UA*05          MKTLMFVFLLGIGLHGAAA 19  
MhcDila-UA*06          ................... 19  
MhcDila-UA*18          ................... 19  
MhcDila-UA*19          ................... 19  
MhcDila-UA*17          .......V........... 19  
MhcDila-UA*04          .......V........... 19  
MhcDila-UA*14          .......V........... 19  
MhcDila-UA*15          .......V........... 19  
MhcDila-UA*16          .......V........... 19  
MhcDila-UA*01          .......V........... 19  
MhcDila-UA*02          .......V........... 19  
MhcDila-UA*03          .......V........... 19  
MhcDila-UA*10          .......V........... 19  
MhcDila-UA*09          .......V........... 19  
MhcDila-UA*20          .......V........... 19  
MhcDila-UA*21          .......V........... 19  
MhcDila-UA*08          ................... 19  
MhcDila-UA*07          ................... 19  
MhcDila-UA*22          .......V.........V. 19  
MhcDila-UA*23          .......V.........V. 19  
4 .
12
11 V
Clustal Consensus *******.*********.* 7
 
 
 
!1 domain 
                           !  $!$          !$ $!     $             $ 
MhcDila-UA*05          VTHSLKYFYTASSGVPNFPEFVAVGLVDEGQMYYYDSNTRRAEPKQDWMSRVTAEDPQYLERETQKSLGAQQTFKANIEILKPRFNQTG 89  
MhcDila-UA*06 ......................T......A.ISH......................S..W.GV..IF..S......G............ 89  
18 ......................S........ID.......KDV..........TD....W.G....R..N..W..V...TA.Q......
19 S . D. KDV TD . . .R N W V. TA Q
7 T ... .. .Q IY S. .L . V .
04 I .LS DV .N ... N E. . I H N . .
4 A .IH K DRAD DW D FA. V. G A Q
15 . T.. .A IH K . .DRAD DWQ D FA . V G GT
6
01 I V . . EGK .Y. GNG. T I .
02 I V . . EGK .Y. GNG. T I
3
10 G Y S D IS C M N .DR TQ .LC H S . ..
9 T A IS ...S. GV .IF S . D .. .
2 . G. I . .. . . . EGK Y. GNG T I G TA
21 I V .. EGKAD Y. GNG T I G TA Q
08 . D. ID. .DR DW ..R . V .
07 G S . ID. DV .DR EQ .LC S . . ..
22 L .A ES FV VN--K V... .. .P N . 7
23 . L I A ES F VN--K V... .. .. . N A 7
4 . . IP.N. T IS ..... . . Y VF. T P. 9
12 . Y S DV SHC M N. . ... . EQ LC S . . 9
11 Y S DV.ISHC M N.. N E W EQ LC H .
Clustal Consensus ****** *** ******:* :* : ***:  :   **** :  ****:.     :* :  *     *  :* *   * ****** 50
  
!2 domain 
                            $                 x$x$ $$$$!   xxxxxxxxxx                        !      ! 
MhcDila-UA*05          GVHIVQNMYGCEWDDETGEVDGNYQFGYDGEDFIALDLKTETWTAPVPQAFITKNKLDNDRAQISYLNNYLTQECIDWLKKYVDYGRSSLLR (92) 181 
MhcDila-UA*06          ....F.W.....R....N.AN.FM.Y....D....F.......I......V...H.W..IK..TARFK........................ (92) 181 
MhcDila-UA*18          ....F.L........V...................F..........KQ..V.....WN....FN.QKK.....I.................. (92) 181 
MhcDila-UA*19          ....F.L........V...................F..........KQ..V.....WN....FN.QKK.....I.....R............ (92) 181 
MhcDila-UA*17          ...VF.V.............N.FH.........V.F......YI..K...V......N.NK.E.AHRKH....................... (92) 181 
MhcDila-UA*04          ....N.R.............N.YD.D.........F......YI..K...V...Q.W...K.V.AQRK.....I.P................ (92) 181 
MhcDila-UA*14          ....N.K..........N..N.FM.W.......V.F..........M...V.....W.....Y.AQTKQ....I........L......... (92) 181 
MhcDila-UA*15          ....N.K..........N..N.FM.W.......V.F..........M...V.....W.....Y.AQTKQ....I........L......... (92) 181 
MhcDila-UA*16          ....N.K..........N..N.FM.W.......V.F..........M...V.....W.....Y.AQTKQ....I........L......... (92) 181 
MhcDila-UA*01          ...VY.R.............N.YD.W........VF......FI..R...V...H.W.....FLAGRKQ.Y..I.PE......N........ (92) 181 
MhcDila-UA*02          ...VY.R.............N.YD.W........VF......FI..R...V...H.W.....FLAGQKQ.Y..I.PE......N........ (92) 181 
MhcDila-UA*03          ...VY.R.............N.YD.W........VF......FI..R...V...H.W.....FLAGQKQ.Y..I.PE......N........ (92) 181 
MhcDila-UA*10          ....A.L............................F..........KQ..V.....WN....FN.QKK.....I.................. (92) 181 
MhcDila-UA*09          ...LY.K.........SN..N.FM.W.......V.F......YI..T...V...H.WN....Y.AQDK.....I.................. (92) 181 
MhcDila-UA*20          ....Y.F.............NAYD.D......ILTF.WR...FI......L...H....NK.H.AGRK.....I.PE............... (92) 181 
MhcDila-UA*21          ....Y.F.............NAYD.D......ILTF.WR...FI......L...H....NK.H.AGRK.....I.PE............... (92) 181 
MhcDila-UA*08          ....Y.F.............NAYD.D......ILTF.WR...FI......L...H....NK.H.AGRK.....I.PE............... (92) 181 
MhcDila-UA*07          ......FIE.........NTN.FT.W........VF.......V......V...H.W.--KVW.TERK.....I.T................ (90) 179 
MhcDila-UA*22          ....................N.YD.W........TF......FI......V...H...W.S.LSASEK.....I.PG............... (92) 179 
MhcDila-UA*23          ....................N.YD.W........TF......FI......V...H...W.S.LSASEK.....I.P................ (92) 179 
MhcDila-UA*24          ...VY.FIE.........NTN.FT.V........VF...I...I......V...H.W.--KVW.TERK...S.I.P...........NP... (90) 179 
MhcDila-UA*12          ......R.V.......SN..N.Y..D.........F..........KQ...K....W.HNK.L.AQTK........................ (92) 181 
MhcDila-UA*11          ......K.............N.YD.Y........VF..R.G.YI..KQ...D....W.HN..R...YK..........V............. (92) 181 
Clustal Consensus      ***: * : *** ** :.:.:.  * ****:*::.:* :  *: **  **. **:* :   .  :  ::* :* *  *::**::***..***  
 
 
 
!3 domain 
                                 $                          xxxxxxxx  $     $   $      
MhcDila-UA*05          TDRPSVSLLQKTSSSPVSCHATGFYPDSATLIWRKDGVELHENVEHGEILLNHDGSFQMSVDLKLPSSVTPEDWRRYDCVFQLYGGKNDI (90) 271 
MhcDila-UA*06          .......F.................................................................................. (90) 271  
MhcDila-UA*18          .......F..................N..........E.I...................................K.............. (90) 271  
MhcDila-UA*19          .......F..................N..........E.I...................................K..... ........ (90) 271  
MhcDila-UA*17          .......F....P..........................I............N..........D.-....-............S.V..N. (88) 269  
MhcDila-UA*04          .EL.........P.............N..........L.I..D.......P.N.......I..D.-....-............S.V.... (88) 269  
MhcDila-UA*14          ..........................N..........E......D..............................K.............. (90) 271  
MhcDila-UA*15          ..........................N..........E......D..............................K.............. (90) 271  
MhcDila-UA*16          ..........................N..........E......D..............................K.............. (90) 271  
MhcDila-UA*01          .EL..............R...................E.I..D.D....................H...........N.....S.V.... (90) 271  
MhcDila-UA*02          .EL..............R...................E.I..D.D....................H...........N.....S.V.... (90) 271  
MhcDila-UA*03          .EL..............R...................E.I..D.D....................H...........N.....S.V.... (90) 271  
MhcDila-UA*10          .EL..............R........................D.D..............................K.............. (90) 271  
MhcDila-UA*09          ..L.......................N...............D.D..............................K.............. (90) 271 
MhcDila-UA*20          .EL....................................I..D.D.....P............N.-....-....K.......S.V.... (88) 269 
MhcDila-UA*21          .EL....................................I..D.D.....P............N.-....-....K.......S.V.... (88) 269 
MhcDila-UA*08          .EL....................................I..D.D.....P............N.-....-....K.......S.V.... (88) 269 
MhcDila-UA*07          .EL..................................E....D.D............................................. (90) 269 
MhcDila-UA*22          .EL....F.........R........N..........E.I....D..............................K.............. (90) 269 
MhcDila-UA*23          .EL....F.........R........N..........E.I....D..............................K.............. (90) 269 
MhcDila-UA*24          ..L....F.........R........N..........E.I ...D..................N.-.........K.............. (89) 268 
MhcDila-UA*12          .......F..................N..........E.I....D..................N.-.........K.........V.... (89) 270 
MhcDila-UA*11          ..L.........P........................E......D.R...P..............H........................ (90) 271  
Clustal Consensus     *: ****:****.**** ********:********** *:**:*:* *** *:*******:**.* **** ****:*:***** * **:* 79  
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Figure S3 (continued) 
 
!2 domain 
                            $                 x$x$ $$$$!   xxxxxxxxxx                        !      ! 
MhcDila-UA*05          GVHIVQNMYGCEWDDETGEVDGNYQFGYDGEDFIALDLKTETWTAPVPQAFITKNKLDNDRAQISYLNNYLTQECIDWLKKYVDYGRSSLLR (92) 181 
MhcDila-UA*06          ....F.W.....R....N.AN.FM.Y....D....F.......I......V...H.W..IK..TARFK........................ (92) 181 
MhcDila-UA*18          ....F.L........V...................F..........KQ..V.....WN....FN.QKK.....I.................. (92) 181 
MhcDila-UA*19          ....F.L........V...................F..........KQ..V.....WN....FN.QKK.....I.....R............ (92) 181 
MhcDila-UA*17          ...VF.V.............N.FH.........V.F......YI..K...V......N.NK.E.AHRKH....................... (92) 181 
MhcDila-UA*04          ....N.R.............N.YD.D.........F......YI..K...V...Q.W...K.V.AQRK.....I.P................ (92) 181 
MhcDila-UA*14          ....N.K..........N..N.FM.W.......V.F..........M...V.....W.....Y.AQTKQ....I........L......... (92) 181 
MhcDila-UA*15          ....N.K..........N..N.FM.W.......V.F..........M...V.....W.....Y.AQTKQ....I........L......... (92) 181 
MhcDila-UA*16          ....N.K..........N..N.FM.W.......V.F..........M...V.....W.....Y.AQTKQ....I........L......... (92) 181 
MhcDila-UA*01          ...VY.R.............N.YD.W........VF......FI..R...V...H.W.....FLAGRKQ.Y..I.PE......N........ (92) 181 
MhcDila-UA*02          ...VY.R.............N.YD.W........VF......FI..R...V...H.W.....FLAGQKQ.Y..I.PE......N........ (92) 181 
MhcDila-UA*03          ...VY.R.............N.YD.W........VF......FI..R...V...H.W.....FLAGQKQ.Y..I.PE......N........ (92) 181 
MhcDila-UA*10          ....A.L............................F..........KQ..V.....WN....FN.QKK.....I.................. (92) 181 
MhcDila-UA*09          ...LY.K.........SN..N.FM.W.......V.F......YI..T...V...H.WN....Y.AQDK.....I.................. (92) 181 
MhcDila-UA*20          ....Y.F.............NAYD.D......ILTF.WR...FI......L...H....NK.H.AGRK.....I.PE............... (92) 181 
MhcDila-UA*21          ....Y.F.............NAYD.D......ILTF.WR...FI......L...H....NK.H.AGRK.....I.PE............... (92) 181 
MhcDila-UA*08          ....Y.F.............NAYD.D......ILTF.WR...FI......L...H....NK.H.AGRK.....I.PE............... (92) 181 
MhcDila-UA*07          ......FIE.........NTN.FT.W........VF.......V......V...H.W.--KVW.TERK.....I.T................ (90) 179 
MhcDila-UA*22          ....................N.YD.W........TF......FI......V...H...W.S.LSASEK.....I.PG............... (92) 179 
MhcDila-UA*23          ....................N.YD.W........TF......FI......V...H...W.S.LSASEK.....I.P................ (92) 179 
MhcDila-UA*24          ...VY.FIE.........NTN.FT.V........VF...I...I......V...H.W.--KVW.TERK...S.I.P...........NP... (90) 179 
MhcDila-UA*12          ......R.V.......SN..N.Y..D.........F..........KQ...K....W.HNK.L.AQTK........................ (92) 181 
MhcDila-UA*11          ......K.............N.YD.Y........VF..R.G.YI..KQ...D....W.HN..R...YK..........V............. (92) 181 
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!3 domain 
                                 $                          xxxxxxxx  $     $   $      
MhcDila-UA*05          TDRPSVSLLQKTSSSPVSCHATGFYPDSATLIWRKDGVELHENVEHGEILLNHDGSFQMSVDLKLPSSVTPEDWRRYDCVFQLYGGKNDI (90) 271 
MhcDila-UA*06          .......F.................................................................................. (90) 271  
MhcDila-UA*18          .......F..................N..........E.I...................................K.............. (90) 271  
MhcDila-UA*19          .......F..................N..........E.I...................................K.............. (90) 271  
MhcDila-UA*17          .......F....P..........................I............N..........D.-....-............S.V..N. (88) 269  
MhcDila-UA*04          .EL.........P.............N..........L.I..D.......P.N.......I..D.-....-............S.V.... (88) 269  
MhcDila-UA*14          ..........................N..........E......D..............................K.............. (90) 271  
MhcDila-UA*15          ..........................N..........E......D..............................K.............. (90) 271  
MhcDila-UA*16          ..........................N..........E......D..............................K.............. (90) 271  
MhcDila-UA*01          .EL..............R...................E.I..D.D....................H...........N.....S.V.... (90) 271  
MhcDila-UA*02          .EL..............R...................E.I..D.D....................H...........N.....S.V.... (90) 271  
MhcDila-UA*03          .EL..............R...................E.I..D.D....................H...........N.....S.V.... (90) 271  
MhcDila-UA*10          .EL..............R........................D.D..............................K.............. (90) 271  
MhcDila-UA*09          ..L.......................N...............D.D..............................K.............. (90) 271 
MhcDila-UA*20          .EL....................................I..D.D.....P............N.-....-....K.......S.V.... (88) 269 
MhcDila-UA*21          .EL....................................I..D.D.....P............N.-....-....K.......S.V.... (88) 269 
MhcDila-UA*08          .EL....................................I..D.D.....P............N.-....-....K.......S.V.... (88) 269 
MhcDila-UA*07          .EL..................................E....D.D............................................. (90) 269 
MhcDila-UA*22          .EL....F.........R........N..........E.I....D..............................K.............. (90) 269 
MhcDila-UA*23          .EL....F.........R........N..........E.I....D..............................K.............. (90) 269 
MhcDila-UA*24          ..L....F.........R........N..........E.I....D..................N.-.........K.............. (89) 268 
MhcDila-UA*12          .......F..................N..........E.I....D..................N.-.........K.........V.... (89) 270 
MhcDila-UA*11          ..L.........P........................E......D.R...P..............H........................ (90) 271  
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CP TM CYT domains 
                       CP                           TM                     CYT 
MhcDila-UA*05          VTKLDKAVIRTN---------EEKPDNTTVIIIAAVVVLALVLIAVIGAVIYK-KKNEKRPPSPISNPE------------VMEQLNPNA---------------------------- (68)  339   
MhcDila-UA*06          ............---------................................-...D...........------------.........---------------------------- (68)  339 
MhcDila-UA*18          ............---------................................-...............------------.........---------------------------- (68)  339 
MhcDila-UA*19          ............---------................................-...............------------.........---------------------------- (68)  339 
MhcDila-UA*17          .I..........---------................................-...............------------.........---------------------------- (68)  337 
MhcDila-UA*04          .I..........---------.G-F.T.II................V.FF...-...A...........------------.........---------------------------- (67)  336 
MhcDila-UA*14          ............---------....................AV.V........-...D........S..------------...E...K.---------------------------- (68)  339   
MhcDila-UA*15          ............---------....................AV.V........-...D...........------------...E...K.---------------------------- (68)  339 
MhcDila-UA*16          ............---------....................AV.V........-...D...........------------...E...K.---------------------------- (68)  339 
MhcDila-UA*01          .I....SE.K..WGKTGIRSE....................AV.V...V....-...............------------..A......---------------------------- (77)  348 
MhcDila-UA*02          .I....SE.K..WGKTGIRSE....................AV.V...VA...-...............------------.........---------------------------- (77)  348 
MhcDila-UA*03          .I....SE.K..WGKTGIRSE....................AV.V...V....-...............------------.........---------------------------- (77)  348 
MhcDila-UA*10          I......E....WGKTGIRTN...TID...................V.FI.C.L...AECRQKLDMS.DSGSP---------K.N.DSKNSTPLIKDSVTSSTGSQGSETPLIKGESE (109) 380 
MhcDila-UA*09          I...........WGKTGIRTN...TIDI......V...........V.FI...L..KAECRQKSDMS.DSGSP---------K.N.DSKNSTPLIKDSVTSSTGSQGSETPLIKD--- (106) 377 
MhcDila-UA*20          ......SE....WGKTGIRTN...TIDI.......A..........VVIMV..-.R.AECRQKSDMS.DSGSP---------K.N.DSKNSTPLIKDSVTSSTGSQGSETPLIKD--- (105) 374 
MhcDila-UA*21          ......SE....WGKTGIRTN...TIDI.......A..........VVIMV..-.R.AECRQKSDMS.DSGSP---------K.N.DSKNSTPLIKDSVTSSTGSQGSETPLIKD--- (105) 374 
MhcDila-UA*08          ......SE....WGKTGIRTN...TIDI.......A..........VVIMV..-.R.AECRQKSDMS.DSGSP---------K.N.GSKNSTPLIKDSVTSSTGSQGSETPLIKD--- (105) 374 
MhcDila-UA*07          I......E....WGKTGIRTN....ID.......V........V.AV.FI...LR.KA.V.QYTECHQKSGSS---------T.SQDS------------------------------ (79)  348 
MhcDila-UA*22          .......E....WGKTGIRTN...TID.................V.V.LRVC.-.R.A.V.QYIECH.T--------------.FPPR-----------ISSIESQKSEIILIKD--- (89)  358 
MhcDila-UA*23          .......E....WGKTGIRTN...TID.................V.V.LRVC.-.R.A.V.QYIECH.T--------------.FPPR-----------ISSIESQKSEIILIKD--- (89)  358 
MhcDila-UA*24          .......E....WGKTGIRTN...TID.................V.V.LRVC.-.R.A.V.QYIECH.T--------------.FPPR-----------ISSIESQKSEIILIKD--- (89)  357  
MhcDila-UA*12          .......E....WGKTGIRTN...TID.................V.V.LRVC.-.R.A.V.QYIECH.T--------------.FPPR-----------ISSIESQKSEIILIKD--- (89)  359 
MhcDila-UA*11          I...........WGKTGIRSE...TIDI......V...........V.LMVC.-.R.A.V.QYSECHQMTSTGSQDSETILIK.LRTSEESLISTPDSVTSSTGSQGSETPLIKD--- (114) 385  
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Figure S4. Three-dimensional homology models of sea bass β2m and MHC class I heavy chain 
extracellular domains. Models generated using the crystal structures of grass carp   β2m [PDB: 3GBL] 
(Chen et al., 2010) and chicken BF2 [PDB: 3BEV] (Koch et al., 2007) as templates. A) Representation of the 
Dila-β2m homology model. Secondary structure elements (SSE), as well as N- and C-termini are labelled. 
The disulfide bond is represented as spheres. B) Representation of the predicted Dila-UA*06 model in 
dark blue. The three extracellular domains are labelled ( α1, α2, α3). Disulfide forming residues are 
represented as spheres. C) Top-view of the predicted Dila-UA*06 model, through a 90º counter-clockwise 
rotation around the x-axis with respect to the orientation presented in B showing the PBD in detail. The eight 
anchor residues important for peptide binding are coloured red and labelled and their side-chains are shown. 
Other conserved residues also contacting the peptide are coloured pink and labelled. D) Representation of 
the predicted Dila-UA*12 model in pink. The cysteine residues represented in yellow could form a putative 
additional S-S bond.  E) Representation of protein variability among the different sea bass sequences 
mapped on the Dila-UA*12 homology model (colour range from dark blue (conserved) to red (variable)). 
Note that most variable positions are located in the PBD. F) Representation of the Dila-UA*06/Dila-β2m 
homology model. The relative positions of each subunit are based on the chicken BF2 [PDB: 3BEV] (Koch et 
al., 2007). Heavy and light chains are represented in dark and light blue, respectively. The plasma membrane 
would be below the α3 domain, while the TCR of a cytotoxic T cell would be on top of the peptide-binding 
domain (PBD). 
 
 
 
 
 
 
CHAPTER 3 
 
Transporters associated with antigen processing (TAP) in sea 
bass (Dicentrarchus labrax, L.): molecular cloning and 
characterization of TAP1 and TAP2 
 
 
 
 
 
 
 
Rute D. Pinto, Pedro J. B. Pereira and Nuno M. S. dos Santos 
Dev Comp Immunol. 2011 35:1173-81 

CHAPTER 3 
 
	   79	  
 
 
 
Developmental and Comparative Immunology 35 (2011) 1173– 1181
Contents lists available at ScienceDirect
Developmental and  Comparative  Immunology
jo ur n al homepage: www.elsev ier .com/ locate /dc i
Short  communication
Transporters  associated  with  antigen  processing  (TAP)  in  sea  bass  (Dicentrarchus
labrax,  L.):  Molecular  cloning  and  characterization  of  TAP1  and  TAP2
Rute  D.  Pintoa,c,  Pedro  J.B.  Pereirab,  Nuno  M.S.  dos  Santosa,∗
a Fish Immunology and Vaccinology Group, IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal
b Protein Crystallography Group, IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal
c ICBAS – Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Largo Prof. Abel Salazar 2, 4099-003 Porto, Portugal
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 2 February 2011
Received in revised form 15 March 2011
Accepted 17 March 2011
Available online 19 April 2011
Keywords:
Dicentrarchus labrax
TAP
Gene cloning
Comparative sequence analysis
Protein structure prediction
Homology modelling
a  b  s  t  r  a  c  t
The  transporters  associated  with  antigen  processing  (TAP),  play  an  important  role  in  the  MHC class  I
antigen  presentation  pathway.  In  this  work,  sea  bass  (Dicentrarchus  labrax)  TAP1  and  TAP2  genes  and
transcripts  were  isolated  and  characterized.  Only  the  TAP2  gene  is  structurally  similar  to its human
orthologue.  As  other  TAP  molecules,  sea  bass  TAP1  and  TAP2  are  formed  by  one  N-terminal  accessory
domain,  one  core  membrane-spanning  domain  and  one  canonical  C-terminal  nucleotide-binding  domain.
Homology  modelling  of the sea bass  TAP  dimer  predicts  that  its  quaternary  structure  is in  accordance
with  that  of  other  ABC  transporters.  Phylogenetic  analysis  segregates  sea bass  TAP1 and  TAP2  into  each
subfamily  cluster  of  transporters,  placing  them  in  the  fish  class  and  suggesting  that  the  basic  structure  of
these  transport-associated  proteins  is evolutionarily  conserved.  Furthermore,  the  present  data  provides
information  that  will  enable  more  studies  on  the  class  I antigen  presentation  pathway  in  this  important
fish  species.
© 2011 Elsevier Ltd. All rights reserved.
1. Introduction
The transporter associated with antigen processing (TAP) is a
key component in the MHC  class I-dependent antigen presen-
tation pathway [reviewed by Peaper and Cresswell, 2008]. TAP
translocates peptides mainly derived from proteasomal cleavage
of ubiquitinated proteins in the cytosol to the ER lumen, where
these peptides are loaded onto MHC  class I molecules (Abele and
Tampé, 2009; Michalek et al., 1993). Stable MHC-peptide com-
plexes migrate to the cell surface for presentation to CD8+ cytotoxic
T lymphocytes and this recognition event triggers elimination of
the presenting cell. TAP is a member of the ABC (ATP-binding cas-
sette) family of transporters, which translocate a wide range of
substrates across membranes in an ATP-dependent manner. ABC
transporters have a conserved architecture of two transmembrane
domains (TMDs) each with six canonical transmembrane helices
that together form the translocation pathway and two cytosolic
nucleotide-binding domains (NBDs) together bearing two  ATP-
binding sites. ATP binding induces the NBDs dimerization, with
the two ATP molecules sandwiched at the interface and bridg-
ing contacts between the two NBDs (Procko et al., 2006). The TAP
∗ Corresponding author. Tel.: +351 226 074 900; fax: +351 226 099 157.
E-mail addresses: rsp@ibmc.up.pt (R.D. Pinto), ppereira@ibmc.up.pt
(P.J.B. Pereira), nsantos@ibmc.up.pt (N.M.S. dos Santos).
translocation complex is composed of two  half-transporters, TAP1
(ABCB2) and TAP2 (ABCB3), each with one TMD  and one NBD
(Kelly et al., 1992; Powis et al., 1991; Spies and DeMars, 1991).
Additionally, TAP molecules have an N-terminal accessory domain
(Procko et al., 2005), also with three to four membrane-spanning
regions, that is not required for peptide binding and transport,
but is essential for tapasin-binding and assembly of the peptide
loading complex (Koch et al., 2004). TAP binds 8–16 amino acid
long peptides [reviewed in Abele and Tampé, 2009] but its peptide
specificity is restricted to the three N-terminal residues and the C-
terminal residue (Uebel et al., 1997). Both TAP subunits were found
to be essential and sufficient for ATP-dependent peptide translo-
cation into the ER lumen (Androlewicz et al., 1993; Meyer et al.,
1994; Shepherd et al., 1993). TAP genes have been identified and
mapped to the MHC  in several non-mammalian species, including
cartilaginous and bony fish (Grimholt, 1997; Hansen et al., 1999;
Ohta et al., 1999a),  chicken (Walker et al., 2005) and the amphibian
Xenopus (Ohta et al., 1999b; Ohta et al., 2003). Here, sea bass TAP1
and TAP2 cDNA and genes have been for the first time identified and
characterized at the molecular, structural and phylogenetic levels.
2. Materials and methods
2.1. Fish
Sea bass, Dicentrarchus labrax,  were kept in a recirculating,
ozone-treated salt-water (20–25‰)  system at 22 ± 1 ◦C and fed
0145-305X/$ – see front matter ©  2011 Elsevier Ltd. All rights reserved.
doi:10.1016/j.dci.2011.03.024
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with commercial pellets twice a day. Fish were sacrificed with a
lethal dose of 2-phenoxyethanol (Panreac; >5 mL/10 L).
2.2. cDNA cloning
RNAs were transcribed to cDNAs following the BioScript RNase
H− (Bioline) protocol. PCR products were purified from agarose
according to QIAquick Gel Extraction Kit (QIAGEN), and cloned fol-
lowing the pGEM®-T Easy Vector Systems instructions (Promega).
Automated sequencing was performed using primers detailed in
Supplementary Table S1.  Complementary DNAs used for 5′ Rapid
Amplification of cDNA Ends (5′RACE) experiments were purified
using High Pure PCR Product Purification Kit reagents (Roche). For
5′RACE experiments the 5′RACE System from Invitrogen (Version
2.0) was followed and Recombinant Terminal Transferase (Fermen-
tas or Roche) used to dATP tail the purified cDNA.
2.2.1. TAP1
Total RNA, extracted from the spleen of a stimulated fish,
was reverse transcribed using primer APv2 (Table S1). The
cDNA was first amplified with primers TAP1FW2/TAP1RV1
(Table S1) followed by a semi-nested amplification using
primers TAP1FW2/TAP1RV2 (Table S1). The amplification product
(∼250 bp) obtained was purified, cloned and sequenced.
To obtain the 5′ untranslated region (UTR), three consecutive
5′RACE experiments were performed using cDNA synthesized from
previously isolated RNA as described above: (i) the tailed cDNA
was first amplified with primers APv/DLTAP1RV2 (Table S1) fol-
lowed by a second PCR using primers TAP1FW1/DLTAP1RV3 (Table
S1); (ii) the tailed cDNA was first amplified with primers APv2/
DLTAP1RV8 (Table S1) followed by a second PCR using primers
AUAP2/DLTAP1RV9 (Table S1); (iii) the tailed cDNA was first ampli-
fied with primers APv/DLTAP1RV11 (Table S1) followed by a second
PCR using primers AUAP/DLTAP1RV12 (Table S1). PCR products of
∼430 (i), ∼750 (ii) and (iii) ∼500 bp were consecutively obtained,
purified, cloned and sequenced.
To obtain the full sea bass TAP1 cDNA, specific primers were
designed at the beginning of the 5′UTR region. The cDNAs from the
spleens of two fish were used as templates in parallel PCR reac-
tions. Primers DLTAP1FW1/APv2 (Table S1) were used in a first
amplification PCR (spleen cDNAs from two differently stimulated
fish) with additional 0.15 U of Pfu DNA polymerase (Promega) fol-
lowed by a nested PCR using primers DLTAP1FW2/AUAP or AUAP2
(Table S1). The obtained ∼3000 bp product was purified, cloned and
2 independent clones from each template were sequenced (Table
S1).
2.2.2. TAP2
Total RNA extracted from the head kidneys of three stimulated
fish was reverse transcribed using primer APv2 (Table S1). The
cDNA was amplified with primers TAP2FW1/TAP2RV1 (Table S1)
followed by a semi-nested PCR using primers TAP2FW1/TAP2RV2
(Table S1). A third amplification was performed with primers
TAP2FW2/TAP2RV2 (Table S1). The obtained product of ∼970 bp
was purified, cloned, and sequenced (Table S1).
This sequence was used to design three specific reverse primers
in order to follow a 5′RACE strategy: DLTAP2RV1, DLTAP2RV2,
DLTAP2RV3 (Table S1). The previously isolated RNA was used
to synthesize first-strand cDNA with primer DLTAP2RV1. The
cDNA was purified, tailed, and first amplified with the primers
APv/DLTAP2RV2. A second PCR was performed with primers
AUAP/DLTAP2RV3 (Table S1)  and a product of ∼800 bp was
obtained, purified, cloned and sequenced.
To obtain the full sea bass TAP2 cDNA, specific primers (Table S1)
were designed at the beginning of the 5′UTR region. DLTAP2FW1
and AUAP2 were used in a first amplification using unstimulated
head kidney cDNA, followed by a semi-nested PCR with primers
DLTAP2FW2/AUAP2. The obtained ∼2500 bp PCR product was  puri-
fied, cloned and 3 independent clones from each template were
sequenced (Table S1).
2.3. Genomic DNA cloning
Genomic DNA (gDNA) was  isolated from sea bass erythro-
cytes from a single fish, as described by Stet et al. (1993).  To
obtain the full TAP1 and TAP2 genes, gDNA was  amplified by
PCR with DLTAP1FW1/DLTAP1RV14 and DLTAP2FW1/DLTAP2RV6
(Table S1),  respectively. The PCR products were purified, cloned and
one clone of each molecule sequenced as before (Table S1).
2.4. Sequence analysis
Full nucleotide and protein sequences from sea bass
TAP molecules were compared to several TAP1 and TAP2
sequences currently available in the GenBank database
[http://www.ncbi.nlm.nih.gov/genbank/]. The multiple
sequence alignment was  made using CLUSTALW (Higgins,
1994) and formatted with Bioedit (Hall, 1998). The
transmembrane/nucleotide-binding domain boundaries
were based on InterPro Scan predictions (Zdobnov and
Apweiler, 2001). The molecular weights of the polypeptide
chains were calculated with the Expasy compute pI/MW
tool [http://www.expasy.org/tools/pi tool.html]. Possible N-
glycosylation sites were predicted with Expasy post-translational
modification tool [http://www.cbs.dtu.dk/services/NetNGlyc/].
The neighbour-joining phylogenetic tree was constructed with
MEGA v3.1 (Kumar et al., 2004), using p-distance parameter and
complete deletion of gaps, and tested for reliability using 2000
bootstrap replications. The percentages of similarity and identity
were calculated with MatGAT (Campanella et al., 2003) using
default parameters.
2.5. Southern blotting
Genomic DNA was  digested with different restriction enzymes
(EcoRI, NcoI and NdeI for TAP1; EcoRI, PstI, and NdeI for TAP2
all zero cutters within the probe), separated in a 0.8% agarose
gel and subjected to Southern blotting (Ausubel et al., 1999).
A portion of the sea bass TAP1 and TAP2 cDNA (partial exon
I) was  amplified with primers DLTAP1FW2/DLTAP1RV12 and
DLTAP2FW2/DLTAP2RV7 (Table S1), labelled and used as probes.
Preparation of the labelled probes, hybridization and post-
hybridization stringency washes were performed accordingly to
Gene ImagesTM AlhPhos DirectTM Labelling and Detection System
(Amersham Biosciences) kit. For signal generation and detection
the Chemiluminescent Signal Generation and Detection with CDP-
StarTM protocol from the same kit was  followed.
2.6. 3D modelling
Two suitable structural templates for Dila-TAP1 and Dila-TAP2,
Sav1866 (PDB: 2hyd) and mouse P-glycoprotein (PDB: 3g61),
were identified by a BLAST search as implemented in the SWISS-
MODEL Protein Modelling Server (Arnold et al., 2006). A multiple
sequence alignment was  used for homology modelling with SWISS-
MODEL in alignment mode (Arnold et al., 2006) revealing identities
of approximately 30% between target and template molecules
with the gaps introduced essentially outside the secondary struc-
ture elements (SSE) and SSE were identified with PROMOTIF
(Hutchinson and Thornton, 1996). The calculated global ener-
gies were of −17,356.039 kJ/mol (TAP1-2hyd), −12,068.762 kJ/mol
(TAP2-2hyd), −10,095.534 kJ/mol (TAP1-3g61 C-terminal) and
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Fig. 1. Alignment of TAP1 and TAP2 amino acid sequences. The TAP1/TAP2 protein sequences were aligned using CLUSTALW. As for other TAPs, no putative N-terminal
leader  sequence was predicted for Dila-TAP1 and -TAP2, nor was any ER retention motif identified in any of the sea bass subunits. Membrane topology and structural features
are  based on human TAP1 and on a 3D homology model of the human core TAP complex, respectively (Oancea et al., 2009; Schrodt et al., 2006). The proposed N-terminal
accessory domain, core transmembrane domain, nucleotide-binding domain are indicated above and below the alignment; membrane-spanning helices are shaded in grey;
and  several other features including CL1 and CL2 (shaded in red), peptide sensor (shaded in green), A-loop, Q-loop, X-loop, C-loop, D-loop, H-loop and Walker A and B motifs
(all  shaded in blue) are denoted above and bellow the alignment, for TAP1 and TAP2. Peptide binding regions 1 (PBR1) and 2 (PBR2) are indicated between TAP1 and TAP2
alignments ( for TAP1 <- - -> for TAP2). Putative N-glycosylation sites are in bold type and underlined, for both Dila-TAP1 and -TAP2 sequences. Location of particular
residues mentioned in the text is denoted with symbols (# –rat, $ – human, and – mouse) either above or below the alignment for TAP1 or TAP2 respectively, and the residues are
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Fig. 1. (Continued ).
underlined. Dashes indicate gaps introduced to optimise similarity between sequences. Dots indicate identity to Dila-TAP1*01 sequence. Asterisks denote residues identical
in  all sequences. Double dots and dots indicate chemical similarity between amino acids, i.e., conserved and semi-conserved substitutions, respectively.
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−1176.007 kJ/mol (TAP2-3g61 N-terminal). Two dimeric models
were generated by superposing the TAP1 and TAP2 homology
models with each template chains (2hyd) or with N- and C-
terminal regions of the unique template’s chain (3g61), and
energies minimized using PHENIX (Adams et al., 2010), with result-
ing QMEAN scores of 0.801 and 0.667, respectively. Model quality
was assessed with WHATCHECK (Hooft et al., 1996) and PROCHECK
(Laskowski et al., 1993) as implemented in the Swiss Model
structure assessment tool. Model pictures were prepared with
PyMOL [http://pymol.org/]. Additionally, for comparison, struc-
tures of the isolated NBD domains of Dila-TAP1 and -TAP2 were
also predicted using the crystal structure of the dimeric form of
rat TAP1 NBD [PDB: 2ixf]. The calculated global energies were
−10,590.928 kJ/mol (TAP1-2ixf) and −11,170.671 kJ/mol (TAP2-
2ixf).
3. Results and discussion
3.1. cDNA sequence
Two different TAP1 cDNAs were obtained from sea bass (Dila-
TAP1) (Fig. S1) and named Dila-TAP1*01 (3188 bp) [GenBank:
HQ328078] and Dila-TAP1*02 (3187 bp) [GenBank: HQ328079].
BLAST analysis confirmed higher similarity with fish TAP1. Both
TAP1 sequences have an open reading frame (ORF) of 2217 bp, a
5′UTR of 136 bp, and a 3′UTR of 834/5 bp excluding the polyadenyla-
tion tail. Within the 3′UTR there are three potential polyadenylation
signals (one non-canonical) and two mRNA instability motifs (Shaw
and Kamen, 1986) (Fig. S1.1A).
Two different TAP2 cDNAs were obtained from sea bass (Dila-
TAP2) (Fig. S1) and named Dila-TAP2*0101 (2563 bp) [GenBank:
HQ328081] and Dila-TAP2*0102 (2605 bp) [GenBank: HQ328082].
BLAST analysis confirmed higher similarity with fish TAP2. The
here obtained sea bass TAP2 sequences have an ORF of 2160 bp
(TAP2*0101) or 2262 bp (TAP2*0102), a 5′UTR of 24 bp, and a 3′UTR
of 397 bp excluding the polyadenylation tail. The larger transcript
is a splice variant where intron 2 is incorporated into the coding
region (see below). Relevance of this sea bass TAP2 isoform remains
to be elucidated, although two splicing forms of human TAP2 have
been described and associated to differential peptide selectivity
(Yan et al., 1999). Furthermore, in humans there is evidence for
a recombinatorial hot spot in intron 2 of the TAP2 locus (Cullen
et al., 1995). Within 3′UTR there are three potential polyadenylation
signals and one mRNA instability motif (Fig. S1.1B).
3.2. Genomic DNA sequence, structure and copy number
The Dila-TAP1 gene (7864 bp) was obtained from a third fish
and named Dila-TAP1*03 [GenBank: HQ328080] (Fig. S1.2.A). Six
single nucleotide differences were found between this sequence
and those just described above for TAP1 cDNAs (Fig. S1.2.A). The
Dila-TAP1 gene contains 13 exons and all intron donor/acceptor
sites flanking the exons match the consensus motifs. Dila-TAP1 13-
exon structure is different from that of the 11-exon human TAP1
(Beck et al., 1992) (Fig S2A). The sea bass molecule has two addi-
tional introns, one within the 5′UTR and the other within human
exon I, but both the location and phase of the remaining introns are
conserved between human and sea bass. Chicken TAP1 gene orga-
nization is identical to the human one (Walker et al., 2005), and so
sea bass TAP1 is, for now, unique in its structure.
Dila-TAP2 gene (5674 bp), obtained from another individual was
named Dila-TAP2*02 [GenBank: HQ328083] (Fig. S1.2.B). It has an
11-exon structure similar to that of the human gene (Beck et al.,
1992) and distinct from those of chicken (Walker et al., 2005) and
Atlantic salmon (Grimholt, 1997), which were described as 9 and
10 exons genes, respectively. All intron donor/acceptor sites follow
the gt/ag rule (Fig. S1.2B),  and both the location and phase of all the
introns are conserved between human and sea bass TAP2 molecules
(Fig. S2B). This is also true for Atlantic salmon TAP2, except for
intron 10, which is absent in this species (Grimholt, 1997).
Regarding the number of copies of genes in the genome, South-
ern blot results suggest that both Dila-TAP1 and Dila-TAP2 are
encoded by single genes (Fig. S3A). Although RFLPs (restriction
fragment length polymorphisms) were observed for Dila-TAP2
between the two analysed fish (Fig. S3B), they are most likely due
to allelic polymorphism. Of note, two types of TAP2 (TAP2A and
TAP2B) have been reported in Atlantic salmon (Grimholt, 1997),
and in rainbow trout (Hansen et al., 1999), with one or both of
them being polymorphic.
3.3. Primary structure analysis
In order to compare TAP proteins from sea bass and other verte-
brates (Table S2), a multiple sequence alignment was made using
CLUSTALW (Higgins, 1994). As observed for other organisms, Dila-
TAP1 protein (83 kDa) is slightly larger than Dila-TAP2*01 (80 kDa),
but about the same molecular mass as Dila-TAP2*02 (84 kDa). Vari-
ation in size can be observed in both molecules across species,
perhaps with more heterogeneity within TAP1 proteins (Fig. 1).
Dila-TAP2*02 is considerably longer than all other TAP2 molecules
described so far. Putative N-glycosylation sites were identified in
TAP1 (four) and TAP2 (five) as reported for Atlantic salmon (four
for TAP1 and one for TAP2) (Grimholt, 1997) and human (four for
TAP1).
A number of transmembrane !-helices were predicted within
both the N-terminal accessory domain and the TMD  of sea bass
TAPs (Swiss Model Domain Annotation Tool), closely resembling
those predicted for the human molecules (10 for Dila-TAP1 and 9
for Dila TAP2). In addition, Dila-TAP1 and -TAP2 have a conserved
ATP binding region, consistent with other transporters.
The predicted N-terminal tapasin-binding domain (or N
domain) of TAP1 and TAP2 consists of 4 and 3 TM regions, respec-
tively. This is a poorly conserved region (no invariant residues) in
the multiple sequence alignment, to which have been attributed
several biochemical interactions including heterodimer formation
(Vos et al., 1999) and tapasin recruitment (Garbi et al., 2003; Koch
et al., 2004). In comparison to TAP2, TAP1 displays a number of
insertions at the final section of the N-domain, which are more
notorious in the sea bass molecules than in other species.
The core TMD  includes the remaining membrane-spanning
regions, six for each sea bass half-transporter. Within this domain
there are 18 invariant residues between all TAP sequences (Fig. 1).
Clusters of amino acids that can alter peptide specificity have been
identified in rat TAP2 core TMD  (Joly and Butcher, 1998), restoring
permissive transport in the restricted TAP2-2b chain (Fig. 1). These
regions are variable in TAP2 across species, but tend to be con-
served in TAP1. A mutation in mouse TAP2 (T293P) is responsible
for a reduction in TAP2 protein levels in the recent Jasmine strain
(Theodoratos et al., 2010). This residue is conserved in TAP2 across
species pointing to a conserved role in TAP stabilization. The TMD  of
human TAP molecules includes two peptide-binding regions (PBR)
(Nijenhuis and Hammerling, 1996; Nijenhuis et al., 1996), which
also show conservation across species. Considering TAP1 and TAP2
separately, there is 45% and 37% identity in PBR1 and 65% and 50%
in PBR2 between human and sea bass molecules. In human TAP2, a
single amino acid substitution (A374D), changes the preference for
the transported peptide (Armandola et al., 1996). This residue is
conserved in all species, except rodents (serine or glutamate in rat;
aspartate in mouse). TAP2 R380 (Momburg et al., 1996) also influ-
ences transport and is present in most species including sea bass,
but not in rat and chicken (glutamine), amphibian (isoleucine) and
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Fig. 2. 3D homology models of the accessory domain-less Dila-TAP1/-TAP2 heterodimer. Models generated based on the crystal structures of Sav1866 [PDB: 2hyd] (A, B, E, F
and  G) and mouse ABCB1 [PDB: 3g61] (C and D) in close outward-facing (ATP-bound) and open inward-facing (ATP-free) conformations, respectively. Dila-TAP1 is in orange
and  Dila-TAP2 in yellow. For both molecules, coupling loops are colored red, the peptide sensor green and conserved motifs of the NBD blue (E, F and G). (A) Horizontal lines
indicate the approximate location of the ER membrane, ER lumen on top and cytoplasm below. Vertical arrows denote the transmembrane domains (TMDs), nucleotide-
binding domains (NBDs) and the intracytoplasmic loops (ICLs). This orientation highlights the outward-facing conformation of the molecule, with the translocation cavity
open  towards the ER lumen. (B) 90◦ clockwise rotation around the y-axis with respect to the orientation presented in A. This orientation highlights two wings of the complex
composed of helices 1, 2, 3 and 6 from one chain and helices 4′ and 5′ from the other (and vice versa) and the NBDs interface in close contact. For TAP2, TM helices are
numbered 1′–6′; coupling helices (CL1′ and CL2′) that assist conformational changes, and also the loop (linker’) that connects the two domains are indicated. (C) Heterodimer
based on ABCB1. (D) 90◦ clockwise rotation around the y-axis with respect to the orientation presented in C. Highlighted the inward-facing conformation of the molecule,
with  the translocation cavity open towards the cytoplasm. NBDs are not in contact with each other. (E) Close-up representation of TAP1/TAP2 dimer rotated 180◦ around the
y-axis as depicted in A. TAP2 molecule is shown as C! trace. (F) Close-up representation of TAP1 NBD interface rotated 180◦ around the y-axis as depicted in A. The conserved
motifs of the NBD are labelled. (G) Close-up representation of the NBDs interface as depicted in B. TAP1 molecule is shown as C! trace.
shark (histidine). Both residues are located in the putative pep-
tide binding/release cavity. Each half-transporter has two coupling
helices or loops, CH1/CL1 and CH2/CL2, and a peptide sensor site has
been identified close to the CL1 (Herget et al., 2007). Mutations on
highly conserved residues of CH1/CL1 (except Q277C) and of sensor
region (G282C, I284C, R287C) interfered with and drastically affected
transport, respectively. In CH2/CL2, only R378C affected transport
and binding and P375C influenced transport but not binding (Oancea
et al., 2009).
Globally, the NBDs are the most conserved with the eight con-
sensus motifs of ABC transporters required for ATP binding and
hydrolysis [reviewed by Kos and Ford, 2009], present in Dila-TAP1
and -TAP2, confirming the existence of two ATPase sites in the
sea bass complex. The tyrosine in the A-loop that helps position-
ing ATP in the catalytic site [reviewed in Kos and Ford, 2009] is
100% conserved in both molecules across species. The Walker A
motif is conserved across all TAP2 and in Dila-TAP1 displays a sin-
gle residue variation (R instead of G at position 4) observed also
in Tetraodon and Xenopus. Three of the residues, including hTAP2
K509/hTAP1 K544, a possible ATP interaction site (Ohta et al., 1999b)
are absolutely invariant. The glutamine in the Q-loop thought to
sense the "-phosphate and to communicate with the TMDs (Seeger
and van Veen, 2009) is totally conserved. The glutamate in the X-
loop that also plays an important role in the translocation event,
but not in substrate binding (Oancea et al., 2009), is present in all
sequences except for Xenopus TAP1/2 (glutamine/aspartate). The
D-loop (SALD) aspartate interacts with the Walker A motif while
alanine contacts the H-loop in trans-NBD (Seeger and van Veen,
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2009). The aspartate is totally invariant across species, but the ala-
nine is not (aspartate/serine in sea bass TAP1/TAP2, respectively),
which could be explained by the nature of the interaction (ala-
nine main-chain to histidine side chain). The C-loop, hallmark of
ABC proteins, is conserved in TAP1 across species (only conserva-
tive replacement in teleosts), displaying variation among TAP2. The
Walker B motif (!!!!DE, ! any aliphatic residue) (Walker et al.,
1982) contacting both "-phosphate and magnesium ion through
the aspartate (hTAP2 D631/hTAP1 D667) (Hopfner et al., 2000; Kos
and Ford, 2009) shows variation in Dila-TAP1 while in Dila-TAP2,
this motif is 100% conserved comparing to hTAPs. Finally, the
histidine (H661, hTAP2) in the H-loop, present in all TAP2, was
considered essential for transport in other ABC transporters (Bliss
et al., 1996; Shyamala et al., 1991). Variation is observed in TAP1
across species: a glutamine (Q701, hTAP1) present in all mammalian
TAP1 was shown to interact with the "-phosphate in human TAP1
(Gaudet and Wiley, 2001); in sea bass an asparagine replaces the
very similar glutamine observed in mammals; in pufferfish an argi-
nine occupies this position, being more similar to the histidine
observed in other fish; surprisingly, chicken displays a glycine at
this position.
Noteworthy, in the context of the sea bass NBDs dimer, almost
all deviations map  to the same ATPase site: [Walker A + Walker
B + H-loop]TAP1 + [D-loop + Signature motif]TAP2. This is in accor-
dance with previous reports [reviewed in Procko et al., 2009], where
one ATPase site is formed by consensus residues, while the sec-
ond contains non-consensus substitutions in one or more motifs
(degenerate site), a common property among eukaryotic ABC trans-
porters (Procko and Gaudet, 2009).
3.4. 3D modelling
The Dila-TAP1 and -TAP2 structures (except their acces-
sory domains) were predicted by comparative modelling using
the Sav1866 crystal structure [PDB: 2hyd] and the mouse
P-glycoprotein crystal structure [PDB: 3g61] as templates, respec-
tively (Figs. 2 and S4).  The accessory domain-less homology models
of Dila-TAP1 and -TAP2 are compatible with the presence of six
TM #-helices in the TMD, followed by a canonical ABC-transporter
NBD, as described for other ABC half-transporters (Fig. 2A–D),
with spatial conservation of important structural amino acids (Figs.
2E–G and S4).  The models of the NBDs, including those calcu-
lated using the crystal structure of the rTAP1 NBD in dimeric form
[PDB: 2ixf], display significant homology with equivalent domains
from homologous molecules, with a RecA-like sub-domain and a
helical sub-domain in both Dila-TAP1 and -TAP2 (Fig. S4). Finally,
the quaternary heterodimeric sea bass TAP models were gen-
erated by superposing the homology models of the individual
subunits onto two different templates, Sav1866 and ABCB1, in
outward/closed (nucleotide-bound) and inward/open (nucleotide-
free) conformations, respectively. In the quaternary models, the
patches of exposed hydrophobic residues are compatible with the
position occupied by the transmembrane regions in homologous
molecules, and a number of conserved (and presumably function-
ally important) residues map  to functionally relevant areas of the
heterodimer (detailed in supplementary section).
3.5. Phylogenetic analysis
TAP1 and TAP2 protein sequences were phylogenetically com-
pared to each other and also to protein sequences of TAPL or ABCB9
(Table S2),  another member of the eukaryote ABC-transporter fam-
ily (Fig. 3). The neighbour-joining tree clearly separates the three
types of amino acid sequences analysed, placing the Dila-TAP1
and the Dila-TAP2 molecules within each respective sub-family.
According to the method used, the sea bass TAP1 clusters with other
Fig. 3. Phylogenetic tree of TAP1, TAP2 and TAPL. An amino acid alignment
(CLUSTALW) of the proteins was used to generate the unrooted neighbour-joining
tree with MEGA v3.1. Node values represent percentages of bootstrap analysis from
2000 replications and complete deletion of gaps. The TAP1 and TAP2 sequences
used are those indicated in Fig. 1, while for TAPL/ABCB9 are: [GenBank: Q9NP78]
(human), [GenBank: Q9JJ59] (mouse) and [GenBank: CAM46975] (zebrafish).
bony fish molecules, being more closely related to the salmonid
ones. In respect to sea bass TAP2, this molecule is also placed in
the teleost group, and is more closely related to those from O.
latipes and O. dancena. Additionally, pair-wise alignments were per-
formed with MatGAT (Campanella et al., 2003) in order to calculate
similarity and identity of TAP amino acids between species. The
results confirm those previously obtained by the neighbour-joining
method, being sea bass TAP1 apparently more closely related to S.
salar and to O. mykiss,  and sea bass TAP2 molecules closer to those
of O. latipes and O. dancena (Table S2).  The percentages of simi-
larity and identity of Dila-TAP1 and -TAP2 to each other (58% and
36%, respectively) are lower than those observed between each of
them and the respective subfamily cluster, indicating that these are
indeed distinct molecules within this species.
4. Conclusions
In the present study, the sea bass TAP1 and TAP2 transcripts
were successfully cloned for the first time. Each consists of one
N-terminal accessory domain, one TMD  (both with multiple trans-
membrane helices) and one NBD located in the cytoplasm. They
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are homologous to the human proteins and several structural fea-
tures resemble those of other TAPs, namely two coupling loops in
the transmission interface of each half-transporter and two ATPase
sites (conserved and degenerate) in the NBDs interface, suggest-
ing a similar function. Importantly, homology modelling suggests a
heterodimeric ABC transporter-like quaternary architecture for sea
bass TAPs. Noteworthy, a TAP2 splice variant has been identified,
which includes intron 2. Gene structure has been determined for
both sea bass TAP molecules, with Dila-TAP1 displaying a unique
organization, and Dila-TAP2 organized as its human homologue;
both molecules are encoded by single-copy genes. Finally, Dila-
TAP1 and -TAP2 are phylogenetically segregated in each sub-family,
being closer to other bony fish molecules. Hence, the present iden-
tification of sea bass TAP genes provides information that will allow
further studies on class I antigen presentation in this important fish
species.
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Supplementary data 
 
Table S1 
Oligonucleotide sequences. 
 
Table S1 
Oligonucleotide sequences. 
Designation Nucleotide sequence 5’- 3’  Use / Function 
APv GGC CAC GCG TCG ACT AGT ACT TTT TTT TTT TTT TTT TTV cDNA synthesis;5’RACE;full cDNA id 
AUAP GGC CAC GCG TCG ACT AGT AC 5’RACE; full cDNA id 
APv2 GAC TCA GGA CTT CAG GAC TTA GTT TTT TTT TTT TTT TTT V cDNA synthesis;5’RACE;full cDNA id 
AUAP2 GAC TCA GGA CTT CAG GAC TTA G 5’RACE; full cDNA id 
T7 TAA TAC GAC TCA CTA TAG GGC GA  sequencing 
SP6 CTA TTT AGG TGA CAC TAT AGA ATA C  sequencing 
TAP1FW1 ACC GGG CGI RTG RCM GAC TGG partial cDNA id 
TAP1FW2 TGA GYY WKY TGA TGT GGT A partial cDNA id 
TAP1RV1 GTA CAR RAY ACI GAC CTT CA partial cDNA id 
TAP1RV2 GWC TCR CCS TCY TCI TTG GC partial cDNA id 
DLTAP1FW1 GCA GCT CGG TCG ACG ACT AA full cDNA & gene id 
DLTAP1FW2 CCG GTG GGG CAT CGT TAA AT full cDNA & gene id/southern 
DLTAP1FW3 GAG GCC ATC ACA GTT ATG sequencing (full cDNA) 
DLTAP1RV1 TGG TTG GCC TTA GCC AGT GA 1st 5’RACE (cDNA synthesis) 
DLTAP1RV2 TGA ACC TTT GCA GCA ATA GT 1st 5’RACE 
DLTAP1RV3 TGG TGG AAG TGT CCA GTG AG 1st 5’RACE 
DLTAP1RV7 CGT ATG CGG CTC ATG GTG AC 2nd 5’RACE (cDNA synthesis) 
DLTAP1RV8 GAC GTT GTA CAT GAG GTC AC 2nd 5’RACE 
DLTAP1RV9 GCA GCA GTC AGT AGC GTC AT 2nd 5’RACE 
DLTAP1RV10 ATG ACA CAT ATC GGC TCC AG 3rd 5’RACE (cDNA synthesis) 
DLTAP1RV11 CAC CAC TGT CAC AAC ATA ACC 3rd 5’RACE 
DLTAP1RV12 GAG TGC CAC CCC CAC AGT T 3rd 5’RACE/southern 
DLTAP1RV13 ACT CCC CAG TGC CCT GCA AA sequencing (full cDNA & gene) 
DLTAP1RV14 CTG TGA GGA GAC ACG GAT TA full gene id 
DLTAP1RV15 GGC AAA TGA CAC CAG GTC TCC AC sequencing (full gene) 
DLTAP1RV16 ATT TTC AGG TGC CAA ACT GC sequencing (full gene) 
DLTAP1RV17 GGT ACT GGT CTT TGT AGC TTA G sequencing (full gene) 
DLTAP1RV18 TTG ACA GGT CCT TGA TGA AC sequencing (full gene) 
DLTAP1RV19 TTC GTT CTC TGT GTC CAA GTC sequencing (full gene) 
TAP2FW1 CTC TGT GAR AYR TTC ATC CC partial cDNA id 
TAP2FW2 AGT GCW GGY TGY MGI GGA GG partial cDNA id 
TAP2RV1 GAG ARS AGM ACR GGI TCC TG partial cDNA id 
TAP2RV2 ACT SAC ACA GGT GCT YTT ICC partial cDNA id 
DLTAP2FW1 GTA CGA GGA CGA CTG TCG GAG AA full cDNA & gene id 
DLTAP2FW2 ATG GCA GAC AAT ACA ACA ATC ATC C full cDNA & gene id/southern 
DLTAP2FW3 TAC TCT GTG CCA TCA GTG CC sequencing (full cDNA & gene) 
DLTAP2FW4 GTC AGC ACA GAG GGA AAA CT sequencing (full cDNA & gene) 
DLTAP2FW5 CTG TTT ATG AGA GTC TTA TAC sequencing (full gene) 
DLTAP2FW6 GTT CCT CGT ATT GAT AGA GAC sequencing (full gene) 
DLTAP2FW7 GGA GGC CCG TCG CTA TGA sequencing 
DLTAP2FW8 GAC AAC TGG CAG CCT GGT TTC sequencing (full gene) 
DLTAP2RV1 CTC TAG ACA ACC TGG ATG TG 5’RACE (cDNA synthesis) 
DLTAP2RV2 TCA CCT GTC TTT ATG GTC TC 5’RACE 
DLTAP2RV3 GGC ACT GAT GGC ACA GAG TA 5’RACE 
DLTAP2RV5 ACT GTT GCA TAA AAC TTT TAT TCA TC full gene id 
DLTAP2RV6 ATT CAT CTT TAC CAG ATA CCA AGA C full gene id 
DLTAP2RV7 GCT CTC TGG CTT TCT GCT TCT sequencing (full gene) 
DLTAP2RV8 CAG AGG GGA AAA TCC ATC ATA C sequencing (full gene) 
DLTAP2RV9 TCT GCC GCC ACT AAC CAC A sequencing (full gene) 
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Table S2 
Accession numbers of sequences used in the present study. 
 
 
 
Table S3 
Percentages of identity and similarity calculated with MatGAT. 
 
 
 
 
Species TAP1 (ABCB2) TAP2 (ABCB3) TAPL (ABCB9) 
Homo sapiens (human) GenBank: CAA40741 GenBank: NP_000535 GenBank: Q9NP78 
Mus musculus (mouse) GenBank: AAB41962 GenBank: AAA39609 GenBank: Q9JJ59 
Rattus norvegicus (rat) GenBank: CAA40742 
GenBank: CAA53055; 
CAA45339 - 
Mesocricetus auratus (Syrian 
hamster) GenBank: AAB58721 GenBank: AAB58722 - 
Gallus gallus (chicken) GenBank: CAH58737 GenBank: CAH58738 - 
Xenopus laevis (African clawed frog) GenBank: AAP36718 GenBank: NP_001081860 - 
Ginglymostoma cirratum (nurse shark) GenBank: AAL59858 - - 
Salmo salar (Atlantic salmon) GenBank: CAB05917 
GenBank: ABQ01992; 
ABQ59650 - 
Oncorhynchus mykiss (rainbow trout GenBank: ABB52828 
GenBank: AAB62237; 
AAD53035 - 
Heterodontus francisci (horned shark) 
GenBank: AF108387+ 
AF1088386 GenBank: CAH58738 - 
Tetraodon nigroviridis (pufferfish) GenBank: CAF88941 - - 
Danio rerio (zebrafish) - GenBank: CAK04959 
GenBank: 
CAM46975 
Oryzias latipes (Japanese medaka) - GenBank: BAD93260 - 
Oryzias dancena (medaka) - GenBank: ACN49154 - !
Table S3 
Percentages of identity and similarity calculated with MatGAT. 
    Similarity (%) Identity (%) 
TAP1  Dila-TAP1*01 - - 
  Dila-TAP1*02 99.9 99.7 
  Dila-TAP1*03 99.7 99.6 
  T. nigroviridis 73.8 59.1 
  S. salar 84.3 67.8 
  O. mykiss 84.4 69.1 
  G. cirratum 64.8 46.3 
  H. francisci 69.9 50.4 
  X. laevis 69.4 47.4 
  G. gallus 52.6 35.9 
  R. norvegicus 63.6 40.9 
  M. musculus 62.6 41.0 
  M. auratus 62.6 40.1 
  H. sapiens 62.7 40.9 
TAP2  Dila-TAP2*0101 - - 
  Dila-TAP2*0202 95.5 95.5 
  Dila-TAP2*02 99.6 99.2 
  O. latipes 88.2 75.5 
  O. dancena 88.3 75.5 
  O. mykiss 2a 66.9 47.0 
  O. mykiss 2b 82.0 66.3 
  S. salar 2a 83.2 67.0 
  S. salar 2b 81.5 66.0 
  D. rerio 78.6 62.9 
  H. francisci 68.9 46.9 
  X. laevis 65.8 43.2 
  G. gallus 60.6 41.6 
  R. norvegicus 2a 64.1 41.9 
  R. norvegicus 2b 63.1 41.8 
  M. musculus 62.4 42.3 
  M. auratus 62.7 42.1 
   H. sapiens 63.6 41.5 
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Figure S1.1. Nucleotide and deduced amino acid sequences of sea bass TAP1 (A) and TAP2 (B) 
cDNAs. The ORF and the predicted protein are shown in uppercase letters. The translation start and stop 
codons and initial methionine are shown in white over black background. Within the 3’UTR, the poly-
adenylation signal sequences are highlighted in bold with boxes and mRNA instability motifs are bold and 
underlined. Differences between the Dila-TAP1 cDNA sequences (accession numbers [GenBank: HQ328079] 
and [GenBank: HQ328081]) are shaded in grey (c=t; c=t; g=a; g=c [H]; a=t [S]; a=g; g=c; t=c; t=g; g=a; and 
one extra c). 
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Figure S1.2. Nucleotide and 
deduced amino acid 
sequences of sea bass 
TAP1 (A) and TAP2 (B) 
genes. The exons are shown 
in uppercase letters, while 
introns are shown in 
lowercase. The ORF is in 
bold. The translation start and 
stop codons and initial 
methionine are shown in 
inverted type. Intron 
donor/acceptor sites are 
underlined. Within the 3’UTR, 
the poly-adenylation signal 
sequences are in bold with 
boxes and mRNA instability 
motifs are bold and 
underlined. Differences to the 
cDNA sequences (accession 
numbers are [GenBank: 
HQ328080] and [GenBank: 
HQ328083]) are indicated: (a) 
cyan – residues different in 
both Dila-TAP1*01 and *02 
(a=c; a=c; g=a; c=t [L]; t=c); 
green – residues different in 
Dila-TAP1*01 (c=t; c=t; g=c 
[H]; a=t [S]); pink – residues 
different in Dila-TAP1*02 
(a=g; g=a; c=g; c=t; g=t). 
Residues shaded in grey 
within the 3’UTR denote the 
place of a 10-nucleotide 
insertion detected in both 
cDNA sequences 
(gaagtaggtg). (b) cyan – 
residues different in Dila-
TAP2*01 (a=c; t=c; g=a; g=c 
[C]; a=g [V]; g=a [I]; c=g [Q]; 
t=a; t=c; t=g [S]; a=t [A]; a=g; t=c; g=c; c=t).  
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Figure S1.2 (continued) 
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Figure S1.2 (continued) 
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Fgure S2. Schematic representation of sea bass and human TAP1 (A) and TAP2 (B) gene structures. 
The human gene is represented above the sea bass one. Boxes represent exons and horizontal lines introns. 
White and black boxes differentiate coding and untranslated regions, respectively. Exon and intron sizes are 
indicated in base pairs. Exon numbers are indicated by Roman numerals. 
 
 
Figure S3. Sea bass TAP1 (A) and 
TAP2 (B) are both single copy genes. 
Southern blot analysis of genomic DNA 
from two animals digested with three 
restriction enzymes (isolated and 
combined). The blots were probed with 
a region of TAP1 or TAP2 (partial exon 
I). Sizes of the MW marker are 
indicated on the left. 
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Figure S4. 3D homology models of accessory domain-less Dila-TAP1/-TAP2 dimer. (A) Close-up 
representation of the modelled heterodimer in closed outward-facing conformation. The two subunits are 
shown side-by-side in the dimer-forming orientations, shifted along the x axis. Dila-TAP1 (orange) in NBD 
dimer interface view and Dila-TAP2 (yellow) in exposed surface view.  Both RecA-like and helical sub-
domains of the NBDs are labelled. The coupling loops are coloured red, the peptide sensor green and 
conserved motifs of the NBD blue. (B) Molecular surface representation of the Dila-TAP dimer in the same 
orientation as in panel A. Nucleotide-binding sites and coupling loops are indicated for Dila-TAP1. The colour 
code is the same as in A. (C) Close-up representation of the modelled heterodimer in open inward-facing 
conformation. The two subunits are shown side-by-side in the dimer-forming orientations, shifted along the x 
axis. The colour code is the same as in A. (D) Molecular surface representation of the Dila-TAP dimer in the 
same orientation as in panel C. Nucleotide-binding sites and coupling loops are indicated for Dila-TAP1. The 
colour code is the same as in A. 
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Mapping several residues on the 3D models 
 
Several residues discussed in Section 3.3 were mapped on the 3D models of TAP1 
and TAP2 and analysed in that context.  
Of the predicted glycosylation sites, only N672QT from TAP1 and N488KT, and N660QT 
from TAP2 are surface-exposed and hence can possibly be modified. Although exposed, 
N293LS, is located very close to the ER membrane in both 2hyd- and 3g61-based models, 
and N458VS is also not accessible in the 3g61-based one. The remaining TAP1 residues 
are probably not post-translationally modified, since they are facing the lumen of the 
translocation cavity (N234), or located at the NBDs dimer interface (N653, N685). N4TT was 
excluded from this analysis since it is located in the N-terminal accessory domain, for 
which no model could be calculated.  
The mTAP2 T293P corresponds to Dila-TAP2 T299 and is located in a helicoidal 
transmembrane region from the TMD (in both 2hyd- and 3g61-based structures), where 
replacement for a proline would probably disrupt the secondary structure and therefore 
alter the protein folding, which can possibly explain the observed reduction of protein 
levels for this mutant in mouse.  
The hTAP2 A373D corresponds to Dila-TAP2 A380 and is located in the contact 
interface between TAP1 and TAP2 helices, being oriented towards the lumen of the 
translocation cavity in the 3g61-based model, but not in the 2hyd-based one. The hTAP2 
R380 corresponds to Dila-TAP2 R386. This residue is also located at the wall of the 
translocation cavity with its side chain in the lumen in the 2hyd-based model, but not in 
the 3g61-based one. At least in one of the predicted TAP dimer structures, both 
mentioned residues can possibly have the same functions in sea bass (change the 
preference of bound peptide and influence transport activity, respectively). 
The conserved residues hTAP1 K544/ hTAP2 K509 correspond in sea bass to TAP1 
K530 and TAP2 K515. According to the 2hyd-based model, both these residues can 
putatively interact with the g-phosphate of the nucleotide as suggested in the previous 
section. 
The aspartate from the D-loop has been reported to interact with the Walker A motif. 
Accordingly, the Dila-TAP1 D659 (D-loop) should interact with Dila-TAP2 N511 (Walker A), 
and Dila-TAP2 D644 (D-loop) with Dila-TAP1 S522 (Walker A). Both interactions can be 
maintained, since each aspartate side chain can bind to the main chain amide of the 
interacting residue. As in mammals (2ixf-based structure), an H-bond between the N511 
OD1 and the D659 main-chain N can be formed. 
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The carbonyl of the D-loop alanine interacts with the side chain of the H-loop 
histidine. Given the nature of the interaction, it can be understood why this alanine is not 
conserved across species (aspartate, asparagine, cysteine, or serine in TAP1; serine or 
cysteine in TAP2). The H-loop is also variable in TAP1 molecules (asparagine, histidine, 
glutamine, arginine or glycine), but is conserved across species in TAP2 molecules 
(histidine). In sea bass, Dila-TAP1 D659 could interact with Dila-TAP2 H668 and Dila-TAP2 
S642 with Dila-TAP1 N684. This interaction probably occurs across species. In the TAP2 D-
loop/TAP1 H-loop contact, the main chain carbonyl from the D-loop residue (alanine, 
serine or cysteine) interacts with side chain residue of the H-loop. In this case, asparagine 
(sea bass), histidine and glutamine in the H-loop can establish the contact; 
accommodation of the bulky arginine side chain would probably imply a rearrangement of 
this segment, while a glycine residue would be unable to establish this contact.  
In the C-loop (LSGGQ), mutation of serine to alanine decreases ATPase activity. 
This residue is conserved in TAP1 molecules across species, but some TAP2 molecules 
naturally bear an alanine at this position, namely pufferfish and mammals. In sea bass, 
Dila-TAP1 S629 probably hydrogen bonds to Dila-TAP2 S522 (Walker A) in a side chain to 
side chain interaction. Furthermore, according to the 2ixf-based model, both serines are in 
position to interact with the ATP g-phosphate. In mammalian TAP2, the Walker A serine is 
replaced by an asparagine (N505), therefore the interaction is also viable. Mutation of the 
C-loop serine to an alanine results in the loss of the interactions in the nucleotide-binding 
pocket, maintained across species. In the 2hyd-based model, Dila-TAP2 S614 may interact 
with Dila-TAP1 N511 (Walker A) also through a hydrogen bond. In mammals, the alanine 
from the C-loop should interact with an asparagine in the Walker A. The longer 
asparagine side chain can probably compensate for the lack of the side chain hydroxyl in 
its interaction partner, making a contact to the alanine main chain in TAP2. In all other 
species this interaction is most likely lost. However, in the 2ixf-based model, this 
interaction is no longer plausible. 
Of the conserved residues described to interact with the nucleotide, only the Q-loop 
Q586 (Dila-TAP1 Q572 and Dila-TAP2 Q557) does not interact with ADP in the 2hyd-based 
model neither with ATP in the 2ixf-based model. The other three contacts are plausible in 
the models: Y512 (A-loop), V520, and D667 (Walker B) (Dila-TAP1 Y496, V506, D652; and Dila-
TAP2 Y481, V491, D637). As in mammals, D652 presumably binds one of the water molecules 
that coordinate the Mg2+. 
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a b s t r a c t
Mammalian tapasin (TPN) is a key member of the major histocompatibility complex (MHC) class I
antigen presentation pathway, being part of the multi-protein complex called the peptide loading
complex (PLC). Several studies describe its important roles in stabilizing empty MHC class I complexes,
facilitating peptide loading and editing the repertoire of bound peptides, with impact on CD8þ T cell
immune responses. In this work, the gene and cDNA of the sea bass (Dicentrarchus labrax) glycoprotein
TPN have been isolated and characterized. The coding sequence has a 1329 bp ORF encoding a 442-
residue precursor protein with a predicted 24-amino acid leader peptide, generating a 418-amino acid
mature form that retains a conserved N-glycosylation site, three conserved mammalian tapasin motifs,
two Ig superfamily domains, a transmembrane domain and an ER-retention di-lysine motif at the C-
terminus, suggestive of a function similar to mammalian tapasins. Similar to the human counterpart, the
sea bass TPN gene comprises 8 exons, some of which correspond to separate functional domains of the
protein. A three-dimensional homology model of sea bass tapasin was calculated and is consistent with
the structural features described for the human molecule. Together, these results support the concept
that the basic structure of TPN has been maintained through evolution. Moreover, the present data
provides information that will allow further studies on cell-mediated immunity and class I antigen
presentation pathway in particular, in this important ﬁsh species.
! 2011 Elsevier Ltd. All rights reserved.
1. Introduction
MHC class I molecules exist on the surface of almost all
nucleated cells, and typically present intracellular, self and non-
self peptides to be screened by the T-cell receptor on CD8þ T
lymphocytes [1]. Only foreign peptides should trigger cytotoxic T
cell activation, whose action would culminate in the death of the
cell presenting the antigen. The class I complexes are formed by
the heavy chain (HC), light chain b2-microglobulin (b2m) and
peptide [2]. Antigen processing is a tightly regulated process that
occurs in the endoplasmic reticulum (ER), with assistance of
several resident chaperones [3]. A lot of effort has been devoted to
studying the class I presentation pathway, allowing to identify
several important steps: generation of peptides in the cytosol;
transport of peptides into the ER; initial folding of the HC upon
entry into the ER, association with b2m and incorporation in the
peptide loading complex (PLC); loading of peptide; exit from the
ER and migration to the cell surface [4]. Cytosolic ubiquitinated
proteins are degraded in the cytoplasm by the proteasome [5].
Some of the originated peptides are transported into the ER
through the transporter associated with antigen presentation
(TAP1/TAP2) [6] and once inside they are further trimmed by
aminopeptidases (ERAP1/ERAP2) [7,8]. Class I HCs are glycopro-
teins, which initial folding is assisted by ER resident calnexin and
also by ERp57 [9,10]. Only then the HC associates with b2m to form
the heterodimer that being highly unstable needs further assis-
tance by other chaperones: calreticulin, ERp57, tapasin and TAP
heterodimer form the PLC which stabilizes the empty dimer and
helps to load high afﬁnity peptides [11]. Tapasin is a central
molecule in this process [12] since it makes the bridge between
the class I itself and the transporter [13]; without tapasin (TPN,
also called TAPBP for TAP binding protein) class I molecules are
unable to bind TAP and surface expression is impaired [14]. So on
one hand, TPN maintains the structure of class I prior to peptide
loading [15], and on the other hand it stabilizes and activates TAP
* Corresponding author. Tel.: þ351 226074900; fax: þ351 226099157.
E-mail addresses: rsp@ibmc.up.pt (R.D. Pinto), diogosilva85@gmail.com (D.V. da
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to increase peptide supply [16e18]. Recently, besides these cell
biological effects, evidence for the biochemical effect of TPN on
peptide editing, by accelerating peptide exchange, has been re-
ported [15,19]. TPN also binds to ERp57 trough a covalent bond
[20], this way protecting the empty peptide-binding groove
against a2 disulﬁde reduction, until that protection is provided by
a peptide ligand [21]. Considered the functional unit of the PLC for
its role in stabilizing empty MHC class I complexes, in facilitating
peptide loading and in editing the repertoire of bound peptides
[22], the crystal structure of the TPN/ERp57 conjugate has been
recently published, outlining important residues in the contact of
these two molecules and also in the contact to the HC through
mutagenesis studies [23]. Other interactions between the PLC
components include the interaction of calreticulin with ERp57
[24], and the lectin-like association of calreticulin with the mon-
oglycosylated N-linked glycan on the HC [13,25]. According to two
independent groups, PDI (protein disulﬁde isomerase) also asso-
ciates with the PLC [26,27]. Recently, Kim et al. [4] proposed
a hypothetical model for the role of PDI, where after catalysing
oxidation of the a2 disulﬁde bond, PDI transfers the peptide it is
carrying to the MHC class I molecule.
Like other members of the antigen presentation pathway, the
TPN gene relies within the MHC: in mammals [28,29] and in birds
[30], in the extended class II region, and in bony ﬁsh [31e34] in the
class I region, being part of a true class I cluster in these ancient
vertebrates. Furthermore, as other class I genes, TPN has been
shown to be IFN-inducible in mammals [35] and also in trout [36]
and salmon [37].
In sea bass, little is known about theMHC class I genes. The need
to understand and characterize the antigen processing and
presentation pathway that could bring insights for further studies
of speciﬁc cell-mediated immunity in sea bass, served as the
starting motivation for the present study. At that time, it was
encouraged by the fact that homologues of mammalian TPN had
been discovered in few teleost species [34,36e38], however none
from the perciforms. In this work, we identify and characterize the
TPN from sea bass, an important species to the aquaculture
industry. For the ﬁrst time we describe its transcript and gene and
perform a comparative analysis at the molecular, structural and
phylogenetic levels using in silico approaches, e.g. homology
modelling.
2. Materials and methods
2.1. Ethics statement
This study was carried out in accordance with European and
Portuguese legislation for the use of animals for scientiﬁc purposes
(Directive 86/609/EEC; Decreto-Lei 129/92; Portaria 1005/92). The
Portuguese competent authority for animal protection, Direcção
Geral de Veterinária, approved the work (approval ID: 520/000/
000/2006).
2.2. Fish
Sea bass, Dicentrarchus labrax, were kept in a recirculating,
ozone-treated salt-water (25e30&) system at 22!1 "C, and fed
with commercial pellets, twice a day. Fish were sacriﬁced with
a lethal dose of 2-phenoxyethanol (Panreac; >5 mL/10 L).
2.3. cDNA cloning
Total RNA previously obtained from the head kidneys of three
stimulated ﬁsh, and extracted according to the Versagene! RNA
tissue kit (Gentra Systems) protocol, was reverse transcribed
following the instructions of the BioScript RNase H# (Bioline)
protocol, with primer APv2 (Table 1). Degenerate primers were
designed based on conserved regions from the multiple alignment
of tapasin amino-acid sequences from Danio rerio (zebraﬁsh,
NP_571049), Oncorhynchus mykiss (rainbow trout, AAZ66039),
Salmo salar (Atlantic salmon, AB227285), and Oryzias latipes
(Japanese medaka, BAB83851). The cDNA was ampliﬁed with
primers TPNFW1 and TPNRV1 (Table 1) in a PCR reaction adjusted
to a ﬁnal volume of 50 ml, containing 200 mM of each dNTP, 1.5 mM
MgCl2, 1$ PCR buffer (Bioline), 0.4 mM of each primer, 2 mL of cDNA
(1:20) and 1.25 U of Taq polymerase (Bioline). PCR cycling condi-
tions were: 94 "C for 2 min; 30 cycles of 94 "C for 45 s, 54 "C for
30 s, 72 "C for 30 s; and 72 "C for 5 min. The obtained product of
Table 1
Oligonucleotide sequences.
Designation Nucleotide sequence 50/30 Use/function
APv GGC CAC GCG TCG ACT AGT ACT TTT TTT TTT TTT TTT TTV cDNA synthesis; 50RACE; full cDNA id
AUAP GGC CAC GCG TCG ACT AGT AC 50RACE; full cDNA id
APv2 GAC TCA GGA CTT CAG GAC TTA GTT TTT TTT TTT TTT TTT V cDNA synthesis; full cDNA id
AUAP2 GAC TCA GGA CTT CAG GAC TTA G Full cDNA id
T7 TAA TAC GAC TCA CTA TAG GGC GA Sequencing
SP6 CTA TTT AGG TGA CAC TAT AGA ATA C Sequencing
TPNFW1 TTC TGG AGT GCT GGT TTG T Partial cDNA id
TPNRV1 CTC CAG STC CAY IGC CAC CTG Partial cDNA id
DLTPNFW2 TGA AAA CCA ACG ATC CAA ACT CTG Full cDNA & gene id; sequencing full gene
DLTPNFW3 CGA GCA GCA CAT CGC AGC AGA G Full cDNA id
DLTPNFW4 ACT GGA CTG CGG CTT CTG G Sequencing full cDNA & gene; southern
DLTPNFW5 TGG GTC GAG GAG GAG GTT TA Sequencing full gene
DLTPNFW6 CCC CAT ATA CCT GCA AGC TG Sequencing full gene
DLTPNFW7 TGG AGC TGA GCT GGG AGT TT Sequencing full gene
DLTPNFW8 ATG GTT GGC GTA GCG CTG GT Sequencing full gene
DLTPNRV1 AGA GAG GGG TGG CAG AAA GT 50RACE (cDNA synthesis);sequencing full gene
DLTPNRV2 CAG CTG GGT CGG TAA TAA AG 50RACE
DLTPNRV3 ACT CTG TCA GGG TTG ATG TC 50RACE
DLTPNRV4 TCT GCA CTG TGG CTG TGT Sequencing full gene
DLTPNRV7 GAG AAA TGT GTT TAT TTC ACT TA Full gene id
DLTPNRV8 AAC AAT CCA GAC TTT GCT TAT GA Sequencing full gene
DLTPNRV9 TTC CAG TGT TCA CGA GAA AAT AC Sequencing full cDNA & gene
DLTPNRV10 CTT GCC ATC GTA AGC CAG AA Sequencing full gene
DLTPNRV11 TTA GCG GTG TCA AGC TCC AG Sequencing full gene; southern
Letter nucleotide code: V ¼ A, C, G; Y ¼ C, T; S ¼ G, C; I ¼ deoxyinosine.
R.D. Pinto et al. / Fish & Shellﬁsh Immunology 32 (2012) 110e120 111
CHAPTER 4 
 
	   103	  
 
 
 
 
 
 
w780 bp was puriﬁed (QIAquick Gel Extraction Kit, QIAGEN) prior
to cloning into Escherichia coli XL-1 competent cells following the
pGEM!-T Easy Vector Systems (Promega). Plasmid DNA was
extracted and sequenced (MWG)with universal primers T7 and SP6
(Table 1).
The obtained partial nucleotide sequence from sea bass tapasin
was used to design three speciﬁc reverse primers in order to obtain
the 50 untranslated region (UTR) of the molecule: DLTPNRV1,
DLTPNRV2, DLTPNRV3 (Table 1). The previously isolated RNA was
used to synthesize ﬁrst-strand cDNA with primer DLTPNRV1
(Table 1), according to BioScript RNase H! (Bioline) protocol. The
cDNA was diluted to 150 mL in distilled water and loaded on
a Sephadex (in H2O) G-50 span column. The 50 RACE System for
Rapid Ampliﬁcation of cDNA Ends, Version 2.0 (Invitrogen) was
followed and 80 units of Recombinant Terminal Transferase
(Roche) were used in order to dATP tail 21 mL of the puriﬁed cDNA.
The tailed cDNA (5 mL) was ﬁrst ampliﬁed with the primers APv and
DLTPNRV2 (Table 1). The reaction was performed in the already
described conditions but with annealing at 55 "C. A second PCRwas
performed with primers AUAP and DLTPNRV3 (Table 1) in the
previously described conditions but with annealing at 57 "C. A PCR
product of w350 bp was obtained and later puriﬁed, cloned and
sequenced as described above.
To obtain the full sea bass tapasin cDNA, speciﬁc primers were
designed at the beginning of the 50 UTR region. DLTPNFW2 (Table 1)
and AUAP2 were used in a ﬁrst ampliﬁcation PCR with the reaction
conditions previously described but adding 0.15 U of Pfu DNA
polymerase (Promega) and using a different cDNA as template
(spleen cDNA, previously available in the laboratory, from a stimu-
lated ﬁsh, synthesized with APv2). The cycling conditions were as
described before, but with annealing at 59 "C for 1 min, and
extension for 1 min 30 s. Second ampliﬁcation PCRs were per-
formed using nested primer DLTPNFW3 (Table 1) and AUAP2. PCR
conditions were the same as the just described above, except that
annealing was at 60 "C for 30 s, and 1 mL of ﬁrst ampliﬁcation PCR
product was used as template. The obtained w2200 bp PCR prod-
ucts were puriﬁed, cloned and four independent clones were
sequenced as before with primers T7, SP6, DLTPNFW4 and
DLTPNRV9 (Table 1).
2.4. Genomic DNA cloning
Genomic DNAwas isolated from sea bass erythrocytes from two
different ﬁsh, as described by Stet et al. [39].
To obtain the full tapasin gene, genomic DNA from two different
ﬁsh was ampliﬁed by PCR using primers DLTPNFW2/DLTPNRV7
(Table 1). The PCRwas performed in a 50 ml PCR reaction (200 mMof
each dNTP, 1.5 mM MgCl2, 5 mL 10# PCR buffer (Bioline), 0.4 mM of
each primer and 1.25 U of Taq DNA polymerase (Bioline) and 0.15 U
of Pfu DNA polymerase (Promega)). The cycling conditions were:
94 "C for 2 min; 30 cycles of 94 "C for 45 s, 52 "C for 30 s, 72 "C for
3 min; and 72 "C for 5 min. The PCR products were puriﬁed, cloned
and independent clones sequenced as before. For primers see
Table 1.
2.5. Sequence analysis
Full nucleotide and protein sequences from sea bass tapasin
were compared to several tapasin sequences currently available in
the GenBank database retrieved using the BLAST program [http://
www.ncbi.nlm.nih.gov/genbank/]. The multiple alignment was
made using CLUSTALW [40] and formatted with Bioedit [41]. The
putative leader sequence was predicted with SignalP 3.0 [42]. The
Ig-like domains were based on InterProScan predictions [43]; and
the transmembrane domain was based on hydrophobicity
tendency and clusters predicted by ProtScale [http://www.expasy.
org/tools/protscale.html] and DrawHCA [http://mobyle.rpbs.univ-
paris-diderot.fr/cgi-bin/portal.py?form¼HCA], respectively, and
also on secondary structure (a-helices) predicted by NetSurfP [44].
Molecular weight was calculated with Expasy compute pI/Mw tool
[http://www.expasy.org/tools/pi_tool.html]. Possible N-glycosyla-
tion sites were predicted on Expasy post-translational modiﬁcation
tool [http://www.cbs.dtu.dk/services/NetNGlyc/]. The Neighbour-
joining phylogenetic tree was constructed using MEGA version 3.1
[45], with p-distance parameter and complete deletion of gaps. The
phylogenetic tree was tested for reliability using 1000 bootstrap
replications. The percentages of similarity and identity were
calculated with MatGAT [46] using default parameters.
2.6. Southern blotting
The gDNA was also digested with different restriction enzymes,
separated in 0.8% agarose gel and subjected to Southern blotting
[47]. Restriction enzymes EcoRI, NcoI, and NdeI (all zero cutters
within the probe and the genomic region of the probe) isolated and
combined were used to digestw9 mg of gDNA overnight at 37 "C.
A portion of the sea bass tapasin cDNA, that included partial
exons 4 and 5, was ampliﬁed with primers DLTPNFW4/DLTPNRV11
(Table 1) in the same PCR conditions (annealing at 59 "C) and later
puriﬁed, labelled and used as a probe.
Preparation of the labelled probe, hybridization and post-
hybridization stringency washes were performed accordingly to
Gene Images" AlhPhos Direct" Labelling and Detection System
(Amersham Biosciences) kit. For signal generation and detection
the Chemiluminescent Signal Generation and Detection with CDP-
Star" protocol from the same kit was followed.
2.7. Homology modelling
A suitable structural template for Dila-TPN, human TPN [PDB:
3f8u] was identiﬁed by a BLAST search as implemented in the
SWISS-MODEL Protein Modelling Server [48]. A manually edited
sequence alignment (w30% identity between target and template,
with gaps introduced essentially outside the secondary structure
elements) was used for homology modelling with SWISS-MODEL
[48] in alignment mode. The resulting theoretical model of the
protein had a calculated global energy of !8666.288 kJ/mol, which
was further minimized with PHENIX [49] to a total energy
of !9308.911 kJ/mol. The differences between target and template
rely essentially within the N-terminus of the protein where simi-
larity is lower between the molecules and where there are two
poorly ordered regions in the template. The secondary structure
elements were compared using PROMOTIF [50]. Model quality was
assessed with WHATCHECK [51] and PROCHECK [52] as imple-
mented in SWISS-MODEL. Model ﬁgures were prepared with
PyMOL [http://pymol.org/].
Fig. 1. Nucleotide and deduced amino acid sequences of sea bass TPN gene [GenBank: HQ328077]. The ORF and the predicted protein sequence are shown in uppercase letters. The
translation start codon and respective residue and stop codon are shaded in grey. The predicted signal peptide is bold, and cysteines are shaded in black. Within the 30UTR, putative
poly-adenylation signal sequences are in bold with grey shading. The intron splicing consensus sites (gt/ag) are underlined. All introns except intron 7 interrupt the coding frame
between the ﬁrst and second bases, as in most members of the Ig superfamily (boxes).
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3. Results and discussion
Three full-length sea bass tapasin (Dila-TPN) cDNA sequences
(Dila-TPN*0101 [GenBank: HQ328073], *0102 [GenBank:
HQ328074], and *0103 [GenBank: HQ328075]) were obtained from
the spleen of one ﬁsh and two full-length genomic sequences were
obtained from erythrocytes of another two individuals (Dila-
TPN*02 [GenBank: HQ328076], and Dila-TPN*03 [GenBank:
HQ328077]).
The Dila-TPN gene (5496 bp) contains eight exons, and all intron
donor/acceptor sites match the consensus motifs (Fig. 1A). Exon I
encodes the 50 UTR and most of the putative leader peptide, exon II
and III the unique domain, exon IV the IgSf V domain, exon V the
IgSf C domain, exon VI the putative hydrophobic transmembrane
domain, and exons VII and VIII the cytoplasmic tail. Exon VIII also
encodes the 30 UTR. The codons in the exon boundaries are split by
phase 1 introns (single exception of the phase 0 split at intron VII)
(Fig. 1A), which together with the fact that some individual exons
correspond to separate functional domains of the protein are
typical features of members of the Ig gene superfamily [53].
However, disruption of the leader peptide by an intron, the pres-
ence of a lysine in the transmembrane region and the short cyto-
plasmic tail are atypical for class I or II loci and yet have also been
described for human tapasin [28]. In general, the sea bass TPN
genomic structure is very similar to those of human [28] (Fig. 2) and
chicken [30] molecules except in the size of the introns: in Dila-
TPN, introns 1 and 2 are slightly larger than those of human and
chicken, while 3 and 7 are considerable smaller than the human
counterparts.
The transcripts have a total size of 2193, 2195 or 2199 bp, with
an open reading frame (ORF) of 1329 bp, a 50UTR of 83 bp, and a 30
UTR 781, 783 or 787 bp long (besides a polyadenylation tail) con-
taining ﬁve potential polyadenylation signals. The different sizes of
the 30UTR are due to the presence of dinucleotide repeats with
distinct sizes, (GT)n¼[2e30], interrupted by one or two AT sequences:
(GT)n[AT]1(GT)n or (GT)n[AT]1(GT)n[AT]1(GT)n (Fig. S1). The micro-
satellite is also present in the genomic sequences (Fig. S1). Although
the pattern of repeats is difﬁcult to interpret, it most likely results
Fig. 2. Schematic representation of sea bass and human TPN gene structures. Boxes and horizontal lines represent exons and introns, respectively. White and black boxes
differentiate coding and untranslated regions, respectively. Values above boxes represent the number of nucleotides. Exon numbers are indicated below boxes by Roman numerals.
Fig. 3. Sea bass tapasin is a single copy gene. Southern blot analysis of genomic DNA from two animals digested with three restriction enzymes (isolated and combined). The blot
was later probed with a region of tapasin that included parts of exons IV and V. All enzymes are zero cutters within the probe: one band can be seen for each of these individual
digestions and for each set. Sizes of the Mw marker are indicated at left.
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from PCR/sequencing errors, especially considering that sea bass
TPN is a single copy gene, as assayed by southern blotting (Fig. 3)
and in accordance with what was described for zebraﬁsh [38].
Other minor differences found when comparing the cDNA with
genomic sequences or the two genomic sequences with each other
are summarized in Tables S1eS3.
The 1329 bp ORF translates into a 442 amino-acid sequence
(Fig. 4). Removal of the putative 24-amino-acid leader sequence of
Dila-TPN, would result in a 418 amino-acid (w45 kDa) mature
protein, making Dila-TPN slightly smaller than mammalian tapa-
sins, which range in size from 428 (human) [14] and 443/444 (rat/
mouse) amino acids [29,54], but similar to TPN of other ﬁsh, which
contain 416e421 amino acids [34] (Fig. 4).
The ER luminal domains of TPN mediate interaction with the
MHC class I HC and ERp57. The N-terminal region of sea bass TPN
displays no homology to any conserved domain, as is the case for
Fig. 4. Alignment of TPN amino acid sequences. The protein sequences of TPN from Dicentrarchus labrax, [GenBank: HQ328073]; Oryzias latipes, [GenBank: BAB83851]; O. dancena,
[GenBank: ACN49160]; Onchorynchus mykiss, [GenBank: AAZ66039]; Salmo salar, [GenBank: AB227285]; Danio rerio, [GenBank: NP_571049]; Gallus gallus, [GenBank: O73895];
Rattus norvegicus, [GenBank: CAC34730]; Mus musculus, [GenBank: AAD17964]; Homo sapiens, [GenBank: AAC20076] were used in the multiple alignment. >< (above the align-
ment): sea bass exon/intron boundaries; >< (below the alignment): chicken/human exon/intron boundaries. Leader peptides are in dark red lettering. Tapasin unique domain, IgSf
V-domain, and IgSf C-domain are indicatated above the alignment. The TM region is underlined, and the cytoplasmic tail is italicized. Three conserved tapasin motifs are shaded in
dark grey, matching the tapasin motifs 3, 5 and 8 as established in mammals. Cysteines are shaded in black, and conserved cysteines within the unique domain of tapasin are
indicated by open arrows. The cysteine involved in association with ERp57 is indicated by superscript 95. Conserved cysteine and tryptophan residues involved in the IgSf V and C
domains fold are indicated by a solid arrow. Residues that affect binding to the MHC class I HC are highlighted in green. Residues within 4.5!A of an ERp57 atom are labelled in blue.
The lysine residue involved in association with TAP is boxed. Residues of mouse TMD tapasin that interact with TAP are coloured in red. ER-retention signals (di-lysine) are shown in
bold type and underlined within the cytoplasmic region. N-glycosylation sites (N-X-S/T) are boxed in grey. Numbers at the right of the alignment denote sizes of the precursor and
mature (within brackets) proteins. Dashes indicate gaps that maximize the alignment; (*) means identical residues, (:) and (.) denote conserved and semi-conserved substitutions,
respectively. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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other organisms and so it is considered a unique tapasin region
(Fig. 4). In particular, the 50 N-terminal amino acids of tapasin are
required for efﬁcient association with MHC class I HC [16]. Several
conserved residues are found in this region, including two cysteines
involved in an intra-chain disulﬁde bridge [23] (in sea bass C7, C83).
By comparing tapasins from different species, Dong et al. [23]
identiﬁed a prominent conserved patch on the surface of
a broader N-terminal domain, which includes residues 1e269,
encompassing the unique tapasin domain and the Ig V-like domain.
Different mutations in this region led to reduced or abrogated
binding of MHC class I HCs to the recombinant conjugate (TPN/
ERp57). In this regard, of the eight mutated residues with the
described effects on HC-binding, ﬁve are absolutely conserved
(hE72/sbE84, hE185/sbE185, hR187/sbR187, hQ189/sbQ189, hQ261/sbQ255)
and three are conservatively substituted (hE11/sbQ11, hD12/sbE12,
hL250/sbI244), suggesting that these amino acids may also be
important for TPN/MHC interaction in other vertebrates, including
sea bass. It is also through the unique tapasin region that TPN
interacts with ERp57 [55], namely through the disulﬁde bridge
between TPN C95 and ERp57 C57. However the tapasin cysteine
(hC95) involved in this covalent bond is only conserved in
mammals, being replaced by a serine in all the other vertebrate
species (sbS107). Although previously postulated that this conjugate
is preserved as a consequence of non-covalent interactions [20],
and in spite of the recently characterized mouse tapasin C95
mutants found to participate in a non-covalent complex with
ERp57, indicating that these molecules are able to interact in the
absence of the disulﬁde bond in the mouse system [56], it remains
to clarify how sea bass tapasin would associate with ERp57, as
previously mentioned for other bony ﬁsh [36] and also for chicken
[30], since only 8 of the 25 residues described to be in close prox-
imity to ERp57 [23] are conserved (P90, P108, L111, L198, A199, G214,
A215, Y251) and another 5 are conservatively substituted (L89, S107,
Q112, N205, T216) in sea bass (Fig. 4).
As expected, Dila-TPN retains the two Ig-like domains identiﬁed
in tapasins from other organisms. Canonical cysteine and trypto-
phan residues (sb-C167, sb-W186, sb-C245 and sb-C288, sb-W302 and
sb-C353), involved in disulﬁde bond formation and stabilization of
the Ig fold [57], are present in the predicted IgSf V and C1 domains
of sea bass TPN. The cysteines in the C domain are conserved across
all species, but those in the V domain are absent in mammals, as
others had previously reported [30,36,37]. Nonetheless, the Ig fold
is still maintained in the C domain of human tapasin, as elucidated
by the TPN-ERp57 crystal structure [23].
Within Dila-TPN exons IV, V and VI, 3 conserved motifs
(matching motifs 3, 5 and 8) were identiﬁed (Fig. 4), of the total
eight ﬁngerprints as established from mammals that provide
a signature for vertebrate tapasins. Within exon IV (Ig V domain)
Fig. 5.1. Three-dimensional homology model of Dila-TPN (excluding the TM and cytoplasmic domains). Model based on the crystal structure of human TPN [PDB: 3f8u [23]]. (A)
Representation of the Dila-TPN model with the N-terminal coloured blue, the Ig V-like domain yellow, and the Ig C-like domain green. This view of the molecule highlights its L-
shaped structure. Spheres represent disulﬁde bridges. (B) Surface representation of Dila-TPN, in the same orientation as depicted in (A). Contacts to MHC class I heavy chain are
labelled in white, and those to ERp57 are coloured red (conserved), brown (semi-conserved) and sand (non-conserved). (C) Surface representation of Dila-TPN rotated 90! clockwise
around the x-axis in respect to the orientation presented in (B). Circles denote disordered regions on the template. (D) Representation of Dila-TPN rotated 90! counter clockwise
around the y-axis in respect to the orientation presented in (A). (E) Surface representation of Dila-TPN, in the same orientation as depicted in (D). Colour code of highlighted residues
as in (B). (F) Surface representation of Dila-TPN, rotated 90! clockwise around the x-axis in respect to the orientation presented in (E). Colour code of highlighted residues as in (B).
Circles denote disordered regions on the template. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
R.D. Pinto et al. / Fish & Shellﬁsh Immunology 32 (2012) 110e120116
Tapasin 
 
	   108	  
 
 
 
 
 
 
a single conserved putative N-glycosylation site (N227) is preserved
in sea bass tapasin. This particular residue is conserved across
species, except for chicken that bears an alanine instead.
Although InterProscan failed to predict a transmembrane
domain in Dila-TPN, hydrophobic-rich helical structures could be
identiﬁed in this region using ProtScale, DrawHCA and NetSurfP.
According to these predictions, the putative transmembrane region
in the Dila-TPN molecule spans residues 380e402 of the mature
protein, in agreement with the boundaries deﬁned in the multiple
sequence alignment in Fig. 4 (residues 382e398). TAP binding was
suggested to occur within this region [14,16,18], namely through
K408 (human), which is conserved in sea bass (K396). This lysine,
only absent in the chicken molecule, is important for proper MHC
class I surface expression and in particular for tapasin stabilization
of human TAP [58]. Although, per se, mutation of the equivalent
residue of mouse tapasin (mTPN) did not abolish the ability to
stabilize TAP2, mK431 and its helical neighbours (located in the
same ﬂank of the helix, mF420, mF424, mG428, mW435) are required
for a fully functional TM domain [59]. Also mE414 in the connecting
peptide is critical, but not sufﬁcient for TAP2 stabilization [59]. All
the above-mentioned residues (K396, V385, L389, G393, W400, and E379
in sea bass) are conserved or conservatively substituted across
species (Fig. 4), and importantly an mTPN chimera containing the
zebraﬁsh TM domain was able to stabilize mTAP2 [59]. Apparently,
the mouse (but not the human) TPN TM/CYT domain is crucial to
interactions involving the MHC class I HC as well as TAP, and is
required for class I expression on the surface of mouse cells [60]. In
the cytoplasmic tail, there is a double lysine motif, at positions
!3 !4 (K415/K416), compatible with a retention signal in the
endoplasmic reticulum [61], present in all sequences except those
of medaka. According to Paulsson et al. [62], this is a retrieval signal
important for the retrograde transport of TPN from the Golgi back
to the ER, controlling the transport of unstable MHC class I mole-
cules and hence the quality of MHC class I antigen presentation.
The Dila-TPN structure (except its transmembrane and cyto-
plasmic domains) was predicted by comparative modelling using
the human tapasin crystal structure (PDB id: 3f8u [23]) as template.
The generated homology model of Dila-TPN is compatible with the
L-shaped structure of human tapasin, with one N-terminal domain
consisting of a seven-stranded b-barrel, an intermediate and one C-
terminal Ig-like domains (Fig. 5.1A, B, D, E). Furthermore, several
important structural amino acids are conserved in the same spatial
position (Fig. 5.1B, C, D, E). These include the pairs of bonded
cysteines in the unique and IgSf C-like domains, the N-glycosylation
site and all the residues postulated to interact with MHC class I HC.
Also the residues in close proximity to ERp57 are in their majority
structurally conserved. The additional pair of cysteines in the IgSf
V-like domain is located so that a disulﬁde bond can be formed
(Fig. 5.1A, D). Secondary structure elements (SSE) of the homology
model and of the template were determined with PROMOTIF [50].
Regarding the unique domain, the model consists of two helices
and seven b-strands. Compared to the template, helices H1 and H3
are missing due, in the case of the ﬁrst helix, to the presence of
a proline in sea bass, and there is one extra helix after strand S2,
corresponding to insertions in the sea bass sequence (Fig. 5.2). Other
differences include longer strands S1 and S2 (another region of
insertions in the model) and shorter strands S3, S4, S6, S7 and S10,
and helixH2. Themain differences observed,within theDila-TPNN-
terminal domain between the target and the template, are due on
one hand to two insertions (low similarity) in themodel, and on the
other hand correspondence to the two poorly ordered regions of the
template (Fig. 5.1C, F). The loop connecting to the following domain
is shorter in sea bass, representing deletions in the respective
sequence (Fig. 5.2). Within the Ig V-like domain, the model displays
Fig. 5.2. Alignment of target and template amino acid sequences. The protein sequences of TPN from Dicentrarchus labrax, [GenBank: HQ328073] and Homo sapiens, [GenBank:
AAC20076]were used in themultiple alignment. Secondary structure elements (SSE) are indicated above the alignment: (^) b-strand, (w) a-helix [determinedwith PROMOTIF [50] for
sea bass (upper); based on crystal structure for human [23] (lower)]; numbering of SSE according to the human molecule. Tapasin unique domain, IgSf V-domain, and IgSf C-domain
are denoted above the alignment and coloured blue, yellow and green, respectively. The two disordered regions of the template structure are in grey lettering. Cysteines involved in
intra-chain disulﬁde bonds are shaded in blue, yellow or green according to the domain they belong to. Residues in close proximity to ERp57, including C95 (highlightedwith an arrow
below the alignment), are shaded in red (conserved), brown (semi-conserved) and sand (non-conserved). Mutated residues affecting MHCI binding to the conjugate are shaded in
light grey. N-glycosylation sites (N-X-S/T) are in bold type and underlined. Dashes indicate gaps thatmaximize the alignment; (*) means identical residues, (:) and (.) denote conserved
and semi-conserved substitutions, respectively. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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one helix and nine b-strands. Compared to the template, S13 is
missing and S14 is shorter, both these reasons contributing to the
existence of a large loop connecting S12 to S14. Finally, the Ig C-like
domain contains sevenb-strands in themodel,with S20, S25 andH5
missing when compared to the template. In spite of the observed
differences in SSEs, overall the predicted three-dimensional struc-
ture of sea bass tapasin matches that of the template.
Phylogenetic comparison of TPN protein sequences from several
organisms reveals that among teleosts sea bass TPN is more closely
related to that fromO. latipes andOryzias dancena (Fig. 6 andTable 2).
Analysing the evolutionary relationship of TPN molecules through
their Ig domains and those of other proteins (TPN-R, CD8a, b2m,
MHC, and IgM light chain) clustered all V and C domains indepen-
dently (Fig. 7),which is in agreementwith Jorgensen et al. [37] results
and broadens their suggestion that both TPN Ig domains are true V
andC domains tomore teleost tapasins. All TPN Ig-V domains cluster
togetherwith high bootstrapping segregating them from TPN-R Ig-V
ones. The TPN Ig-C domains are not in a single cluster but instead
appear mixed with TPN-R Ig-C domains, although low bootstrap
levels are not supportive of such branching order.
In conclusion, in the present study the sea bass tapasin cDNA
and gene were for the ﬁrst time successfully cloned. Dila-TPN
consists of a signal peptide, unique domain, IgSf V-like domain,
IgSf C-like domain, transmembrane domain, and cytoplasmic tail
Fig. 6. Phylogenetic tree of TPN. An amino acid alignment (CLUSTALW) of the proteins
was used to generate the unrooted Neighbour-joining tree. Node values represent
percentages of bootstrap analysis from 1000 replications and complete deletion of
gaps. Accession numbers from TPN sequences have been referred in Figure 4. Those of
TPN-R, used as out-group, are as follows: Homo sapiens [GenBank: Q9BX59], Bos Taurus
[GenBank: A6QNK8], Mus musculus [GenBank: Q8VD31], Gallus gallus [GenBank:
Q5ZIA8], Tetraodon nigroviridis [GenBank: CAF97838], Oncorhynchus mykiss [GenBank:
AAZ66043], Salmo salar [GenBank: B5X4M8].
Table 2
TPN amino acid percentages of similarity and identity determined with MatGat.
Dicentrarchus labrax [GenBank: HQ328073]
Similarity (%) Identity (%)
Oryzias latipes
[GenBank: BAB83851]
88.8 76.4
Oryzias dancena
[GenBank: ACN49160]
88.2 75.8
Oncorhynchus mykiss
[GenBank: AAZ66039]
84.2 73.6
Salmo salar
[GenBank: AB227285]
84.4 72.7
Danio rerio
[GenBank: NP_571049]
83.5 67.5
Gallus gallus
[GenBank: O73895]
50.2 32.5
Rattus norvegicus
[GenBank: CAC34730]
49.6 31.1
Mus musculus
[GenBank: AAD17964]
50.1 31.4
Homo sapiens
[GenBank: AAC20076]
50.0 29.8
Fig. 7. Phylogenetic relationship between Ig domains of TPN, TPN-R, CD8a, b2m, MHC,
and IgM generated with Mega version 3.1 [45]. The branches were validated by
bootstrap analysis from 1000 replications, which are represented by percentages in
branch nodes. Accession numbers from TPN sequences have been referred in ﬁgure 4,
and those of TPN-R in ﬁgure 6. The remaining are the following: H. sapiens b2m IgC
[GenBank: P61769], D. labrax b2m IgC [GenBank: HQ290128]; H. sapiens HLA-A2 IgC
[GenBank: P01892], G. gallus MHCI BF2 IgC [GenBank: Q95601], D. labrax MHCI IgC
[GenBank: HQ290107]; D. labrax MHCIIa IgC [GenBank: ABH09449], D. labrax MHCIIb
IgC [GenBank: ABH09453], H. sapiens HLA-DMa [GenBank: NP_006111], H. sapiens
HLA-DMb [GenBank: NP_002109]; D. labrax IgMLc IgV [GenBank: CAC16856], D. labrax
IgMLc IgC [GenBank: CAC16856]; D. labrax CD8a IgV [GenBank: AAZ66439], H. sapiens
CD8a IgV [GenBank: NP_741969].
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matching other known tapasins. The presented gene is homologous
to the human one and characteristics like exon/intron boundaries,
and the presence of a single N-glycosylation site and an ER reten-
tion motif, also resemble those from other tapasin genes. Although
there are regions of insertions and deletions, within the N-domain
and the IgSf-V domain of sea bass TPN when compared to the
humanmolecule, the theoretical model of Dila-TPN is similar to the
L-shaped structure of hTPN. Monoclonal and/or polyclonal anti-
bodies against sea bass tapasin are currently not available. Thus, the
present identiﬁcation of sea bass tapasin provides information that
will enable the production of new tools for studying the class I
antigen presentation pathway in this important ﬁsh species.
Acknowledgements
Funding from FCT e Fundação para a Ciência e a Tecnologia,
Portugal (POCTI/CVT/44925/2006), supported this work. Rute D.
Pinto acknowledges FCT PhD fellowship BD/42327/2007, ﬁnanced
by POPH-QREN and co-funded by FSE and MCTES. The funders had
no role in study design, data collection and analysis, decision to
publish, or publication of the manuscript. No additional external
funding was received for this study.
Appendix. Supplementary data
Supplementary data associated with this article can be found in
the online version, at doi:10.1016/j.fsi.2011.10.029.
References
[1] Pamer E, Cresswell P. Mechanisms of MHC class Ierestricted antigen pro-
cessing. Annu Rev Immunol 1998;16:323e58.
[2] Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC.
Structure of the human class I histocompatibility antigen, HLA-A2. Nature
1987;329:506e12.
[3] Peaper DR, Cresswell P. Regulation of MHC class I assembly and peptide
binding. Annu Rev Cell Dev Biol. 2008;24:343e68.
[4] Kim Y, Kang K, Kim I, Lee YJ, Oh C, Ryoo J, et al. Molecular mechanisms of MHC
class I-antigen processing: redox considerations. Antioxid Redox Signal 2009;
11:907e36.
[5] Finley D. Recognition and processing of ubiquitin-protein conjugates by the
proteasome. Annu Rev Biochem 2009;78:477e513.
[6] Procko E, Gaudet R. Antigen processing and presentation: TAPping into ABC
transporters. Curr Opin Immunol 2009;21:84e91.
[7] Blanchard N, Shastri N. Coping with loss of perfection in the MHC class I
peptide repertoire. Curr Opin Immunol 2008;20:82e8.
[8] Chang SC, Momburg F, Bhutani N, Goldberg AL. The ER aminopeptidase,
ERAP1, trims precursors to lengths of MHC class I peptides by a “molecular
ruler” mechanism. Proc Natl Acad Sci USA 2005;102:17107e12.
[9] Zhang Y, Baig E, Williams DB. Functions of ERp57 in the folding and assembly
of major histocompatibility complex class I molecules. J Biol Chem 2006;281:
14622e31.
[10] Diedrich G, Bangia N, Pan M, Cresswell P. A role for calnexin in the assembly of
the MHC class I loading complex in the endoplasmic reticulum. J Immunol
2001;166:1703e9.
[11] Wearsch PA, Cresswell P. The quality control of MHC class I peptide loading.
Curr Opin Cell Biol 2008;20:624e31.
[12] Momburg F, Tan P. Tapasin-the keystone of the loading complex optimizing
peptide binding by MHC class I molecules in the endoplasmic reticulum. Mol
Immunol 2002;39:217e33.
[13] Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin
and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules
with TAP. Immunity 1996;5:103e14.
[14] Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herberg JA, Grandea AG, et al.
A critical role for tapasin in the assembly and function of multimeric MHC
class I-TAP complexes. Science 1997;277:1306e9.
[15] Chen M, Bouvier M. Analysis of interactions in a tapasin/class I complex
provides a mechanism for peptide selection. EMBO J 2007;26:1681e90.
[16] Bangia N, Lehner PJ, Hughes EA, Surman M, Cresswell P. The N-terminal
region of tapasin is required to stabilize the MHC class I loading complex. Eur J
Immunol 1999;29:1858e70.
[17] Tan P, Kropshofer H, Mandelboim O, Bulbuc N, Hammerling GJ, Momburg F.
Recruitment of MHC class I molecules by tapasin into the transporter asso-
ciated with antigen processing-associated complex is essential for optimal
peptide loading. J Immunol 2002;168:1950e60.
[18] Garbi N, Tiwari N, Momburg F, Hammerling GJ. A major role for tapasin as
a stabilizer of the TAP peptide transporter and consequences for MHC class I
expression. Eur J Immunol 2003;33:264e73.
[19] PraveenPV,YanevaR,KalbacherH,Springer S.TapasineditspeptidesonMHCclass
I molecules by accelerating peptide exchange. Eur J Immunol 2010;40:214e24.
[20] Peaper DR, Wearsch PA, Cresswell P. Tapasin and ERp57 form a stable
disulﬁde-linked dimer within the MHC class I peptide-loading complex.
EMBO J 2005;24:3613e23.
[21] Kienast A, Preuss M, Winkler M, Dick TP. Redox regulation of peptide recep-
tivity of major histocompatibility complex class I molecules by ERp57 and
tapasin. Nat Immunol 2007;8:864e72.
[22] Wearsch PA, Cresswell P. Selective loading of high-afﬁnity peptides onto
major histocompatibility complex class I molecules by the tapasin-ERp57
heterodimer. Nat Immunol 2007;8:873e81.
[23] Dong G, Wearsch PA, Peaper DR, Cresswell P, Reinisch KM. Insights into MHC
class I peptide loading from the structure of the tapasin-ERp57 thiol oxido-
reductase heterodimer. Immunity 2009;30:21e32.
[24] Frickel EM, Riek R, Jelesarov I, Helenius A, Wuthrich K, Ellgaard L. TROSY-NMR
reveals interaction between ERp57 and the tip of the calreticulin P-domain.
Proc Natl Acad Sci USA 2002;99:1954e9.
[25] Wearsch PA, Jakob CA, Vallin A, Dwek RA, Rudd PM, Cresswell P. Major
histocompatibility complex class I molecules expressed with monoglucosy-
lated N-linked glycans bind calreticulin independently of their assembly
status. J Biol Chem 2004;279:25112e21.
[26] ParkB,LeeS,KimE,ChoK,Riddell SR,ChoS,etal. Redoxregulation facilitatesoptimal
peptide selection byMHC class I during antigen processing. Cell 2006;127:369e82.
[27] Santos SG, Campbell EC, Lynch S, Wong V, Antoniou AN, Powis SJ. Major
histocompatibility complex class I-ERp57-tapasin interactions within the
peptide-loading complex. J Biol Chem 2007;282:17587e93.
[28] Herberg JA, Sgouros J, Jones T, Copeman J, Humphray SJ, Sheer D, et al.
Genomic analysis of the Tapasin gene, located close to the TAP loci in the
MHC. Eur J Immunol 1998;28:459e67.
[29] Grandea III AG, Comber PG, Wenderfer SE, Schoenhals G, Fruh K, Monaco JJ,
et al. Sequence, linkage to H2-K, and function of mouse tapasin in MHC class I
assembly. Immunogenetics 1998;48:260e5.
[30] Frangoulis B, Park I, Guillemot F, Severac V, Auffray C, Zoorob R. Identiﬁcation
of the Tapasin gene in the chicken major histocompatibility complex.
Immunogenetics 1999;49:328e37.
[31] ClarkMS,ShawL,KellyA,SnellP, ElgarG.CharacterizationoftheMHCclass I region
of the Japanese pufferﬁsh (Fugu rubripes). Immunogenetics 2001;52:174e85.
[32] Lukacs MF, Harstad H, Grimholt U, Beetz-Sargent M, Cooper GA, Reid L, et al.
Genomic organization of duplicated major histocompatibility complex class I
regions in Atlantic salmon (Salmo salar). BMC Genomics 2007;8:251.
[33] Mehta RB, Nonaka MI, Nonaka M. Comparative genomic analysis of the major
histocompatibility complex class I region in the teleost genus Oryzias.
Immunogenetics 2009;61:385e99.
[34] Matsuo MY, Asakawa S, Shimizu N, Kimura H, Nonaka M. Nucleotide sequence
of the MHC class I genomic region of a teleost, the medaka (Oryzias latipes).
Immunogenetics 2002;53:930e40.
[35] Herrmann F, Trowsdale J, Huber C, Seliger B. Cloning and functional analyses
of the mouse tapasin promoter. Immunogenetics 2003;55:379e88.
[36] Landis ED, Palti Y, Dekoning J, Drew R, Phillips RB, Hansen JD. Identiﬁcation
and regulatory analysis of rainbow trout tapasin and tapasin-related genes.
Immunogenetics 2006;58:56e69.
[37] Jorgensen SM, Grimholt U, Gjoen T. Cloning and expression analysis of an
Atlantic salmon (Salmo salar L.) tapasin gene. Dev Comp Immunol 2007;31:
708e19.
[38] Sultmann H, Murray BW, Klein J. Identiﬁcation of seven genes in the major
histocompatibility complex class I region of the zebraﬁsh. Scand J Immunol
2000;51:577e85.
[39] Stet RJ, van Erp SH, Hermsen T, Sultmann HA, Egberts E. Polymorphism and
estimationof thenumberofMhcCycaclass I andclass II genes in laboratory strains
of the common carp (Cyprinus carpio L.). Dev Comp Immunol 1993;17:141e56.
[40] Higgins DG. CLUSTAL V: multiple alignment of DNA and protein sequences.
Methods Mol Biol. 1994;25:307e18.
[41] Hall T. BioEdit. Biological sequence alignment editor for Windows. NC, USA:
North Carolina State University; 1998.
[42] Bendtsen JD, Nielsen H, von Heijne G, Brunak S. Improved prediction of signal
peptides: SignalP 3.0. J Mol Biol. 2004;340:783e95.
[43] Zdobnov EM, Apweiler R. InterProScan e an integration platform for the
signature-recognition methods in InterPro. Bioinformatics 2001;17:847e8.
[44] Petersen B, Petersen TN, Andersen P, Nielsen M, Lundegaard C. A generic
method for assignment of reliability scores applied to solvent accessibility
predictions. BMC Struct Biol. 2009;9:51.
[45] Kumar S, Tamura K, Nei M. MEGA3: integrated software for molecular
evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004;
5:150e63.
[46] Campanella JJ, Bitincka L, Smalley J. MatGAT: an application that generates
similarity/identity matrices using protein or DNA sequences. BMC Bio-
informatics 2003;4:29.
[47] Ausubel FM, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current
protocols in molecular biology. New York: John Wiley and Sons, Inc; 1999.
[48] Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-
based environment for protein structure homology modelling. Bioinformatics
2006;22:195e201.
R.D. Pinto et al. / Fish & Shellﬁsh Immunology 32 (2012) 110e120 119
CHAPTER 4 
 
	   111	  
 
[49] Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, et al. PHE-
NIX: a comprehensive python-based system for macromolecular structure
solution. Acta Crystallogr D Biol Crystallogr 2010;66:213e21.
[50] Hutchinson EG, Thornton JM. PROMOTIF e a program to identify and analyze
structural motifs in proteins. Protein Sci 1996;5:212e20.
[51] Hooft RW, Vriend G, Sander C, Abola EE. Errors in protein structures. Nature
1996;381:272.
[52] Laskowski RAMMW,Moss D, Thornton JM. PROCHECK: a program to check the
stereochemical quality of protein structures. J Appl Cryst 1993;26:283e91.
[53] Williams AF, Barclay AN. The immunoglobulin superfamily-domains for cell
surface recognition. Annu Rev Immunol 1988;6:381e405.
[54] Deverson EV, Powis SJ, Morrice NA, Herberg JA, Trowsdale J, Butcher GW. Rat
tapasin: cDNA cloning and identiﬁcation as a component of the class I MHC
assembly complex. Genes Immun 2001;2:48e51.
[55] Dick TP, Bangia N, Peaper DR, Cresswell P. Disulﬁde bond isomerization and
the assembly of MHC class Iepeptide complexes. Immunity 2002;16:87e98.
[56] Simone LC, Wang X, Tuli A, Solheim JC. Effect of a tapasin mutant on the
assembly of the mouse MHC class I molecule H2-K(d). Immunol Cell Biol
2010;88:57e62.
[57] Ioerger TR, Du C, Linthicum DS. Conservation of cys-cys trp structural triads
and their geometry in the protein domains of immunoglobulin superfamily
members. Mol Immunol 1999;36:373e86.
[58] Petersen JL, Hickman-Miller HD, McIlhaney MM, Vargas SE, Purcell AW,
Hildebrand WH, et al. A charged amino acid residue in the transmembrane/
cytoplasmic region of tapasin inﬂuences MHC class I assembly and matura-
tion. J Immunol 2005;174:962e9.
[59] Papadopoulos M, Momburg F. Multiple residues in the transmembrane helix
and connecting peptide of mouse tapasin stabilize the transporter associated
with the antigen-processing TAP2 subunit. J Biol Chem 2007;282:9401e10.
[60] Simone LC, Wang X, Tuli A, McIlhaney MM, Solheim JC. Inﬂuence of the
tapasin C terminus on the assembly of MHC class I allotypes. Immunogenetics
2009;61:43e54.
[61] Jackson MR, Nilsson T, Peterson PA. Identiﬁcation of a consensus motif for
retention of transmembrane proteins in the endoplasmic reticulum. EMBO J
1990;9:3153e62.
[62] Paulsson KM, Jevon M, Wang JW, Li S, Wang P. The double lysine motif of
tapasin is a retrieval signal for retention of unstable MHC class I molecules in
the endoplasmic reticulum. J Immunol 2006;176:7482e8.
R.D. Pinto et al. / Fish & Shellﬁsh Immunology 32 (2012) 110e120120
Tapasin 
 
	   112	  
Supplementary data 
 
Table S1 
Differences in Dila-TPN*01 compared to Dila-TPN*02 (excluding microsatellite). 
 
(a) 1 replacement translated in 1 different amino acid: A47/T47 (numbering of the mature protein) 
(b) 1 replacements translated in 1 different amino acids: R238/H238 (numbering of the mature protein) 
(c) 1 replacement translated in 1 different amino acid: K342/T342 (numbering of the mature protein) 
 
 
 
Table S2 
Differences in Dila-TPN*01 compared to Dila-TPN*03 (excluding microsatellite). 
 
(a) 1 replacement translated in 1 different amino acid: A47/T47 (numbering of the mature protein) 
(b) 1 replacements translated in 1 different amino acids: S178/L178 (numbering of the mature protein) 
(c) 1 replacement translated in 1 different amino acid: K342/T342 (numbering of the mature protein) 
 
 
 
 
 
 
 
Table S1 
Differences in Dila-TPN*01 compared to Dila-TPN*02 (excluding microsatellite). 
  Feature Replacements 
Nucleotide Full Length 18 
 5' UTR 0 
 Exon 1 (coding) 0 
 Exon 2 3a 
 Exon 3 3 
 Exon 4 1b 
 Exon 5 2c 
 Exon 6 0 
 Exon 7 0 
 Exon 8 (coding) 0 
 3' UTR 9 
Protein Mature 3 
 
(a) 1 replacement translated in 1 different amino acid: A47/T47 (numbering of the mature protein) 
(b) 1 replacements translated in 1 different amino acids: R238/H238 (numbering of the mature protein) 
(c) 1 replacement translated in 1 different amino acid: K342/T342 (numbering of the mature protein) 
 
 
 
 
 
Table S2 
Differences in Dila-TPN*01 compared to Dila-TPN*03 (excluding microsatellite). 
  Feature Replacements 
Nucleotide Full Length 17 
 5' UTR 0 
 Exon 1 (coding) 0 
 Exon 2 2a 
 Exon 3 2 
 Exon 4 2b 
 Exon 5 2c 
 Exon 6 0 
 Exon 7 0 
 Exon 8 (coding) 0 
 3'UTR 9 
Protein Mature 3 
 
(a) 1 replacement translated in 1 different amino acid: A47/T47 (numbering of the mature protein) 
(b) 1 replacements translated in 1 different amino acids: S178/L178 (numbering of the mature protein) 
(c) 1 replacement translated in 1 different amino acid: K342/T342 (numbering of the mature protein) 
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Table S3 
Differences in Dila-TPN*02 compared to DilaTPN*03. 
 
(a) 2 replacements translated in 2 different amino acids: L178/S178 and R238/H238 (numbering of the mature 
protein) 
(b) 1 replacement translated in 1 different amino acid: K342/T342 (numbering of the mature protein) 
 
 
 
 
 
Figure S1. Microsatellite region of TPN transcripts and genes. Number of repeats are indicated for each 
molecule: (GT)n[AT]1(GT)n or (GT)n[AT]1(GT)n[AT]1(GT)n. In order to overcome the difficulty to ascertain 
whether the differences observed between Dila-TPN*0101, *0102, *0103, *02 and *03 were due to technical 
error or could be occurring in vivo, a slightly broader region that included the microsatellite was assessed in a 
new individual so that cDNA (liver and spleen) and genomic DNA (gDNA) from the same fish could be used as 
templates. Primers DLTPNFW8 and DLTPNRV8 (Table 1) were used in the PCR reactions, and amplification 
products were purified, cloned and sequenced. Sequencing of three clones from each different template 
resulted in the here-represented additional sequences: two sequences from liver cDNA (Dila-TPN*04L01 and 
*04L02), one from spleen cDNA (Dila-TPN*04Sp01) and three from gDNA (Dila-TPN*04g01, *04g02 and 
*04g03). These results show that even using cDNA and gDNA from the same fish, differences were still 
observed in the microsatellite although with gaps in only one region. So, especially considering that TPN is a 
single-copy gene (for further details see Results and Discussion section) it is likely that the differences 
observed are due to PCR/sequencing errors. 
 
Table S3 
Differences in Dila-TPN*02 compared to Dila-TPN*03. 
  Feature Replacements Insertions Deletions 
Gene Full Length 67 18 18 
 5' UTR 0 0 0 
 Exon 1 (coding) 0 0 0 
 Intron 1 22 6 3 
 Exon 2 1 0 0 
 Intron 2 2 0 0 
 Exon 3 1 0 0 
 Intron 3 3 0 0 
 Exon 4 3a 0 0 
 Intron 4 7 0 0 
 Exon 5 2b 0 0 
 Intron 5 10 0 0 
 Exon 6 0 0 0 
 Intron 6 4 2 15 
 Exon 7 0 0 0 
 Intron 7 0 0 0 
 Exon 8 (coding) 0 0 0 
 3'UTR 12 10 0 
Protein Mature 3 0 0 
 
(a) 2 replacements translated in 2 different amino acids: L178/S178 and R238/H238 (numbering of the mature protein) 
(b) 1 replacement translated in 1 different amino acid: K342/T342 (numbering of the mature protein) 
  
 
 
  
 Dila-TPN*0101        CTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT----ATGTGTGTGTGTGTGTGTGTGTATGTGTGTGT--CTAAGA (GT)19AT(GT)10AT(GT)4 
Dila-TPN*0102        CTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTATGTGTGTGTGTGTGTGTGTGTATGTGTGTGTGTCTAAGA (GT)21AT(GT)10AT(GT)5  
Dila-TPN*0103        CTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT----ATGTGTGTGTGTCTAAGA (GT)30AT(GT)5  
Dila-TPN*02          CTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT----ATGTGTGTGTGTGTGTGTGT--------------CTAAGA (GT)19AT(GT)9  
Dila-TPN*03          CTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT----------------------------ATGTGTGTGTGTCTAAGA (GT)18AT(GT)5  
Dila-TPN*04L01       CTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT--------------------------ATGTGTGTGTGTCTAAGA (GT)19AT(GT)5   
Dila-TPN*04L02       CTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT--------------------------------ATGTGTGTGTGTCTAAGA (GT)16AT(GT)5 
Dila-TPN*04Sp01      CTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT----ATGTGTGTGTGTCTAAGA (GT)30AT(GT)5 
Dila-TPN*04g01       CTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTATGTGTATGTGTGTGTGTGTGT--CTAAGA (GT)26AT(GT)2AT(GT)7 
Dila-TPN*04g02       CTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTATGTGTATGTGTGTGTGTGTGTGTCTAAGA (GT)26AT(GT)2AT(GT)8 
Dila-TPN*04g03       CTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT--ATGTGTATGTGTGTGTGTGTGTGTCTAAGA (GT)25AT(GT)2AT(GT)8 
                     ************************************                                 *********  ****** 
 
Figure S1: Microsatellite region of TPN transcripts and genes. Number of repeats are indicated for each molecule: (GT)n[AT]1(GT)n or 
(GT)n[AT]1(GT)n[AT]1(GT)n. In order to overcome the difficulty to ascertain whether the differences observed between Dila-TPN*0101, *0102, *0103, 
*02 and *03 were due to technical error or could be occurring in vivo, a slightly broader region that included the microsatellite was assessed in a new 
individual so that cDNA (liver and spleen) and genomic DNA (gDNA) from the same fish could be used as t mplates. Primers DLTPNFW8 and 
DLTPNRV8 (Table 1) were used in the PCR reactions, and amplification products were purified, cloned and sequenced. Sequencing of three clones 
from each different template resulted in the here-represented additional sequences: two sequences from liver cDNA (Dila-TPN*04L01 and *04L02), 
one from spleen cDNA (Dila-TPN*04Sp01) and three from gDNA (Dila-TPN*04g01, *04g02 and *04g03). These results show that even using cDNA 
and gDNA from the same fish, differences were still observed in the microsatellite although with gaps in only one region. So, especially considering 
that TPN is a single-copy gene (for further details see Results and Discussion section) it is likely that the differences observed are due to 
PCR/sequencing errors.  
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a b s t r a c t
Mammalian calreticulin (CRT) is a key molecular chaperone and regulator of Ca2þ homeostasis in
endoplasmic reticulum (ER), also being implicated in a variety of physiological/pathological processes
outside the ER. Importantly, it is involved in assembly of MHC class I molecules. In this work, sea bass
(Dicentrarchus labrax) CRT (Dila-CRT) gene and cDNA have been isolated and characterized. The mature
protein retains two conserved motifs, three structural/functional domains (N, P and C), three type 1 and 2
motifs repeated in tandem, a conserved pair of cysteines and ER-retention motif. It is a single-copy gene
composed of 9 exons. Dila-CRT three-dimensional homology models are consistent with the structural
features described for mammalian molecules. Together, these results are supportive of a highly
conserved structure of CRT through evolution. Moreover, the present data provides information that will
allow further studies on sea bass CRT involvement in immunity and in particular class I antigen
presentation.
! 2013 Elsevier Ltd. All rights reserved.
1. Introduction
Calreticulin (CALR or CRT) was ﬁrst identiﬁed as a high-afﬁnity
Ca2þ-binding protein in the sarcoplasmic reticulum of skeletal
muscle [1]. Different designations have been attributed to it, but the
accepted term calreticulin reﬂects both its calcium binding nature
and its localization in the sarcoplasmic/endoplasmic reticulum (SR/
ER) of muscular/non-muscular tissues, respectively (reviewed in
[2]). Being present in vertebrates, invertebrates and higher plants
(reviewed in [3]), its importance has been demonstrated by mul-
tiple functions both inside (chaperoning and Ca2þ storage/release)
and outside the ER (many physiological/pathological processes)
(reviewed in [4,5]).
Calreticulin can be divided into three domains (reviewed in [6]):
the amino-terminal N domain, the ﬂexible mid proline-rich P
domain, both taking part in chaperone activity, and the highly
acidic carboxyl-terminal C domain responsible for the Ca2þ-buff-
ering activity (reviewed in [5,6]) that ends with the ER-retrieval
sequence [7]. The overall shape of CRT includes a globular struc-
ture (N/C domains) [8e10] and an extended arm-like hairpin
structure (P domain) [11]. Besides Ca2þ [12e14], CRT also binds ATP
[15] and Zn2þ [16], which affect its ability to suppress aggregation
of non-glycosylated proteins [17]. Hence, CRT acts as a lectin
chaperone (interacts with monoglycosylated proteins) and as a
classical chaperone (has polypeptide-binding capacity/senses a
protein conformational state) [17].
Of notice is the involvement of CRT in major histocompatibility
complex (MHC) class I folding and high afﬁnity peptide loading
(reviewed in [18,19]). Importantly, assembly occurs within the ER
(reviewed in [20,21]) and is dependent on CRT [22].
Studies of calreticulin in teleost ﬁsh are still limited to a few
species [23e27]. Here we report the identiﬁcation and character-
ization of calreticulin from European sea bass, a relevant species for
the Mediterranean aquaculture industry. Full cDNA and gene se-
quences as well as gene copy number have been determined.
Moreover, in silico structural (primary sequence and 3D homology
modelling) and phylogenetic analyses have been performed in or-
der to further characterize this molecule.
2. Materials and methods
2.1. Fish
Sea bass, D. labrax, were kept in a recirculating, ozone-treated
salt-water (20e25&) system at 22 " 1 #C and fed with commercial
pellets twice a day. Fish were sacriﬁced with a lethal dose of 2-
phenoxyethanol (Panreac; >5 mL/10 L).
* Corresponding author. Tel.: þ351 226 074 900; fax: þ351 226 099 157.
E-mail addresses: rsp@ibmc.up.pt (R.D. Pinto), amoreira@ibmc.up.pt
(A.R. Moreira), ppereira@ibmc.up.pt (P.J.B. Pereira), nsantos@ibmc.up.pt,
nmsdossantos@hotmail.com (N.M.S. dos Santos).
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2.2. cDNA cloning
RNAs were extracted according to Versagene! RNA tissue kit
(Gentra Systems) instructions and transcribed to cDNAs following
the BioScript RNase H! (Bioline) protocol. PCR products were
cloned into pGEM"-T Easy (Promega). Automated sequencing was
performed using primers detailed in Supplementary Table S1.
50 RACE experiments were performedwith the 50 RACE System from
Invitrogen (Version 2.0) and Recombinant Terminal Transferase
(Fermentas or Roche) was used to dATP tail the puriﬁed cDNA.
Total RNA extracted from the head-kidney of one ﬁsh was
reverse transcribed with primer APv2 (Table S1). Degenerate
primers were designed based on conserved regions of calreticulin
across several vertebrate species. The cDNA was ampliﬁed with
primers CnxCrtFW1 and CnxCrtRV1 (Table S1) and products were
obtained at the 4th round of PCR. A product of approximately
400 bp was puriﬁed, cloned and sequenced.
This ﬁrst product from sea bass calreticulin was used to design
speciﬁc reverse primers. As the distance to the 50 end of the
transcript was still considerable, also a degenerate forward primer
was designed using the calnexin/calreticulin multiple alignment.
Total RNA from head-kidney was synthesized with APv2 and
ampliﬁed with the set of primers CrtFw1/DLCrtRV5 followed by
two consecutive ampliﬁcations with CrtFW1/DLCrtRV4 (Table S1).
The obtained w350 bp product was cloned and sequenced.
To obtain the 50 UTR of calreticulin, the resulting sequence was
used to design two speciﬁc reverse primers (Table S1). Total RNA
extracted from the spleen of one ﬁsh was synthesized with
DLCrtRV7. The tailed cDNA was ampliﬁed with primers APv2/
DLCrtRV7 followed by a 2nd ampliﬁcation with AUAP2/DLCrtRV6
(Table S1). The obtainedw400 bp product was puriﬁed, cloned and
sequenced.
To obtain the full sea bass calreticulin cDNA, speciﬁc primers
(Table S1) were designed at the beginning of the 50 UTR region.
Fig. 1. Alignment of CRT amino acid sequences. Amino acid sequences were retrieved from GenBank (Table S2) and aligned with CLUSTALW [50]. Dashes indicate gaps that
maximize the alignment and dots denote residues identical to the ﬁrst sequence of the alignment. Identical residues, conserved and semi-conserved substitutions are denoted
below the alignment with, (*), (:) and (.), respectively. Residue numbers are given right of the sequences; numbers in parenthesis refer to the mature proteins. Predicted N, P and C
domains are indicated above the alignment [10], with junction regions represented by black boxes (open ones along the alignment). Letters (s) or (h) above the alignment denote b-
strands or a-helices, respectively; different b-sheets within the globular domain are denoted with different colours. The two CRT signature motifs within the N domain are boxed
and labelled (Calreticulin-1 and -2). Type 1 (or A) and 2 (or B) tandem repeats are indicated above the alignment (also underlined and in bold type in the sea bass sequence).
Putative nuclear localization signal is shaded in grey. The region interacting with rheumatoid arthritis shared epitope is shaded cyan in the rabbit sequence [46]. Residues of human
CRT that contact ERp57 [43] are shaded green. Canonical cysteines involved in an intra-chain disulﬁde bond (connecting b6 and b7) as well as a third cysteine (absent in Rana
rugosa) are displayed in inverted type. Histidines within the N domain (putative sites for Zn2þ binding) are shaded in yellow. Mouse residues that can putatively bind Zn2þ are
shaded orange [9]. Putative N-glycosylation signal identiﬁed in some species is shaded dark blue. Mouse and human CRT residues known to interact with Ca2þ in the globular
domain are shaded dark red [8,9]. Residues involved in carbohydrate binding are shaded light (hydrogen bonds) and dark (hydrophobic interactions) purple [9]. Hydrophobic patch
on the P domain putatively involved in peptide binding is shaded red [10]. Residues involved in the formation of three small hydrophobic cores in the rat P domain are underlined
and in bold type [11]. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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DLCrtFW1 and APV were used in a ﬁrst ampliﬁcation using liver
cDNA, followed by a semi-nested PCR with primers DLCrtFW2/
AUAP. The obtained w2100 bp PCR product was puriﬁed, cloned
and 3 independent clones were sequenced.
2.3. Genomic DNA cloning and Southern blotting
Genomic DNA (gDNA) was isolated from sea bass erythrocytes
from a single ﬁsh [28]. The calreticulin gene was obtained by partial
ampliﬁcation using different sets of primers (Table S1). PCR prod-
ucts were puriﬁed, cloned and one clone of each product sequenced
as before. Full calreticulin gene was assembled by overlapping the
partial sequences.
Sea bass genomic DNA was digested with different restriction
enzymes and subjected to Southern blotting [32], as detailed in
Fig. S3.
2.4. Sequence analysis
Nucleotide and protein sequences from sea bass calreticulin
were compared to several homologues currently available at the
GenBank database [http://www.ncbi.nlm.nih.gov/genbank/]. The
multiple sequence alignment was made using CLUSTALW [29] and
formatted with Bioedit [30]. Domain boundaries were derived from
the murine structure [10]. Calreticulin family signature motifs were
based on InterPro Scan predictions [31]. The molecular weights
of the polypeptide chains were calculated with the Expasy com-
pute pI/MW tool [http://www.expasy.org]. N-glycosylation sites
and putative signal peptide sequences were predicted at [http://
www.cbs.dtu.dk/services/NetNGlyc/] and [http://www.cbs.dtu.dk/
services/SignalP/], respectively.
2.5. 3D modelling
Suitable structural templates for sea bass calreticulin, mouse
(PDB: 3rg0) and rat (PDB: 1hhn) calreticulins, were identiﬁed by a
BLAST search as implemented in the SWISS-MODEL Protein
Modelling Server [33]. Homology modelling was performed with
SWISS-MODEL in automated mode [33] revealingw62% andw79%
identity between target and template molecules, respectively. Gaps
were introduced only in the truncated area of the template 3rg0, in
this case involving secondary structure elements. The secondary
structure elements were compared with PROMOTIF [34]. Model
quality was assessed withWHATCHECK [35] and PROCHECK [36] as
implemented in the Swiss Model structure assessment tool. Model
pictures were prepared with PyMOL [http://pymol.org/].
Fig. 1. (continued).
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3. Results and discussion
3.1. cDNA, gene and Southern blot analysis
The sea bass calreticulin (Dila-CRT) full-length cDNA has been
obtained by homology cloning, performing RT-PCR on mRNA
extracted from the liver of one ﬁsh. Sequence analysis conﬁrmed
highest similarity with other ﬁsh CRTs. The here-reported Dila-CRT
sequence [GenBank: JX235975] has a total size of 2065 bp, con-
taining a 50 UTR of 34 bp, an ORF of 1281 bp and a 30 UTR of 750 bp
(excluding the poly(A) tail). Three mRNA instability motifs [37] and
two potential polyadenylation signals could be identiﬁed within
the 30 UTR.
In the Dila-CRT gene [Genbank: JX235974], which is 6462 bp
long, all intron donor/acceptor sites follow the gt/ag consensus rule,
and codons in the exon boundaries are split by phase-one (1e3), or
phase-zero (4e8) introns (Fig. S1). Exon I encodes the 50 UTR, the
putative leader peptide and the ﬁrst 34 nucleotides of mature CRT
e the start of the N domain; exons II-IV cover most of the N domain
length; exon V encodes the ﬁnal part of N domain (last 99 nucle-
otides) and the beginning of the P domain (111 nucleotides), which
continues through exon VI; exon VII encodes P domain ﬁnal 105
nucleotides, as well as the ﬁrst part of the C domain (39 nucleo-
tides) that continues through exon VIII; ﬁnally exon IX contains the
last part of the C domain and the 30 UTR (Fig. S1). The sea bass CRT
nine-exon genomic structure (Fig. S2) is identical to that of human
[38], mouse [39] and ﬁsh CRTs [23,25,27]. Furthermore, although
intron sizes are highly variable, intron phases and locations as well
as exon sizes are conserved between sea bass, human [38] and
other species [27] CRTs.
Southern blot analysis revealed that Dila-CRT is a single-copy
gene (Fig. S3), which is in agreement to what has been described
not only for human [40] andmouse [39] CRTs but also for its teleost
homologues including zebraﬁsh [23] and rainbow trout [25],
despite rainbow trout tetraploidy.
3.2. Primary structure analysis
Amino acid sequences of CRT from several species (Table S2)
were aligned with that of Dila-CRT using CLUSTALW (Fig. 1). In sea
bass, a predicted 406-residue (47.2 kDa) mature protein would be
generated by cleavage of the putative 20-amino acid signal peptide.
It is the second largest CRT among all analysed species (Fig. 1).
Sea bass CRT contains the typical N, P and C CRT domains, the
two ﬁrst displaying higher identity/similarity among the different
species than the C domains (Fig. 1). Within the N domain two
conserved CRT family signature motifs (K99HEQKIDCGGGYVKIF114
and I131MFGPDICG139) were identiﬁed in Dila-CRT (Fig. 1), both
consisting of highly conserved regions. Each of these motifs bears a
conserved cysteine residue (in sea bass -sb- C106, C138) involved in
the formation of an intramolecular disulﬁde bridge [41]. The
equivalent linkage is required for efﬁcient carbohydrate binding to
mouse CRT [9]. However, in bovine brain CRT, a third also highly
conserved cysteine residue at the N-domain (sbC144) was shown to
be involved instead [42]. CRT binds Zn2þ [16] with low afﬁnity [13],
presumably through ﬁve highly conserved histidine residues
located at its N-domain [16] (sbH43, H100, H124, H146 and H171 in
Fig. 1). Teleosts display an additional histidine within this domain
(sbH156), also observed in Drosophila melanogaster and Arabidopsis
thaliana (Fig. 1). Although some of these residues are buried, mouse
H42 is exposed and in the vicinity of other residues that could
potentially participate in Zn2þ binding: D118, D121, H123 and D125 [9],
all highly conserved across species (Fig. 1).
In the arm/P domain, the triplicate A (or type 1) and B or (type 2)
repeats (PXXIXDPDAXKPEDWDE and GXWXPPIXNPXYX, respec-
tively) ordered as ‘111222’ as in other described calreticulins
(reviewed in [3]) are also observed in Dila-CRT (Fig. 1): A e
A206.D222, A224.D238 and P240.E256; B e G260.K273, G274.K287
and G288.T301 (only three non-conservative replacements among
all six motifs in sea bass e D231, K279 and H292). A putative nuclear
localization signal (NLS)e P204PKKIKDPDe identiﬁed in rabbit CRT
P domain (reviewed in [2]) is highly conserved among the different
species, with only two conservative substitutions in Dila-CRT:
P205AKKIKDPE. The tip of the P domain is the binding site to
ERp57 [43], and mutational analysis on rabbit CRT identiﬁed some
of the residues involved: E239, D241, E243 and W244 [44]. With
exception of E239 that is conservatively substituted by an aspartate
in teleosts (sbD237), the remaining residues are conserved across
species (sbD239, sbE241, sbW242) (Fig. 1), suggesting that binding to
ERp57 may be conserved as well. CRT has long been hypothesized
Fig. 1. (continued).
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Fig. 2. Three-dimensional homology models of sea bass CRT globular/partial arm domains and arm domain alone. Models generated using the crystal structure of mouse CRT
[PDB: 3rg0] [10] and rat CRT NMR structure [PDB: 1hhn] [11] as templates. A) Dila-CRT globular/partial arm domain homology model. Secondary structure elements (SSE), as well
as N- and C-termini are labelled. The disulﬁde bond is represented as spheres. Note that C domain contributions to the globular region include: strands b19 and b20 and helix a3. B)
Surface representation of the Dila-CRT globular/partial arm domain homology model. The Ca2þ-, glycan- and putative Zn2þ-binding sites are labelled and coloured dark red,
purple (light for hydrogen bonds and dark for hydrophobic contacts) and orange, respectively. C) Dila-CRT arm domain homology model. The six b-sheet strands are labelled. N
and C terminal regions are also indicated. D) Same as panel C with relevant residues highlighted. The ERp57-binding site is coloured green. Residues putatively involved in
complementary peptide binding are coloured red and labelled. Residues forming the three hydrophobic cores of the P domain are coloured black and labelled. E) Alignment of
target and template amino acid sequences. The protein sequences of CRT from Dicentrarchus labrax, Mus musculus and Rattus norvegicus were used in the multiple sequence
alignment (see details in Fig. 1). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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to play a role in autoimmunity [45]. Ling S. et al. [46] ﬁndings
indicate that the rheumatoid arthritis shared epitope (SE e a ﬁve
residue motif from HLA-DRB1 alleles known as a risk factor for
disease severity [47] and to interact with cell surface CRT [48])
activated signaling maps to the 234e240 region of the (rabbit) CRT
P-domain and depends primarily on E234 and E240, and to a lesser
extent on D237 [46]. These key residues are absolutely conserved in
Dila-CRT (E235, E241, and D238) and highly conserved across species
(Fig. 1) suggesting functional relevance.
No potential glycosylation site has been predicted for Dila-CRT.
Depending on the species, calreticulin may have none, one or
more potential glycosylation sites, suggesting that the glycosylation
pattern is not a conserved feature of the protein (reviewed in [3]).
Similarly to other CRTmolecules, Dila-CRT C domain is highly acidic,
containing 38 glutamate and 15 aspartate residues in a total of 118
amino acids (32 and 12%, respectively) (Fig. 1). In mammals, these
series of negatively charged residues at the carboxy-terminus of the
protein bind over 50% of the ER luminal Ca2þ e buffering activity
(reviewed in [5,6]). Similar highly charged C-terminal domains have
been reported to be in part responsible for the anomalous SDS-PAGE
mobility of mammalian (reviewed in [2]) and ﬁsh [24] CRT at
w60 kDa instead of the expected w46 kDa. Finally, Dila-CRT ends
with an ER-retrieval sequence (Fig.1) similar tomost CRTs across the
analyzed species. Variants (HEEL and HDEL) to the canonical KDEL
signalwere found in Ixodes paciﬁcus, D.melanogaster andA. thaliana.
Absence of the typical motif in Gallus gallus CRT is most probably a
consequence of the molecule being incomplete.
Both CNX and CRT lectin/globular domains contain a single high
afﬁnity Ca2þ-binding site [9,49]. As revealed by the crystal struc-
tures of human and mouse CRT globular domains, the bound Ca2þ
ion, playing a crucial stabilization role, is coordinated by the
following ligands: the backbone carbonyls of Q26, K62, K64, two
water molecules and the side-chain carbonyl oxygens of D328 [8,9].
The Ca2þ ion, bound on the opposite site of the arm domain
insertion [10], does not interfere with glycan recognition as was
elucidated by Kozlov et al. [9] and the carbohydrate-binding site,
located at the concave b-sheet, correlates well with previous
mutagenesis studies identifying CRT residues essential for carbo-
hydrate interactions [9]. Namely, residues Y109, K111, Y128, D135, D317
and D125 are involved in polar contacts, while M131 and W319 are
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Fig. 3. Phylogenetic tree of CRT amino acid sequences from different vertebrate species. Neighbour-joining tree calculated with MEGA v5.05 [51], using p-distance parameter
and pairwise deletion of gaps. The branches were validated by bootstrap analysis from 1000 replications, represented by percentages in branch nodes. The sequences of precursor
forms of CRT were used. Calnexin molecules from distinct species were used as outgroup (accession numbers detailed in Table S2).
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engaged in hydrophobic interactions with carbohydrate moieties
[9]. Other contacts include G124 and N154 (H bonds), F74, C105, C137,
H145 and I147 (hydrophobic) [9]. All these residues show strict
conservation across species, with the exception of the conservative
substitutions of aspartates 125 and 317 for glutamates in some
species (Fig. 1). According to Pocanschi et al. [10], within the lectin
domain there is also a polypeptide-binding site that mediates CRT
classical chaperone activity, and which precise location remains
unknown. A hydrophobic patch along the P domain possibly con-
stitutes a secondary polypeptide-binding site [10]. Residues A213,
A214, P216, W289, P292 and I294 were found to contact other CRT
molecule, of which only A214 is not conserved (Fig. 1). Three small
hydrophobic cores have been described within the P domain each
involving two tryptophans and one lysine [11], all conserved in sea
bass (K216/W220/W290; K233/W237/W276; K250/W254/W262) and
almost strictly conserved across species (Fig. 1).
The arm domain is linked to the lectin domain by a small
structured region, the junction region [10] that includes L203eK206
and P301eN304 on each end, structured around the aromatic ring of
Y299, forming a small hydrophobic core [10]. All these residues are
conserved or conservatively substituted in sea bass (Fig. 1).
3.3. 3D modelling
The crystal structure of the ER luminal region of the dog cal-
nexin revealed twomain structural components: a globular domain
and an extended arm-like domain [49]. There is no experimental
structure of any full-length CRT available, but the structures of CRT
fragments have been determined: rat CRT arm domain [11], mouse
CRT globular domain (with bound carbohydrate) [9], human CRT
globular domain [8] and mouse CRT globular/partial arm domains
[10]. All these turned out to be suitable templates for modelling the
sea bass molecule. The Dila-CRT structure was predicted by
comparative modelling using the mouse CRT [PDB: 3rg0 [10]] and
rat CRT [PDB: 1hhn [11]] crystal and NMR structures as templates
for the globular/partial arm domains and arm domain alone,
respectively (Fig. 2). As expected, the homology model of Dila-CRT
is structurally compatible with the globular/lectin and arm/P do-
mains described for other CRT molecules (Fig. 2). As described for
the crystal structures of human and mouse calreticulins [8e10]
(and also the homologous CNX [49]), the modelled sea bass CRT
globular domain assumes a b-sandwich structure assembled from a
seven-stranded concave b-sheet and a six-stranded convex b-sheet
(with a small b-sheet covering the space between the ﬁrst two, two
short a-helices and a long a-helix that runs along and beyond the
convex b-sheet) (Fig. 2A). Importantly, as mentioned for the
mammalian CRT structures [8e10], the C domain is part of the
globular domain, providing the central strands b19 and b20
(Fig. 2A). Functionally and structurally relevant residues involved in
Ca2þ-, carbohydrate- and Zn2þ-binding that are conserved in Dila-
CRT were mapped to the 3rg0-based model (Fig. 2B and E). Also in
accordance to rat CRT structural report [11], the modelled Dila-CRT
arm domain consists of an extended hairpin fold, involving the
entire P domain sequence with both chain ends in close proximity,
stabilized by three anti-parallel b-sheets with a helical turn at the
tip of the hairpin (Fig. 2C). Again, conserved residues involved in
ERp57 and secondary peptide binding, as well as those forming the
three hydrophobic cores were mapped to the 1hhn-based model
(Fig. 2D and E).
3.4. Phylogenetic analysis
In order to analyse the evolutionary relationships of CRT pro-
teins from different organisms, a neighbour-joining tree was con-
structed using calnexin as an out-group (Fig. 3), with both groups of
proteins clearly separated. Within the calreticulin group, each class
of organisms segregates with high bootstrapping. As expected,
Dila-CRT clusters with other bony ﬁsh (Actinopterygii) sequences
being closely related to the Oreochromis niloticus one, from the
same order (Perciformes). Additionally, a series of pair-wise align-
ments were performedwithMatGAT in order to calculate similarity
and identity of CRT amino acid sequences between species. The
results conﬁrm those previously obtained with the neighbour-
joining method (Table S3): highest identity is observed with
O. niloticus CRT (w85%) and the lowest to the plant molecule
(w52%). Considering the different classes of organisms analysed,
those showing more similarity towards Dila-CRT are the bony ﬁsh
followed by mammals, interestingly with human CRT showing
highest identity (w71%) among the mammalian species.
4. Conclusions
In the present study, the CRT transcript and gene from European
sea bass were successfully cloned. All characteristic domains and
critical features present in CRTs from other species are also found in
Dila-CRT. Furthermore, characteristics such as gene organization
and copy-number are also conserved between species. Phyloge-
netic analysis places sea bass CRT among the Actinopterygii cluster,
with a high degree of similarity between CRTs from different spe-
cies. Dila-CRT 3D homologymodels have been compared to those of
other vertebrate molecules. Altogether these results indicate that
the reported molecule is orthologue of the other CRTs described for
other species, providing important primary data for future studies
on diverse aspects of CRT chaperoning function, namely the MHC
class I antigen presentation pathway in this species.
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Table S1 
Primers used in this study. 
 
Letter nucleotide code: H= A, C, T; R= A, G; Y= C, T; S= G, C; W= A, T; V= A, G, C; N= A, T, C, G; I= 
deoxyinosine. 
 
Table S2 
Accession numbers of sequences used in this study. 
 
Table S1 
Primers used in this study. 
 
Designation Nucleotide sequence 5’-3’  Usage 
APv GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTTTTTV cDNA synthesis 
AUAP GGCCACGCGTCGACTAGTAC PCR (full cDNA) 
APv2 GACTCAGGACTTCAGGACTTAGTTTTTTTTTTTTTTTTTV cDNA synthesis; 5'RACE (PCR); PCR (full cDNA) 
AUAP2 GACTCAGGACTTCAGGACTTAG 5'RACE (PCR) 
T7 TAATACGACTCACTATAGGGCGA sequencing 
SP6 CTATTTAGGTGACACTATAGAATAC sequencing 
CnxCrtFW1 ATGTTYGGNCCIGAYAAITG PCR (partial cDNA) 
CnxCrtRV1 CCRTCCATITCYTCRTCCCA  PCR (partial cDNA) 
CrtFw1 CTCCAGACCAGCCAGGACGC PCR (partial cDNA); southern blot 
DLCrtFW1 CCTTACCTGCTGCTGCCGGACA PCR (full cDNA); PCR (partial gene); sequencing 
DLCrtFW2 GACACAAGCCGCCGACATGAA PCR (full cDNA) 
DLCrtFW4 GGACATGCTGCCTGCGAAGA sequencing 
DLCrtFW6 CACTCCTGATGCCACCATGT sequencing 
DLCrtFW7 GAGCAGGAGGACATGGAGAG PCR (partial gene) 
DLCrtFW9 GACGACAGAGCCAAGATTGA PCR (partial gene) 
DLCrtFW10 TGAGTACCTTTGCAGAGTCA PCR (partial gene) 
DLCrtFW11 GAAACCTGGGGAGCTACTAAG PCR (partial gene) 
DLCrtFW12 TCACACAGGCAGCGGAGCAA PCR (partial gene) 
DLCrtRV2 GTCGATCCTCACCTCGTATG sequencing 
DLCrtRV4 GTCAGCTCGTCATCCTTGCA PCR (partial cDNA) 
DLCrtRV5  TTCTTCGCAGGCAGCATGTCC PCR (partial cDNA) 
DLCrtRV6 CTGCTCGCGCTTGATGGTGAA 5'RACE (PCR) 
DLCrtRV7 CTCTGACCTCGACCAAAGCAACAT 5'RACE (cDNA synthesis); southern blot 
DLCrtRV8 AAAACAGTGTGCGCCCACGG PCR (partial gene); sequencing 
DLCrtRV10 TCAGGGTCAGGGATGGTCTC PCR (partial gene) 
DLCrtRV11 GTCGTCGTCCTCCATCTCTT PCR (partial gene) 
DLCrtRV13 TTAGTAGCTCCCCAGGTTTC PCR (partial gene) 
DLCrtRV14 GCTTCCACTCGCCATAGTCT sequencing 
DLCrtRV16 AGTAGAGCCTGACCAATACA PCR (partial gene) 
DLCrtRV18 GCTGGCCATTAGAAAGACTGC PCR (partial gene) 
 
Letter nucleotide code: H= A, C, T; R= A, G; Y= C, T; S= G, C; W= A, T; V= A, G, C; N= A, T, C, G; I= deoxyinosine. 
Table S2 
Accession numbers of sequences used in this study. 
 
Species CRT CNX 
O. niloticus XP_003448810 - 
O. latipes ENSORLP00000003650 - 
O. mykiss NP_001117950 - 
S. salar ACI32936 - 
D. rerio AAH68336 NP_998613 
I. punctatus AAQ19852 NP_001187109 
L. calcarifer ADQ92842 - 
P. olivaceus ABG00263 - 
T. rubripes ENSTRUP00000024064  - 
G. gallus AAS49610 NP_001025791 
X. laevis NP_001080765 NP_001080326 
X. tropicalis NP_001001253 - 
R. rugosa BAA11425 - 
R. norvegicus NP_071794 - 
M. musculus NP_031617 - 
O. cuniculus NP_001075704 - 
B. taurus NP_776425 NP_001099082 
H. sapiens NP_004334 AAA36125 
I. pacificus AAR29955 - 
D. melanogaster CAA45791 - 
A. thaliana AAC49695 - 
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Table S3 
D. labrax CRT precursor is highly similar to the CRT molecules from different species. 
 
 
 
 
 
Table S3 
D. labrax CRT precursor is highly similar to the CRT molecules from different species. 
 
  Similarity (%) Identity (%) 
D.labrax 100.0 100.0 
O.niloticus 93.0 84.8 
O.latipes 92.0 81.7 
O.mykiss 90.4 79.1 
S.salar 90.1 79.6 
D.rerio 88.3 77.7 
I.punctatus 92.3 79.7 
L.calcarifer 89.2 77.2 
P.olivaceus 90.1 77.8 
T.rubripes 89.0 76.1 
G.gallus 81.5 67.6 
X.laevis 83.8 66.5 
X.tropicalis 84.3 68.9 
R.rugosa 82.4 67.2 
R.norvegicus 83.6 69.0 
M.musculus 84.0 69.5 
O.cuniculus 85.2 69.7 
B.taurus 84.7 69.2 
H.sapiens 85.7 71.3 
I.pacificus 77.0 63.5 
D.melanogaster 74.9 59.5 
A.thaliana 71.1 52.2 
 
The percentages of similarity and identity were calculated with MatGAT [37] using default parameters. 
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Figure S1. Nucleotide 
and deduced amino acid 
sequence of sea bass 
CRT gene. The ORF and 
the corresponding 
predicted protein 
sequence are both shown 
in uppercase letters. The 
translation start and stop 
codons and the initial 
methionine are boxed. 
The predicted signal 
peptide is highlighted in 
bold type, and cysteines 
involved in intramolecular 
disulfide link are in 
inverted type. Codons split 
by phase 1 introns are 
shaded in grey. The intron 
splicing consensus 
sequences (gt/ag) are 
underlined. Within the 
3’UTR, the putative 
instability motifs are 
shaded in grey and in bold 
type. 
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Figure S1 (continued) 
 
 
 
Figure S2. Sea bass and human 
CRT gene structures. Boxes 
represent exons and horizontal 
lines introns. White and black 
boxes differentiate coding and 
untranslated regions, respectively. 
Values above/below boxes and 
below/above the lines represent 
the number of nucleotides (size) of 
exons and introns, respectively. 
Exon numbers are indicated close 
to boxes by Roman numerals. 
 
 
 
Figure S3. Sea bass CRT is 
a single copy gene. 
Southern blot analysis of 
genomic DNA from three 
animals digested with four 
restriction enzymes (EcoRI, 
NcoI, NdeI or BamHI; all zero 
cutters within the probe). The 
blot was later probed with a 
region of CRT that included 
part of exon III. A portion of the sea bass calreticulin cDNA (exon III) was amplified with primers 
CrtFW1/DLCrtRV7 (Table S1), labelled and used as probe. Preparation of the labelled probes, hybridization 
and post-hybridization stringency washes were performed accordingly to Gene ImagesTM AlhPhos DirectTM 
Labelling and Detection System kit (Amersham Biosciences). For signal generation and detection the 
Chemiluminescent Signal Generation and Detection with CDP-StarTM protocol from the same kit was followed. 
One band can be seen for each digestion. Sizes of the MW marker are indicated on the left. 
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Abstract 
 
PDI (PDIA1) and ERp57 (PDIA3), members of the PDI family and of the thioredoxin 
(Trx) superfamily, are multifunctional proteins with wide physiological roles and have been 
implicated in several pathologies. Importantly, they are both involved in the MHC class I 
antigen presentation pathway. This paper reports the isolation and characterization of full 
cDNA and genomic clones from sea bass (Dicentrarchus labrax, L.) PDI (Dila-PDI) and 
ERp57 (Dila-ERp57). The genes are ~12.4 and ~7.1 kb long, originating 2155 and 2173 
bp transcripts and encoding 497 and 484 amino acids mature proteins, for Dila-PDI and -
ERp57, respectively. The PDI gene consists of eleven exons and ERp57 of thirteen. As 
described in other species, both molecules are composed of four Trx-like domains (abb’a) 
followed by a C-terminal tail, retaining two CGHC active sites and an ER-signalling 
sequence, suggestive of a conserved function. Additionally, three-dimensional homology 
models further support Dila-PDI and Dila-ERp57 as orthologs of mammalian PDI and 
ERp57, respectively. Finally, high similarity is observed to their vertebrate counterparts (> 
69% identity), especially among the few ones from closely related teleosts (>79% 
identity). Hence, these results provide relevant primary data and will enable further studies 
to clarify the roles of PDI and ERp57 in European sea bass immunity. 
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1. Introduction 
 
In mammals, the family of protein disulfide isomerases (PDIs) includes 21 related 
members (reviewed in [1]), abundant in the endoplasmic reticulum (ER) where they play a 
critical role in protein folding and quality control (reviewed in [2]). However, membership is 
mostly based in sequence and structural similarity rather than in a common function 
(reviewed in [3]), therefore including members without redox activity on cysteine residues 
but that hold relevant chaperone-like activities (reviewed in [4]). The basic unit of PDIs is a 
thioredoxin-like domain, homologous to the cytosolic reductase thioredoxin (Trx) 
(reviewed in [5]) that can either be catalytically active (a-type) or inactive (b-type) 
(reviewed in [3]). The first typically contain a CXXC active site motif, while the second lack 
the cysteines making them redox-inactive (reviewed in [3]). Additionally, among PDIs the 
non-catalytic domains have lower sequence identities than the catalytic ones, showing in 
some cases structural variations to the Trx fold (βαβαβαββα) (reviewed in [4]). PDI family 
members, which have distinct official designations according to the HUGO gene 
nomenclature committee - HGNC (reviewed in [1], vary in length and domain arrangement 
and most are soluble proteins with a C-terminal KDEL-like ER-localization signal 
(reviewed in [3, 6]). 
PDI itself (PDIA1 according to HGNC) is the founding member of the PDI family 
(reviewed in [3]), the first known to act as a catalyst of disulfide bond formation [7]. 
Besides its critical role in the formation, breakage and rearrangement of disulfides 
(reviewed in [8, 9]) and as a chaperone [10], it is also the subunit of distinct protein 
complexes (reviewed in [4]), being actually recognized as a versatile and multifunctional 
protein that participates in a variety of processes at distinct cellular locations (reviewed in 
[11]). Not surprisingly, PDI is implicated in several pathophysiologic conditions such as 
neurodegenerative diseases, autoimmunity and cancer (reviewed in [11]). PDI has a 
[abb’xa’c] domain organization, where a, b, b’ and a’ are the four Trx-like domains, x is a 
19-residue linker connecting b’ to a’, and c is an acidic carboxyl tail [12-14]. A CGHC 
redox-active site is present at each of the a and a’ domains, where the upstream cysteine 
forms mixed disulfides with substrate proteins, while the downstream one is involved in 
the escape pathway [15]. The b’ domain harbours a hydrophobic pocket, which is the 
major substrate binding site [16, 17]. Two yeast PDI crystal structures (determined at 4 
and 22 ºC) unveiled a highly flexible protein, where the catalytic domains represent two 
mobile arms connected to a non-catalytic rigid base, allowing binding of substrates of 
various sizes and conformations [13, 18]. In the twisted ‘U form’, the active sites face each 
other at opposite ends of the U with the hydrophobic patches on b and b’ domains buried 
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inside the U [13], while in the ‘boat form’ the molecule adopts a more open conformation 
in which the catalytic domains do not face each other [18]. Despite the considerable 
amount of information available, little is known regarding PDI’s activities in vivo, reflect of 
its likely essential nature and broad substrate specificities [3]. 
First isolated in 1988 [19], ERp57 (according to HGNC) is a homolog of PDI 
(reviewed in [20]) and one of the family members with highest identity to PDI [1]. Mainly 
existing in the ER, but also localized in the nucleus [21], cytoplasm [22] and cell surface 
[23-25], ERp57 has been linked to several physiological (e.g. modulation of platelet 
function [26]) and disease states, such as cancer [23] and Alzheimer’s (reviewed in [20]). 
Similarities to PDI include sequence identity (~50% in a or a’ domains; ~20% in b or b’ 
domains), domain organization, presence of a CGHC motif at the active sites (reviewed in 
[20]), and a strikingly similar overall U shape, as shown by both solution and crystal 
structures [27, 28]. On the other hand, distinctive features comprise a highly charged 
region within the b’ domain (no hydrophobic pocket) [27], which is the calnexin binding 
site, localized on the opposite side of the PDI substrate binding site (reviewed in [29]), and 
a shorter basic C-terminal domain (reviewed in [20]). As PDI, it is a multifunctional 
oxireductase, although catalyzing at a lower rate thiol oxidation, reduction and 
isomerisation in vitro [30] and possibly in ER as well [31]. Contrary to PDI, ERp57 
specifically acts on glycosylated substrates through interaction with the lectin-like 
chaperones calnexin (CNX) and calreticulin (CRT) [32]. Furthermore, ERp57 is most 
widely known for its involvement in the immune system, due to the critical role in MHC 
class I assembly (reviewed in [33]). At an early stage, ERp57 and CNX assist disulfide 
bond formation of glycosylated MHC class I heavy chain (HC), enabling subsequent 
dimerization with soluble β2m [33]. This early oxidative folding of HC is delayed upon 
ERp57 inactivation [34]. At a late stage, the empty heterodimer enters the peptide-loading 
complex (PLC; CRT/ERp57/TAP/TPN), in order to acquire peptide ligands [33]. ERp57 
binds TPN through its catalytic domains [28] and despite formation of a covalent bond 
[35], the interaction seems to be stabilized by cumulative protein-protein contacts 
(reviewed in [4]). Additionally, ERp57 may function independently of its structural role in 
the PLC, specifically reducing α2 in released sub-optimally loaded/unstable complexes 
(reviewed in [3]). As ERp57 [35, 36], PDI has been implicated in class I assembly as well 
[37]: it facilitates optimal peptide binding, maintaining HC oxidized state (re-oxidation of 
α2) [37]; and serves as a redox-regulated peptide carrier, delivering peptides from TAP to 
HC [38]. PDI has been further involved in the regulation of PLC disassembly [39]. 
Previously we have reported the characterization of European sea bass molecules 
[40-43] described in the literature to be involved in MHC class I antigen presentation and 
PDI/ERp57 
 
	   136	  
processing. Here we report the isolation of sea bass PDI and ERp57 full genes and 
transcripts with further in silico analysis at both structural and phylogenetic levels. 
Collectively, these studies will enable the development of functional studies of class I 
pathway in this relevant fish species. 
 
 
2. Materials and methods  
 
2.1. Fish 
Sea bass, Dicentrarchus labrax, were kept in a recirculating, ozone-treated salt-
water (20-25‰) system at 22 ± 1 ºC and fed with commercial pellets twice a day. Fish 
were sacrificed with a lethal dose of 2-phenoxyethanol (Panreac; >0.5 mL/L). 
 
2.2. cDNA cloning 
RNAs were transcribed to cDNAs following the BioScript RNase H- (Bioline) 
protocol. PCR products were purified and cloned into pGEM-T Easy (Promega). 
Automated sequencing was performed using primers detailed in Supplementary Table S1. 
5’RACE experiments were performed following the 5´RACE System v. 2.0 (Invitrogen) 
and Recombinant Terminal Transferase (Fermentas or Roche) was used to dATP-tail the 
purified cDNA. 
 
2.2.1. PDI 
A partial genomic sequence of sea bass PDI retrieved from the EMBL gene 
database ([http://www.ebi.ac.uk/genomes/]: [CABK01014256]; contig ctg479172) was 
used to design three specific primers for direct use in 5’RACE. To obtain the 5’ 
untranslated region (UTR), a 5’RACE was performed using cDNA synthesised with 
DLPDIRV2 (Table S1) using total RNA extracted from the liver of a non-stimulated fish, as 
described above. The tailed cDNA was first amplified with primers APv/DLPDIRV3 (Table 
S1) followed by a second PCR using primers AUAP/DLPDIRV4 (Table S1). The ~850 bp 
fragment obtained was purified, cloned and sequenced. 
To obtain the full sea bass PDI transcript, specific primers were designed at the 
beginning of the 5’ UTR region. The same initial liver total RNA was reverse transcribed 
using primer APv (Table S1). Primers DLPDIFW2/AUAP (Table S1) were used in a first 
amplification PCR followed by a second PCR step using the same primers or the set 
DLDIFW3/AUAP (Table S1). The ~2200 bp fragment obtained was purified, cloned and 4 
independent clones sequenced. 
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2.2.2. ERp57 
Total RNA from the spleen of one fish was reverse transcribed with primer APv 
(Table S1). Degenerate primers were designed on conserved regions of ERp57 across 
several vertebrate species. The spleen cDNA was amplified with primers ERp57FW1 and 
ERp57RV1 (Table S1). A semi-nested PCR was performed with primers 
ERp57FW1/ERp57RV2 and the obtained product of ~700 bp was purified, cloned and 
sequenced. 
To reach the 5’ UTR, two consecutive 5’RACE experiments were performed: (i) total 
RNA extracted from the spleen of one fish was reverse transcribed with primer 
DLERp57RV5 and the tailed cDNA was first amplified with APv/DLERp57RV4 followed by 
a PCR with AUAP/DLERp57RV3 (Table S1); (ii) total RNA extracted from the head kidney 
of one fish was reverse transcribed with primer DLERp57RV7 and the tailed cDNA was 
first amplified with APv2/DLERp57RV7 (Table S1), followed by an amplification with 
AUAP2/DLERp57RV6 (Table S1). PCR products of ~400 (i), and ~300 (ii) were 
consecutively obtained, purified, cloned and sequenced. 
To obtain the full sea bass ERp57 cDNA, specific primers (Table S1) were designed 
at the beginning of the 5’ UTR region. DLERp57FW9 and AUAP were used in an 
amplification using the same non-stimulated liver cDNA used for PDI isolation. The 
obtained ~2200 bp PCR product was purified, cloned and 3 independent clones were 
sequenced. 
 
2.3. Genomic DNA cloning 
Genomic DNA (gDNA) was isolated from sea bass erythrocytes from a single fish, 
as previously described [44]. The full PDI gene was obtained through five separate PCR 
amplifications using the following sets of primers: DLPDIFW2/DLPDIRV9, 
DLPDIFW6/DLPDIRV2, DLPDIFW10/DLPDIRV10, DLPDIFW7/DLPDIRV8 and 
DLPDIFW5/DLPDIRV6 (Table S1). The PCR products of ~4.5, ~2.5, ~0.6, ~1.4 and ~4.0 
kb, respectively, were purified, cloned and one clone of each product sequenced as 
before. The full PDI gene was assembled from the overlapping partial sequences. 
To obtain the full ERp57 gene, gDNA was amplified by PCR with 
DLERp57FW8/DLERp57RV11 (Table S1) followed by a nested PCR with primers 
DLERp57FW9/DLERp57RV12 (Table S1). The PCR product (~7.0 kbp) was purified, 
cloned and one clone sequenced as before. 
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2.4. Sequence analysis 
Full nucleotide and protein sequences from sea bass PDI and ERp57 molecules 
were compared to several PDI and ERp57 sequences currently available in the GenBank 
database [http://www.ncbi.nlm.nih.gov/genbank/]. The multiple sequence alignment was 
made using CLUSTALW [45] and formatted with Bioedit [46]. Two Trx domain profiles as 
well as their respective Trx-family active sites have been identified with Prosite [47]. The 
Trx domain boundaries were based on human PDI [14]. The potential nuclear localization 
signal was predicted at PredictProtein [www.predictprotein.org]. The molecular weights of 
the polypeptide chains were calculated with the Expasy compute pI/MW tool 
[http://www.expasy.org]. Putative N-glycosylation sites and signal peptide sequences 
were predicted using NetNGlyc 1.0 [http://www.cbs.dtu.dk/services/NetNGlyc] and 
SignalP 4.1 [http://www.cbs.dtu.dk/services/SignalP] servers, respectively. Hydrophobicity 
was predicted with Protscale [http://web.expasy.org/protscale/] and drawhca 
[http://mobyle.rpbs.univ-paris-diderot.fr/cgi-bin/portal.py?form=HCA]. The Neighbour-
joining phylogenetic tree was constructed with MEGA version 5.05 [48], using p-distance 
parameter and pairwise deletion of gaps, and tested for reliability using 1000 bootstrap 
replications. The percentages of similarity and identity were calculated with MatGAT [49] 
using default parameters. 
 
2.5. Southern blotting 
Genomic DNA was digested with different restriction enzymes (EcoRI, NcoI, BamHI 
and HindIII for ERp57; all zero cutters within the probe), separated in a 0.8% agarose gel 
and subjected to Southern blotting [50]. A portion of sea bass ERp57 cDNA (exon I) was 
amplified with primers DLERp57FW8/DLERp57RV6 (Table S1), labelled, and used as 
probe. Preparation of the labelled probe, hybridization and post-hybridization stringency 
washes were performed accordingly to Gene Images AlhPhos Direct Labelling and 
Detection System (Amersham Biosciences) kit. For signal generation and detection the 
Chemiluminescent Signal Generation and Detection with CDP-Star protocol from the 
same kit was followed. 
 
2.6. 3D modelling 
Suitable structural templates for sea bass PDI (human PDI from PDB entries 1mek 
[51] and 3uem [14]) were identified by a BLAST search as implemented in the SWISS-
MODEL Protein Modelling Server [52]. Homology modelling was performed with SWISS-
MODEL in automated mode [52] with 80% and 74.5% identity between target and 
template molecules, respectively. The only gap introduced (3uem alignment) involves 
secondary structure elements (SSE). The resulting theoretical models of sea bass PDI a 
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domain alone, and of bb’a’ domains, have calculated global energies of -1739.826 kJ/mol 
and -10853.179 kJ/mol, respectively. By superposing both homology models with human 
ERp57 (PDB entry 3f8u [28]), a full-length model of Dila-PDI was generated. SSE for the 
models were computed with PROMOTIF [53]. Model quality was assessed with 
WHATCHECK [54] and PROCHECK [55] as implemented in the Swiss Model structure 
assessment tool. Model representations were prepared with PyMOL (http://pymol.org/). 
Similarly, a suitable structural template for sea bass ERp57 (human ERp57 from 
PDB entry 3f8u [28]) was identified by a BLAST search as implemented in the SWISS-
MODEL Protein Modelling Server [52]. Homology modelling was also performed with 
SWISS-MODEL in automated mode [52]. The calculated global energy of the model is -
19239.387 kJ/mol. The alignment shows high identity (~77%) between the target and 
structural template molecules with one gap introduced outside the SSE (data not shown). 
The SSE were determined with PROMOTIF [53]. Model quality structural assessment and 
preparation of model figures were performed as previously described for PDI. 
 
 
3. Results and discussion 
 
3.1. cDNA, gene and Southern blot analysis 
3.1.1. PDI 
The sea bass PDI (Dila-PDI) full-length cDNA has been obtained through homology 
cloning, by performing RT-PCR on mRNA extracted from the liver of one fish. BLAST 
analysis confirmed highest similarity with fish PDI. The here-reported Dila-PDI sequence 
[GenBank: JX891476] has a total size of 2155 bp, containing a 5’ UTR of 161 bp, an ORF 
of 1542 bp and a 3’ UTR of 452 bp (excluding the poly(A) tail). Within the 3’ UTR no 
mRNA instability motifs were detected [56] but two potential non-canonical 
polyadenylation signals could be identified (Fig. S1A).  
In the Dila-PDI gene [Genbank: JX891477], which is 12386 bp long, intron 
donor/acceptor sites follow the gt/ag consensus rule (except for intron 4 - gt/gg), and 
codons in the exon boundaries are split by phase-one (1, 2 and 8) or phase-zero (3, 4-7, 9 
and 10) introns (Fig. 1A). The different regions encoded by each exon are described in 
Table S2. Some regions are encoded by more than one exon, e.g. each domain is 
encoded by three different exons, while the x linker and the C-terminal portion are 
encoded by two exons. The sea bass PDI eleven-exon genomic structure (Fig. 2A) is 
identical to that of the human gene [57]. Intron sizes are highly variable, but intron phase 
and location are conserved between sea bass and human PDI molecules, the same being 
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true for exon sizes (exception for exons I, X, and XI) (Fig. 2A). 
 
 
Figure 1. Nucleotide 
and deduced amino 
acid sequences of 
sea bass PDI and 
ERp57 genes. The 
ORF and the 
corresponding 
predicted protein 
sequences of sea 
bass PDI (A) and 
ERp57 (B) are shown 
in uppercase letters. 
The translation start 
and stop codons and 
the initial methionine 
are boxed. The 
predicted signal 
peptide is highlighted 
in bold type. Codons 
split by phase 1 or 2 
introns are shaded in 
grey. The intron 
splicing consensus 
sequences (gt/ag) are 
underlined. Within the 
3’UTR, the putative 
instability motifs are 
underlined while poly-
adenylation signal 
sequences are 
shaded in grey and in 
bold type. Exons are 
identified above the 
sequences. 
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Figure 1 (continued) 
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Figure 1 (continued) 
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Figure 1 (continued) 
 
3.1.2. ERp57 
Similar to Dila-PDI, the sea bass ERp57 (Dila-ERp57) full-length cDNA was 
obtained by homology cloning. BLAST analysis confirmed highest similarity with the few 
fish ERp57 molecules described. The Dila-ERp57 sequence [GenBank: JX891474] has a 
total length of 2173 bp, containing a 5’ UTR of 164 bp, an ORF of 1503 bp, and a 3’ UTR 
of 506 bp (excluding the poly(A) tail). Within the 3’UTR, one mRNA instability motif [56] 
and three potential polyadenylation signals were identified (Fig. S1B).  
In Dila-ERp57 gene [Genbank: JX891475] that is 7119 bp long, all intron 
donor/acceptor sites follow the gt/ag consensus rule, and codons in the exon boundaries 
are split by phase-two (1, 5-8 and 11), phase-one (3, and 4) or phase-zero (2, 9, 10 and 
12) introns (Fig. 1B). The typical domains of the protein are encoded by three to five 
exons (Table S2), while the x linker, C-terminal tail, UTRs, and signal peptide coding 
information are present in single exons. The sea bass ERp57 has a thirteen-exon 
genomic structure, identical to those of human [58] (Fig. 2B) and mouse [24] (not shown).  
Conservation of exon sizes (except exons I and XIII), intron phase and location is 
observed between sea bass and human ERp57 (Fig. 2B). 
Southern blot analysis revealed that Dila-ERp57 is a single-copy gene (not shown), 
which is in agreement to what has been described for human [58] and mouse molecules 
[24]. Among salmonids, however, two copies of ERp57 appear to be present [59, 60]. 
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Figure 2. Comparison between sea bass and human PDI and ERp57 gene structures. Boxes represent 
exons and horizontal lines introns of PDI (A) and ERp57 (B). White and black boxes differentiate coding and 
untranslated regions, respectively. Values above/below boxes and below/above the lines represent the 
number of nucleotides (size) of exons and introns, respectively. Exon numbers are indicated close to boxes by 
Roman numerals. 
 
 
3.2. Primary structure analysis 
 
3.2.1. PDI 
Amino acid sequences of PDI (PDIA1) from several species (Table S3) were aligned 
with that of Dila-PDI (Fig. 3). In sea bass, a predicted 497-residue (55.1 kDa) mature 
protein would be generated by cleavage of the putative 16-amino acid signal peptide. 
Variation in polypeptide size occurs across species, Dila-PDI being the second largest 
protein of all analysed species, essentially due to a long acidic (E/D-rich) C-terminal 
region (Fig. 3). 
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Figure 3. Alignment of PDI amino acid sequences. Amino acid sequences were retrieved from GenBank 
(Table S3) and aligned with CLUSTALW [45]. Dashes indicate gaps that maximize the alignment and dots 
denote residues identical to the first sequence of the alignment. Identical residues, conserved and semi-
conserved substitutions are denoted below the alignment with (*), (:) and (.), respectively. Residue numbers 
are given to the right of the sequences, with numbers in parenthesis referring to the mature proteins. Signal 
peptides are shaded in grey and denoted above the alignment. Predicted a, b, b’, and a domains based on 
human PDI [14], are indicated above the alignment, with junction regions represented by black boxes. The two 
Trx signature motifs of domains a and a’ are boxed, with each active site shaded in black. Non-catalytic 
cysteines are shaded in dark blue. Residues possibly involved in triggering PDI conformational changes, 
including cis-prolines near each active site [13], are shaded in orange [14]. Arginine residues relevant for 
reoxidation are shaded cyan [70]. Two buried polar residues related to the redox state [13] are shaded in 
purple. Hydrophobic patch on the b’ domain putatively involved in peptide/substrate binding is shaded yellow 
[13]. Contacts of x-linker with b’ or a’ are shaded in light salmon; direct contacts between b’ and a’ domains 
are shaded in green [14]. Residues identified as part of the substrate binding site of b’ domain are shaded in 
red [16, 66]. One low complexity region at the C-terminal extension is underlined and in bold type. KDEL-like 
ER-retention signals are boxed. 
 
Sea bass PDI contains the four typical Trx domains followed by a C-terminal tail, 
overall organized as abb’xa’c (Fig. 3). Within a and a’ domains, two Trx superfamily 
signature motifs (L43VEFYAPWCGHCKALAPEY and F387VEFYAPWCGHCKQLTPIW) 
were identified in Dila-PDI, both consisting of highly conserved regions (Fig. 3). Each of 
                       Signal peptide              !a domain                                                                   x 
D.labrax          ---------MLKLLLLCTLAVASRAEIAEEED-VLVLKKSNFDEALAAHPNLLVEFYAPWCGHCKALAPEYAKAAGMLKAEGSAVRLGKVDATEETELAQDYGVRGYPTI 100 (84)  
O.niloticus       ---------...F.IF......IN........-.........N...Q....I...............................DI.............T.E......... 100 (84) 
T.nigroviridis    --------MKF.F.....VV..........D.-.............K.................N...........K..E...E...A............EF........ 101 (84) 
D.rerio           ---------...F.IV.A..AM.A........-.........E...K....V...................S...........DI..A.......S....EF........ 100 (84) 
X.tropicalis      -------MMRAV..FG.S.LIVA..N.P..R.-......D......KQY.FI...................E....V..S..LPI..........SD...EF........ 102 (84) 
X.laevis          -------MMRAV..FG.A.L.VA.PD.S..K.-......D......KQY.YI...................E....I..S..LPI..........SD...EF........ 102 (86) 
G.gallus          ---MAVVRVRAIVA...LV.ALGL..PL....G....RAA..EQ.....RH........................AQ......EI..A.......A....QF........ 107 (85) 
O.cuniculus       ------MLRRAV.C.ALAVT-.GW.WA.....N.....S...A.E....KH.........................K......DI..A.......SD...Q......... 103 (83) 
R.norvegicus      ------MLSRAL.C.ALAW.ARVG.DAL....N.........A......NY........................AK......EI..A.......SD...Q......... 104 (83) 
M.musculus        ------MLSRAL.C.ALAW.ARVG.DAL....N.........E......KY........................TK......EI..A.......SD...Q......... 104 (83) 
H.glaber          ------MLSRAL.C.ALAA.ARVG.DAP....H.........E....T.KY.........................K......EI..A.......SD...Q......... 104 (85) 
B.taurus          ------MLRRAL.C.AL.ALFRAG.GAPD...H....H.G.........KY.........................K......EI..A.......SD...Q......... 104 (84) 
H.sapiens         ------MLRRAL.C.AVAAL.RAD.--P....H....R....A......KY.........................K......EI..A.......SD...Q......... 102 (85) 
D.melanogaster    ----MKFLICALF.AASYV.ASAE..VKV..G-...ATVD..KQLI.DNEFV.......................QQ.AEKE.PIK.A.....V.G...EQ.A......L 105 (86) 
S.cerevisiae      MKFSAGAVLSWSS...ASSVF.QQEAV.P.DSA.VK.ATDS.N.YIQS.DLV.A..F........NM....V...ET.VEKN--IT.AQI.C..NQD.CMEHNIP.F.SL 108 (86) 
Clustal Consensus                              * . *:     .* : :     :*.**:*******: :**** ***  *  :   : *.::*.* : :*  :. : *:*:: 45   
 
                                                    !b domain                                                                  x 
D.labrax          KFYKGGEKESPKEYSAGRQAEDIVSWLKKRTGPAVTTLSAVTEAESLIADSEVAVIGFFKDLNSDGAKAYEKAAEAIDDIPFAITSDDAIYSKFEVSKDSVVLFKKFDEG 210 (194)  
O.niloticus       ..F...D.............D..............A..NE..D.......N..........AE.A..Q......Q........K..N..V..........I......... 210 (194) 
T.nigroviridis    ..F..............................S.A..QE..Q..A.V..N..........AE.AD...F.............V...E..H................... 211 (194) 
D.rerio           ..F.....GN........................A...ND.MQ...I...N..........VE.EDS..FI.T...V.....G.....SVFA....A............. 210 (194) 
X.tropicalis      ..F.N.D.A.........E.A...N.........AS..GDEAGVAA.VDS...........PA.EP..VFLQ....V.....G...SE.AF..Y.LG..GI......... 212 (194) 
X.laevis          ..F.N.D.S.........E.A.F.N.........AS...DEAAVAA.V.S............E.EL..VFLQ....V..V..G...SE.AF..H.LG..GI......... 212 (196) 
G.gallus          ..FRN.D.AA.R..T...E.D.............A...TDAAA..T.VDS...V.......VT..A..EFLL...SV.....G.S.SADVF..YQL.Q.G.......... 217 (195) 
O.cuniculus       ..F.N.DTA.....T...E.D...N.........A...ADSAA....VES...........VE..A..QFLL....T.....GL.ASSDVF.RYQ.HQ.G.......... 213 (193) 
R.norvegicus      ..F.N.DTA.....T...E.D...N.........A....DTAA....VDS...T.......AG..S..QFLL....V.....G...NSDVF..YQLD..G.......... 214 (193) 
M.musculus        ..F.N.DTA.....T...E.D...N.........A....DTAA....VDS...T.......VE..S..QFLL..........G...NSGVF..YQLD..G.......... 214 (193) 
H.glaber          ..F.N.DTA.....T...E.D...N.........AS...DGAA....VES...........VE..F..QFLL..........G...NSDVF.RYQLDQ.G.......... 214 (195) 
B.taurus          ..F.N.DTA.....T...E.D...N.........AS...DGAA..A.VES...........ME..S..QFFL...V......G...NSDVF..YQLD..G.......... 214 (194) 
H.sapiens         ..FRN.DTA.....T...E.D...N.........A...PDGAA....VES...........VE..S..QFLQ..........G...NSDVF..YQLD..G.......... 212 (195) 
D.melanogaster    ..FRS.---..V...G....A..IA.VT.K...PAKD.TS.AD..QFLK.N.I.I.......E.EE..TFT.V.N.L.SFV.GVS.NADVIA.Y.AKDNG.....P..DK 212 (193) 
S.cerevisiae      .IF.NSDVNNSID.EGP.T..A..QFMI.QSQ...AVVADLPAYLANETFVTPVIVQSG.IDADFN.TF.SM.NKHFN.YD.VSAENADDDF.LSIYLP.AMDEPVVYN. 218 (196) 
Clustal Consensus *:::..    . :* . * *  :: :: *:: *..  :               .::   *   .  :  :  . :  :.  *  : .     : .    . :    . :  74   
 
                                         !b’ domain                                                                            x 
D.labrax          RNTFDGELTKEKLLAFVKGNQLPLVIEFTEQTAPKIFGGDIKSHILMFLPKAASDFQAKMDQFKKAAEGFKGQILFIFIDS-------DVDDNQRILEFFGLKKE-ECPA 312 (296)  
O.niloticus       ......D....A..S...A....................E.................D.......................-------..............R..-.... 312 (296) 
T.nigroviridis    ....E..V...N..N...S................................D.....D.......................-------E.E..............-.... 313 (296) 
D.rerio           .......VS..S..N.I.A.............................V....K...D..............K........-------.................-...V 312 (296) 
X.tropicalis      ..AYE.DI...EV.S.I.A.R.............M....E..T...F....S...YKE.LED.....AS...K........-------.HT..............-.... 314 (296) 
X.laevis          ..A.E..I...EV.S.I.A.R.............M....E..T...F....S...Y.D.LEN.....AS...K........-------.HT..............-.... 314 (298) 
G.gallus          ..N.E.D...DN..N.I.S....................E..T...L....SV..YEG.L.N..T..GN...K........-------.HS..............-.... 319 (297) 
O.cuniculus       ..N.E..V......D.I.H....................E..T...L...RS.A.HDG.LSG..Q.......K........-------.HA..............-.... 315 (295) 
R.norvegicus      ..N.E..I......D.I.H....................E..T...L....SV..YDG.LSN..........K........-------.HT..............-.... 316 (295) 
M.musculus        ..N.E..I......D.I.H....................E..T...L....SV..YDG.LSS..R.......K........-------.HT..............-.... 316 (295) 
H.glaber          ..N.E..I......D.I.H....................E..T...L....SE..YDS.LSN..........K........-------.HA..............-.... 316 (297) 
B.taurus          ..N.E..V......D.I.H....................E..T...L....SV..YEG.LSN......S...K........-------.HT..............-.... 316 (296) 
H.sapiens         ..N.E..V...N..D.I.H....................E..T...L....SV..YDG.LSN..T...S...K........-------.HT..............-.... 314 (297) 
D.melanogaster    KSV.E...NE.N.KK.AQVQS...IVD.NHES.S.....S....L.F.VSREGGHIEKYV.PL.EI.KKYRDD...VT.S.-------.EE.HT..F....MN..-.V.T 314 (295) 
S.cerevisiae      KK--ADIADADVFEKWLQVEA..YFG.IDGSVFAQYVESGLPLGY.FYNDEE--ELEEYKPL.TEL.KKNR.LMN.VS..ARKFGRHAGNLNMKEQFPL.AIHDMT.DLK 324 (302) 
Clustal Consensus :.   .    : .  : : : ** . ::  .  .  . . :    *::  .   . .     :.  *   :. : *: *.:          :  . : :*.:..  *    101  
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                                                          Figure 3 (continued) 
 
these motifs contains two conserved cysteine residues (C51 and C54; C395 and C398), which 
are part of the CGHC active site (Fig. 3). This site is important for efficient oxireductase 
activity, and any individual enzyme that contains it along with a b’-like domain is capable 
of catalyzing oxidation, reduction and isomerisation of disulfide bonds (reviewed in [29]). 
Two non-active site cysteines near the N-terminus of yeast PDI (absent in all vertebrate 
species) form a disulfide [61] that is highly stable and affects a domain redox activity [62], 
but the two additional cysteines in the b’ domain of mammalian PDI (conserved in all 
analysed vertebrates) are present as thiol groups, and have no influence in enzymatic 
activity [63]. The redox potentials of a and a’ domains in mammalian PDI are similar [64], 
a property thought to be related with conservation of two residues near each active site: 
E47/K81, E391/K422 in H. sapiens [13]. In yeast PDI (yPDI), E55/Q87 and L400/K434 are present 
instead, hence, a and a’ domains have asymmetric redox states [62] (and accessibilities), 
both consistent with the experimental three-dimensional structure [13]. Since all other 
species show conservation of the residues present in hPDI (hPDI; Fig. 3), symmetric 
redox potential of the catalytic domains is expected. According to a recent study on hPDI, 
cysteines in the active sites are involved in a redox-regulated mechanism to control hPDI 
chaperone activity (higher when oxidized) [14]. Apparently, oxidized hPDI adopts a loose 
conformation, whereas the reduced molecule is very compact, suggesting that different 
redox conditions induce significant conformational changes that affect chaperone activity 
[14]. Conservation of the CGHC motif at both Dila-PDI active sites, suggests oxireductase 
as well as redox-regulated chaperone activities might be evolutionarily conserved. The b’ 
domain is the core/primary site for substrate binding, but contiguous portions of the other 
domains also contribute to this binding [65]. In yPDI, a continuous hydrophobic surface 
 
                                                                        !a’ domain                                             x 
D.labrax          IRLITLEDEMTKYKPESDAITAESITAFCTLFTEGKLKPHLMSQDIPEDWDKTPVKVLVGKNFEEVVFDSSKNVFVEFYAPWCGHCKQLTPIWEKLGEKYK-DSADVIVA 421 (405) 
O.niloticus       ..........................E..K.................K....N.............A.NP...................A...........-....T... 421 (405) 
T.nigroviridis    .......................G..H...Q.V.................................A..P...................A...........-....T... 422 (405) 
D.rerio           .......E.........SE....N.IS...S.V..T................N.............A.NPAN.................A...DQ....F.-.N.NIV.. 421 (405) 
X.tropicalis      V......E.........ADLS..A.KE..DS.L...V........VSD....N...I...........NEE..................A...DQ......-.HENI.I. 423 (405) 
X.laevis          V......E.........SDLS..A.KE..DR.L...V........V..........I............EE..................A...DQ......-.HESI.I. 423 (407) 
G.gallus          V......E..........DL..DK.KE..NK.L...I........L......Q.............A..EN..................A...D....T.R-.HENIVI. 428 (406) 
O.cuniculus       V......E..........EL...G..E..QR.L...I.......EL.....RQ.............A..EK..................A...D....T..-EHQ.IVI. 424 (404) 
R.norvegicus      V......E..........EL...K..Q..HH.L...I.......EL......Q.............A..EK..................A...D....T..-.HENIVI. 425 (404) 
M.musculus        V......E..........EL...K..E..HR.L...I.......EV......Q.......A.....A..EK..................A...D....T..-.HENI.I. 425 (404) 
H.glaber          V......E..........EL..QK..E..QH.L...I.......EL......Q.............A..EK..................A...D....T..-.HE.I.I. 425 (406) 
B.taurus          V......E..........EL...K..E..HR.L...I.......EL.D....Q.............A..EK..................A...D....T..-.HENIVI. 425 (405) 
H.sapiens         V......E.........EEL...R..E..HR.L...I.......EL......Q...........D.A..EK..................A...D....T..-.HENIVI. 423 (406) 
D.melanogaster    ....K..ED.A.......DLS..T.E..LKK.LD....Q..L..EL......N......SS...S.AL.K..S.L..............A..YDQ.A....-.NE.IVI. 423 (404) 
S.cerevisiae      YG.PQ.SE.AFDELSDKIVLESKA.ESLVKD.LK.DAS.IVK..E.F.NQ.-SS.FQ.....HD.I.N.PK.D.L.LY.........R.A.TYQE.ADT.ANATS..LI. 433 (411) 
Clustal Consensus   *  *.::  .  .:.  : :. *  :   * .*  .  : **:: .: *  .*  **. *.:.:. :  :.*:* :*********:*:* :::*.:.:     . ::* 153  
 
                                                                         !C-terminal tail                     x 
D.labrax          KMDSTANEIEAVKVHSFPTLKFFPAGDERKVIDYNGERTLEGFTKFLESGGKEGGAPAADDEDDLDAEDLDDVDEGQDEDSDGEDDDGHDEL 513 (497) 
O.niloticus       .........D................E...............................G..-...EP...E.DSDSE.---GTD..NE.... 509 (493) 
T.nigroviridis    ..........T.............................D.................G.EDE.E..DA----------------------- 491 (474) 
D.rerio           ........................................D................VG.E-E.EE.D...LD.AEE.---.SDVEE..... 509 (493) 
X.tropicalis      .............I............PGKN.A...........S.......QD-..AD-E.LE..EDA.ES.LE.-------.DEAHTK... 506 (488) 
X.laevis          .............I............PGK..V.......Q...S.......QD-..AD-E.LE..EEA.ET.LE.-------.D.IHTK... 506 (490) 
G.gallus          ........V....I............SG.N.............K.......QD-..A.D..LE..ETDEET.LE..D.----D.QKIQK... 515 (493) 
O.cuniculus       ........V.................PG.T..........D..K.......QD-..GDE.GLE..EEAEEP.LE.--.----DDQKAVR... 509 (489) 
R.norvegicus      ........V................SAD.T..........D..K.......QD-..GDN..L.-.EEALEP.ME.--.----DDQKAVK... 509 (488) 
M.musculus        ........V................SAD.T..........D..K.......QD-..GDDE.L.-.EEALEP.ME.--.----DDQKAVK... 509 (488) 
H.glaber          ........V...........R....STD.T....S........R...D...Q.-..GED..L.-.EEAEEP.ME.--.----DDQKAVK... 509 (490) 
B.taurus          ........V................SAD.T..........D..K.......QD-..GDD..LE..EEAEEP.LE.--.----DDQKAVK... 510 (490) 
H.sapiens         ........V................SAD.T..........D..K.......QD-..GDD..LE..EEAEEP.ME.--.----DDQKAVK... 508 (491) 
D.melanogaster    ........L.SI.IS....I.Y.RK-EDN....F.LD...DD.V...DAN.EVADSEPVEETEEEEEAPK------------------K... 496 (477) 
S.cerevisiae      .L.H.E.DVRG.VIEGY..IVLY.G.KKSESVV.Q.S.S.DSLFD.IKEN.HFDVDGK.LY.EAQEKAAEEADADAELA---D.E.AI.... 522 (500) 
Clustal Consensus *:* * *::  : : .:**:  :          :. .*: :.: .*:. .*.          :  :                           177  
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formed by exposed hydrophobic patches is suggested to be crucial for the interaction with 
its substrates [13]. Despite the lack of perfect sequence conservation across species (Fig. 
3), conserved patches of hydrophobic residues are similarly observed (not shown). In the 
reduced form, the a’ domain extensively packs with both the b’ domain and the x-linker, 
shielding substrate-binding areas, which explains the lower chaperone activity of reduced 
hPDI [14]. Contacts between the x-linker and the b’ or a’ domains occur with a similar 
pattern in yPDI, ERp57 and reduced bb’xa’ (hPDI: K326, Y327, F342, F346 at b’ domain; I351, 
H354, M356, S357, Q358, W364, D365 at x-linker; K370, V371, G374, K375, N430, E431 at a’ domain), 
but direct interactions between domains b’ and a’ are mainly observed in reduced bb’xa’ 
(hPDI: R300, F304, I318, L320, M324, K326 at b’ domain; P395, W396, T428, E431, H438, F440 at a’ 
domain) [14]. Considerably reduced activity with substrates was observed for mutations of 
the conserved P441 (located near the a’ domain active site in the 3D structure) [13], 
implicating it, together with H438 and W396, in sensing the redox switch of the a´ domain 
active site and triggering the conformational changes [14]. All these residues are 
conserved in Dila-PDI as well as in the considered vertebrates (Fig. 3); some were 
previously identified for substrate binding, namely R300, I318, M324 [16] and Y327 [66], but 
further residues were also indicated for substrate binding: T241, Q243, A245, I248, F249, G250, 
G251, T255, H256, I257, L287, F288, D297, L317, I318, T319, E321, E322, T325 [16, 66]. Only T255 is 
substituted for a serine in teleosts, all other residues being conserved across vertebrates 
(Fig. 3). As other PDI molecules (reviewed in [1]), the C-terminal extension of Dila-PDI 
has an E/D-rich Ca2+-binding region (Fig. 3); furthermore, these negatively charged 
residues were shown to play an important role in the activity of yPDI [13]. 
 
3.2.2. ERp57 
Precursor sequences of ERp57 (PDIA3) molecules from different species (Table S3) were 
also aligned with that of sea bass (Fig. 4). The Dila-ERp57 displays a 484-residue mature 
form (54.2 kDa) after cleavage of a 16-residue potential leader peptide. It is the longest 
molecule among all analysed species (Fig. 4). Similar to other ERp57 molecules, Dila-
ERp57 comprises the same basic domain organization as PDI, i.e., two catalytic domains 
separated by two non-catalytic ones, x-linker and C-terminal region (abb’xa’c) (Fig. 4). At 
the sequence level, both sea bass molecules show higher identity between a domains 
(~45% for both) and lower among b domains (~25 and ~11% for b and b’, respectively), 
as described for mammals (reviewed in [20]). Throughout the molecules some indels are 
also observed (Fig. S2). Each catalytic domain bears a Trx signature motif 
(L38VEFFAPWCGHCKRLAPEY and L387IEFYAPWCGHCKNLEPKF), with a CGHC active 
site, conserved across species (Fig. 4). However, slightly distinct redox potentials 
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Figure 4. Alignment of ERp57 amino acid sequences. Amino acid sequences were retrieved from 
GenBank (Table S3) and aligned with CLUSTALW [45]. Dashes indicate gaps that maximize the alignment 
and dots denote residues identical to the first sequence of the alignment. Identical residues, conserved and 
semi-conserved substitutions are denoted below the alignment with (*), (:) and (.), respectively. Residue 
numbers are given to the right of the sequences, with numbers in parenthesis referring to the mature proteins. 
Signal peptides are shaded in grey and denoted above the alignment. Predicted a, b, b’, and a domains, 
based on human PDI [14], are indicated above the alignment, with junction regions represented by black 
boxes. The two Trx signature motifs of domains a and a’ are boxed, with each active site shaded in black. 
Non-catalytic cysteines are shaded in dark blue. Arginine residues relevant for reoxidation are shaded cyan 
[70]. Residues of human ERp57 that contact CNX/CRT are shaded orange. Residues involved in TPN binding 
are shaded green (a domain) and dark salmon (a´ domain). Two low complexity regions, at b’ domain and the 
C terminus extension, are underlined and in bold type. Putative nuclear localization signal is shaded in sepia. 
KDEL-like ER-retention signals are boxed. 
 
                             Signal peptide       !a domain                                                                         x      
D.labrax               --------MLRLIFVAALAGFSRAS-DVLDYTDDDFESKIGDH---GLALVEFFAPWCGHCKRLAPEYEAAATRLKG---IVSLVKVDCTSN-SNTCSKYGVSGYPTLKI 94  (78)   
O.niloticus            --------......L..........-...E........R....---E.I............................---..A.A.....A.-................. 94  (78)   
S.salar ACI33158       --------..K.F.FVV...AAL..-..IEF.....D......---.MI.............K......V.......---..G.A.....VH-N.V.Q............ 94  (78) 
S.salar NP_001161991   --------..K.F.FIV...AA...-..IEFS....D......---.MI..................F.V.......---..A.A.....VQ-N.V.Q............ 94  (78) 
O.mykiss JX441982      --------..K.F.FVV..RVAL..-..IEF.....D......---.MI.............K......V.......---..G.A.....VH-N.V.Q............ 94  (78) 
O.mykiss EZ774749      -----------------------------------------------MI..................F.V.......---..A.A.....VQ-N.V.Q............ 59   
D.rerio                -------M..A.L.LV.F.AAA...-...E......D.R....---D.I............................---..P.A.....A.-.KV.G............ 95  (78) 
T.nigroviridis         --------..A.MLL......TQ..-...EF..N.........---EII....................T...S...---..P.A.....A.-.D..............V 94  (78) 
T.rubripes             --------..K.MLL...T..TQ.AS...EF..N.........---EII....................K...A...---V.P.A.......-..I....Q........V 95  (79) 
X.laevis               --MNRQLLGAFFLLL.VT..TQA.GS....L...N...VVAQ.---SIL.............K......I...K...---TL..A.....A.-..I.N............ 101 (80) 
X.tropicalis           --MNRQLLGAFF-LL.VT..TQA.GS....L...N...TVSQ.---SIL.............K......I...K...---TL..A.....A.-....N............ 100 (80) 
G.gallus               MSVPRPSRAAL.LL.PL..LSAG..-..VELS.A....GLAER--P..V............................---..P.......A.-....N............ 103 (79) 
H.glaber               MRSHRLELFSVVALLLST.RLAA..-...EL...T...RVS.TGSA..M.......................S....---..P.A.....A.-T...N....T....... 105 (81) 
O.cuniculus            ---MRLAMFPGVALLL.A.RLAA..-...EL...N...R.T.TGSA..M............................---..P.A.....A.-T...N............ 102 (81) 
B.taurus               MRLRRLALFPG.ALLL.A.RLAA..-...EL...N...R.T.TGSS..M.............K..............---..P.A.....A.-T...N............ 105 (81) 
M.musculus             MRFSCLALLPGVALLL.S.RLAA..-...EL..EN...RVS.TGSA..M............................---..P.A.....A.-T...N............ 105 (81) 
R.norvegicus           MRFSCLALLPGVALLL.S.LLAS..-...EL..EN...RVS.TGSA..M............................---..P.A.....A.-T...N............ 105 (81) 
H.sapiens              MRLRRLALFPGVALLL.A.RLAA..-...EL...N...R.S.TGSA..M............................---..P.A.....A.-T...N............ 105 (81) 
D.melanogaster         ----MMWRLAGVLLLGFI.IS.G.EQ...ELG....ATTLKQ.---ETT..M.Y..........K...AK..EIV.DDDPPIK.A.....EAGKE.....S......... 103 (84) 
C.elegans              ----MIWVQA-ALVASF..FA.-.GGA..E...GN.DDL.QT.---DI...K.Y........KI.....R..PK.ASNDPP.A.......TE-KTV.D.F..K.F..... 100 (82) 
Clustal Consensus                                                       ** *:********:: **:  **  : .    : *.*****   .  * *: *.*:****: 38   
 
                                                     !b domain                                                                      x 
D.labrax               FRDGEETGPYDGPRTADGIVSFLKKQAGPASVELKTDADFQKYITDQDASVVGFFADDKSTAQTEFLKAASALRDNYRFAHTNSEALLQSHGIDGEGVILFRPPRLSNKF 204 (188)  
O.niloticus            ....D.S.......N.................V..DN..LE.FLA................E.A........................K..D.E..........Q.N... 204 (188) 
S.salar ACI33158       .....DA..............H..............E...T..VG.R...........G.P.KA....S.....ESF........E...K.SVE...I.....S..N... 204 (188) 
S.salar NP_001161991   .K...DA.A............H.......S.I....E...T..VG.R..........GG.P..A....S.....ESF.......GE...KN.VE...I.....A...... 204 (188) 
O.mykiss JX441982      .....DA.A.....N......H..............E...T..VG.R..........GG.P.KA....S.....ESF........E...K..VE...I.....S..N... 204 (188) 
O.mykiss EZ774749      .K...DA.A............H.......S......E...T..VG.R..........GG.P..A....S.....ESF.......GE...K..VE...I.....A...... 169  
D.rerio                .....DS.G............H.............NE...E...G.R..........GG.A..G..........ES.......N.D..KK.......I....S.Q..... 205 (188) 
T.nigroviridis         ......S.S......S....AYF...V.....M.TDEEQL.RF.SNE..............E.A...........Q.......A......QK.QA..IV.....Q.RS.. 204 (188) 
T.rubripes             ......S.A......S.....YF...V.....A.AGEEEL..F.SEK.S..............V...........K.......A.V..K.QNVGP..IV.....T.K... 205 (189) 
X.laevis               .....DS.S.....S......TM.........D.RSVEE.E.FVA.K..A.....R.LY.GPHS......NT..E.......DEKE.VDKYDTN....V.....H.A... 211 (190) 
X.tropicalis           .....DS.S............TM.........D.RSVGE.E.F.S.K........R.LY.GPHS......NT..........DEKE.VDKYDSN...FV....QH.A... 210 (190) 
G.gallus               ......S.T............H..........A.SSV...E.F.G.K........R.ASGD.YS..M...NN..........SE.Q.V.KYEE.....V.Y..S..A... 213 (189) 
H.glaber               ......A.A............H....S.....P.R.EEE.K.F.S.K........R.LF.E.HS.......NF..S.......V.S.VKEYDDN...IT....SH.A... 215 (191) 
O.cuniculus            ......A.A............H..........P.G.EE..K.F.S.K........K.LF.E.HS.......N...K.......V.S.VKEYDD....IT....SH.T... 212 (191) 
B.taurus               ......S.A............H..........P..SEEE.E.F.S.K........K.LF.E.HS.......N...........V.S.VNKYDD....IT....SH.T... 215 (191) 
M.musculus             ......A.A............H..........P.R.EEE.K.F.S.K........R.LF.DGHS.......N...........I.S.VKEYDDN...ITI...LH.A... 215 (191) 
R.norvegicus           ......A.A............H..........P.R.EDE.K.F.S.K........R.LF.DGHS.......N...........V.S.VKEYDDN...ITI...LH.A... 215 (191) 
H.sapiens              ......A.A............H..........P.R.EEE.K.F.S.K...I....D.SF.E.HS.......N...........V.S.VNEYDDN...I.....SH.T... 215 (191) 
D.melanogaster         ..QD.VSQD.N...E.S..AKYMRA.V....KTVR.V.ELK.FLDTK.TTLF.Y.S.SD.KLAKI...F.DKN.EK...G.SSEKEV.DKQ.-ETDKIV.I.A.H..... 212 (193) 
C.elegans              ..N.VPAQD.....D.....K.MRG.S..S.K....V.E.E.FTGGDENV.I...E-SE.KLKDSY..V.DTE..RFS....SNKDIIKKA.-YSDD.VV.V.KK.H... 208 (190) 
Clustal Consensus      *::.  :  *:*** :.**.  :: * **:*  :    :: ::    :  :.*:*    .     ::* *.  *: : *.*:.   ::..     : . :  .  * .** 84   
 
                                                   !b´domain                                                                        x 
D.labrax               EDSSVAY-SEDKYTSNKIKRFIQDNIFGICPHMTDDNKDQLKGKDLLVAYYDVDYDKNPKGSNYWRNRVMKVAKSFLDQGKKLNFAVASKNIFSHDVSEFGMDGSSGE-L 312 (296)  
O.niloticus            .....KF-.D..................F....N.N...................E..................G.............N..M.N.EL....LN-P...-. 311 (295) 
S.salar ACI33158       .EG..KF-...TF.NA...Q........M...........M..............E..................G.....N..........S..Q.IA.M.L.A....-. 312 (396) 
S.salar NP_001161991   .E.VIKF-....F.NAM..K........M...........M.D............E.........................T.........S....I..M.L.A....-. 312 (396) 
O.mykiss JX441982      .E...KF-...TF.NA...P........M...........M..............E..................G.....N..........S..Q.IA.M.L.A....-. 312 (396) 
O.mykiss EZ774749      .E..IKF-....F.NAM..K.V......M...........M.D............E.........................T.........S....I..M.L.A....-. 277  
D.rerio                .....LF-T...F..A...K..........A...E....................E..................G........S....N..R.......L.L......-. 313 (296) 
T.nigroviridis         .....R.-A....S.S...K.L.........V..EE.....SS.......F.L..KL.................T...E.R..S....N.SPYGGVLE...LSPQ.SD-A 312 (295) 
T.rubripes             .....K.-..E..............VL.F.....E......M.............ER.................T...E.........N.AR.MSVL....LEDH.SA-G 313 (297) 
X.laevis               ..G..TFPADE.I..G...K........L...L.Q....LIQ.....I.......E..V..T..............V.A.........NRKS.G.E.T...L.ANT..-. 320 (299) 
X.tropicalis           .....TFPADE.I..S...K........L...L.E....LIQ.............E..V..T..............V.A.........NRKA.G.E.T...L.AGT..-. 319 (299) 
G.gallus               ...T.K.-T...I..A...K...E..........E....LIQ.............E..A...........MI..K...A.H..S.....RKT.G.EL....L.N.V..-A 321 (297) 
H.glaber               ..KT...-T.Q.M..G...K...E..........E....LIQ.....I.......E..T...........M...K...A.H........RKT...EL.D..LES.T..-I 323 (299) 
O.cuniculus            ..KT...-T.Q.M.TG...K...E..........E....LIQ.....I.......E..A...........M...K...A.H........RKT...EL.D..LES.T..-V 320 (299) 
B.taurus               ..KT...-T.Q.M..G.......E..........E....L.Q.....I.......E..A...........M...K...A....H.....RKT...EL.D..LESTT..-I 323 (299) 
M.musculus             ..KT...-T.K.M..G...K....S...L.....E....LIQ.....T.......E..A...........M...K...A.H........RKT...EL.D..LESTT..-V 323 (299) 
R.norvegicus           ..KI...-T.K.M..G...K...ES...L.....E....LIQ.....T.......E..T...........M...T...A.H........RKT...EL.D..LESTT..-I 323 (299) 
H.sapiens              ..KT...-T.Q.M..G...K...E..........E....LIQ.....I.......E..A...........M...K...A.H........RKT...EL.D..LESTA..-I 323 (299) 
D.melanogaster         .S..IKF--.GSSE.D-LST.VKE.FH.LVG.R.Q.SVKDFQN-P.IT...S...Q.....T.......L....E.VG---QI...I...DD.Q.ELN.Y.Y.FVGD--K 313 (294) 
C.elegans              DTNEFK.--DGN.DTD...N.LVHETV.FAGIR.QG.LF.FEQ.PIVIV..N...V.D...........L...QNYKR---.VQ...SN.EE..SEIETN.LGERKDSDK 313 (295) 
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Figure 4 (continued) 
 
have been described for hERp57 a and a’ active sites, with values comparable to that of 
PDI [30]. Two additional cysteines (sbC74 and C81) forming a structural disulfide within the 
a domain [30] are observed (similarly to yPDI, Fig. 3, 4 and S3). Furthermore, a third 
residue (sbC233) is present in the ERp57 b’ domain of all vertebrates (Fig. 4). The a’ 
domain cysteine residues (and their redox state) were reported to play a critical role in the 
control of the DNA-binding activity of ERp57 [67]. 
ERp57, but not PDI, has been shown to bind CNX and CRT [68], specifically 
through b and b’ defined regions [27, 69]. The human ERp57 residues suggested by 
mutagenesis studies to be involved in CRT binding (including V267, Y269, F299, K274, R280 
and N281) [69], correlate well with those identified by NMR and mutagenesis studies as 
part of the CNX binding site (K214, D266, V267, A273, K274, N277, Y278, W279, R280, N281, R282 and 
R344) [27, 69]. Among these 14 residues implicated in human ERp57 interaction with 
CNX/CRT, 12 are identical while 2 are conservatively substituted in Dila-ERp57 (Fig. 4), 
suggesting similar interactions may occur. Of note, the main contacts occur through the b’ 
domain, whereas the b domain provides additional contacts strengthening the interaction 
[27]. An arginine, located at the β5-α4 loop of active domains, critical for the catalytic 
function, especially reoxidation, in all human PDIs [70], is present in both Dila-PDI and 
Dila-ERp57 as well as across species (Fig. 3, 4, S2 and S3). 
 
 
                                                                              !a’ domain                                             x 
D.labrax               PLVTIRTAKGDKYAMTEEFSRDGKALERFLQDYFDGKLKRYLKSEPIPESNDGPVKVVVAENFDSIVNDDSKDVLIEFYAPWCGHCKNLEPKFNELGEKLGSDPNVVIAK 422 (406) 
O.niloticus            .V.A.........T...................................N.....................................S....YT......AD........ 421 (405) 
S.salar ACI33158       .V.G.........V...................................N......T.......A...EED................S....WK......S....I.... 422 (406) 
S.salar NP_001161991   .V.G.........V.A..............................S..N......T.......A...NEE................S....WK......S....I.... 422 (406) 
O.mykiss JX441982      .V.G.........V...................................N......T.......A...EED................S....WK......S....I.... 422 (406) 
O.mykiss EZ774749      .V.G.........V.A..............................S..N......T.......A...NEE................S....WK......S....I.... 387  
D.rerio                ...G.........V.K....................N.........V..N.......L.............................S....YK......SE...I.... 423 (406) 
T.nigroviridis         .......T..Q......T..P......G..HS..A.T..P......V..D..........................................YK......AN...I.... 422 (406) 
T.rubripes             ..........E........LP.........LS....S..P.........N.....................................S....YK......AD...I.... 423 (406) 
X.laevis               .V.G.K....E.FV.Q.........................M...S...........A......EL...E.................T....YK......AD...I.... 430 (409) 
X.tropicalis           .V.G.K....E....Q.........................M...A..................E...........................YK.......D...I.... 429 (409) 
G.gallus               .V.A........FV.Q....................N..K......V..N..............E...AED.....................YK......SK...I.... 431 (407) 
H.glaber               .V.A......E.FV.Q....................N...........................E...NEN.....................YK......SK...I.... 433 (409) 
O.cuniculus            .V.A......E.FV.Q....................N...........................E...NEN.....................YK......SK...I.... 430 (409) 
B.taurus               .V.AV.....E.FV.Q..............E.....N...........................E...NEN.....................YK......RK...I.... 433 (409) 
M.musculus             .V.A......E.FV.Q...........Q...E....N..............E............D...EED.....................YK......SK...I.... 433 (409) 
R.norvegicus           .V.A......E.FV.Q...............E....N............T.E.........S..D...AED.....................YK......SK...I.... 433 (409) 
H.sapiens              .V.A......E.FV.Q....................N...........................E...NEN.....................YK......SK...I.... 433 (409) 
D.melanogaster         .V.LA.DE.NL...LKD...VEN--.QD.VEKLLANE.EP.I..........A....A..K...DL.INNG..T.............K.S.IYE..A...QDE-D.A.V. 420 (401) 
C.elegans              .I.A.L.NE-G..P.DQ...V.N--.QQ.VDEVLA.NAEP.M......D-EQ.D...A.GK..KELIM.AD................S.A..YE..A...NKE-D.I... 418 (400) 
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                                                                            !C-terminal tail            x 
D.labrax               MDATANDVPSPYEVSGFPTLYFAPAGRKMSPKKYEGGREVSDFLSYLKREATNPLVMQEE---SKKKKKKKDEDEDDKTEL 500 (484)  
O.niloticus            ...................I..S.....L......................S........---P......-------.S.. 492 (476) 
S.salar ACI33158       ..........Q...R....IF.....Q................I....K.......A...---ETS....-------.N.. 493 (477) 
S.salar NP_001161991   ..........Q...R....IF.....Q.........A......I............A...---ETS..NI-------QI.. 493 (477) 
O.mykiss JX441982      ..........Q...R....IF.S...Q................I....E.......A...---ETS..NI-------QI.. 493 (477) 
O.mykiss EZ774749      ..........Q...R....IF.....Q.........A......I............A...---KS...---------Q... 456  
D.rerio                ...................I..S.....QN.............I.........TV.V..D---K..S...-------.S.. 494 (477) 
T.nigroviridis         ..P......A....R....I..S...Q..N..................K..A.TP.VA..---P.....--------.N-- 490 (474) 
T.rubripes             ......................S...Q.RN.......................AP.V...---T......-------RV.. 494 (478) 
X.laevis               .........PQ...R....I......N.QN..R........E......K.....P.VK.D--EKP.....-------.E.. 502 (481) 
X.tropicalis           ..........Q...R....I..T...S.QK..R...............K.....P.VK.D--EKP.....-------.E.. 501 (481) 
G.gallus               ..............R....I......K.Q..............I........STP.L...DKAK.S...A-------.ED. 505 (481) 
H.glaber               .........F....R....I..S..NQ.Q..........L...I...Q......PII...-KPK.-...A-------QED. 505 (481) 
O.cuniculus            ..............R....I..S..NK.L..........L...I...Q......PII.D.-KPK.-...A-------QED. 502 (481) 
B.taurus               ..............R....I..S..NK.QN.........L...I..........P.I...-KPK.-...A-------QED. 505 (481) 
M.musculus             ..............K....I..S..NK.LT.........LN..I...Q......PII...-KPK.-...A-------QED. 505 (481) 
R.norvegicus           ..............K....I..S..NK.LT.........LN.LI...Q......PII...-KPK.-...A-------QED. 505 (481) 
H.sapiens              ..............R....I..S..NK.LN.........L...I...Q......P.I...-KPK.-...A-------QED. 505 (481) 
D.melanogaster         .........PEFN.R.....FWL.KDA.NK.VS.N.....D...K.IAK...TE.KGFDR----SG.P.--------.... 489 (470) 
C.elegans              .........PMF..R.....FWL.KNA.SN.IP.N.....K..V.FISKHS.DG.KGFSR----DG....-------.... 488 (470) 
Clustal Consensus      **.******  ::* ****::: * . * .*  *:*.**:.:::.:: ..::      .       .          :     220  
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ERp57’s crucial involvement in the folding process of MHC class I has been 
indicated by detection of disulfide-bonded intermediates with class I HC [71, 72]. The N-
terminal cysteines from both active sites have been associated with ERp57 reductase 
activity on partially folded (non-β2m associated) HCs in vitro [72]. ERp57 activity 
independent from CNX/CRT has been reported in the class I pathway both as a catalyst 
and as a member of the PLC [73]. However, recent evidence has been provided for CRT-
mediated recruitment of MHC through the detection of HC/β2m/CRT intermediate before 
PLC engagement, which was strictly glycan-dependent [74]. ERp57 associates covalently 
with TPN [75], through formation of a disulfide bond between TPN C95 and the N-terminal 
cysteine at the redox-active site of the a domain (hERp57 C57), which is conserved across 
species (Fig. 4). Furthermore, this stable association is reinforced by multiple protein-
protein interactions [35]. Accordingly, mutation of the cysteines of the a’ domain active site 
(not covalently linked to TPN) significantly diminished the efficacy of complex formation 
[75]. Contacts at TPN interface [28] include 15 residues from the a domain (hERp57 A54, 
W56, C57, G58, H59, T86, T89, C92, N93, V97, S98, G99, Y100, P101 and R119), 13 of which are 
conserved and 2 conservatively substituted in Dila-ERp57 (Fig. 4); 12 and 3 respectively, 
across species (Fig. 4); and 12 residues from the a’ domain (K366, P404, W405, C406, G407, 
H408, K410, N411, T437, V447, R448, and F450) of which 10 are totally conserved, one 
conservatively substituted and only one not conserved throughout species (Fig. 4). All this 
points to an evolutionary conservation of the lectin-independent interaction between TPN 
and ERp57; however the corresponding cysteine residue and many of the TPN residues 
described to be involved in the non-covalent interactions are not conserved in non-
mammalian tapasins including Dila-TPN [40], raising questions on how this interaction 
might occur in non-mammalian vertebrate species [40].  
Two segments of low complexity were also identified along the sea bass protein 
(Fig. 4). A nuclear localization signal (NLS) and an ER retention KDEL-like sequence are 
present in the C-terminal region of Dila-ERp57 and are predominant features across 
species (Fig. 4). This suggests that besides putative ER localization, Dila-ERp57 may also 
be imported to the nucleus. Interestingly, each salmonid species has one NLS-containing 
and one NLS-less molecule (Fig. 4), which can be related to function differentiation, as 
recently reported [60]. Furthermore, consistent with its distinct basic nature, the C-terminal 
region has been shown to enhance ERp57 binding to CRT [69]. As this feature of the 
ERp57 carboxyl tail is conserved across species (Fig. 4), its specific role in CRT binding 
may be evolutionarily conserved as well. 
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3.3. 3D modelling 
The crystal structures of yeast PDI (yPDI) that revealed two variations of the 
arrangement of its four domains, yielding a ‘twisted U’-like [13] or a ‘boat shaped’ 
molecule [18], were found to be weak templates for modelling Dila-PDI mostly due to very 
low sequence identity (< 30%). Despite the lack of an experimental structure of full-length 
human PDI (hPDI), several crystal or solution structures of hPDI fragments exist, namely 
of the a [51], b [76], b’x [77], or a’ domain (unpublished, [PDB: 1x5c]), and also of the bb’ 
tandem [16], and more recently of the bb’xa’ domain [14]. All these turned out to be 
suitable templates for modelling the sea bass molecule. The Dila-PDI structure was 
predicted by comparative modelling using the isolated hPDI a domain [PDB: 1mek; [51]] 
and bb’xa’ segment [PDB: 3uem; [14]] NMR and crystal structures as templates, 
respectively (Fig. 5A and B). Superposing the two Dila-PDI models to the human ERp57 
structure [28] enabled visualization of the full molecule. Together, the partial homology 
models of Dila-PDI are structurally compatible with the four Trx-like domains described for 
other PDI molecules (Fig. 5A). As described for the experimental structures of human and 
yeast PDI, each individual domain of sea bass PDI (a, b, b’ and a’) assumes the typical 
Trx fold, i.e., a five-stranded central β-sheet structure with two α-helices on each side 
(Fig. 5A), and the topological arrangement βαβαβαββα (only α3-helix is missing at the 
a' domain). Furthermore, Dila-PDI also fits well the compact structural module described 
for the reduced hPDI bb’xa’, where the a’ domain tightly packs with the b’ domain and x-
linker [14]. Superposing the partial homology models of Dila-PDI with full-length hERp57 
[28] crystal structures reveals compatibility with overall shape of the molecules. 
Functionally and structurally relevant residues that are conserved in Dila-PDI were 
mapped to both 1mek- and 3uem-based models (Fig. 5A and B). 
The Dila-ERp57 structure was predicted by homology modelling using the human 
ERp57 [PDB entry 3f8u; [28]] crystal structure as template for the full molecule (Fig. 5C 
and D). Despite the fact that both a and a’ domains are fixed by interactions with TPN, the 
crystal structure of hERp57 [28] revealed an arrangement of the four Trx-like domains 
highly similar to that of yPDI [13], in accordance to previous data on the shape of free 
ERp57 in solution [27]. The homology model of Dila-ERp57 is structurally compatible with 
the four Trx-like domains described for the hERp57 molecule (Fig. 5C), but minor 
variations to the prototypical Trx fold occur in the b (βαβαβαβαβα) and a’ (βαβαβ ββα) 
domains, bearing an additional helix and missing helix α3, respectively. Conserved 
residues involved in TPN and CNX/CRT binding, as well as other structurally relevant 
residues were mapped (Fig. 5C and D). 
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Figure 5. Three-dimensional homology models of sea bass PDI and ERp57. Dila-PDI models were 
generated using the human PDI a domain NMR structure [PDB entry 1mek; [51]] and human PDI bb’xa crystal 
structure [PDB entry 3uem; [14]] as templates. Dila-ERp57 model was generated using human ERp57 crystal 
structure [PDB entry 3f8u; [28]] as template. A) Stereo view of Dila-PDI homology models. The a domain, 
based on 1mek template, is colored yellow, while the bb’xa portion, based on 3uem structure, is colored grey; 
linker regions are in black. Superposing both partial models to human ERp57 [PDB entry 3f8u; [28]] generated 
the combined model. All cysteines are represented as spheres. Non-catalytic cysteines are colored dark blue. 
Residues possibly involved in triggering PDI conformational changes, including Cis-prolines near each active 
site [13], are shaded in orange [14]. Arginine residues relevant for reoxidation are colored cyan [70]. Two 
buried polar residues related to the redox state [13] are colored purple. Contacts of x-linker with b’ or a’ are 
colored salmon; direct contacts between b’ and a’ domains are colored green [14]. Residues identified as part 
of the substrate binding site of b’ domain are colored red [16, 66]. The side of interaction with substrate is 
denoted with an arrowhead. For reference, some of the highlighted residues are labeled. B) Alignment of 
target and template amino acid sequences. The protein sequences of PDI from Dicentrarchus labrax and 
Homo sapiens were used in the multiple sequence alignment (see details in Figure 3). Secondary structure is 
indicated above the alignment with s (β strand) and h (α helix). Modeled regions are also indicated with 
yellow/grey horizontal bars above the alignment. C) Stereo view of Dila-ERp57 homology model. Dila-
ERp57 model is colored light pink with linker regions in black. All cysteines are represented as spheres. Non-
catalytic cysteines are in dark blue. Arginine residues relevant for reoxidation are in cyan [70]. Residues 
involved in TPN binding are colored green (a domain) and dark salmon (a´ domain). Residues identified as 
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|Figure 5 (continued)| part of the calnexin/calreticulin binding site of b’ domain are colored orange. The side of 
interaction with CNX/CRT P domain is denoted with an arrowhead. For reference, some of the highlighted 
residues are labeled. D) Alignment of target and template amino acid sequences. The protein sequences 
of ERp57 from Dicentrarchus labrax and Homo sapiens were used in the multiple sequence alignment (see 
details in Figure 4). Secondary structure is indicated above the alignment with s (β strand) and h (α helix). 
Modeled regions are indicated with pink horizontal bars above the alignment.  
 
3.4. Phylogenetic analysis 
In order to analyse the evolutionary relationships of PDI (PDIA1) and ERp57 (PDIA3) 
proteins from different organisms, a joint neighbour-joining tree was constructed including 
also representatives of PDIA2, PDIA4, PDIA5 and PDIA6 molecules (Table S3), with all 
groups of proteins clearly separated (Fig. 6). However, yeast PDI (PDIA1) stands outside 
of the displayed clusters, reflecting its ancestral existence. Within the PDI (PDIA1) group, 
each class of organisms segregates with high bootstrapping. As expected, Dila-PDI 
clusters with other bony fish (Actinopterygii) sequences being closely related to T. 
nigroviridis and O. niloticus PDI, the last one also from the order Perciformes. A similar 
arrangement is observed within the ERp57 cluster: organisms segregating by class, 
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Figure 6. Phylogeny of PDI and ERp57 and other PDI family members. Neighbor-joining tree calculated 
with MEGA v5.05 [48], using p-distance parameter and pairwise deletion of gaps. The branches were 
validated by bootstrap analysis from 1000 replications, represented by percentages in branch nodes. 
Representatives from PDI (PDIA1), ERp57 (PDIA3), PDIA2 and PDIA4-6 were included in the analysis (Table 
S3). Sequences of precursor proteins from all molecules were used. 
 
except for the two invertebrates that cluster together, and Dila-ERp57 being more similar 
to O. niloticus, among the teleost species. Additionally, a series of pair-wise alignments 
were performed with MatGAT in order to calculate similarity and identity of PDI and 
ERp57 amino acid sequences between species. The results confirm those previously 
obtained with the neighbour-joining method (Table S4). Highest identity is observed in 
both molecules with the mentioned O. niloticus (~88% and 87%, for PDI and ERp57, 
respectively) and the lowest with S. cerevisiae (~29%), followed by roundworm and fruit 
fly (46 and 47%, respectively). Considering the different classes of organisms analysed, 
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those displaying higher similarity towards European sea bass molecules are the bony fish, 
despite the striking degree of conservation observed across all vertebrates (>69% 
identity). Dila-PDI and Dila-ERp57 precursors share 34% identical and 53.6% similar 
amino acids. 
 
 
4. Conclusions 
 
In the present study, the European sea bass PDI (PDIA1) and ERp57 (PDIA3) 
transcripts and genes were successfully identified and characterized. As observed for 
counterparts from other species, Dila-PDI and Dila-ERp57 share the same basic domain 
organization with typical domains and other critical features conserved in both. Distinct 
properties between them include some indels, the nature of the b’ domain and the nature 
and size of the C-terminal region. Other characteristics such as gene organization are 
also distinct between them, but conserved across species. Joint phylogenetic analysis 
segregated these two members of the Trx superfamily, placing sea bass molecules 
among the Actinopterygii clusters, with high identity observed among these enzymes in 
the different species. Both Dila-PDI and Dila-ERp57 3D homology models have been 
predicted and compared to human homologs. Altogether these results point to an 
orthology between the reported molecules and those described for other species. Hence, 
important primary data has been provided to perform further studies on the diverse PDI 
and ERp57 functions in immunity, specifically their involvement in MHC class I antigen 
presentation in this species. 
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Supplementary data 
 
Table S1 
Oligonucleotide sequences. 
 
Letter nucleotide code: V= A, C, G; I= deoxyinosine; R= A, G; M= A, C; Y= C, T; W= A, T; K= G, T; S= G, C.  
 
 
 
Table S1 
Oligonucleotide sequences. 
 
Designation Nucleotide sequence 5’- 3’  Use / Function 
APv GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTTTTTV cDNA synthesis/5’RACE/full cDNA id 
AUAP GGCCACGCGTCGACTAGTAC 5’RACE/full cDNA id 
APv2 GACTCAGGACTTCAGGACTTAGTTTTTTTTTTTTTTTTTV 5’RACE 
AUAP2 GACTCAGGACTTCAGGACTTAG 5’RACE 
T7 TAATACGACTCACTATAGGGCGA sequencing 
SP6 CTATTTAGGTGACACTATAGAATAC sequencing 
DLPDIFW2 GTGCGATGCCACGTCAGTAG full cDNA & partial gene id/sequencing 
DLPDIFW3 AACCGTAGCCGACCGTGTCT full cDNA & partial gene id 
DLPDIFW4 AAGCAGCTGAAGCCATAGAC sequencing 
DLPDIFW5 TGCACCTTGGTGTGGACACT partial gene id 
DLPDIFW6 CATTCCCTTCGCCATCACAT partial gene id 
DLPDIFW7 CAGCGCATCCTGGAGTTCTT partial gene id 
DLPDIFW10 CTGCCTCTGGTCATCGAGTT partial gene id 
DLPDIFW11 GATTACAATGGGGAGAGAAC sequencing 
DLPDIFW12 TGAGGGGCTGTGTAGGTCAT sequencing 
DLPDIFW13 GAACATGCCTCCCCATATCA sequencing 
DLPDIFW14 GGATGCATGTTGAGCTTTGAC sequencing 
DLPDIFW15 GAGAAGTCGGCCACGATCAC sequencing 
DLPDIFW16 CTGGCCACCTTTTCCTTCTT sequencing 
DLPDIFW17 GGGTAATGAGCGTACAGTTG sequencing 
DLPDIFW18 GATATGTAATCCTCCAAGTTCTC sequencing 
DLPDIFW19 GAAGTTGGAGGCGGTAGTGG sequencing 
DLPDIRV2 ATGCAGCTTTGGGCAGAAAC 5’RACE (cDNA synthesis)/partial gene id 
DLPDIRV3 AGATTTTAGGGGCGGTCTGC 5’RACE/sequencing 
DLPDIRV4 GCAGCTGGTTGCCCTTGAC 5’RACE 
DLPDIRV5 CCTCCTTACCGCCGCTCT sequencing 
DLPDIRV6 GGAGGAGGGGAGCCAATTC partial gene id/sequencing 
DLPDIRV8 ACTTAAGAGTGGGGAAGCTG partial gene id 
DLPDIRV9 ACAACGCTGTCCTTGGACAC partial gene id 
DLPDIRV10 GTGTGCAGAATGCGGTGATG partiall gene id 
DLPDIRV13 GACAAGCATGCAGCTCTAGT sequencing 
DLPDIRV14 GTATCACGCCACACAGGTAA sequencing 
ERp57FW1 GAGTTYTTCGCNCCITGGTG partial cDNA id 
ERp57RV1 CCWCCYTCRTAYTTCTTTGG partial cDNA id 
ERp57RV2 TCATIACYCKRTTYCKCCA partial cDNA id 
DLERp57FW7 CTCCCTGGTGCGGACACT sequencing 
DLERp57FW8 TATCGACCTGTCTGCATCTG full cDNA & gene id/southern 
DLERp57FW9 GAGCTGCCACAGACACAAC full gene id 
DLERp57FW12 ACCACGACTCAGCAACAAG sequencing 
DLERp57FW13 GCACATCCAACAGCAACACA sequencing 
DLERp57FW14 GGAATCTGCCCCCACATGAC sequencing 
DLERp57FW16 CTGCTCAAAACATCCCTTAG sequencing 
DLERp57FW17 TTCAGTCGGTGACTCCAGTT sequencing 
DLERp57FW18 AGCAGTCCGATCTGTTGAAG sequencing 
DLERp57RV3 GGTAGCCACTGACACCATA 5’RACE 
DLERp57RV4 ATAGGGACCAGTTTCCTCTC 5’RACE 
DLERp57RV5 ACAATCCCATCTGCAGTCCT 5’RACE (cDNA snthesis) 
DLERp57RV6 CGAGTCCGTGGTCTCCGATCT 5'RACE/southern 
DLERp57RV7 GACCAGAGAGACGATGCCTTTCAG 5'RACE/sequencing 
DLERp57RV10 ATCAACATCATAATAAGCCACCAG sequencing 
DLERp57RV11 GATTTTGTGGGCCTTTTTAT full gene id 
DLERp57RV12 TCACAATTCTTCCAAATGTA full gene id !
Letter nucleotide code: V= A, C, G; I= deoxyinosine; R= A, G; M= A, C; Y= C, T; W= A, T; K= G, T; S= G, C.  
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Table S2 
Distinct regions encoded by each exon. 
  
 
 
 
Table S3 
Accession numbers of sequences used in this study. 
 
 
 
 
 
Table S2 
Distinct regions encoded by each exon. 
 
  Exon Region(s)     
PDI I 5' UTR, signal peptide, a domain part 1 (a domain-p1) 
 II a domain-p2   
 III a domain-p3, b domain-p1  
 IV b domain-p2   
 V b domain-p3, b' domain-p1  
 VI b' domain-p2   
 VII b' domain-p3, x linker-p1  
 VIII x linker-p2, a' domain-p1  
 IX a' domain-p2   
 X a' domain-p3, c-terminal tail (ctail)-p1 
 XI ctail-p2, 3' UTR  
ERp57 I 5' UTR, signal peptide, a domain-p1 
 II a domain-p2   
 III a domain-p3   
 IV a domain-p4, b domain-p1  
 V b domain-p2   
 VI b domain-p3   
 VII b domain-p4, b'domain-p1  
 VIII b' domain-p2   
 IX b' domain-p3, x linker, a´domain-p1 
 X a' domain-p2   
 XI a' domain-p3   
 XII a' domain-p4   
  XIII c terminal tail, 3' UTR !!
 
 
Table S3 
Accession numbers of sequences used in this study. 
 
Species PDI (PDIA1) ERp57 (PDIA3) PDIA2 PDIA4 PDIA5 PDIA6 
D. labrax   - CBN81869 - XP_003458276 
O. niloticus XP_003448052 XP_003455475 - XP_003443545 XP_003454923 - 
O. latipes - - - XP_004081050 XP_004081476 XP_004083501 
T. nigroviridis CAG06136 CAG01048 - CAF97973 CAG08268  CAG03659 
T. rubripes - XP_003967256 - XP_003967904 XP_003962200 XP_003971872 
S. salar - 
ACI33158; 
NP_001161991 - - NP_001133435 ACI33422 
O. mykiss - JX441982; EZ774749 - - - - 
D. rerio NP_998529 NP_001186666 - AAI17630  AAI54607 AF387900 
I. punctatus - - - - - AFL70280 
X. laevis AAH46736 NP_001080051 NP_001083648 NP_001088331 AAH76861 NP_001086643  
X. tropicalis AAH64877 NP_989329 NP_001011281 XP_002941424 CAJ81340 XP_002940166  
G. gallus P09102 NP_989441 XP_003642202 CAG31923 XP_422097 XP_419952 
R. norvegicus P04785 NP_059015 - EDL88288 XP_003750011 - 
M. musculus BAE40274 NP_031978 NP_001074539 BAE27045 NP_082571 AAH06865  
H. glaber EHB09338 EHB10367 - - - - 
O. cuniculus P21195 NP_001164786 - - - - 
B. taurus P05307 NP_776758 - - - - 
H. sapiens NP_000909 NP_005304 AAH75029 BAF83660 NP_006801 NP_005733 
D. melanogaster AAF49659 AAF58609 - - - - 
S. cerevisiae NP_009887 - - - - - 
C. elegans - NM_059594 - P34329  - - 
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Table S4 
Percentages of identity and similarity calculated with MatGat. 
 
Table S4 
Percentages of identity and similarity calculated with MatGat. 
 
    Similarity (%) Identity (%) 
PDI D. labrax - - 
 O. niloticus 93.8 88.0 
 T. nigroviridis 89.5 84.8 
 D. rerio 92.0 81.5 
 X. tropicalis 84.0 69.5 
 X. laevis 84.8 71.1 
 G. gallus 83.1 69.4 
 O. cuniculus 83.6 72.1 
 R. norvegicus 83.2 72.9 
 M. musculus 83.6 73.1 
 H. glaber 84.4 72.5 
 B. taurus 83.2 71.8 
 H. sapiens 84.2 72.5 
 S. cerevisiae 52.7 28.8 
ERp57 D. labrax - - 
 O. niloticus 94.2 87.0 
 S. salar 89.6 79.8 
 D. rerio 91.0 82.2 
 T. nigroviridis 86.6 74.4 
 X. laevis 85.1 70.3 
 X. tropicalis 86.0 73.0 
 G. gallus 84.8 74.1 
 H. glaber 85.9 72.8 
 O. cuniculus 86.5 74.2 
 B. taurus 86.7 74.0 
 M. musculus 85.9 71.5 
 R. norvegicus 85.7 70.9 
 H. sapiens 86.7 73.6 
  D. melanogaster 64.6 47.0 
 !
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Figure S1. Nucleotide and deduced amino acid sequences of sea bass PDI and ERp57 cDNAs. 
Nucleotide sequences (untranslated regions and ORF) of sea bass PDI (A) and ERp57 (B) are shown in 
lowercase letters while the predicted protein sequences are shown in uppercase letters. The translation start 
and stop codons and the initial methionine are boxed. The predicted signal peptide is highlighted in bold type. 
Within the 3’UTR, the putative instability motifs are underlined while poly-adenylation signal sequences are 
shaded in grey and in bold type. 
 
PDI/ERp57 
 
	   166	  
 
Figure S2. Joint alignment of sea bass PDI and ERp57 amino acid sequences. Amino acid sequences 
were retrieved from GenBank (Table S3) and aligned with CLUSTALW [45]. Dashes indicate gaps that 
maximize the alignment and dots denote residues identical to the first sequence of the alignment. Identical 
residues, conserved and semi-conserved substitutions are denoted below the alignment with (*), (:) and (.), 
respectively. Residue numbers are given to the right of the sequences, with numbers in parenthesis referring 
to the mature proteins. Signal peptides are shaded in grey and denoted above the alignment. Predicted a, b, 
b’, and a domains based on human PDI [14], are indicated above the alignment, with junction regions 
represented by black boxes. Also above the alignment are indicated the secondary structure elements from 
each molecule (‘s’ for strands and ‘h’ for helices). The two Trx signature motifs of domains a and a’ are boxed, 
with each active site shaded in black. Non-catalytic cysteines are shaded in dark blue. Residues possibly 
involved in triggering PDI conformational changes, including cis-prolines near each active site [13], are 
shaded in orange [14]. Arginine residues relevant for reoxidation are shaded cyan [70]. Low complexity 
regions are underlined and in bold type. Putative nuclear localization signal is shaded in sepia. KDEL-like ER-
retention signals are boxed. 
 
 
                    Signal peptide        !a domain                                                                             x   
                                           ss    hhhhhhhh  sssssss    hhhhhhhhhhhhhhhh          ssss     hhhhhh      ssssss   ss  
                                           ss     hhhh     ssssss     hhhhhhhhhhhhhhhh         sssss    hhhhhh       ssssss  ssss 
Dila-PDI           MLKLLLLCTLAVASRAEIAEEEDVLVLKKSNFDEALAAHPNLLVEFYAPWCGHCKALAPEYAKAAGMLKAEGSAVRLGKVDATEETELAQDYGVRGYPTIKFYKGGEKES 110 (94)  
Dila-ERp57         ..R.IFVAA..GF...S-----...DYTDDD.ESKIGD.GLA....F........R.....EA..TR..G---I.S.V...C.SNSNTCSK...S....L.IFRD..ETG 102 (82) 
Clustal Consensus  **:*:::.:**  ***.     ***  ...:*:. :. *   ****:******** *****  **  **.    * * ***.*.::: ...*** ****:*:::.**: . 67   
 
                                           !b domain                                                                            x  
                            hhhhhhhhh       ss   hhhhhhhhh   ssssss      hhhhhhhhhhhh      ssss  hhhhhh      ssssss           sss 
                   s        hhhhhhhhhhh    ssss  hhhhhhh      ssssss     hhhhhhhhhhhhh     ssss  hhhhhhh    ssssss  hhh       sss 
Dila-PDI           PKEYSAGRQAEDIVSWLKKRTGPAVTTLSAVTEAESLIADSEVAVIGFFKDLNSDGAKAYEKAAEAIDD-IPFAITSDDAIYSKFEVSKDSVVLFK------KFDEGRNT 213 (197) 
Dila-ERp57         .--.DGP.T.DG...F...QA...SVE.KTDADFQKY.T.QDAS.V...A.DK.TAQTEFL...S.LR.NYR..H.NSE.LLQSHGIDGEG.I..RPPRLSN..EDSSVA 210 (194) 
Clustal Consensus  *  *.. * *:.***:***::*** . *.: :: :. *:*.:.:*:*** * :* . . : ***.*: *   ** *..:*: ... :. :.*:**:      **::.  : 127  
 
                                        !b’ domain                                                                              x 
                          hhhhhhhhhhh    sss     hhhhh     ssssss           hhhhhhhhhhhhhhh    sssss    hhhhhhhhh         sssss   
                          hhhhhhhhhhh      ss    hhhh    ssssss       hhhhhhhhhhhhhhhhhhhh     ssssss    hhhhhhh          sssss  
Dila-PDI           FDG-ELTKEKLLAFVKGNQLPLVIEFTEQTAPKIFGGDIKSHILMF----LPKAASDFQAKMDQFKKAAEGFKGQILFIFIDSDVDDNQRILEFFGLKKEECPAIRLITL 318 (302) 
Dila-ERp57         YSEDKY.SN.IKR.IQD.IFGICPHM.DDNKDQLK.K.LLVAYYDVDYDKN..GSNYWRNRVMKVA.SFLDQGKKLN.AVASKNIFSHDVSEFGMDGSSG.L.LVTIR.A 320 (304) 
Clustal Consensus  :.  : *.:*:  *::.* : :  .:*::.  :: * *:      .     **.:. :: :: :. *:  .   :: * . ..:: .::     :. .. * * : : *  171  
 
                                                                   !a’ domain                                                   x 
                        ss        hhhhhhhhhhhh                      sss hhhhhhhh     sssssss    hhhhhhhhhhhh         ssssssss 
                      sss          hhhhhhhhhhhh                     sss    hhhhh     sssssss    hhhhhhhhhhhhhhhh      sssssss 
Dila-PDI           EDEMTKYKPESDAITAESITAFCTLFTEGKLKPHLMSQDIPEDWDKTPVKVLVGKNFEEVVFDSSKNVFVEFYAPWCGHCKQLTPIWEKLGEKYKDSADVIVAKMDSTAN 428 (412) 
Dila-ERp57         KGDKYAMT-.EFSRDGKALER.LQDYFD....RY.K.EP...SN.G-....V.AE..DSI.N.D..D.LI...........N.E.KFNE....LGSDPN.VI....A... 428 (412) 
Clustal Consensus  :.:    . *. :  .:::  *   : :**** :* *: ***. *  ****:*.:**:.:* *.**:*::***********:* * :::****  ...:*::****:*** 245  
 
                                                                    !C-terminal tail                     
                               sssss        sss     hhhhhhhhh 
                               sssss        ss      hhhhhhhhhh   h 
Dila-PDI           EIEA-VKVHSFPTLKFFPAGDERKVIDYNGERTLEGFTKFLESGGKEGGAPAADDEDDLDAEDLDDVDEGQDEDSDGEDDDGHDEL 513 (497) 
Dila-ERp57         DVPSPYE.SG....Y.A...RKMSPKK.E.G.EVSD.LSY.KR---.ATN.LVMQ.E-----------SKKKKKKKD..E.DKT.. 500 (484) 
Clustal Consensus  :: :  :* .**** * *** : .  .*:* * :..* .:*:    *.  * . :*:           . :.:....**:*.: ** 282  
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Figure S3. Joint alignment of PDI and ERp57 amino acid sequences from several species. Amino acid 
sequences were retrieved from GenBank (Table S3) and aligned with CLUSTALW [45]. Dashes indicate gaps 
that maximize the alignment and dots denote residues identical to the first sequence of the alignment. 
Identical residues, conserved and semi-conserved substitutions are denoted below the alignment with (*), (:) 
and (.), respectively. Residue numbers are given to the right of the sequences, with numbers in parenthesis 
referring to the mature proteins. Signal peptides are shaded in grey and denoted above the alignment. 
Predicted a, b, b’, and a domains, based on human PDI [14], are indicated above the alignment, with junction 
regions represented by black boxes. The two Trx signature motifs of domains a and a’ are boxed, with each 
active site shaded in black. Non-catalytic cysteines are shaded in dark blue. Arginine residues relevant for 
reoxidation are shaded cyan [70]. Residues possibly involved in triggering PDI conformational changes, 
including cis-prolines near each active site [13], are shaded in orange [14]. Two buried polar residues related 
to the redox state [13] are shaded purple in human and yeast PDI. Hydrophobic patch on the b’ domain 
putatively involved in peptide/substrate binding is shaded yellow in yPDI [13]. Contacts of x-linker with b’ or a’ 
are shaded in light salmon; direct contacts between b’ and a’ domains are shaded in green [14]. Residues 
identified as part of the substrate binding site of b’ domain are shaded in red [16, 66]. Residues of human 
ERp57 that contact CNX/CRT are shaded orange. Residues involved in TPN binding are shaded green (a 
domain) and dark salmon (a´ domain). Low complexity regions are underlined and in bold type. ERp57 
putative nuclear localization signal is shaded in sepia. KDEL-like ER-retention signals are boxed. 
                            Signal peptide              !a domain                                                                             x   
D.labrax[Dila-PDI]     ---------MLKLLLLCTLAVASRAEIAEEED-VLVLKKSNFDEALAAH---PNLLVEFYAPWCGHCKALAPEYAKAAGMLKAEGSAVRLGKVDATEE-TELAQDYGVRGYPTIKFYKGG 106 (90)  
O.niloticus            ---------...F.IF......IN........-.........N...Q..---..I...............................DI..........-...T.E...........F... 106 (90) 
T.nigroviridis         --------MKF.F.....VV..........D.-.............K..---...............N...........K..E...E...A.......-.....EF..........F... 107 (90) 
D.rerio                ---------...F.IV.A..AM.A........-.........E...K..---..V...................S...........DI..A.......-S....EF..........F... 106 (90) 
X.tropicalis           -------MMRAV..FG.S.LIVA..N.P..R.-......D......KQY---.FI...................E....V..S..LPI..........-SD...EF..........F.N. 108 (90) 
X.laevis               -------MMRAV..FG.A.L.VA.PD.S..K.-......D......KQY---.YI...................E....I..S..LPI..........-SD...EF..........F.N. 108 (92) 
G.gallus               ---MAVVRVRAIVA...LV.ALGL..PL....G....RAA..EQ.....---RH........................AQ......EI..A.......-A....QF..........FRN. 113 (91) 
O.cuniculus            ------MLRRAV.C.ALAVT-.GW.WA.....N.....S...A.E....---KH.........................K......DI..A.......-SD...Q...........F.N. 109 (89) 
R.norvegicus           ------MLSRAL.C.ALAW.ARVG.DAL....N.........A......---NY........................AK......EI..A.......-SD...Q...........F.N. 110 (89) 
M.musculus             ------MLSRAL.C.ALAW.ARVG.DAL....N.........E......---KY........................TK......EI..A.......-SD...Q...........F.N. 110 (89) 
H.glaber               ------MLSRAL.C.ALAA.ARVG.DAP....H.........E....T.---KY.........................K......EI..A.......-SD...Q...........F.N. 110 (91) 
B.taurus               ------MLRRAL.C.AL.ALFRAG.GAPD...H....H.G.........---KY.........................K......EI..A.......-SD...Q...........F.N. 110 (90) 
H.sapiens              ------MLRRAL.C.AVAAL.RAD.--P....H....R....A......---KY.........................K......EI..A.......-SD...Q...........FRN. 108 (91) 
D.melanogaster         ----MKFLICALF.AASYV.ASAE..VKV..G-...ATVD..KQLI.DN---EFV.......................QQ.AEKE.PIK.A.....V.-G...EQ.A......L..FRS. 111 (92) 
S.cerevisiae           MKFSAGAVLSWSS...ASSVF.QQEAV.P.DSA.VK.ATDS.N.YIQS.---DLV.A..F........NM....V...ET.VEKN--IT.AQI.C..N-QD.CMEHNIP.F.SL.IF.NS 114 (92) 
 
D.labrax[Dila-ERp57]   --------------M.RLIF..AL.GFSRAS-D..DYTDDD.ESKIGD.---GLA....F........R.....EA..TR..G---I.S.V...C.SN-SNTCSK...S....L.IFRD. 98  (82) 
O.niloticus            --------------M.RLIFL.AL.GFSRAS-D..EYTDDD.ESRIGD.---ELI....F........R.....EA..TR..G---I.A.A...C.AN-SNTCSK...S....L.IFRD. 98  (82) 
S.salar ACI33158       --------------M.KLFFFVVL.GA.LAS-D.IEFTDDD..SKIGD.---GMI....F........K.....EV..TR..G---I.G.A...C.VH-NNVC.K...S....L.IFRD. 98  (82) 
S.salar NP_001161991   --------------M.KLFFFIVL.GA.RAS-D.IEFSDDD..SKIGD.---GMI....F........R....FEV..TR..G---I.A.A...C.VQ-NNVC.K...S....L.IF.D. 98  (82) 
O.mykiss JX441982      --------------M.KLFFFVVL.RV.LAS-D.IEFTDDD..SKIGD.---GMI....F........K.....EV..TR..G---I.G.A...C.VH-NNVC.K...S....L.IFRD. 98  (82) 
O.mykiss EZ774749      -----------------------------------------------------MI....F........R....FEV..TR..G---I.A.A...C.VQ-NNVC.K...S....L.IF.D. 63   
D.rerio                -------------MM.AL.FLVAF.AA.RAS-D..EYTDDD..SRIGD.---DLI....F........R.....EA..TR..G---I.P.A...C.AN-SKVCGK...S....L.IFRD. 99  (82) 
T.nigroviridis         --------------M.ALMLL.AL.GFTQAS-D..EFTDND.ESKIGD.---EII....F........R.....ET..TS..G---I.P.A...C.AN-SDTCSK...S....L.VFRD. 98  (82) 
T.rubripes             --------------M.KLMLL.ALTGFTQAASD..EFTDND.ESKIGD.---EII....F........R.....E...TA..G---V.P.A...C.SN-SNICSK.Q.S....L.VFRD. 99  (83) 
X.laevis               --------MNRQ..GAFF.LL.VT.GTQAAGSD..D.TDD..ESVV.Q.---SI.....F........K.....EI..TK..G---TLS.A...C.AN-SNICNK...S....L.IFRD. 105 (84) 
X.tropicalis           --------MNRQ..GAFF-LL.VT.GTQAAGSD..D.TDD..ESTVSQ.---SI.....F........K.....EI..TK..G---TLS.A...C.AN-SNTCNK...S....L.IFRD. 104 (84) 
G.gallus               ------MSVPRPSRAALL.L.PLL.LS.GAS-D.VE.SDAD.ESG..ER--PGLV....F........R.....EA..TR..G---I.P.V...C.AN-SNTCNK...S....L.IFRD. 107 (83) 
H.glaber               ------MRSHRLE.FSVVALLL.T.RL.AAS-D..E.TDDT.ESRVSDTGSAGLM....F........R.....EA..SR..G---I.P.A...C.AN-.NTCNK...T....L.IFRD. 109 (85) 
O.cuniculus            ---------.RLAMFPGVALLLAA.RL.AAS-D..E.TDD..ESRITDTGSAGLM....F........R.....EA..TR..G---I.P.A...C.AN-.NTCNK...S....L.IFRD. 106 (85) 
B.taurus               ------MRLRRLA.FPGLALLLAA.RL.AAS-D..E.TDD..ESRITDTGSSGLM....F........K.....EA..TR..G---I.P.A...C.AN-.NTCNK...S....L.IFRD. 109 (85) 
M.musculus             ------MRFSCLA..PGVALLLAS.RL.AAS-D..E.TDE..ESRVSDTGSAGLM....F........R.....EA..TR..G---I.P.A...C.AN-.NTCNK...S....L.IFRD. 109 (85) 
R.norvegicus           ------MRFSCLA..PGVALLLAS.LL.SAS-D..E.TDE..ESRVSDTGSAGLM....F........R.....EA..TR..G---I.P.A...C.AN-.NTCNK...S....L.IFRD. 109 (85) 
H.sapiens              ------MRLRRLA.FPGVALLLAA.RL.AAS-D..E.TDD..ESRISDTGSAGLM....F........R.....EA..TR..G---I.P.A...C.AN-.NTCNK...S....L.IFRD. 109 (85) 
D.melanogaster         ----------MMWR.AGV.LLGFI.ISSGA.QD..E.GDDD.ATT.KQ.---ETT..M..........R.K.......EIV.DDDPPIK.A...C..AGK.TCSK.S.S....L.IFRQD 107 (88) 
C.elegans              ----------MIWVQA-A.VASFL.FAS-AGGA..EYTDG...DLIQT.---DIA..K..........KI....ER..PK.ASNDPP.A.V...C.T.-KTVCDKF..K.F..L.IFRN. 104 (86) 
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Figure S3 (continued) 
 
 
                                                   !b domain                                                                                  x 
D.labrax[Dila-PDI]     EKESPKEYSAGRQAEDIVSWLKKRTGPAVTTLSAVTEAESLIADSEVAVIGFFKDLNSDGAKAYEKAAEAIDD-IPFAITSDDAIYSKFEVSKDSVVLFK------KFDEGRNTF--DGE 217 (201)  
O.niloticus            D.............D..............A..NE..D.......N..........AE.A..Q......Q....-....K..N..V..........I....------.........--..D 217 (201) 
T.nigroviridis         ...........................S.A..QE..Q..A.V..N..........AE.AD...F.........-....V...E..H..............------.........--E.. 218 (201) 
D.rerio                ..GN........................A...ND.MQ...I...N..........VE.EDS..FI.T...V..-...G.....SVFA....A........------.........--... 217 (201) 
X.tropicalis           D.A.........E.A...N.........AS..GDEAGVAA.VDS...........PA.EP..VFLQ....V..-...G...SE.AF..Y.LG..GI....------.......AY--E.D 219 (201) 
X.laevis               D.S.........E.A.F.N.........AS...DEAAVAA.V.S............E.EL..VFLQ....V..-V..G...SE.AF..H.LG..GI....------.......A.--E.. 219 (203) 
G.gallus               D.AA.R..T...E.D.............A...TDAAA..T.VDS...V.......VT..A..EFLL...SV..-...G.S.SADVF..YQL.Q.G.....------.......N.--E.D 224 (202) 
O.cuniculus            DTA.....T...E.D...N.........A...ADSAA....VES...........VE..A..QFLL....T..-...GL.ASSDVF.RYQ.HQ.G.....------.......N.--E.. 220 (200) 
R.norvegicus           DTA.....T...E.D...N.........A....DTAA....VDS...T.......AG..S..QFLL....V..-...G...NSDVF..YQLD..G.....------.......N.--E.. 221 (200) 
M.musculus             DTA.....T...E.D...N.........A....DTAA....VDS...T.......VE..S..QFLL.......-...G...NSGVF..YQLD..G.....------.......N.--E.. 221 (200) 
H.glaber               DTA.....T...E.D...N.........AS...DGAA....VES...........VE..F..QFLL.......-...G...NSDVF.RYQLDQ.G.....------.......N.--E.. 221 (202) 
B.taurus               DTA.....T...E.D...N.........AS...DGAA..A.VES...........ME..S..QFFL...V...-...G...NSDVF..YQLD..G.....------.......N.--E.. 221 (201) 
H.sapiens              DTA.....T...E.D...N.........A...PDGAA....VES...........VE..S..QFLQ.......-...G...NSDVF..YQLD..G.....------.......N.--E.. 219 (202) 
D.melanogaster         ---..V...G....A..IA.VT.K...PAKD.TS.AD..QFLK.N.I.I.......E.EE..TFT.V.N.L.S-FV.GVS.NADVIA.Y.AKDNG.....------P..DKKSV.--E.. 219 (200) 
S.cerevisiae           DVNNSID.EGP.T..A..QFMI.QSQ...AVVADLP-.YLANETFVTP..VQSGKIDA.FNATFYSM.NKHFNDYD.VSAENADDDF.LSIYLP.AMDEP-----VVYNGKKADI----- 223 (201) 
 
D.labrax[Dila-ERp57]   .--ETGP.DGP.T.DG...F...QA...SVE.KTDADFQKY.T.QDAS.V...A.DK.TAQTEFL...S.LR.NYR..H.NSE.LLQSHGIDGEG.I..RPPRLSN..EDSSVAY-SEDK 215 (199) 
O.niloticus            D--ESGP.DGP.N.DG...F...QA...SVV.KDNADL.KFL..QDAS.V...A.DK.TEQAEFL...S.LR.NYR..H.NSE.LLKSHDIEGEG.I..RPPQLNN..EDSSVK.-S.DK 215 (199) 
S.salar ACI33158       .--DAGP.DGP.T.DG...H...QA...SVE.KTEADFTKYVG.RDAS.V...A.DG.PAKAEFL.S.S.LRESFR..H.NSEELLQ.HS.EGEGII..RPSRLNN..E..SVK.-SEDT 215 (199) 
S.salar NP_001161991   .--DAGA.DGP.T.DG...H...QA..SSIE.KTEADFTKYVG.RDAS.V...A.GG.PAQAEFL.S.S.LRESFR..H.NSGELLQ.NG.EGEGII..RPARLSN..E.SVIK.-SEDK 215 (199) 
O.mykiss JX441982      .--DAGA.DGP.N.DG...H...QA...SVE.KTEADFTKYVG.RDAS.V...A.GG.PAKAEFL.S.S.LRESFR..H.NSEELLQ.HG.EGEGII..RPSRLNN..E.SSVK.-SEDT 215 (199) 
O.mykiss EZ774749      .--DAGA.DGP.T.DG...H...QA..SSVE.KTEADFTKYVG.RDAS.V...A.GG.PAQAEFL.S.S.LRESFR..H.NSGELLQ.HG.EGEGII..RPARLSN..E.SSIK.-SEDK 180  
D.rerio                .--DSGG.DGP.T.DG...H...QA...SVE.KNEADF.KY.G.RDAS.V...A.GG.AAQGEFL...S.LRESYR..H.NNEDLLK.HGIDGEGII..RSPQLSN..EDSSVL.-TEDK 216 (199) 
T.nigroviridis         .--ESGS.DGP.TSDG..AYF..QV...SVM.TDEEQLQRF.SNEDAS.V...A.DK.TEQAEFL...S.LR.QYR..H.NAE.LLQSQKIQAEGI...RPPQLRS..EDSSVRY-AEDK 215 (199) 
T.rubripes             .--ESGA.DGP.TSDG...YF..QV...SVA.AGEE.LQKF.SEKDSS.V...A.DK.TAQVEFL...S.LR.KYR..H.NAEVLLKSQN.GPEGI...RPPTLKN..EDSSVKY-SEEK 216 (200) 
X.laevis               .--DSGS.DGP.S.DG...TM..QA...SVD.RS.E.F.KFV..KDA..V...R..Y.GPHSEFL...NTLRENYR..H.DEKELVD.YDTNGEG....RPPHLAN..ED.SV..PA.EK 223 (202) 
X.tropicalis           .--DSGS.DGP.T.DG...TM..QA...SVD.RS.G.F.KF.S.KDAS.V...R..Y.GPHSEFL...NTLR.NYR..H.DEKELVD.YDSNGEGF...RPQHLAN..EDSSV..PA.EK 222 (202) 
G.gallus               .--ESGT.DGP.T.DG...H...QA...SVA..S.ADF.KF.G.KDAS.V...R.ASG.AYSEFM...NNLR.NYR..H..EEQLVQ.Y.EDGEG...YRPSRLAN..EDSTVKY-TEDK 224 (200) 
H.glaber               .--EAGA.DGP.T.DG...H...QS...SVP.RTEE.FKKF.S.KDAS.V...R..F.EAHSEFL...SNFR.SYR..H.NVESLVKEYDDNGEGIT..RPSHLAN..EDKTVAY-TEQK 226 (202) 
O.cuniculus            .--EAGA.DGP.T.DG...H...QA...SVP.GTEEDFKKF.S.KDAS.V......F.EAHSEFL...SNLR.KYR..H.NVESLVKEYDDDGEGIT..RPSHLTN..EDKTVAY-TEQK 223 (202) 
B.taurus               .--ESGA.DGP.T.DG...H...QA...SVP.KSEE.F.KF.S.KDAS.V......F.EAHSEFL...SNLR.NYR..H.NVESLVN.YDDDGEGIT..RPSHLTN..EDKTVAY-TEQK 226 (202) 
M.musculus             .--EAGA.DGP.T.DG...H...QA...SVP.RTEE.FKKF.S.KDAS.V...R..F...HSEFL...SNLR.NYR..H.NIESLVKEYDDNGEGITI.RPLHLAN..EDKTVAY-TEKK 226 (202) 
R.norvegicus           .--EAGA.DGP.T.DG...H...QA...SVP.RTED.FKKF.S.KDAS.V...R..F...HSEFL...SNLR.NYR..H.NVESLVKEYDDNGEGITI.RPLHLAN..EDKIVAY-TEKK 226 (202) 
H.sapiens              .--EAGA.DGP.T.DG...H...QA...SVP.RTEE.FKKF.S.KDASIV...D.SF.EAHSEFL...SNLR.NYR..H.NVESLVNEYDDNGEGII..RPSHLTN..EDKTVAY-TEQK 226 (202) 
D.melanogaster         .--VSQD.NGP.E.SG.AKYMRAQV...SK.VRT.A.LKKFLDTKDTTLF.Y.S.SD.KL..IFL.F.DKNREKYR.GHS.EKEVLD.QG-ET.KI..IRAPHLSN..ESSSIK.--E.S 222 (203) 
C.elegans              V--PAQD.DGP.D.DG..KFMRGQS..SSKE.KT.A.F.KFTGGD.NV.....E-SE.KLKDS.L.V.DTER.RFS..H..NKD.IK.AG-YS.D..V.VPKKLHN...TNEFKY--..N 218 (200) 
Clustal Consensus          .  * . * :  :   .  :  *.   :                :.       .     :   *.   .   *  :                           ::            47   
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D.labrax[Dila-PDI]     LTKEKLLAFVKGNQLPLVIEFTEQTAPKIFGGDIKSHILMFLPKAASDFQAKMDQ--FKKAAEGFKGQILFIFIDSDVD---DNQRILEFFGLKKEECP--AIRLITLEDEMTKYKPESD 330 (314)  
O.niloticus            ....A..S...A....................E.................D....--......................---...........R.....--................... 330 (314) 
T.nigroviridis         V...N..N...S................................D.....D....--...................E.E---.................--................... 331 (314) 
D.rerio                VS..S..N.I.A.............................V....K...D....--..........K...........---.................--V.......E.........S 330 (314) 
X.tropicalis           I...EV.S.I.A.R.............M....E..T...F....S...YKE.LED--.....AS...K.........HT---.................--.V......E.........A 332 (314) 
X.laevis               I...EV.S.I.A.R.............M....E..T...F....S...Y.D.LEN--.....AS...K.........HT---.................--.V......E.........S 332 (316) 
G.gallus               ...DN..N.I.S....................E..T...L....SV..YEG.L.N--..T..GN...K.........HS---.................--.V......E.......... 337 (315) 
O.cuniculus            V......D.I.H....................E..T...L...RS.A.HDG.LSG--..Q.......K.........HA---.................--.V......E.......... 333 (313) 
R.norvegicus           I......D.I.H....................E..T...L....SV..YDG.LSN--..........K.........HT---.................--.V......E.......... 334 (313) 
M.musculus             I......D.I.H....................E..T...L....SV..YDG.LSS--..R.......K.........HT---.................--.V......E.......... 334 (313) 
H.glaber               I......D.I.H....................E..T...L....SE..YDS.LSN--..........K.........HA---.................--.V......E.......... 334 (315) 
B.taurus               V......D.I.H....................E..T...L....SV..YEG.LSN--......S...K.........HT---.................--.V......E.......... 334 (314) 
H.sapiens              V...N..D.I.H....................E..T...L....SV..YDG.LSN--..T...S...K.........HT---.................--.V......E.........E 332 (315) 
D.melanogaster         .NE.N.KK.AQVQS...IVD.NHES.S.....S....L.F.VSREGGHIEKYV.P--L.EI.KKYRDD...VT.S..EE---.HT..F....MN...V.--T....K..ED.A....... 332 (313) 
S.cerevisiae           ADADVFEKWLQVEA..YFG.IDGSVFAQYVESGLPLGY.FYNDEEELEEYKPLFTELA..NRGLMNFVSIDARKFGRHAGNLNMKEQFPL.AIHDMTED-LKYG.PQ.SE.AFDELSDKI 342 (320) 
 
D.labrax[Dila-ERp57]   Y.SN.IKR.IQD.IFGICPHM.DDNKDQLK.K.LLVAYYDVDYDKNPKGSNYWRNRVM.V.KSFLDQGKKLN.AVASKN---IFSHDVSE..MDGSSGE-LPLVT.RTAKGDKYAMT.EF 331 (315) 
O.niloticus            Y.SN.IKR.IQD.IFGFCPHMNDNNKDQLK.K.LLVAYYDVDYEKNPKGSNYWRNRVM.V.KGFLDQGKKLN.AVANKN---MFNHE.SE...N-PSGE-LPVVA.RTAKGDKYTMT.EF 330 (314) 
S.salar ACI33158       F.NA.IKQ.IQD.IFGMCPHM.DDNKDQMK.K.LLVAYYDVDYEKNPKGSNYWRNRVM.V.KGFLDQGNKLN.AVASKN---SFSQDIAEM..DASSGE-LPVVG.RTAKGDKYVMT.EF 331 (315) 
S.salar NP_001161991   F.NAMIKK.IQD.IFGMCPHM.DDNKDQMKDK.LLVAYYDVDYEKNPKGSNYWRNRVM.V.KSFLDQGKTLN.AVASKN---SFSHDISEM..DASSGE-LPVVG.RTAKGDKYVMA.EF 331 (315) 
O.mykiss JX441982      F.NA.IKP.IQD.IFGMCPHM.DDNKDQMK.K.LLVAYYDVDYEKNPKGSNYWRNRVM.V.KGFLDQGNKLN.AVASKN---SFSQDIAEM..DASSGE-LPVVG.RTAKGDKYVMT.EF 331 (315) 
O.mykiss EZ774749      F.NAMIKK..QD.IFGMCPHM.DDNKDQMKDK.LLVAYYDVDYEKNPKGSNYWRNRVM.V.KSFLDQGKTLN.AVASKN---SFSHDISEM..DASSGE-LPVVG.RTAKGDKYVMA.EF 296  
D.rerio                F.SA.IKK.IQD.IFGICAHM..DNKDQLK.K.LLVAYYDVDYEKNPKGSNYWRNRVM.V.KGFLDQGKKLS.AVANKN---RFSHDVSEL..DGSSGE-LPLVG.RTAKGDKYVMK.EF 332 (315) 
T.nigroviridis         YSSS.IKK.LQD.IFGICPVM..ENKDQLSSK.LLVAYFDLDY.LNPKGSNYWRNRVM.V.KTFLDEGRKLS.AVANKS---PYGGV..E...SPQSSD-APLVT.RTTKGQKYAMT.TF 331 (315) 
T.rubripes             Y.SN.IKR.IQD.V.GFCPHM..DNKDQLM.K.LLVAYYDVDYERNPKGSNYWRNRVM.V.KTFLDEGKKLN.AVANKA---RFMSV.SE...EDHSSA-GPLVT.RTAKGEKYAMT.EF 332 (316) 
X.laevis               I.SG.IKK.IQD.IFG.CPHL.QDNKDL.Q.K.LLIAYYDVDYEKNVKGTNYWRNRVM.V.KSFVDAGKKLN.AVANRK---SFGHEVTE...DANTGE-LPVVG.KTAKGEKFVMQ.EF 339 (318) 
X.tropicalis           I.SS.IKK.IQD.IFG.CPHL..DNKDL.Q.K.LLVAYYDVDYEKNVKGTNYWRNRVM.V.KSFVDAGKKLN.AVANRK---AFGHEVTE...DAGTGE-LPVVG.KTAKGEKYAMQ.EF 338 (318) 
G.gallus               I.SA.IKK.IQE.IFGICPHM..DNKDL.Q.K.LLVAYYDVDYEKNAKGSNYWRNRVMMI.KKFLDAGHKLS.AVASRK---TFGHE.SE...DNSVGE-APVVA.RTAKGDKFVMQ.EF 340 (316) 
H.glaber               M.SG.IKK.IQE.IFGICPHM..DNKDL.Q.K.LLIAYYDVDYEKNTKGSNYWRNRVMMV.KKFLDAGHKLN.AVASRK---TFSHE.SD...ESSTGE-IPVVA.RTAKGEKFVMQ.EF 342 (318) 
O.cuniculus            M.TG.IKK.IQE.IFGICPHM..DNKDL.Q.K.LLIAYYDVDYEKNAKGSNYWRNRVMMV.KKFLDAGHKLN.AVASRK---TFSHE.SD...ESSTGE-VPVVA.RTAKGEKFVMQ.EF 339 (318) 
B.taurus               M.SG.IKR.IQE.IFGICPHM..DNKDLLQ.K.LLIAYYDVDYEKNAKGSNYWRNRVMMV.KKFLDAGKKLH.AVASRK---TFSHE.SD...ESTTGE-IPVVAVRTAKGEKFVMQ.EF 342 (318) 
M.musculus             M.SG.IKK.IQDSIFG.CPHM..DNKDL.Q.K.LLTAYYDVDYEKNAKGSNYWRNRVMMV.KKFLDAGHKLN.AVASRK---TFSHE.SD...ESTTGE-VPVVA.RTAKGEKFVMQ.EF 342 (318) 
R.norvegicus           M.SG.IKK.IQESIFG.CPHM..DNKDL.Q.K.LLTAYYDVDYEKNTKGSNYWRNRVMMV.KTFLDAGHKLN.AVASRK---TFSHE.SD...ESTTGE-IPVVA.RTAKGEKFVMQ.EF 342 (318) 
H.sapiens              M.SG.IKK.IQE.IFGICPHM..DNKDL.Q.K.LLIAYYDVDYEKNAKGSNYWRNRVMMV.KKFLDAGHKLN.AVASRK---TFSHE.SD...ESTAGE-IPVVA.RTAKGEKFVMQ.EF 342 (318) 
D.melanogaster         SESD-.ST...E.FHG..GHR.QDSVKDFQN-PLITAYYSVDYQKNPKGTNYWRNRVL.V.K.FVG---QIN.AIASK.---.F.HE.NEY.YDFVGD--KPVV.ARD.KNLKYALKDEF 332 (313) 
C.elegans              YDTD.IKN.LVHETVGFAGIR.QGNLFQFEQKP.VIVYYNVDYVKDPKGSNYWRNRVL.V.QNYKR---KVQ.AV.NKE---EFSSEI.TN..GERKDSDKP.VA.LTNE-GKYPMDQEF 331 (313) 
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Figure S3 (continued) 
 
 
 
                                                           !a’ domain                                                                         x 
D.labrax[Dila-PDI]     AITAESITAFCTLFTEGKLKPHLMSQDIPEDWDKTPVKVLVGKNFEEVVFDSSKNVFVEFYAPWCGHCKQLTPIWEKLGEKYKDSA-DVIVAKMDSTANEIEA-VKVHSFPTLKFFPAGD 448 (432) 
O.niloticus            ........E..K.................K....N.............A.NP...................A..............-.T............D.-...............E 448 (432) 
T.nigroviridis         .....G..H...Q.V.................................A..P...................A..............-.T.............T-................ 449 (432) 
D.rerio                E....N.IS...S.V..T................N.............A.NPAN.................A...DQ....F..N.-NIV.............-................ 448 (432) 
X.tropicalis           DLS..A.KE..DS.L...V........VSD....N...I...........NEE..................A...DQ.......HE-NI.I............-..I............P 450 (432) 
X.laevis               DLS..A.KE..DR.L...V........V..........I............EE..................A...DQ.......HE-SI.I............-..I............P 450 (434) 
G.gallus               DL..DK.KE..NK.L...I........L......Q.............A..EN..................A...D....T.R.HE-NIVI.........V..-..I............S 455 (433) 
O.cuniculus            EL...G..E..QR.L...I.......EL.....RQ.............A..EK..................A...D....T..EHQ-.IVI.........V..-...............P 451 (431) 
R.norvegicus           EL...K..Q..HH.L...I.......EL......Q.............A..EK..................A...D....T...HE-NIVI.........V..-..............SA 452 (431) 
M.musculus             EL...K..E..HR.L...I.......EV......Q.......A.....A..EK..................A...D....T...HE-NI.I.........V..-..............SA 452 (431) 
H.glaber               EL..QK..E..QH.L...I.......EL......Q.............A..EK..................A...D....T...HE-.I.I.........V..-.........R....ST 452 (433) 
B.taurus               EL...K..E..HR.L...I.......EL.D....Q.............A..EK..................A...D....T...HE-NIVI.........V..-..............SA 452 (432) 
H.sapiens              EL...R..E..HR.L...I.......EL......Q...........D.A..EK..................A...D....T...HE-NIVI.........V..-..............SA 450 (433) 
D.melanogaster         DLS..T.E..LKK.LD....Q..L..EL......N......SS...S.AL.K..S.L..............A..YDQ.A.....NE-.IVI.........L.S-I.IS....I.Y.RK-E 449 (430) 
S.cerevisiae           VLESKA.ESLVKD.LK.DAS.IVK..E.F.N-QDSS.FQ.....HD.I.N.PK.D.L.LY.........R.A.TYQE.ADT.ANATS..LI..L.H.E.DVRG-.VIEGY..IVLY.G.K 460 (438) 
 
D.labrax[Dila-ERp57]   SRDGKALER.LQDYFD....RY.K.EP...S-NDG....V.AE..DSI.N.D..D.LI...........N.E.KFNE....LGSDP-N.VI....A...DVPSPYE.SG....Y.A...R 449 (433)  
O.niloticus            SRDGKALER.LQDYFD....RY.K.EP...N-NDG....V.AE..DSI.N.D..D.LI...........S.E.KYTE....LA.DP-N.VI....A...DVPSPYE.SG...IY.S...R 448 (432) 
S.salar ACI33158       SRDGKALER.LQDYFD....RY.K.EP...N-NDG...TV.AE..DAI.NEED.D.LI...........S.E.K.KE....LSSDP-NIVI....A...DVPSQYE.RG...IF.A...Q 449 (433) 
S.salar NP_001161991   SRDGKALER.LQDYFD....RY.K.EPS..N-NDG...TV.AE..DAI.NNEE.D.LI...........S.E.K.KE....LSSDP-NIVI....A...DVPSQYE.RG...IF.A...Q 449 (433) 
O.mykiss JX441982      SRDGKALER.LQDYFD....RY.K.EP...N-NDG...TV.AE..DAI.NEED.D.LI...........S.E.K.KE....LSSDP-NIVI....A...DVPSQYE.RG...IF.S...Q 449 (433) 
O.mykiss EZ774749      SRDGKALER.LQDYFD....RY.K.EPS..N-NDG...TV.AE..DAI.NNEE.D.LI...........S.E.K.KE....LSSDP-NIVI....A...DVPSQYE.RG...IF.A...Q 414  
D.rerio                SRDGKALER.LQDYFD.N..RY.K.EPV..N-NDG......AE..DSI.N.D..D.LI...........S.E.KYKE....LSEDP-NIVI....A...DVPSPYE.SG...IY.S...R 450 (433) 
T.nigroviridis         SPDGKALEG.LHSYFA.T...Y.K.EPV...-NDG....V.AE..DSI.N.D..D.LI...........N.E.KYKE....LANDP-NIVI....P...DVP.PYE.RG...IY.S...Q 449 (433) 
T.rubripes             LPDGKALER.LLSYFD.S...Y.K.EP...N-NDG....V.AE..DSI.N.D..D.LI...........S.E.KYKE....LA.DP-NIVI....A...DVPSPYE.SG....Y.S...Q 450 (434) 
X.laevis               SRDGKALER.LQDYFD....RYMK.ES...S-NDG....A.AE..D.L.N.E..D.LI...........T.E.KYKE....LA.DP-NIVI....A...DVPPQYE.RG...IY.A...N 457 (436) 
X.tropicalis           SRDGKALER.LQDYFD....RYMK.EA...S-NDG....V.AE..D.I.N.D..D.LI...........N.E.KYKE....LG.DP-NIVI....A...DVPSQYE.RG...IY.T...S 456 (436) 
G.gallus               SRDGKALER.LQDYFD.N..KY.K.EPV..N-NDG....V.AE..D.I.NAED.D.LI...........N.E.KYKE....LSKDP-NIVI....A...DVPSPYE.RG...IY.A...K 458 (434) 
H.glaber               SRDGKALER.LQDYFD.N..RY.K.EP...S-NDG....V.AE..D.I.NNEN.D.LI...........N.E.KYKE....LSKDP-NIVI....A...DVPFPYE.RG...IY.S..NQ 460 (436) 
O.cuniculus            SRDGKALER.LQDYFD.N..RY.K.EP...S-NDG....V.AE..D.I.NNEN.D.LI...........N.E.KYKE....LSKDP-NIVI....A...DVPSPYE.RG...IY.S..NK 457 (436) 
B.taurus               SRDGKALER.LEDYFD.N..RY.K.EP...S-NDG....V.AE..D.I.NNEN.D.LI...........N.E.KYKE....LRKDP-NIVI....A...DVPSPYE.RG...IY.S..NK 460 (436) 
M.musculus             SRDGKALEQ.LQEYFD.N..RY.K.EP...S-NEG....V.AE..DDI.NEED.D.LI...........N.E.KYKE....LSKDP-NIVI....A...DVPSPYE.KG...IY.S..NK 460 (436) 
R.norvegicus           SRDGKALER.LQEYFD.N..RY.K.EP...T-NEG....V.AES.DDI.NAED.D.LI...........N.E.KYKE....LSKDP-NIVI....A...DVPSPYE.KG...IY.S..NK 460 (436) 
H.sapiens              SRDGKALER.LQDYFD.N..RY.K.EP...S-NDG....V.AE..D.I.NNEN.D.LI...........N.E.KYKE....LSKDP-NIVI....A...DVPSPYE.RG...IY.S..NK 460 (436) 
D.melanogaster         SVEN--LQD.VEKLLANE.E.YIK.EP...S-NDA....A.A...DDL.INNG.DTLI...........K.S..Y.E.A..LQ.E--..AIV...A...DVPPEFN.RG....FWL.KDA 447 (438) 
C.elegans              SVDN--LQQ.VDEVLA.NAE.YMK.EP..D--EQGD...A.....K.LIM.AD.D.LI...........S.A.KY.E.A..LNKE--...I....A...DVPPMFE.RG....FWL.KNA 445 (437) 
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                                                           !C-terminal tail                     x 
D.labrax[Dila-PDI]             ERKVIDYNGERTLEGFTKFLESGGKEGGAPAADDEDDLDAEDLDDVDEGQDEDSDGEDDDGHDEL 513 (497) 
O.niloticus                    ...............................G..-...EP...E.---DS.SEDGTD..NE.... 509 (493) 
T.nigroviridis                 .............D.................G.EDE.E..DA----------------------- 491 (474) 
D.rerio                        .............D................VG.E-E.EE.D...L---DDA.ED.SDVEE..... 509 (493) 
X.tropicalis                   GKN.A...........S.......QD.A.D-E.L..LE..DES.LEE---GDEAHT-----K... 506 (488) 
X.laevis                       GK..V.......Q...S.......QD.A.D-E.L..LEE.DET.LEE---GD.IHT-----K... 506 (490) 
G.gallus                       G.N.............K.......QD.A.ADD.L..LETD.ET.LEEGDD..QKIQ-----K... 515 (493) 
O.cuniculus                    G.T..........D..K.......QD.AGDEDGL..LEE..EP.LEE--D.DQKAV-----R... 509 (489) 
R.norvegicus                   D.T..........D..K.......QD.AGDND.LD-LEE.LEP.MEE--D.DQKAV-----K... 509 (488) 
M.musculus                     D.T..........D..K.......QD.AGDDE.LD-LEE.LEP.MEE--D.DQKAV-----K... 509 (488) 
H.glaber                       D.T....S........R...D...Q..AGEDD.LD-LEE..EP.MEE--D.DQKAV-----K... 509 (490) 
B.taurus                       D.T..........D..K.......QD.AGDDD.L..LEE..EP.LEE--D.DQKAV-----K... 510 (490) 
H.sapiens                      D.T..........D..K.......QD.AGDDD.L..LEE..EP.MEE--D.DQKAV-----K... 508 (491) 
D.melanogaster                 DN....F.LD...DD.V...DAN.--EV.DSEPV.ETEEE.EAPK----------------K... 496 (477) 
S.cerevisiae                   KSESVV.Q.S.S.DSLFD.IKEN.HFDVDGK.LY.EAQEKAAEEADADAELA.EEDAI---.... 522 (500) 
 
D.labrax[Dila-ERp57]           KMSPKK.E.G.EVSD.LSY.KREATNPLVMQEE---SKKKKKKK.E..DDKTEL----------- 500 (484)  
O.niloticus                    KLSPKK.E.G.EVSD.LSY.KREASNPLVMQEE---PKKKKKK-------KSEL----------- 492 (476) 
S.salar ACI33158               KMSPKK.E.G.EVSD.ISY.KKEATNPLVAQEE---ETSKKKK-------KNEL----------- 493 (477) 
S.salar NP_001161991           KMSPKK.E.A.EVSD.ISY.KREATNPLVAQEE---ETSKKNI-------QIEL----------- 493 (477) 
O.MYKISS JX441982              KMSPKK.E.G.EVSD.ISY.KEEATNPLVAQEE---ETSKKNI-------QIEL----------- 493 (477) 
O.mykiss EZ774749              KMSPKK.E.A.EVSD.ISY.KREATNPLVAQEE---KSKKK---------QTEL----------- 456 (456) 
D.rerio                        KQNPKK.E.G.EVSD.ISY.KREATNTVVVQE.---KKKSKKK-------KSEL----------- 494 (477) 
T.nigroviridis                 KMNPKK.E.G.EVSD.LSY.KKEAANTPVV.EE---PKKKKK--------KN------------- 490 (474) 
T.rubripes                     K.NPKK.E.G.EVSD.LSY.KREATNAPVVQEE---TKKKKKK-------RVEL----------- 494 (478) 
X.laevis                       KQNPKR.E.G.EVSE.LSY.KKEATNPPVVKE.--EKPKKKKK-------KEEL----------- 502 (481) 
X.tropicalis                   KQ.PKR.E.G.EVSD.LSY.KKEATNPPVVKE.--EKPKKKKK-------KEEL----------- 501 (481) 
G.gallus                       KQSPKK.E.G.EVSD.ISY.KREATSTPVLQEE.KAKKSKKKA-------KEDL----------- 505 (481) 
H.glaber                       KQSPKK.E.G.E.SD.ISY.QREATNPPIIQEE-KPKK-KKKA-------QEDL----------- 505 (481) 
O.cuniculus                    KLSPKK.E.G.E.SD.ISY.QREATNPPIIQDE-KPKK-KKKA-------QEDL----------- 502 (481) 
B.taurus                       KQNPKK.E.G.E.SD.ISY.KREATNPPVIQEE-KPKK-KKKA-------QEDL----------- 505 (481) 
M.musculus                     KLTPKK.E.G.E.ND.ISY.QREATNPPIIQEE-KPKK-KKKA-------QEDL----------- 505 (481) 
R.norvegicus                   KLTPKK.E.G.E.NDLISY.QREATNPPIIQEE-KPKK-KKKA-------QEDL----------- 505 (481) 
H.sapiens                      KLNPKK.E.G.E.SD.ISY.QREATNPPVIQEE-KPKK-KKKA-------QEDL----------- 505 (481) 
D.melanogaster                 KN.PVS...G.EVDD.L.YIAKEATTELKGFDR----SGKPK--------KTEL----------- 489 (470) 
C.elegans                      KSNP.P...G.EVKD.VS.ISKHSTD.LKGFSR----DGKKKK-------KTEL----------- 488 (470) 
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The first reports from fish MHC class I molecules are from the early 1990’s [1]. 
Since then, they have been identified and characterized from a multitude of species, but 
information on biological functions of these molecules in fish immune system remains 
limited. The present work describes new and important information about the genetics and 
the predicted structure of MHC class I molecules in European sea bass (Dicentrarchus 
labrax, L.): heavy chains and β2m, the subunits of the complexes that present peptide 
antigens to cytotoxic CD8+ T cells, were isolated and characterized; moreover, the sea 
bass molecules TAP1, TAP2, TPN, CRT, PDI and ERp57, with recognized functions in the 
mammalian class I antigen presentation pathway, have also been identified and described 
in detail. Now, the challenge is to use this information to investigate functions of the sea 
bass immune system, exploring new avenues for vaccine development and to investigate 
immune responses against specific pathogens.  
 
In the future, it will be important to determine the exact number of MHC-I loci 
present in the sea bass genome and to assign each transcript to a specific locus, which 
would enable an evaluation of the level of polymorphism between alleles. Specific probes 
for the Cyt-L1 and Cyt-L2 could be used to access the number of genes from each 
sublineage. Genotyping studies can then be enrolled determining variability of individual 
locus and assessing diversity on populations. Distinct genotyping methods have been 
developed and used throughout years [2-4], but great advantages are attributed to next 
generation sequencing (NGS) tools, which widespread use is expected in the future [5, 6]. 
Such studies will provide a framework for further analyses of MHC infectious disease 
associations. 
Most diseases associated with human MHC (HLA) are autoimmune [7], commonly 
involving class II genes, but class I associations (e.g. HLA-B27) also exist [8]. In 
comparison, little is know in relation to resistance or susceptibility to infectious diseases 
[9]. Convincing evidence for strong reproducible associations between infectious diseases 
and MHC is coming from studies in non-mammalian species, like those in chickens [10, 
11]. Congenic chicken lines varying only in B haplotype have demonstrated the B 
haplotype effect on resistance to Marek’s disease [12]. More recently, significant 
associations between resistance to infectious diseases caused by viral and bacterial 
pathogens and MHC class I and class II polymorphism has been reported in Atlanctic 
salmon [13]. One explanation for such strong correlations is that, despite having multiple 
loci, a single class I locus and a single class II locus are dominantly expressed [14]. In 
chicken disease susceptibility has been further linked to co-evolved MHC-I and TAP 
polymorphisms [15], clearly demonstrating the relevance of genomic linkage of such 
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genes [16]. Perhaps in species with a high number of class I loci like sea bass, this might 
be more difficult to demonstrate, but for instance in sticklebacks different haplotypes have 
been selected by distinct parasites [17].  
The MHC-I/peptide recognition by the TCR ultimately regulates the immune 
responses of CD8+ T cells, which are fundamental during e.g. viral infections. Sea bass is 
susceptible to viral pathogens, being quite sensitive to viruses of the genus Betanodavirus 
[18-20], the causative agents of viral nervous necrosis (VNN) [21], also known as viral 
encephalopathy and retinopathy (VER). This infection causes necrosis of the central 
nervous system (brain, retina and spinal cord), and the clinical signs include lethargy, 
abnormal behaviour, loss of equilibrium, spiral swimming and darkening of the fish [21]. 
The disease leads to massive mortality of larvae and juvenile populations in several 
teleost marine species [22]. Disease manifestation may correlate with innate or adaptive 
immunity [23-25], but in fact knowledge on the immune responses of this species against 
the virus is still scarce [26]. The mechanism(s) of infectivity and pathogenesis are 
unknown, and it remains to be determined whether the virus evades, actively blocks, or 
uses the molecular recognition factors of the host’s immune system [27]. 
 Activation of MHC class I genes during infection with infectious salmon anaemia 
virus (ISAV) has been reported in Atlantic salmon, suggesting that the virus does not 
counteract the class I antigen pathway at the transcriptional level [28]. MHC class I 
activation during an infectious hematopoietic necrosis virus	    (IHNV) infection in 
rainbow trout has also been reported [29]. In sea bass, one study presented an integrated 
view on some innate and adaptive responses of sea bass to VNN infection in naïve fish, 
identifying cellular and molecular candidate elements whose immunobiology might be 
modulated by in vivo VNN infection [26]. The genes coding for the T cell-specific molecule 
TCRβ, and for the T cell co-receptors CD4 and CD8α did not show any significant 
transcriptional variations [26]. Could this be due to some sort of viral strategy targeting the 
MHC class I pathway genes? Analyzing the behaviour of the key components of the MHC-
I pathway may help evaluate the importance of T cell-dependent responses to a given 
infection, thus opening windows for possible interventions in order to optimise fish 
defences. The measurement of expressed immune genes, which will provide information 
on how sea bass respond to particular stimuli/pathogen, can be done on transcripts and at 
the protein level.  
Viruses have evolved strategies to prevent the generation and presentation of 
antigenic peptides, resulting in their ability to escape from the immune system. 
Interestingly, viruses can target many crucial steps of antigen processing simultaneously, 
and many of the viral proteins that target antigen presentation directly assault the peptide-
loading complex per se [30]. Preventing this binding will result in a reduced pool of 
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peptides in the ER available for association with MHC-I, ultimately resulting in a reduced 
level of MHC-I cell surface expression [30]. E.g. there are viral proteins that target TAP, 
preventing it to bind peptides and ultimately blocking the translocation of peptides into the 
ER [31, 32]. Another way to prevent peptide translocation is to prevent ATP binding to the 
TAP subunits [33]. A combination of both mechanisms has also been described [34]. 
Abrogation of the MHC/TPN interaction was reported, preventing MHC integration in the 
PLC [35]. The quality control mediated by tapasin in the PLC can also be negatively 
affected [36]. Finally, the different elements of the PLC can be targeted to degradation by 
interaction with viral proteins [37-39].  
The current work has provided basic knowledge for the production of antibodies, 
namely monospecific polyclonal antibodies (m-pAbs) against specific peptides from the 
identified molecules. Such tools have been generated for sea bass heavy chain (α3 
region), β2m, TPN, TAP1 and TAP2, and are currently being tested (preliminary data 
detailed in Appendix). A similar strategy should be employed in order to produce m-pAbs 
for Dila-CRT, -PDI and -ERp57. Nevertheless, it would be worth testing commercial 
antibodies against CRT, ERp57 and PDI from mammalian species, given the high level of 
identity observed between them (~ 70% with human).  
 Collectively, our data point to an evolutionary conservation of basic structures and 
functions, with predicted orthology of the sea bass molecules to their mammalian 
equivalents; in the particular case of the class I α chains, orthology is predicted to 
Actinopterygii and salmonid counterparts only, which is not surprising, since orthology is 
not broadly observed even among mammalian MHC class I genes. Nonetheless, further 
specificities were observed, such as the presence of two types of HC transcripts with 
divergent cytoplasmic and 3’ UTRs, a 13-exon TAP1 gene, and a TAP2 isoform with 
incorporated intron 2, whose relevance remains to be determined. The highest levels of 
conservation were observed among the common chaperones CRT, ERp57 and PDI, 
which are known to be involved in a variety of other functions beyond the class I pathway, 
and are probably not subjected to the same selective pressures of the MHC-encoded 
proteins. The comparative structural analyses that was done in the previous chapters for 
each molecule individually, suggests that the described multiple interactions between 
them in the context of the PLC (in mammals) may be overall evolutionarily conserved. 
Significant conservation of residues in the interplay was observed for all except the 
TPN:ERp57 interaction. Dila-TPN, as other non-mammalian TPNs, lacks the cysteine that 
should be involved in the covalent association with ERp57 and many of the residues that 
further support this association are also not conserved.  Hence, important questions are 
raised, such as: are these key players still capable of forming a stable conjugate in sea 
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bass and other non-mammalian vertebrates? How do they associate? Antibodies, through 
co-immunoprecipitation experiments could help answering these questions, as well as 
confirm (or not) all the other predicted interactions among the PLC members. Additionally, 
the experimental resolution of the structures of these molecules, either isolated or in 
complexes, would also bring valuable insights. 
Since the first crystallographic study revealed a short peptide bound within the 
groove of the molecule [40],  the structure of peptide-binding specificity of MHC class I 
has been analyzed extensively in human and mouse. Distinct MHC HCs molecules have 
distinct peptide binding specificities in such a way that peptide-binding motifs could be 
defined.  Among non-mammalian vertebrates, only in chicken there are experimental 
crystallographic data of the full MHC class I complex [41] and sequences of individual 
peptides and peptide pools leading to peptide motifs for the dominantly expressed 
classical MHC class I molecules (except for the crystallized molecule) [42, 43]. In fish 
there are no crystallographic models of MHC complexes, and only one report with data on 
peptide-binding specificity: class I peptide-MHC ligand-binding motif has been reported in 
Atlantic salmon [44]. Recently, grass carp classical class I locus and β2m were expressed 
and refolded in vitro (viral immunogenic peptides predicted by bioinformatics), and 
tetramer techniques were used to identify the CTL response [45]. These studies might 
contribute to the understanding of viral defence mechanisms in general and to the design 
of peptide vaccines against viral diseases in particular [46]. 
The current work on sea bass MHC class I molecules has enabled to start in vitro 
refolding experiments aiming at crystallizing a sea bass MHC class I trimeric complex 
(Appendix). We attempted to refold several recombinant proteins of Dila-UA molecules 
with Dila-β2m or human β2m in the presence of different synthetic peptides. In none of the 
experiments did we get a trimeric complex. Other peptides capable of triggering T cell 
activation should be investigated. The nodavirus capsid or coat protein is the main viral 
antigen employed shown to be immunogenic in fish [47-50]. Accordingly, the produced 
recombinant nodavirus capsid protein, which is capable of self-assembly to form virus-like 
particles, has been shown to be immunogenic and induce a protective immune response 
in sea bass [51]. With these premises, studies on putative peptide ligands may have a 
value for both the in vitro refolding experiments and for understanding peptide binding to 
Dila-UA molecules.  
Alternatively, to identify peptide binders for DILA-UA sequences, we have 
transfected a human lymphoblastoid cell line with some of the sea bass representatives of 
both Cyt-L1 and Cyt-L2 (detailed information in Appendix). Full Dila-UA transcripts have 
been used in combination with GFP. The transfections worked, but none of the molecules 
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reached the surface. Possibly the fish molecules did not pass the quality machinery of the 
mammalian host cells.  
This strategy would also enable to clarify putative distinct functions of Cyt-L1 and 
Cyt-L2 molecules. The distinct specificities observed within the cytoplasmic regions of the 
characterized class I α chains, including presence of Y residues and LI motifs with roles in 
endosomal targeting, are highly suggestive of putative different functions. It is mandatory 
to clarify this in near future. To overcome this perhaps working with chimeras of sea bass 
and human HCs would make it possible to track the two types of sea bass cytoplasmic 
tails to distinct organelles/pathways. 
 
In conclusion, there is still a lot to investigate about antigen presentation in fish. 
Indeed, many questions are still unanswered [52]. The limitations include the lack of 
specific antibodies available, which is not completely understood. It has been proposed 
that the heavily glycosylated surface of fish cells results in production of antibodies that 
bind to the glycosylated surface of all fish cells, rather than the specific antigen target [52]. 
Importantly, comparative genomic analyses are giving insights on both similarities and 
species-specificities of immune systems in lower vertebrates [53]. This type of approach 
(genomic immunology) has been impacting the understanding of mammalian immune 
systems, providing new ways to overcome defective or inadequate immune functions [53]. 
Hopefully, advances in this field will help design antiviral strategies for the farming of 
European sea bass, contributing to the development of vaccines, selection of disease-
resistant breeds and broadly to a better understanding of the evolution of the immune 
system [54].  
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I. Production of monospecific polyclonal antibodies against 
sea bass (Dicentrarchus labrax, L.) MHC class I heavy chain, 
β2m, tapasin, TAP1 and TAP2 
 
Based on the work presented in this thesis, monospecific polyclonal antibodies 
could be produced against some of the molecules composing the peptide loading 
complex. Due to the limited time available, within the time-frame of this thesis, only very 
preliminary tests could be performed, which are briefly summarised below. 
 
Materials and Methods 
 
Peptides 
Short peptides from the sea bass molecules MHC-I HC, β2m, TPN, TAP1 and TAP2 
were used as immunogens in rabbits (Table 1). Selection of peptides was based on 
antigenicity, accessibility, solubility and epitope prediction. Peptide synthesis, 
immunization of animals and affinity purification was done at Davids Biotechnologie 
GmbH. 
 
Lymphocyte isolation 
Sea bass lymphocytes were isolated either from blood or from distinct organs. Blood 
was collected into a heparinised syringe and diluted 1:1 in sea bass PBS (10 mM 
NaH2PO4.H2O pH 7.2, 184 mM NaCl). After centrifuging 15 min at 300 g and 4 ºC, the 
supernatant was collected into another tube and centrifuged for (10 min, 550 g, 4 ºC). The 
pellet was resuspended in 3 mL of sbPBS. This cell suspension was added on top of an 
equal volume of Lymphoprep and centrifuged (30 min, 1100 g 4 ºC, no brake). The layer 
containing lymphocytes was carefully collected with a Pasteur pipette and washed in 
sbPBS, by centrifuging (10 min, 550 g, 4 ºC). After resuspending in 2 mL sbPBS and 
counting, cells were adjusted to 1 x 106, pelletized by centrifuging (10 min, 550 g, 4 ºC), 
and stored at -20 ºC.  
Organs (thymus, spleen, head kidney, gills, or intestine) were homogenized by 
passing them through a cell filter and resuspended in sbPBS. Cell suspensions were 
washed twice by centrifugation (10 min, 550 g, 4 ºC). Pellets were resuspended in sbPBS 
and added on top of an equal volume of Lymphoprep. Lymphocytes were collected, 
washed twice and resuspended as described above. Cells were counted and pellets 
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stored. 
 
SDS-PAGE 
Samples were prepared by addition of gel loading buffer (GLB) and a reducing 
agent (β-mercaptoethanol), adjusted with distilled water to a final volume of 30 µL, boiled 
for 5 min, and run in a SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel 
electrophoresis). Depending on the molecules, distinct percentages of resolving gels were 
used. 
 
Western Blot 
Samples in gels were transferred to nitrocellulose membranes (transfer buffer: 25 
mM Tris, 192 mM glycine, 20% methanol), for 1 hour at 19V. Membranes were Ponceau 
stained, scanned and blocked by incubating for 1 hour at RT, or overnight at 4 ºC, in 5% 
low fat milk in T-TBS (20 mM Tris Base, 137 mM NaCl, 0.1% v/v Tween 20). Incubation 
with variable concentrations of primary antibody (IgG purified serum) was performed in 
blocking buffer overnight at 4 ºC. Washes (5 x 5 min) were made in T-TBS at RT with 
shaking. Incubation with secondary antibody (sheep anti-rabbit HRP-conjugated 1:10000) 
was done four 1 hour at RT and washes performed as before. For detection, ECL 
(Supersignal WestDura Extended Duration or Supersignal WestPico Chemiluminescent 
Substrate, Thermo Scientific) was used and the films exposed for variable times. 
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Results 
 
Dila-UA antiserum 
The anti-serum was initially tested on the extracellular portion (V1-K276, mature 
protein; Fig. S3 Chapter 2) of His-tagged Dila-UA*12(C91) produced as recombinant 
protein and purified by nickel affinity chromatography. Different dilutions of the antiserum 
were used (1:1000, 1:5000, 1:10000), yielding no band at all in the negative control 
(without primary antibody), and a well-defined band at the expected size (~33 kDa) with 
decreasing intensities towards the highest dilution (not shown). The recombinant was 
used as a positive control (+) in further tests with fish cell lysates from different organs. 
Again different dilutions of the primary antibody were tested. In Figure 1, are depicted the 
WB results in which a 1:2500 dilution of the Dila-UA antiserum was used in fish samples 
from different organs. Three bands can be clearly seen close to the 45 kDa Mw marker on 
the thymus sample from one fish (expected size 38-43 kDa, Table 1). Exposing the film for 
longer periods made all the three bands visible in the sample of thymus from the other 
individual fish as well (not shown). No bands could be seen in samples from other organs, 
except a low Mw one (< 14.4 kDa), not expected, in a head kidney (HK) sample.  
Taking into account the variable size of the MHC-I HCs (Chapter 2, Table 1) and 
that the thymus is organ where highest expression was observed (Chapter 2, Fig. 8), this 
antibody seems promising as a sea bass MHC-I marker. However more tests need to be 
done in order to optimise it. 
 
Dila-β2m antisera 
Two antisera (#1 and #2; Table 1) were produced for Dila-β2m.  Both anti-sera were 
initially tested on bacterial lysates containing the recombinant denatured histidine-purified 
Dila-β2m (I6V-M101, mature protein; Fig. 4 Chapter 2) using different dilutions (1:1000, 
1:5000, 1:10000). Antiserum #1 yielded no band at all in the negative control (no primary), 
and a well-defined band at the expected size with decreasing intensities towards the 
highest dilution (Fig. 2, upper panel). No bands could be observed when antiserum #2 
was used (Fig. 2, upper panel). Recombinant Dila-β2m was used as a positive control (+) 
in further tests with fish cell lysates from different organs, using only antiserum #1. Again 
different dilutions of the primary antibody were tested. Although some bands can be seen 
close to the size of the recombinant protein in the 1:1000 dilution (Fig. 2, lower panel), 
with emphasis for a stronger one in the gills sample, further tests are needed to conclude 
whether these bands represent a specific reaction and the conditions improved such that 
the antibody can be used in functional studies. 
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Dila-TPN antiserum 
For Dila-TPN there is no recombinant protein available, so the tests were performed 
immediately on sea bass cell lysates. Tests were initially performed using different 
dilutions of the primary antibody. Figure 3 displays the results when a 1:10000 dilution 
was tested in samples from three individuals. The expected size is 45 kDa, and some 
bands can be observed close to this size, the strongest one in a gill sample (Fig. 3). The 
weaker bands on the film may correspond to the stronger ones seen in the Ponceau-
stained membrane (Fig. 3), in which case they might not be specific. Further tests are 
necessary to clarify this. 
 
Dila-TAP1 antisera 
Three antisera (#0, #4 and #5; Table 1) were produced for Dila-TAP1. As no 
recombinant TAP1 protein was available, tests were performed on sea bass cell lysates 
from different organs, using different dilutions of the primary antibody. Antiserum #0 
always stained many bands, independently of the dilution used, and no band of 83 kDa 
(expected size) could be observed (Fig. 4A). Antiserum #4 stained fewer bands, but still 
none close to the expected size (Fig. 4B). Antiserum #5 was the only staining a band 
close to the expected size (83 kDa), although lower and higher Mw bands with low 
intensity are also seen (Fig. 4C). Thus, antiserum #5 appears as the most promising 
antibody against Dila-TAP1, which conditions may well be worth of further optimisation. 
 
Dila-TAP2 antisera 
Three antisera (#0, #1 and #4; Table 1) were produced for Dila-TAP2. As no 
recombinant TAP2 protein was available, tests were performed on sea bass cell lysates 
from different organs, using different dilutions of the primary antibody. Antiserum #0 only 
stained bands <45 kDa, when the expected size is 80 kDa (Fig. 5A). Antiserum #1 did not 
work at all, independently of the dilution used (Fig 5B). Antiserum #4 stained a single 
band (1:1000 dilution) close to the expected size (80 kDa) in spleen samples (Fig. 5B). A 
1:2500 dilution has also been shown to work (not shown). Hence, antiserum #4 appears 
as a very promising antibody to TAP2. Tests using samples from different organs will help 
defining the potential use of this antibody in functional tests. 
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Table 1 
Features of the sera produced against the sea bass molecules. 
 
 
 
 
Figure 1. Western blot using  anti-Dila-UA serum. Antiserum tested in 1:2500 dilution on sea bass cell 
lysates from two different fish (left and right to the MW, respectively). Sensitive ECL plus 1 hour film exposure 
time was used. Film is shown at left and Ponceau stained membrane at right. Sizes of MW are indicated. +, 
recombinant Dila-UA*12; SP, spleen; HK, head kidney; Thy, thymus; PBL, peripheral blood lymphocytes. 
 
 
 
 
Sea bass molecule Type Antigen Region Expected Mw Recombinant protein
Dila-UA Rabbit IgG VSLLQKTPSSPVSCHATGFY IgSf-C (!3 region) 38.3-43.9 kDa Yes (33 kDa)
Dila-"2m Rabbit IgG #1 SDNPKITIKPKVQVYSRDPGE      #2 DGEEIQNAKQTDLAF
N-term mature  
IgSf-C 11.6 kDa Yes (12.8 kDa)
Dila-TPN Rabbit IgG PLSLELSWEFKGSDGKSR IgSf-C 45 kDa No
Dila-TAP1 Rabbit IgG
#0 YAELVRKQNMGFHRKEEEAK    
#4 EDKLVLKDLSLEI                        
#5 EKANHIVVLSDGTVKEEGSH
C-terminus          
NBD                    
C-terminus               
83 kDa No
Dila-TAP2 Rabbit IgG
#0 KGSYYKLREKLFTEGNSPQR    
#1 TIPDTDDAANGKEKKQKA          
#4 EKADQIVVVSGGRVQERGTHQE
C-terminus           
N domain of TMD                    
C-terminus               
80 kDa No
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Figure 2. Western blot using anti-β2m sera. The two antisera (#1 and #2) were tested in different dilutions 
(1:1000, 1:5000, 1:10000) on bacterial lysates containing recombinant β2m (upper panels) and on sea bass 
cell lysates (lower panels). Normal ECL plus 5 min exposure time and sensitive ECL plus 10 sec exposure 
time were used for the recombinant and the fish cells, respectively. Films are shown at left and Ponceau 
stained membranes on right. Sizes of MW are indicated. Zero, no primary antibody; +, bacterial cell lysates 
with recombinant β2m; HK, head kidney; SP, spleen. 
 
 
 
 
 
Figure 3. Western blot using anti-TPN serum. Antiserum  tested in 1:10000 dilution on sea bass cell lysates 
from three different fish (1, 2, 3) as detailed in the membrane. The expected size is 45 kDa. Sensitive ECL 
plus 30 min film exposure time were used. Film is shown at left and Ponceau stained membrane at right. 
Sizes of MW are indicated. PBL, peripheral blood lymphocytes; HK, head kidney; SP, spleen. 
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Figure 4. Western blot using anti-TAP1 sera. The three antisera (TAP1#0, TAP1#4 and TAP1#5) were 
tested on sea bass cell lysates. from different organs. Expected size is 83 kDa. (A) TAP1#0 tested with a 
1:1000 dilution is shown. (B) TAP1#4 (C) TAP1#5, both tested in different dilutions (1:1000, 1:5000, 1:10000).  
Sensitive ECL and 10 sec (A) or 1 min (B and C) exposure times on film were used. Films are shown at left 
and Ponceau stained membranes on right. Sizes of MW are indicated. Zero, no primary antibody; Thy, 
thymus; SP, spleen.  
 
 
 
Appendix 
 
	   194	  
 
Figure 5. Western blot of anti-TAP2 sera. The three antisera (TAP2#0, TAP2#1 and TAP2#4) were tested 
on sea bass cell lysates from different organs. The expected size is 80 kDa. (A) TAP2#0 tested with a 1:1000 
dilution is shown. (B) TAP2#1 (left side of MW) and TAP2#4 (right side of MW), were both tested in different 
dilutions (1:1000, 1:5000, 1:10000).  Sensitive ECL and 1 min (A) or 5 min (B) exposure times on film were 
used. Films are shown at left and Ponceau stained membranes on right. Sizes of MW are indicated. Zero, no 
primary antibody; Thy, thymus; HK, head kidney; SP, spleen.  
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II. Preliminary studies aiming at determination of the 
three-dimensional structure of sea bass (D. labrax, L.) 
MHC class I complexes 
 
A significant effort has been devoted on attempting to determine the three-
dimensional structure of sea bass MHC class I complexes. Although the 3D structure has 
not been determined within the time-frame of the working plan, several techniques have 
been applied and the results obtained worth to be considered as a starting point for 
defining conditions to grow suitable crystals that can be used for disclosing the 3D 
structure of the sea bass MHC class I complexes. This work is summarized below. 
 
Materials and Methods 
 
Recombinant protein production: from vector design to protein storage 
The extracellular portion of three sea bass heavy chain (HC) transcripts (Dila-
UA*06, *09 or *12; see chapter 2), encoding residues V1-K276 (mature protein; Fig. S3 
Chapter 2), after PCR incorporation of a methionine at the 5’ end, were cloned in pET28a 
vector (using the NcoI/XhoI restriction sites) for recombinant expression in E. coli BL21. 
Sea bass β2-microglobulin (β2m) encoding residues I6-M101 (mature protein; Fig. 4 
Chapter 2) – starting in the equivalent position to the human recombinant protein – was 
similarly expressed in BL21 after PCR incorporation of a methionine at the 5’ end and 
substitution of isoleucine-6 for valine (necessary for the correct NcoI restriction site), and 
ligation to the mentioned pET28a vector (also using the NcoI/XhoI restriction sites). All 
constructs were verified by sequencing.  
Inductions were made with 0.5 mM IPTG at 37 ºC. As previously described for 
similar molecules of other organisms, recombinant expression resulted in accumulation of 
insoluble material in inclusion bodies. Inclusion bodies were isolated by cell lysis and 
repeated washes, essentially as described by Nagai and Thorgensen [1], and solubilised 
under denaturing conditions (8 M urea buffer). The recombinant proteins were purified 
through the use of the C-terminal 6-histidine tag, using HIS Select Nickel Affinity Gel 
(Sigma). Concentrations were determined using Micro BCA Protein Assay Reagent Kit 
(Pierce). Aliquots were kept at -80ºC, until further use.  
Two new β2m constructs were made. Sea bass β2m encoding residues S1-M101 
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(mature protein, Fig. 4 Chapter 2) was expressed in BL21 strain after PCR incorporation 
of a methionine at the 5’ end and a substitution of the serine-1 for an alanine (necessary 
for the correct NcoI restriction site), and ligation to the mentioned pET28a vector (using 
the NcoI/XhoI restriction sites). Sea bass β2m encoding residues M(-15)-M101 (precursor, 
Fig. 4 Chapter 2) was similarly expressed in BL21 strain after PCR substitution of the 
lysisine–(-14) for a glutamic acid (necessary for the correct NcoI restriction site), and 
ligation to the mentioned pET28a vector (also using the NcoI/XhoI restriction sites). Both 
constructs were verified by sequencing. Inductions tests were made with 0.5 mM IPTG at 
37 ºC, 30 ºC and 24 ºC.  Whatever the temperature, the amount of precursor β2m was 
very little, when compared to that of mature β2m (rβ2mS1V). Regarding rβ2mS1V, 
induction tests at 37 ºC resulted in higher amounts of produced protein, but all of it was 
insoluble. Lowering the induction temperature, reduces the total amount of produced 
protein, but augments its solubility. So, at 24 ºC, most of the rβ2mS1V was soluble. 
Soluble fraction was collected, purified through the C-terminal His tag, and buffer 
exchanged by dialysis (to 20 mM Tris pH 8.0/100 mM NaCl). Again, concentrations were 
determined using Micro BCA Protein Assay Reagent Kit (Pierce). Aliquots were kept at -
80 ºC, until further use.  
 
Human β2m recombinant protein 
Human recombinant β2m was kindly provided by Prof. Sheena E. Radford (Astbury 
Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, 
University of Leeds, UK). It has been over expressed in a BL21(DE3) E. coli strain. The 
protein sequence is that of human β2m with an additional N-terminal methionine, such 
that the polypeptide is 100 residues in length. It was diluted in dH2O, and aliquots stored 
at -80 ºC until further use.  
 
Synthetic peptides 
Twelve synthetic peptides were designed by Pedro A. Reche (Department of 
Immunology, Faculty of Medicine, Complutense University of Madrid, Spain) based on 
mammalian peptide/HLA, but taking in account the sequences of the sea bass α chains, 
and synthesized by Sigma (Table 2).  Peptides were dissolved either in 80% (v/v) 
dimethylformamide/dH2O or in 50% (v/v) acetonitrile/dH2O. Aliquots were kept at -20 ºC, 
until further use. 
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In vitro refolding 
The MHC-I complex was attempted to be assembled in vitro from purified 
components, by simultaneous refolding of all constituents, by dilution of denaturing 
conditions at 4 ºC, with a 1:2:10 ratio of HC:β2m:peptide, according to protocol described 
by Garboczi et al [2]. A mixture of the twelve peptides was used. Controls were made in 
the same conditions, but not using peptides, or either using HC or β2m alone (individual 
refolding). After 48h in refolding buffer (400 mM L-arginine, 100 mM Tris pH 8.0, 2 mM 
EDTA, 0.5 mM PMSF, 5 mM reduced glutathione, 0.5 mM oxidized glutathione), samples 
were concentrated using Milipore stirred cells with 10 kDa cutoff polyethersulfone 
ultrafiltration membranes and/or 10 kDa cutoff centrifuge ultrafiltration devices (for 200 mL 
and 10 mL experiments, respectively). Concentrated refolded mixtures were further 
submitted to size exclusion chromatography and buffer exchanged (20 mM Tris pH 8.0, 
150 mM NaCl, 2 mM EDTA), using either Superose 12TM 10/300 GL, Superdex 75TM 
10/300 GL, or HiPrep 16/60 Sephacryl S-100 HR gel filtration columns (Amersham 
Biosciences). Collected fractions were always analyzed by SDS-PAGE, after TCA 
precipitation, and sometimes analyzed by mass spectrometry and/or circular dichroism. 
Mass spectrometry (MS) was used to evaluate the presence of bound peptide in a given 
fraction, and also to determine the precise molecular weight of each complex constituent, 
namely HC, β2m and peptide, and hence its nature. Circular dichroism (CD) was used to 
evaluate the secondary structure of the HCs and of β2m. 
 
Also soluble sea bass recombinant β2m was used in new in vitro refolding 
experiments, using the previously three recombinant transcripts of HC and the same type 
of controls. Additional experiments were made, using human recombinant β2m (hrβ2m). 
As before, the MHC-I complex was attempted to be assembled in vitro from purified 
components, by simultaneous refolding of all constituents, by dilution of denaturing 
conditions at 4 ºC, with a 1:2:10 ratio of HC:β2m:peptide. A mixture of the twelve peptides 
was used. Controls were made in the same conditions, but not using peptides, or either 
using HC or β2m alone (individual refolding). Again, after 48h in refolding buffer (400 mM 
L-arginine, 100 mM Tris pH 8.0, 2 mM EDTA, 0.5 mM PMSF, 5 mM reduced glutathione, 
0.5 mM oxidized glutathione), the samples were concentrated using 10 kDa cutoff 
centrifuge ultrafiltration devices (10 mL experiments). Concentrated refolded mixtures 
were further submitted to size exclusion chromatography and buffer exchanged (this time 
to 10 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA), using Superose 12TM 10/300 GL gel 
filtration column (Amersham Biosciences). Collected fractions were analyzed by SDS-
PAGE. Circular dichroism (CD) was used to evaluate the secondary structure of β2m. 
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Results 
 
In vitro refolding with Dila-β2m (I6V-M101) 
Chromatograms were identical either using or not using peptide (Fig. 6). After SDS-
PAGE, it could be seen that both HC and β2m eluted separately (Fig. 6A), further 
confirmed by refolding experiments of HC and β2m individually (Fig. 7). Dila-UA*12 and 
09 elute from the column essentially as single peaks (Fig, 7A and B), while Dila-UA*06 
elutes as several smaller peaks, showing greater tendency to aggregate (Fig. 7C). β2m 
elutes from the column as two peaks (Fig. 7D), possibly due to dimer formation. Both 
concentrated refolding mixtures and eluted fractions from size exclusion of experiments 
with and without peptide were analysed by mass spectroscopy (MS). MS revealed a 
molecular weight of 33 kDa for the HC alleles and 12.2 kDa for the β2m (Fig. 8), but 
peptides of known molecular weight (Table 2) were not identified (Fig. 8). Although the CD 
plot suggests a typical curve for a protein mainly made of β strands (Fig. 9), calculated 
percentages of secondary structure elements suggest that refolded β2m was not in 
conformation with other known molecules [3-5], having ~16% α-helix, when others have 
0%; and ~25% β-sheet, when others have 42-59% (Table 3). We hypothesized that this 
behaviour of sea bass β2m could be related to the fact that the recombinant protein starts 
at an equivalent position to the human recombinant β2m, based on an amino acid 
alignment, and not at position 1 of sea bass mature protein according to SignalP 
prediction. Supporting this, Esposito [6] shows that in human β2m, removal of the N-
terminal hexapeptide facilitated aggregation and fibril formation. Hence, a soluble β2m 
without the leader peptide predicted by SignalP was produced and refolding experiments 
repeated. 
 
In vitro refolding with Dila-β2m (S1V-M101) 
Despite the new soluble recombinant β2m produced, chromatograms were again 
identical either using or not the peptide mixture (Fig. 10). In SDS-PAGE analysis, it could 
be seen HC and rβ2mS1V eluting together in one of the peaks. As before, Dila-UA*12 and 
*09 elute from the column essentially as single peaks, while *06 elutes as several smaller 
peaks, showing greater tendency to aggregate (not shown). Also β2m elutes from the 
column as two peaks. However, the first peak elutes at the same time/volume as the HC 
(Fig. 10), which could be shown by size exclusion of individually refolded rβ2mS1V (Fig. 
11). So, although eluting together, sea bass HCs and sea bass β2m are not interacting.  
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In vitro refolding with human β2m 
Chromatograms of refolding experiments with Dila-UA*12 and human β2m are 
identical either using or not the peptide mixture (Fig. 12). SDS-PAGE analysis shows that 
Dila-UA*12 and human β2m elute separately (Fig. 12). Differently from sea bass 
recombinant β2m proteins (both tested forms), human recombinant β2m elutes from the 
column as a single peak (Fig. 13). 
 
 
Table 2 
Synthetic peptides. 
 
 
 
Table 3 
Comparison of secondary structure elements from different β2m molecules, according to circular dicrhoism 
analysis. 
 
Note: human, chicken and grass carp data from references [3]; [4]; [5]. 
 
Table 1 
Synthetic peptides. 
 
PEPTIDE SEQUENCE MW (Da) 
57 QVMKNGVEL 999,18 
99 CKVTHGNTV 940,06 
101 VTHGNTVKY 1000,1 
81 FHLTKTVPF 1071,28 
102 THGNTVKYY 1064,15 
21 HTSPKVQVY 1040,18 
89 FTPMDGDKY 1055,17 
41 TLICHVTGF 972,16 
73 LAFKQDWHF 1150,34 
20 KHTSPKVQV 1005,17 
67 EAKQTDLAF 1004,11 
79 WHFHLTKTV 1127,33 
 
 
Table 2 
Comparison of secondary structure elements from different !2m molecules, 
according to circular dichroism analysis. 
 
!2m samples "-helix (%) !-sheet (%) Other (%) 
sea bass -15F 16.4 25.3 58.2 
sea bass -5E 16.6 24.1 59.3 
r!2mS1V 19.3 13.5 67.1 
human  0 59 41 
chicken  0 46 52 
grass carp  0 42.3 57.7 
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Figure 6. Refolding experiments of recombinant Dila-UA*12(C91) with denatured Dila-β2m. 
Chromatograms show the elution profile of an FPLC Superose 12TM 10/300 GL gel filtration column. The flow 
rate was 0.5 mL/min, typical loading sample volumes were 0.2 mL and the elution was monitored at an 
absorbance of 280 nm. Experiments using recombinant Dila-UA*12(C91) and β2m with (A) and without (B) 
peptide are shown. Reduced SDS-PAGE gels (15%) of several fractions corresponding to the distinct peaks 
are also presented. At left are denoted molecular weight markers. (C) Superposition of the two described 
experiments. (D) Comparison of both experiments to calibration curves. 
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Figure 7. Refolding experiments of individual (A) recombinant Dila-UA*12(C91), (B) *09(C61), (C) 
*06(C7) and (D) β2m. Chromatograms show the elution profile of an FPLC Superose 12TM 10/300 GL gel 
filtration column. The flow rate was 0.5 mL/min, typical loading sample volumes were 0.2 mL and the elution 
was monitored at an absorbance of 280 nm. Reduced SDS-PAGE gels (15%) of several fractions 
corresponding to the distinct peaks are also presented. At left are denoted molecular weight markers.  
 
 
 
Figure 8. MS plots of recombinant Dila-UA*12(C91) and denatured Dila-β2m refolding experiments. 
Both concentrated refolding mixtures and fractions B13 (Fig. 8A and B) of experiments with and without 
peptides were analysed. The windows of mass are 0.70–40 kDa and 0.7-2.5 kDa for AB and CD, respectively. 
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Figure 9. CD spectra from two samples of 
refolded recombinant Dila-β2m. The curves 
suggest main percentage of β strands. 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Refolding experiments of recombinant Dila-UA*12(C91) with soluble Dila-β2m. 
Chromatograms show the elution profile of an FPLC Superose 12TM 10/300 GL gel filtration column. The flow 
rate was 0.5 mL/min, typical loading sample volumes were 0.2 mL and the elution was monitored at an 
absorbance of 280 nm. Experiments using recombinant Dila-UA*12(C91) and soluble β2m (rβ2mS1V) with (a) 
and without (b) peptide are shown. Reduced SDS-PAGE gels (15%) of several fractions corresponding to the 
distinct peaks are also presented. At left are denoted molecular weight markers. (c) Superposition of the two 
described experiments. (d) Comparison of both experiments to calibration curves. 
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Figure 11. Refolding experiment of individual 
rβ2mS1V.  Chromatogram shows the elution 
profile of an FPLC Superose 12TM 10/300 GL gel 
filtration column. The flow rate was 0.5 mL/min, 
typical loading sample volumes were 0.2 mL and 
the elution was monitored at an absorbance of 
280 nm. Reduced SDS-PAGE gel (15%) of 
several fractions corresponding to the distinct 
peaks is also presented. At left are denoted 
molecular weight markers.  
 
 
 
 
 
Figure 12. Refolding experiments of recombinant Dila-UA*12(C91) with human β2m. Chromatograms 
show the elution profile of an FPLC Superose 12TM 10/300 GL gel filtration column. The flow rate was 0.5 
mL/min, typical loading sample volumes were 0.2 mL and the elution was monitored at an absorbance of 280 
nm. Experiments using recombinant Dila-UA*12(C91) and human β2m with (A) and without (B) peptide are 
shown. Reduced SDS-PAGE gels (15%) of several fractions corresponding to the distinct peaks are also 
presented. At left are denoted molecular weight markers. (C) Superposition of the two described experiments. 
(D) Comparison of both experiments to calibration curves.  
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Figure 13. Comparison of chromatograms from 
sea bass and human recombinant β2m. Sea bass 
non-refolded (NR, light green) and refolded (R, light 
blue) rβ2mS1V experiments and human β2m 
individually refolding experiment (pink) are 
shown. 
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III. Transfecting a human cell line with constructs bearing 
sea bass (D. labrax, L.) recombinant MHC class I heavy 
chains with EGFP attached to its C terminus 
 
As an alternative way to identify binder peptides for Dila-UA sequences, a human 
lymphoblastoid cell line was transfected with some of the sea bass transcripts, including 
representatives from both Cyt-L1 and Cyt-L2 groups. Although the transfections have 
worked, sea bass molecules did not reach the cell surface, precluding the initial goal. The 
results are summarized below. 
 
Materials and Methods 
Constructs 
Plasmid EGFP-N1 was used to ligate Dila-UA*06(C7), *03(C28), *09(C61), *12(C91) 
or *11(C63) after PCR modification of the appropriate HC sequence to remove the stop 
codon, substitute lysine-(-18) for glutamic acid (for a complete correct kosak consensus 
sequence), and add an EcoRI restriction site at the 5’ end and a SmaI site at the 3’ end. 
All constructs were verified by sequencing; they all have an eight amino acid linker 
attaching HC C terminus to the N terminus of EGFP.  
 
Transfecting 721.221 human cell line 
721.221 (hereon referred to as 221 cells) is an EBV-transformed human B 
lymphoblastoid cell line that does not express endogenous HLA-A, -B and -C [7]. 221 cells 
were transfected to express different amounts of sea bass MHC class I. Cells were 
cultured in RPMI 1640 medium supplemented with 10% heat inactivated fetal bovine 
serum (FBS), 1x antibiotic and antimycotic solution, 1x sodium pyruvate, and 1x non-
essential amino acids (from hereon called RPMI+). The 221 transfectants were 
supplemented with 1 mg/mL geneticin (Gibco).  
Generation of cells expressing different levels of sbMHC class I protein: 30 µg of the 
vector pEGFP-N1 either empty or containing GFP-tagged Dila-UA*06 (C7), *03(C28), 
*09(C61), *12(C91) or *11(C93) were linearized overnight at 37 ºC with ApaLI 
(Fermentas). The DNA solution was then cleaned with phenol and chloroform solutions, 
precipitated with 100% ethanol and washed with 70% ethanol. The DNA was 
resuspended in 100 µL of nuclease free water (Bioline). DNA linearization was confirmed 
by running the sample in 1% agarose DNA gel. For each transfection, 107 cells were 
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washed three times in RPMI 1640 medium, and the sedimented cells resuspended in 900 
µL of RPMI 1640 medium. Thirty µg of DNA were added and the cells were transferred to 
a Gene Pulser Cuvette (Biorad), which was then placed on ice for 5 minutes. The cells 
were electroporated at 230 volts and 250 µF. The cells were left at room temperature for 5 
min and then transferred to 50 mL tubes. Twenty four mL of RPMI+ were added and the 
cells plated in 24-well plates (1 mL per well). After one day of incubation at 37 ºC and 7 % 
CO2, 1 mL of RPMI+ with 2 mg/mL geneticin was added per well. Later, 1 mL of media 
was removed and another 1 mL of 221 media with 1 mg/mL of geneticin was added every 
three days, until the media changed color. The cells were then assessed for GFP 
expression by flow cytometry (CellQuestTM, Becton Dickinson), and positive populations 
with different levels of expression were sorted by dilution.  
 
Western blot on cell lysates 
Preparing cell lysates: 107 cells were lysed for 30 min on ice in 200 µL of lysis buffer 
(1% Nonidet P-40, 10 mM Tris pH 7.6, 130 mM NaCl) containing 1:100 protease inhibitors 
cocktail (Sigma). After centrifuging 10 min at 4 ºC, the supernatant was collected and 
stored at -20 ºC. These cell lysates were used for western blotting, where mouse anti-
GFP mAb (clone JL-8, BD Clonetech) was used at 0.14 µg/mL and HRP-conjugated goat 
anti-mouse IgG Immunopure (Pierce) 16 ng/mL.  
 
Microscopy 
Cytospins were prepared with 2 x 105 or 5 x 105 cells. The appropriate volume of 
cell suspension was centrifuged for 5 min at 300 g and RT, washed and resuspended in 
200 µL PBS. Adhesion of cells to slides was made by centrifugation for 5 min at 1000 rpm 
and RT. Cells were fixed with 4% paraphormaldehyde in PBS for 10 min and stopped by 
subsequently washing in PBS. Slides were incubated with DAPI for 15 min in the dark. 
Vectashield and a coverslip were added to the slides. Image analysis was performed in 
AxioImager Z1 (Carl Zeiss, Germany). One analysis of live cells was performed on a 
Laser Scanning Confocal Microscope Leica SP2 AOBS SE (Leica Microsystems, 
Germany). 
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Results 
 
Transfection assessment by flow cytometry 
Mock cells, transfected with pEGFP-N1 alone, showed GFP expression levels of 102 
to 103, while the cells transfected with the different Dila-UA sequences had GFP 
expression levels of 101 to 102, showing, however, for each allele, a population of cells not 
expressing GFP (Fig. 14). In order to make these populations homogenous for GFP 
expression, selected transfectants were sorted by dilution. Although there was still a small 
population of cells not expressing GFP, the percentage of GFP-expressing cells could be 
improved (not shown).   
 
Western blot  
Mock cells show a band at the expected size for GFP alone (~26.9 kDa), while cells 
transfected with the different sea bass transcripts show either no band, one band at the 
size of GFP alone (~26.9 kDa), one band at the size of the recombinant (HC + GFP ~70 
kDa) or even two bands one for GFP alone and one for the recombinant (Fig. 15). 
 
Microscopy 
In HC-transfectants, most samples showed no fluorescence at all (not shown); 
fluorescence was detected as bright spots or lines near the nuclei, especially in two 
samples from C91-transfected cells, suggestive of localization in compartments (Fig. 16). 
There was no fluorescence confined to the plasma membrane. These results show that 
sea bass MHC class I/GFP fusion proteins did not reach the cell surface. Perhaps they did 
not pass the ER quality control. We could not detect fluorescence on HC-transfectants by 
confocal microscopy. In mock samples (transfected with the empty vector), the cells were 
all fluorescent (fixed and live cells). A picture of live cells analysed by confocal microscopy 
is shown in Figure 16.  
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Figure 14. Flow cytometry results for GFP expression. Mock cells, transfected with pEGFP-N1 alone, 
showed GFP expression levels of 102 to 103, while the cells transfected with the different Dila-UA transcripts 
had GFP expression levels of 100 to 102, showing however for each allele a population of cells not expressing 
GFP. Results for each allele and for mock are presented separately. Non-transfected 221 control cells are 
always indicated in red. 
 
 
Figure 15. Western blots on transfectant cell lysates with an anti-GFP mAb. Mock cells, transfected with 
pEGFP-N1 alone, show a band close to the 31 kDa marker (expected size 26.9 kDa). The cells transfected 
with the different sbHCs show either no band, one band at the size of GFP alone (26.9 kDa), one band at the 
size of the construct HC+GFP (expected size 70.8 kDa for C91) or even two bands one for GFP alone and 
one for the recombinant HC+GFP.  
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Figure 16. Pictures of fluorescence microscopy from mock and Dila-UA-transfectants where 
fluorescence could be detected. Dila-UA-transfectants: fluorescence was detected as bright spots or lines 
near the nuclei, suggestive of localization in compartments. Mock cells: all cells were all fluorescent (result on 
live cells).   
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